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Abstract 
 
Developmental biology is an important field of study, as breakthroughs in this field can be 
used to understand aspects of evolution, more complex biological processes, and even 
diseases, such as cancer. Pathways and developmental programs are often highly conserved 
between organisms, especially vertebrates, allowing for studies within model organisms to 
have implications in humans.  
 
Zebrafish have long been used in the study of developmental biology due to their fast 
replication times, translucent embryos and relatively low cost. Much is known about early 
zebrafish embryology due to results from mutagenesis studies, however some aspects of 
development continue to remain unclear.  
 
It is known that maternal products control early development, including setting up the axes 
and providing the transcripts required prior to zygotic genome activation, but the timing of 
the production of these transcripts is unknown. To be accurately localized within the embryo, 
these transcripts are deposited prior to fertilization, during egg development (oogenesis). The 
oocyte goes through many important changes in gene expression, chromatin conformations, 
meiotic stages and maturation processes during oogenesis, all of which are essential for 
normal embryonic development.  
 
In this thesis, I have used next generation sequencing techniques to profile and characterize 
the rapidly changing transcriptome during each stage of oogenesis, using the zebrafish as a 
model organism.  Specifically, a method for accurate staging and collection of high quality 
oocytes was developed based on previous work on zebrafish and Xenopus oogenesis. Once 
separated into stages the small RNA content of stage I oocytes was closely examined and 
profiled using RNA-Seq. Following this, the transcriptomes of each stage of oogenesis were 
characterized using whole molecule polyA RNA-Seq. An in depth analysis of the 
transcriptomes elucidated the timings of important oogenic events and identified specific 
expression patterns within each stage. Finally, I compared the small RNA of stage I oocytes 
with polyA RNA to examine and identify common features.  
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1.1 Early embryonic development 
 
The question of how life is formed and develops from a single cell into a multicellular 
organism is one of the most astonishing processes in biology and is one that has been studied 
in detail by scientists for many years. The most popular organism for studying early 
vertebrate development thus far has been the South African clawed frog, Xenopus laevis. 
Many experiments in Xenopus have identified key developmental processes that have since 
been recognised as occurring in all animals. An interesting example of this is the delayed 
onset of zygotic transcription in embryos until the maternal to zygotic transition.  
1.1.1 The maternal to zygotic transition and transcriptional quiescence in the early embryo   
 
The timing of the maternal to zygotic transition (MZT) varies between species - in mice, this 
occurs soon after the first cell division, whereas in zebrafish and Xenopus it is delayed until 
the 10th and 12th cell division, respectively (Newport and Kirschner 1982, Newport and 
Kirschner 1982, Duval, Bouvet et al. 1990, Tadros and Lipshitz 2009, Paranjpe, Jacobi et al. 
2013). Embryos divide and develop in the absence of zygotic transcription by relying on 
products that are maternally deposited within the egg during oogenesis. These cell divisions 
occur in synchronous rhythmic waves known as “cleavages” until the zygotic genome is 
activated (Figure 1.1) (Kimmel, Ballard et al. 1995, Forgács and Newman 2005). Throughout 
the cleavage stages, the cells become increasingly smaller, as they lack gap phases required 
for growth, which changes the DNA to cytoplasm ratio to a critical level were zygotic 
transcription is no longer repressed, gap phases are then reintroduced to the cell cycle and 
division becomes asynchronous (Edgar, Kiehle et al. 1986, Kane and Kimmel 1993, Prioleau, 
Huet et al. 1994, Zamir, Kam et al. 1997). Interestingly, transcription is possible during this 
time, at least of injected plasmid DNA for a short period before it to is also repressed, 
indicating that the zygotic machinery for transcription is present and functional, but an 
unknown suppressive mechanism is working to repress zygotic transcription during this time 
(Newport and Kirschner 1982, Newport and Kirschner 1982). Activation of the zygotic 
genome has been shown to be regulated different epigenetic changes to histones in different 
species, such as a change in the H1 histone variants present in Drosophila (PÈrez-Montero, 
Carbonell et al. 2013) and changes in the methylation patterns of histone H3 in the zebrafish 
(Vastenhouw, Zhang et al. 2010), suggesting this transcriptional quiescence is mediated by a 
unique chromatin conformation established during oogenesis (Prioleau, Huet et al. 1994, 
Prioleau, Buckle et al. 1995), which has yet to be fully described.  
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Figure 1.1 Maternal to zygotic transition in zebrafish embryos 
 
Overview of the RNAs present during early zebrafish embryo development and the timing of 
the maternal to zygotic transition (MZT). The embryo relies only on maternally provided 
RNAs until MZT where zygotic transcription is activated. 
 
 1.1.2 Maternal control of early development  
 
The maternally supplied factors to the egg are essential for driving development during the 
cleavage stage and control every aspect of mitosis without relying on transcription of new 
RNAs (Dosch, Wagner et al. 2004). Mutations within these supplied factors are referred to as 
‘maternal effect mutations’ and although they generally have no effect on the mother, they 
prevent normal zygotic development even if the mutated allele has not been passed to the 
offspring (Dosch, Wagner et al. 2004, Marlow 2010).  This is possible as maternal products 
are supplied to developing eggs through neighbouring somatic cells and then solely relied 
upon during early development (Marlow 2010). Attempts to understand this fascinating 
process are best carried out in species where zygotic transcriptional quiescence is extended, 
such as the Xenopus or zebrafish.  
The majority of vertebrate ‘maternal effect genes’ have been identified through large-
scale mutagenesis screens carried out in the zebrafish (Mullins, Hammerschmidt et al. 1994, 
Solnica-Krezel, Schier et al. 1994, Driever, Solnica-Krezel et al. 1996, Dosch, Wagner et al. 
2004). A well rounded review of these screens and the maternal genes identified has been 
done by Abrams and Mullins (2009). Similar screens are being continued as a part of the 
Zebrafish Mutation Project – an effort within our team at the Wellcome Trust Sanger Institute 
Maternal RNAs Zygotic RNAs 
Transcription of Zygotic Genes 
Reliance on Maternal Products 
MZT 
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to knockout every gene within the zebrafish genome and provide the zebrafish community 
with access to the embryos containing alleles generated, phenotypic information, and in some 
cases, transcriptional profiling of the mutants (Kettleborough, Busch-Nentwich et al. 2013). 
Analysis of these maternal effect mutations has shown that maternally provided factors not 
only drive early embryonic cell division, but also specify cell fate and begin patterning of the 
embryo (Tadros and Lipshitz 2009, Marlow 2010). The first two axes of the embryo are 
established through asymmetric deposition of maternal products. 
1.1.3 Maternal products specify the initial axes of the embryo 
 
Axis specification occurs very early in embryonic development with some aspects already 
determined within the egg. Maternally provided mRNAs and proteins are asymmetrically 
localized within the egg during oogenesis, resulting in differences between daughter cells in 
the developing embryo and differential expression of genes. Early in oogenesis, vegetal pole 
RNAs are deposited on the future-vegetal side of the cell (Guraya 1979, Marlow and Mullins 
2008, Bontems, Stein et al. 2009), while β-catenin collects at the animal pole (Bellipanni, 
Varga et al. 2006).  Other vegetal specifying factors are then recruited during oogenesis to 
the vegetal side of the cell firmly establishing the vegetal pole of the egg (Figure 1.2A) 
(Howley and Ho 2000, Kosaka, Kawakami et al. 2007, Abrams and Mullins 2009). 
Expression of vegetal factors inhibit the formation of the micropyle, a zebrafish specific 
structure through which sperm enters to fertilize the egg, ensuring it forms at the animal pole 
of the cell (Figure 1.2A) (Marlow and Mullins 2008). Once formed, the animal-vegetal axis 
loosely predicts the orientation of the anteroposterior axis of the embryo (Figure 1.2C) 
(Abrams and Mullins 2009). 
Fertilization initiates movement of vegetally located, maternally provided ‘dorsal 
determinants’ via the cytoskeleton network towards the animal pole of the cell, to a region 
called the dorsal organizer (Jesuthasan and Stahle 1997, Nojima, Shimizu et al. 2004, Weaver 
and Kimelman 2004, Nojima, Rothhamel et al. 2010). These determinants are inherited 
asymmetrically and influence gene expression in daughter cells to drive expression of dorsal 
specific genes, driving the specification of the dorsoventral axis (Figure 1.2B) (Nojima, 
Rothhamel et al. 2010). Both the animal-vegetal and dorsoventral axes are determined using 
maternal products deposited in the developing egg during oogenesis. Axis determination in 
zebrafish has been reviewed in detail by Langdon and Mullins (2011). 
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Figure 1.2 The animal-vegetal, dorsoventral and anteroposterior axis in zebrafish 
 
A) Zebrafish egg with animal (orange) and vegetal (green) poles established. Sperm (black) 
enters through the micropyle at the animal pole. Dorsal determinants (red) are initially 
located vegetally. B) Fertilization triggers movement of the dorsal determinants via the 
cytoskeletal network specifying the future dorsal side and the dorsoventral axis (black arrow). 
C) Adult zebrafish labelled with dorsoventral and anteroposterior axes. Image taken by 
Christopher Dooley. D – dorsal, V – ventral, A – anterior, P – posterior.  
 
1.2 Using zebrafish as a model organism for studies of early development 
 
Zebrafish (Danio rerio) are small (three to four cm), tropical, teleost (bony) fish that 
originated in the waters of the Ganges River of India and Myanmar. Zebrafish are often a 
used as a model organism as they are small vertebrate species that is easy to care for and 
produces of hundreds of offspring from a single mating. Zebrafish are ideally suited for 
developmental biology research as they produce external embryos, this provides easy access 
to every developmental stage and allows injections or other manipulations to take place that 
would not be possible in other model species, such as the mouse (Mus musculus) (Laale 
1977). Although other species exist which produce external embryos, for instance Xenopus, 
which have been used in developmental biology research for many decades, the zebrafish 
offers a unique feature: their embryos remain translucent through embryonic development 
(Laale 1977). This has allowed studies of organogenesis in vivo, as well as in-depth 
investigations of gene expression patterns (Dawid 2004), which were previously impossible.  
Their use has become widespread more recently, as new technologies increase the 
availability of techniques – in particular the publishing of the zebrafish genome has 
accelerated research and opened many new avenues of investigation (Howe, Clark et al. 
2013). Interestingly, zebrafish genes have a significant level of homology to human genes 
and synteny is conserved between zebrafish and human chromosomes (Gates, Kim et al. 
1999, Barbazuk, Korf et al. 2000), making zebrafish a great model for understanding the 
Animal 
 
  
D V 
Sperm 
A B 
V 
C 
D 
Vegetal 
V 
A 
P 
1.2 Using zebrafish as a model organism for studies of early development 
 
6 
$
!
$
$ $
function of vertebrate genes and for modelling human disease. Many examples of zebrafish 
models did exist previously, however there were a number of limitations to using zebrafish as 
a model until recently – a number of which have been reviewed in detail by Ingham (2009). 
Briefly, previous methods of generating specific mutations and transgenic organisms have 
had limited success in zebrafish due to the lack of in vitro culture techniques for generating 
pluripotent stem cells and the lack of a complete genome sequence to design constructs, 
however recent advances with site-specific nucleases, such as zinc finger nucleases and 
CRISPRs, has opened up the zebrafish to these types of techniques and advanced the 
zebrafish as a model organism of choice (Doyon, McCammon et al. 2008, Huang, Xiao et al. 
2011, Xiao, Wang et al. 2013, Gagnon, Valen et al. 2014). For more information on this 
topic, Blackburn, Campbell et al. (2013) have provided an excellent review on the use and 
potential of site-specific nucleases in the zebrafish.  
All of these aspects make the zebrafish an ideal organism for studies of development, 
and many labs worldwide have begun investigating early development using the zebrafish – 
however the reliance of early development on maternal factors provided by the oocyte 
indicates the importance of studying oogenesis and, in particular, maternal RNAs provided to 
the embryo. Studies on egg development in the zebrafish are lacking, leading to a gap in the 
knowledge needed to fully understand the implications of findings in the embryo. Studies of 
oogenesis are generally very difficult due to limited sample sizes, and difficulties in 
collecting multiple stages from the same individual, however as zebrafish have continually 
renewing germ stem cells and very large ovaries consisting of oocytes at every stage of 
development (Draper 2012), they are ideal for use in studies of oogenesis. 
1.3 Oogenesis in the zebrafish  
 
Oogenesis in the zebrafish can be divided into five stages, each easily identifiable through 
descriptions provided by Selman, Wallace et al. (1993). Germ stem cells within the ovary 
divide continually to produce additional stem cells and primary oocytes that develop initially 
as small cysts of interconnected cells (Saito, Morinaga et al. 2007, Draper 2012). Primary 
oocytes, referred to as stage I oocytes, begin to undergo meiosis and arrest during prophase I 
until oocyte maturation (Masui and Clarke 1979, Kalinowski, Berlot et al. 2004, Aizen and 
Thomas 2015). During this time the oocyte grows exponentially accumulating products 
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needed for embryonic development and establishes the primary axis of development: the 
animal-vegetal axis. 
The earliest currently known asymmetrically localized transcript, Bucky ball (buc), 
can be identified in stage I oocytes (Marlow and Mullins 2008, Bontems, Stein et al. 2009). 
Expression of Buc protein induces the formation of a prominent structure adjacent to the 
nucleus known as the Balbiani body or mitochondrial cloud (Figure 1.3) (Billett and Adam 
1976, Marlow and Mullins 2008). The Balbiani body is found in all animal oocytes and 
consists of a transient collection of mitochondria, vesicles, endoplasmic reticulum, and Golgi 
body (Billett and Adam 1976, Guraya 1979, de Smedt, Szollosi et al. 2000, Pepling and 
Spradling 2001, Cox and Spradling 2003, Pepling, Wilhelm et al. 2007, Marlow and Mullins 
2008, Pepling 2010). Maternal RNAs important for specifying the vegetal pole localize to 
Buc protein and are stored within the Balbiani body (Guraya 1979, Marlow and Mullins 
2008, Bontems, Stein et al. 2009). By stage II the Balbiani body begins to disassemble and 
the vegetal maternal RNAs are deposited on the vegetal side of the oocyte (Marlow and 
Mullins 2008). The positioning of the vegetal RNAs at the vegetal pole initiates localization 
of animal pole RNAs to the opposite end of the oocyte establishing the animal-vegetal axis.  
Once the axis is specified cortical granules begin to form in the cytoplasm and align 
to the membrane of the oocyte (Figure 1.3) (Ben-Yosef and Shalgi 2001). The oocyte 
continues to grow until signals from the steroid 17α, 20β-dihydroxy-4-pregnen-3-one 
(progesterone) initiates oocyte maturation during stage IV (Nagahama, Yoshikuni et al. 1995, 
Zhu, Rice et al. 2003, Lessman 2009, Lubzens, Young et al. 2010). Briefly, oocyte 
maturation involves advancement of the cell cycle from prophase I to metaphase II, 
movement and asymmetric localization of the nucleus to the animal pole of the oocyte (to aid 
extrusion of the polar body), cessation of transcription, and germinal vesicle breakdown 
(Selman, Wallace et al. 1993, Selman, Petrino et al. 1994, Lessman 2009). As transcription 
ceases these changes are mediated by transcripts stored within the oocyte that are 
translationally controlled by deadenylation and subsequent re-polyadenylation – processes 
that are also observed during early embryonic development (Hake and Richter 1994, 
Stebbins-Boaz, Hake et al. 1996, Tay, Hodgman et al. 2000, Cui, Sartain et al. 2013). During 
maturation, the oocyte also clears and gains osmoregulatory abilities in preparation for 
activation and fertilization (Lessman 2009). 
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Figure 1.3 Stages of oogenesis in zebrafish 
 
Image showing features of each stage of oogenesis including Balbiani Body formation and 
dissolution, accumulation of cortical granules, asymmetric localization of the nucleus and 
establishment of the animal-vegetal axis. Adapted from Marlow (2010). 
 
Fertilization off the egg triggers a release of calcium ions (Ca2+) that depolarizes the 
membrane and leads to cortical granule exocytosis (Ben-Yosef and Shalgi 2001, Lessman 
2009, Mei, Lee et al. 2009). The cortical granules contain enzymes that alter the outer 
membrane of the egg preventing polyspermy – where multiple sperm from fertilizing the egg 
(Figure 1.3) (Ben-Yosef and Shalgi 2001, Mei, Lee et al. 2009). Polyspermy is also blocked 
in teleost fishes by changes to the micropyle after fertilization; ensuring only one sperm 
enters (Hart and Donovan 1983, Hart, Becker et al. 1992). The increase of Ca2+ also leads to 
the resumption of the cell cycle and completion of meiosis (Ben-Yosef and Shalgi 2001).  
A detailed review of oocyte maturation in the zebrafish is available from Lessman 
(2009) and an overview of oogenesis has been provided by Lubzens, Young et al. (2010).  
1.4 Next generation sequencing  
1.4.1 Next generation sequencing basics and workflow 
 
DNA sequencing has advanced in throughput massively over the last decade with the advent 
of next generation sequencing platforms (NGS) (Shendure and Ji 2008). The cost of DNA 
sequencing is constantly dropping and new methods to take advantage of this technology 
have been developed; including whole transcriptome analyses (Parkhomchuk, Borodina et al. 
2009). Previous technologies for looking at RNAs were limited – analysis using microarrays 
and quantitative real-time PCR rely on predetermined probes and are not sensitive to 
detection of rare variants. Conversion of RNA to cDNA for use with NGS, termed RNA-Seq, 
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overcomes these limitations and allows the discovery of new transcripts and isoforms, as well 
as having virtually unlimited sensitivity for detecting rare variants (Tang, Barbacioru et al. 
2009, Wetterbom, Ameur et al. 2010). Multiple different technologies have been developed 
for NGS, each with different benefits and disadvantages, however they all involve the same 
workflow concepts: DNA is fragmented and common adaptors are ligated to fragment ends, 
DNA is anchored and amplified from the common adaptors to produce an array of localized 
PCR ‘colonies’ containing identical amplified fragments, sequencing primers are then 
hybridized, and fluorescent labels are washed over the array – sequences for each PCR 
colony are image-detected allowing sequencing of the entire array in parallel libraries (Mitra 
and Church 1999, Mitra, Shendure et al. 2003, Margulies, Egholm et al. 2005, Shendure and 
Ji 2008, Turcatti, Romieu et al. 2008). A side by side comparison of NGS technologies has 
been done by Smith, Quinlan et al. (2008) showed a number of differences between the 
methods which need to be taken into account when choosing which to use, however the 
results achieved were very similar between experiments. Illumina sequencing is the most 
prevalently used NGS technology at this time, and the majority of sequencing the at 
Wellcome Trust Sanger Institute is done using this technique (Quail, Kozarewa et al. 2008); 
it has a wide variety of applications, has reads of up to 300 bp, and has the lowest cost per 
base sequenced (Liu, Li et al. 2012, van Dijk, Auger et al. 2014). As opposed to technologies 
such as 454, the majority of errors in Illumina sequencing are substitutions rather than 
insertions or deletions, which can be detected by looking at the paired-end read data or 
through the calls made by the rest of the molecules within the PCR colony, and is reflected in 
the quality score (Shendure and Ji 2008). An in depth review of the various NGS 
technologies and the history of their use has been provided by van Dijk, Auger et al. (2014), 
which discusses the pros and cons of each in detail. 
1.4.2 RNA-Seq and transcriptomics  
 
RNA-Seq has become a popular way of analysing the RNA within a sample and methods of 
RNA extraction can be adapted to target different types of RNA molecules. Figure 1.4 
outlines the basic method used for generating Illumina RNA-Seq libraries for sequencing. 
Briefly: RNA is extracted from the sample and fragmented. The RNA fragments are aligned 
to random primers and converted to cDNA. Once stabilized as cDNA, the fragments are size 
selected for inserts of ~200 – 300 nucleotides (nt) and adaptors are ligated to the ends. 
Common sequences within the adaptors are used to prime PCR cycles to produce the PCR 
colonies needed for massively parallel sequencing.  
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Figure 1.4 RNA-Seq library method overview 
 
Basic overview of the steps to construct an RNA-Seq library. RNA is extracted and 
fragmented into small pieces. RNA fragments are converted to cDNA using random primers 
and size selected for relatively short sequences (~200-300 nt). Adaptors are ligated to ends of 
the cDNAs and PCR is used to amplify the target.  
 
Once sequenced, a number of bioinformatically challenging steps need to be taken to 
analyse the data produced and uncover the RNAs within the original sample – most programs 
available for this include three steps: alignment of the reads to a reference genome, 
transcriptome reconstruction, and quantification of the RNAs and various isoforms present 
RNA Extraction 
RNA Fragmentation 
cDNA Conversion 
Size Selection 
Adapter Ligation 
PCR 
Fragments Sequenced 
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(Garber, Grabherr et al. 2011). Many alignment programs exist and they are constantly being 
developed and updated (van Dijk, Auger et al. 2014). Miller, Koren et al. (2010) have 
provided a review of assembly algorithms that were available at the start of this project. 
Although new algorithms have been developed, the main difficulties in RNA-Seq analysis are 
still due to the very large datasets produced (multiple gigabases or terabases in size) and the 
need for computer systems with very large memory for alignment programs to be able to 
align the reads to the genome (Martin and Wang 2011, van Dijk, Auger et al. 2014).  
Alternative alignment programs exist for use when a reference genome is not 
available, or in prokaryotic species with limited splicing, and more information about these 
programs can be gained through reading reviews by Gongora-Castillo and Buell (2013) and 
Martin and Wang (2011). 
1.4.3 Zebrafish transcriptomics to date 
 
Many papers on the zebrafish transcriptome have been published, including studies using 
ESTs, microarrays, and RNA-Seq type analyses. As zebrafish are great models for early 
development, the majority of studies have been focused on early embryonic development, 
however many examples of studies into the transcriptome of adult tissues using ESTs, 
microarrays, and RNA-Seq exist as well (Li, Chia et al. 2004, Douglas 2006, Collins, White 
et al. 2012, Qian, Ba et al. 2014, Vaz, Wee et al. 2015).  
The transcriptome of early development in zebrafish was first analysed using ESTs in 
2003 (Lo, Lee et al. 2003), followed by microarray based studies (Mathavan, Lee et al. 
2005). As techniques for isolating specific cell types improved, microarrays were done on 
germ-cell precursors from embryos rather than on whole embryos (Brown, Snir et al. 2008). 
These studies provided essential information about the timings of expression of genes during 
early embryonic development and gave insight into processes happening at this time, 
however the methods used were not very sensitive and could not be used with unknown 
isoforms and genes. These studies were improved upon in 2011 by using polyA RNA-Seq 
analysis (Aanes, Winata et al. 2011, Vesterlund, Jiao et al. 2011), and extended to study both 
the small RNA (Wei, Salichos et al. 2012, Yao, Ma et al. 2014) and long non-coding RNA 
content (Pauli, Valen et al. 2012) of embryos during early development. More recently, the 
full potential of using RNA-Seq technology for transcriptome research has begun to be 
realized in studies of the maternal to zygotic transition, where expression from maternal and 
zygotic genomes has been picked apart (Harvey, Sealy et al. 2013) and information about 
differential transcription start sites has been uncovered (Haberle, Li et al. 2014). There is a 
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wealth of sequencing data already existing on early embryonic development, however studies 
focusing on other aspects of development in the zebrafish are still needed. Focusing a 
transcriptomic study on the development of the egg pairs nicely with the information already 
available and could give further insights into aspects of the regulation of early development – 
especially during transcriptional quiescence prior to the maternal to zygotic transition.  
Gene expression studies of oogenesis have been done before (Knoll-Gellida, Andre et 
al. 2006), however the advances in sequencing technology and the power of RNA-Seq to 
investigate the transcriptome provide an opportunity to gain a massive amount of information 
in addition to the knowledge we already have. RNA-Seq studies of adult tissues have 
included whole ovaries (Collins, White et al. 2012, Desvignes, Beam et al. 2014, Vaz, Wee 
et al. 2015), however a stage specific exploration of the transcriptome during oogenesis has 
not been done. Looking stage-specifically is important for understanding developmental 
processes at work and to identify the gene networks involved. In particular, a greater 
understanding of stage I oocytes would provide essential information about the specific 
processes occurring such as the transition from germ stem cell to primary oocyte and the 
initiation of meiosis. For a full review of current transcriptomic research in types fish, see 
Qian, Ba et al. (2014). 
1.5 Scope of this thesis 
 
The aim of this thesis is to profile the transcriptome of the zebrafish during oogenesis using 
RNA-Seq technology and to provide a resource about gene expression for other researchers 
interested in this area. Specifically, the first aim is to develop a method for the isolation and 
collection of high quality oocytes in a stage specific manner, suitable for RNA-Seq analysis. 
The second aim is to analyse the small RNA peak observed in early oogenesis, establish what 
it is composed of and compare it’s content with predictions from previous research. The third 
aim is to profile the transcriptome of each stage of oogenesis using RNA-Seq technology and 
describe the stages through GO term analysis. The final aims are to extensively characterize 
the small RNA and polyA RNA of stage I oocytes.  
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2.1 Introduction 
 
For transcriptomic studies, collection of the samples is one of the most important aspects of 
study design as RNA content is quickly and easily damaged or changed. Many aspects need 
to be considered to ensure that a sample has good quality RNA, the most important being: 
that the sample is unchanged by methods used to collect it, and that once collected the sample 
is not affected by the storage conditions used until it is ready to be processed. 
The testing of various methods of oocyte collection to preserve RNA quality, and 
identification of the method chosen for use in all following experiments, are described within 
this chapter. 
2.1.1 Collecting samples for RNA analysis 
 
Unlike other types of samples, collecting RNA must be done as quickly as possible and with 
the utmost care. The production of RNAs in response to internal and environmental stimuli 
occurs rapidly to facilitate fast responses within the cell. For instance, early experiments on 
Drosophila salivary glands showed chromosomal changes and differential RNA production 
within 3 minutes of a 5oC change in incubation temperature (Ritossa 1962). Therefore, to 
collect a sample representative of a specific state, minimal exposure to external stimuli is 
needed and processing must be done as fast as possible.  
As well as producing new RNAs rapidly, the cell can degrade RNA rapidly which 
results in changes to the expression profile of a sample. The structure of RNA is not stable 
for long periods of time and cells contain ribonucleases (RNases) that accelerate the 
breakdown of specific RNAs. This is beneficial to the cell as it assists rapid changes in gene 
expression in response to stimuli and ensures the ribonucleotides can be quickly reused for 
further RNA production. However, when assessing RNA experimentally, this degradation 
can lead to unpredictable changes in the gene expression profile rendering the sample 
unrepresentative of the state being studied – leading to misleading or incorrect results. 
Decreasing the amount of time before the sample is stabilized prevents these changes in gene 
expression.  
To acquire good quality, representative, RNA from a sample: quick processing, and 
minimal changes in environment are needed.  
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2.1.2 Staging of oocytes during oogenesis 
 
Selman, Wallace et al. (1993) were the first to define the 5 stages of oogenesis based on 
morphology, physiological and biochemical events – a system of classification that is still 
widely used today and was used to stage the oocytes used in all experiments throughout this 
body of work. Correct staging of cells limits cross stage contamination during sample 
collection, ensuring accurate and representative downstream results.  
Staging, according to Selman, Wallace et al. (1993) is described as follows: 
In stage I (primary growth stage), oocytes reside in nests with other oocytes (Stage IA) 
and then within a definitive follicle (Stage IB), where they greatly increase in size. In stage 
II (cortical alveolus stage), oocytes are distinguished by the appearance of variably sized 
cortical alveoli and the vitelline envelope becomes prominent. In stage III (vitellogenesis), 
yolk proteins appear in oocytes and yolk bodies with crystalline yolk accrue during this 
major growth stage. Oocytes develop the capacity to respond in vitro to the steroid 17α, 
20β-dihydroxy-4-pregnen-3-one (DHP) by undergoing oocyte maturation. In stage IV 
(oocyte maturation), oocytes increase slightly in size, become translucent, and their yolk 
becomes non-crystalline as they undergo final meiotic maturation in vivo (and in response 
to DHP in vitro). In stage V (mature egg), eggs (approx. 0.75 mm) are ovulated into the 
ovarian lumen and are capable of fertilization. 
Large differences in size exist between the stages, with stage Is varying between 7 µm and 
140 µm in size, while mature eggs are ~0.75 mm (Bally-Cuif, Schatz et al. 1998). Test 
extractions done within the lab have shown the amount of RNA accumulated in the cell at 
each stage remains in proportion to their size, with stage V cells having extremely large 
amounts of RNA and stage I cells have relatively little RNA. At the time of writing, 
sequencing technologies have advanced and samples with minimal RNA, down to single cells 
can be processed to obtain their transcriptomes (Islam, Zeisel et al. 2013). However at the 
time of experimental design and processing, minimum requirements for sequencing existed 
and it was determined that multiple cells would need to be pooled in order to meet this 
requirement, especially for the relatively small stage I oocytes. As a result, an unequal 
numbers of cells from the different stages were collected until an equal amount of total RNA 
was obtained for each sample.  
To accommodate the number of cells required, methods for the collection of oocytes 
were developed, while limiting potential changes to gene expression, as discussed in Section 
2.1.1. 
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2.1.3 Existing methods for collecting oocytes 
 
As many cells were needed for enough RNA to be obtained for transcriptome sequencing, an 
extended incubation of the ovaries during collection was necessary. By incubating the ovaries 
within a defined culture medium that has been shown to facilitate normal oocyte 
development, a minimal amount of changes in gene expression due to environmental factors 
can be achieved. In addition, this increases the number of oocytes that can be collected per 
fish, reducing the number of fish needing to be sacrificed.  
Methods of collecting and culturing oocytes to study oogenesis in vitro were mainly 
focused on frogs and other fish species until more recently (Dumont 1972, Wallace and 
Misulovin 1978, Tyler, Sumpter et al. 1990), as the zebrafish has gained in popularity as a 
model organism. Various methods for the collection of oocytes in the zebrafish for the long-
term culture of immature oocytes to produce fertilizable eggs have now been described. The 
aim of in vitro culture such as this is to mimic the in vivo environment as closely as possible, 
allowing the cell to respond innately and continue normal development, while remaining 
accessible for further analysis. With this in mind, a system for collecting large numbers of 
oocytes was designed based on previous work describing the in vitro culture of zebrafish 
oocytes.  
While deriving their classification system, Selman, Wallace et al. (1993) analysed 
ovaries incubated in 75% L-15 medium (including L-glutamate) at a pH of 7.5, a commonly 
used medium for other fish species at the time. Following this, Selman, Petrino et al. (1994) 
developed a method for culturing stage IV oocytes as they underwent maturation and used 
60% L-15 medium (including L-glutamate) at a pH of 7.5. These protocols have been further 
refined more recently to develop a more reliable and robust system for in vitro maturation of 
oocytes with 90% L-15 medium (with L-glutamate) at a pH of 9.0 (Seki, Kouya et al. 2008).  
As opposed to the later stages, little has been published on in vitro culture of early 
stage oocytes (stage I & II). Only one method exists in the literature and was developed by 
Tsai, Rawson et al. (2010) for use with cryopreservation studies. Their findings indicate that 
similar to the late stage oocytes, 90% L-15 medium (with L-glutamate) at a pH of 9.0 is ideal 
for the culture of early stage oocytes.  
 The culture of late stage zebrafish oocytes in other types of media have been 
infrequently tested and published, such as EM-199 medium (Li, Mao et al. 1993), but the 
availability, more extensive publication record, and the consistency of medium components 
needed for the various stages of oogenesis led to the selection of 90% L-15 medium (with L-
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glutamate) as a base medium for all in vitro experimental work and is hereafter referred to as 
‘modified L-15 medium’. The specific additives and pH levels discussed in these various 
publications were tested within the lab to obtain an incubation method suitable for all stages 
of oocyte development. 
2.1.4 Dissociation of oocytes from the ovary 
 
Developing oocytes remain in close association with the somatic cells of the ovary even after 
dissection and incubation in vitro. Stage I oocytes form small clusters of cells or nests and are 
connected to one another by intracellular bridges at the beginning of oogenesis (Selman, 
Wallace et al. 1993). As a result, it is difficult to isolate cells from those of other stages and 
in the early stages, to ascertain the number of cells within a cluster. There are various 
methods in the literature describing methods of dissociating cells, including physical 
dissociation and enzymatic dissociation, which are discussed below. 
2.1.4.1  Physical dissociation of oocytes 
 
Careful manipulation of ovaries after dissection, teasing the oocytes away from the ovary and 
somatic ovarian tissues is the most common way to obtain individual oocytes. Small scissors 
and forceps are used to break up larger clusters of oocytes and the clusters are gently pipetted 
up and down using a plastic Pasteur pipette (Hanna and Zhu 2011, Peyton and Thomas 2011) 
or pulled through large gauge (21-23) needle and syringe (Kochakpour and Moens 2008) to 
dissociate the cells. Both are very time consuming, but are tried and tested methods of oocyte 
isolation and result in intact healthy oocytes for downstream use. 
Methods used to separate oocytes can affect results or cause damage, even in unusual 
or unexpected ways – for instance Hagedorn and Carter (2011) found that when transferring 
late stage oocytes for in vitro fertilization (IVF), the widely-used metal spatulas resulted in 
lower fertilization rates versus Teflon-coated spatulas. Oocytes are clearly very sensitive and 
thorough testing of all protocols used to isolate them are necessary to minimize changes in 
gene expression in response to any physical manipulation or differences between collections.  
2.1.4.2  Enzymatic dissociation of oocytes 
 
Enzymatic dissociation is commonly used in cell culture during the splitting or dividing of 
populations of cells between culture flasks and for isolating single cells to derive monoclonal 
colonies. Typically 1X trypsin is added to the cells for 10-15 minutes to digest the cells and 
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the reaction is halted by the addition of bovine serum albumin (BSA) containing medium. In 
tissues or when trypsin is unsuitable, enzymes such as collagenase and hyaluronidase are 
used. Methods using all these enzymes have previously discussed in the literature in the 
context of separating cells from oocytes. Hyaluronidase is used to remove cumulus cells from 
Mus musculus oocytes and eggs for IVF (Nagy, Gertsenstein et al. 2003) and can be adapted 
for use in Danio rerio (Guan, Rawson et al. 2008). Collagenase treatment has been reported 
to be most successfully used with >90% survival rates in both Xenopus (Gagnon and Mowry 
2011) and Danio rerio, when short incubation times are used (Guan, Rawson et al. 2008), 
however it should be noted that collagenase treatment is mainly used after physical 
dissociation to remove follicular cells from oocytes rather than as a method of inter-oocyte 
dissociation (Peyton and Thomas 2011).  
These procedures are quick and non-labour intensive, however these enzymes are 
known to have low levels of non-specific protease activity that can cause damage to cells 
during prolonged incubation (Tokmakov, Iwasaki et al. 2005), leading to the need for an 
extended period of recovery after incubation – increasing the amount of time taken to 
stabilize the sample. As a result, it can be preferable not to use enzymatic dissociation, 
depending on the downstream application of the cells. 
2.1.5 Storage of samples 
 
Collecting large numbers of cells for RNA analysis requires careful processing procedures 
and storage. Once removed from the organism, tissues begin to degrade as RNases within the 
cell or from the environment digest endogenous RNAs (Rossier, Dao et al. 2009). If left 
unprotected or at room temperature, changes to the gene expression profile result and 
samples must be discarded. Two methods are commonly used for the storage of tissues and 
cells for RNA analysis – dropping the temperature of a sample by snap freezing in liquid 
nitrogen and placing samples in RNA protectant solutions such as RNALater. 
Snap freezing has been the standard technique used for many decades and has many 
benefits over using solutions purchased from companies. The precise contents of purchased 
solutions are proprietary information; limiting knowledge of what specifically has been added 
to your sample and what potential changes this will have on results. Similarly, when samples 
are processed for RNA extraction, buffers may interact with the RNA protectant solutions, 
again affecting results. Snap freezing offers benefits compared to RNA protectant solutions, 
however it requires the use and handling liquid nitrogen, which can be dangerous and extra 
safety precautions need to be taken during handling.  
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RNALater is safe to handle and has been shown to protect samples from the 
degradation associated with thawing after being snap frozen (Botling, Edlund et al. 2009). 
Single cells can easily be transferred and immediately protected in RNALater, while the cells 
to be snap frozen must be kept at room temperature together before freezing – increasing the 
processing time and potentially resulting in degradation. This is not an issue for tissues or 
whole embryos being snap frozen as enough material can be collected in a very short period 
of time, but needs to be taken into consideration for deriving a method for collection and 
storage of large numbers of individual cells, separated by sorting. 
2.1.6 Parameters and measures of RNA quality 
 
With multiple potential sources of damage, having a precise and reliable method to detect the 
quality of RNA samples is necessary. Initial assessments, for sample degradation, can be 
measured effectively using denaturing gels and bioanalyzer traces. As mRNA only accounts 
for 1-3% of the total RNA (Palmer 2014), RNA is usually assessed by appearance of the 
ribosomal RNAs (rRNAs) which account for >80% of the total RNA. Using either method, 
large bands or peaks representing the 18S and 28S rRNA peaks can be observed at 1.9 
kilobases (kb) and 4.0 kb, respectively (Krupp 2005); any smearing, additional peaks or lack 
of peaks can be a sign of poor sample quality (Peterson and Freeman 2009). A quality score 
can be determined using Bioanalyzer plots by looking at the ratio of the area of the 28S: 18S 
peaks as the 28S is relatively unstable compared to the 18S RNA (Palmer 2014), allowing for 
comparison between samples which would appear similar by gel electrophoresis. Samples 
with ratios of >1.0 are considered of good quality and usable for the vast majority of 
applications (Palmer 2014). Additionally, RNA integrity number (RIN) scores were 
calculated using the Bioanalyzer and are measured on a scale of 1-10.  
2.2 Methods 
2.2.1 Oocyte staging 
 
Adult female H Longfin and AB zebrafish (Danio rerio) were culled using an overdose of 
anaesthetic in accordance with the home office procedures. Ovaries were dissected from the 
fish using sterilized equipment and washed in hank’s balanced salt solution (HBSS) (PAA 
Laboratories) or modified L-15 medium (Sigma) containing 1X penicillin & streptomycin 
(Invitrogen) and transferred to fresh solution in a 10 cm petri dish. Oocytes were removed 
from ovary masses using forceps and viewed under a Leica MZ 95 dissecting microscope; 
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images were taken using a Leica DFC420 camera and processed using Leica Application 
Suite software V3.8. Images and live cells were measured and compared to the staging 
protocol described by Selman, Wallace et al. (1993). An expert visiting the lab, Shreelaja 
Nair, additionally confirmed the oocyte staging to be accurate and reliable.  
To calculate the average RNA content of an oocyte of each stage, an ovary was 
dissected as described above and individual oocytes were then counted and pooled according 
to stage, by transferring using a mouth pipette to an eppendorf. Excess liquid was removed 
and samples were snap frozen in liquid nitrogen. RNA was extracted using a 
Trizol/chloroform extraction as follows: 600 µL TRIzolTM reagent (Thermo Fisher Scientific) 
was added and samples were homogenized. 200 µL chloroform was added to the sample, 
then samples were vortexed for 30 seconds and spun down at 13,200 rpm for 15 minutes in a 
microfuge (this speed was used for all following spins), and supernatant retained. An 
additional 200 µL of chloroform was added to the sample, followed by vortexing and 
spinning down again. Samples were precipitated using 100% isopropanol for 1 hour at -20oC. 
Once spun down at 13,200 rpm for 30 minutes, the isopropanol was carefully removed and 
the precipitate was washed using 70% ethanol and spun down again for 1 minute. The pellet 
was air dried at room temperature for exactly 25 minutes, and then 89 µL of clean autoclaved 
water was added and the sample was and left to dissolve for 25 minutes. DNAse digestion 
was done by adding 10 uL of 10X TURBO Buffer (Ambion) and 1uL of TURBO DNAse 
(Ambion), vortexing and incubating for 30 minutes at 37oC. Enzymes were removed by 
adding 100µL of water and 200µL phenol-chloroform isoamyl and spinning down the 
solution for 3 minutes at 4oC and retaining the supernatant. 600µL of 100% ethanol and 10µL 
of lithium chloride was added and left at -20oC overnight to allow the sample to precipitate. 
Samples were spun for 15 minutes at 4oC and washed with 70% ethanol as above. Pellets 
were air dried at room temperature for 25 minutes and resuspended in 10µl of sterile, RNase-
free, water. RNA was quantified using a Qubit (Thermo Fisher Scientific) and the average 
RNA content of a cell was calculated. 
2.2.2 RT-PCR 
 
Further confirmation of appropriate staging by pooling several cells (stage I ~4500, stage II 
~1000, stage III ~450, and stage IV ~50) isolated via manual dissociation and extracting total 
RNA for quantitative real time (RT-PCR) was done. RNA was extracted using a 
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Trizol/chloroform extraction (Section 2.2.1), DNAse digested and resuspended in 50µL of 
water. 
cDNA was prepared from the 1µL of each sample RNA using Oligo dT primers 
(Invitrogen) with RNaseOUT (Invitrogen) and Superscript II Reverse Transcriptase 
(Invitrogen). Standards were serially diluted 8 times and sample cDNA diluted 1:2, and 3µL 
used from each in the RT-PCR reactions.  
mRNAs were selected for RT-PCR based on data from previously published work 
showing differential expression within the stages of oogenesis. An early marker in oogenesis 
is zorba, the highest expression of which is seen during stage I (Bally-Cuif, Schatz et al. 
1998), while insulin-like growth factor 3 (igf3) is expressed only during oocyte maturation at 
stage IV (Li, Liu et al. 2011). Cyclin B1, ziwi and vasa fluctuate throughout oogenesis 
(Houwing, Kamminga et al. 2007, Houwing, Berezikov et al. 2008, Kim and Richter 2008, 
Yasuda, Kotani et al. 2010, Kotani, Yasuda et al. 2013), which will aid correct staging. For a 
full listing of mRNA expression changes at each stage as determined by in-situ staining and 
RT-PCR results, see supplementary Table S1. 
RT-PCR primers were designed using Primer3 (Rozen S 2000) and ordered from 
Sigma. RT-PCR was set up using the ThermoScript RT-PCR system (Thermo Fisher 
Scientific) and run using an Applied Biosystems 7000 Real-Time PCR System to calculate 
absolute quantification. For full information on RT-PCR primer sequences, see Table 2.1. 
 
Gene Primer Names Primer Sequences 
Vasa vasaF CCTGCTGCCTATCCTACAGC 
  vasaR CAGGTCCCGTATGCAAACTT 
Ziwi ziwiF CTTTTCCAGCACGAGGAGAC 
  ziwiR GGGATGTTGAATGGGTCATC 
Cyclin B1 cycb1F TCCATGTTCCTTCCGTCTCTC 
  cycb1R CATGTGCATCTGCTTCTGGT 
Bucky Ball bucF CCATCCTGAAAGGGATGAGA 
  bucR GCCTGCTCACGTAGATCACA 
Zorb zorbF GACCTGTTCGGTGGAGTTGT 
  zorbR TCTCCACAAATGCAGCACTC 
Ifg3 ifg3F CCAGGATTCATGCTGAAGGT 
  ifg3R ACATCCACGCACACAACACT 
ODC odcF GATGGCCTGGCTGTATGTTT 
 odcR GTTTGCAGGCTGAGTGTGAA 
 
 
Table 2.1 RT PCR Primer Sequences 
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2.2.3 Culture medium 
 
An adult female H Longfin zebrafish was culled by overdose of anaesthetic and dissected to 
remove the ovary mass. Ovaries were washed using HBSS, divided into smaller pieces, and 
incubated in 90% L-15 medium at various pH levels (7.0-9.0) for 24 hours. Ovary sections 
were stained with 0.2% Trypan Blue (Thermo Fish Scientific) for 1 minute and washed in 
HBSS. Photographs were taken and oocytes were separated from the ovary mass and scored 
for colour, with blue indicating cell death. 
2.2.4  Dissociation of oocytes from the ovary 
2.2.4.1  Enzymatic dissociation – Concentration testing 
 
Due to the numbers of large numbers of early stage oocytes needed, prolonged incubation in 
collagenase was analysed as a potential method to aid oocyte dissociation. The concentrations 
of collagenase to be tested were made up in HBSS and warmed to room temperature. A 
female wild type zebrafish was culled and dissected to remove the ovaries. Ovary tissue was 
transferred to a small dish and washed in HBSS. Ovaries were then transferred to a 
collagenase-containing dish to be viewed under a dissecting microscope. Ovary tissue was 
incubated in collagenase-containing media for a given time period, then washed in modified 
L15 medium before being observed and photographed. See Table 2.2 for concentrations of 
collagenase used and the length of time tissues were incubated. 
 
Concentration Collagenase Incubation Time 
1mg/ml 2 hours 
500 µg/ml 2 hours 
250 µg/ml 1 hour 
125 µg/ml 1 hour 
200 µg/ml 30 minutes 
100 µg/ml 30 minutes 
50 µg/ml 30 minutes 
 
Table 2.2 Experimental set up used to measure oocyte survival after collagenase 
treatment 
2.2.4.2  Enzymatic dissociation – Testing types of enzymes 
 
To compare the effectiveness of a short incubation in trypsin with incubation in collagenase, 
dilutions of collagenase (50 µg/ml) and trypsin (0.05%, 0.025%, 0.01%) were made up in 
HBSS. An adult female H Longfin zebrafish was culled and the ovaries dissected. The ovary 
mass was washed in HBSS then transferred to enzyme solution for 10 minutes. After 
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incubation, oocytes were placed in modified L-15 medium (containing 5% BSA) and 
observed. 
2.2.4.3  Physical and enzymatic dissociation testing  
 
To test if physical interactions or enzyme treatment had an effect on the quality of RNA 
obtained from collected oocytes, adult H Longfin zebrafish were culled and dissected to 
remove their ovaries. Ovary masses were washed in HBSS and 4 samples each of 400 stage I 
oocytes were collected under test conditions, as described below and in Table 2.3, and 
transferred to eppendorfs for snap freezing in liquid nitrogen. Oocytes remained within 
culture media for a maximum of 45 minutes total for each condition. RNA was extracted 
from the samples using the RNEasy mini kit (Qiagen) according to the manufacturer’s 
protocol and 1 µl of RNA was analysed on an Agilent Bioanalyzer using an RNA 6000 Pico 
chip (Agilent).  
The four conditions tested were: (1) ‘Normal’ – a control testing protocol based on 
results from previous experiments the optimum concentration and ideal enzyme to aid 
dissociation was determined. Once washed in HBSS, ovary masses were transferred to a petri 
dish containing 50 µg/ml collagenase diluted in HBSS. Forceps were used to aid separation 
of oocytes, and once isolated oocytes were immediately transferred to an eppendorf for snap 
freezing, reducing the amount of time spent within the dish. (2) ‘Needle’ – Once washed in 
HBSS, ovary masses were transferred to a petri dish containing 50 µg/ml collagenase diluted 
in HBSS and separated into smaller groupings using forceps. Groups of oocytes were then 
pulled through a 21G Microlance 3 needle (BD) attached to a 1 mL syringe (Sigma), and 
quickly transferred to an eppendorf for snap freezing, reducing the amount of time spent 
within the dish. (3) ‘Long Incubation’ – Once washed in HBSS, ovary masses were 
transferred to a petri dish containing 50 µg/ml collagenase diluted in HBSS and separated 
using forceps. Oocytes were left within the petri dish for the full 45 minutes before being 
transferred to an eppendorf for snap freezing. (4) ‘Enzyme Free’ – Once washed in HBSS, 
ovary masses were transferred to a petri dish containing HBSS without enzymes. Forceps 
were used to aid separation of oocytes, and once isolated oocytes were immediately 
transferred to an eppendorf for snap freezing, reducing the amount of time spent within the 
dish. 
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Condition Needle Used? Length of Incubation? Enzymes Used? 
Normal No Short Yes 
Needle Yes Short Yes 
Long Incubation No Long Yes 
Enzyme Free No Short No 
 
Table 2.3 Experimental set up used to determine the effect of collection protocols on 
RNA quality 
2.2.5 Sample storage 
 
An adult female zebrafish was culled using an overdose of anaesthetic and dissected to 
remove the ovary mass. Ovary tissue was placed in HBSS and processed, separating out stage 
I and II oocytes with forceps, a needle, and a mouth pipette. Oocytes were then placed in 
RNALater or snap frozen in liquid nitrogen. RNA was extracted from samples using the 
Trizol/chloroform method described previously (Section 2.2.1) and resuspended in 50 µl of 
sterile RNase free water. 1 µl of sample RNA was analysed on an Agilent Bioanalyzer using 
an Agilent RNA 6000 Nano chip RNA integrity, and the resultant traces were compared.  
2.3 Results 
2.3.1 Oocyte RNA content correlated with size 
 
Following dissection to remove the ovary, oocytes were found to be grouped together within 
the ovary mass (Figure 2.1) and were difficult to separate. In particular, smaller, early stage 
oocytes were very difficult to separate. 
 Following the methods of staging described by Selman, Wallace et al. (1993) oocytes 
were collected and visually analysed for stage specific characteristics (as described above in 
2.1.2). As can be observed in Figure 2.1, all stages of oogenesis have been accurately 
identified and can reliably be differentiated. An expert in the field additionally confirmed the 
staging of the oocytes. Differing amount of RNA were extracted from each stage, in relation 
to the size of the oocyte (Table 2.4, Figure 2.2). 
 
Stage Number of Cells RNA Concentration Total Volume RNA per oocyte 
Ia 85 13.6 ng/µl 10 µl 1.6 ng 
Ib 80 23.4 ng/µl 10 µl 2.9 ng 
II 105 88.7 ng/µl 10 µl 8.4 ng 
III 70 180 ng/µl 10 µl 25.7 ng 
IV 60 1450 ng/µl 10 µl 241.6 ng 
 
Table 2.4 Average RNA content of zebrafish oocytes  
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Figure 2.1 Dissected zebrafish oocytes  
 
A) The oocytes are strongly bonded together within the ovary mass. B) Illustration of an 
adult ovary adapted from Beer and Draper (2013). Oocytes are labelled in yellow, with 
<20 µm oocytes are indicated in purple. A-anterior, P-posterior, D-dorsal, V-ventral. C) 
Zebrafish oocyte stages Ia-IV. Staging was preformed according to Selman, Wallace et al. 
(1993). Oocytes massively increase in size and change visibly during oogenesis. Germinal 
Vesicle Breakdown (GVBD) occurs in stage IV and can be identified by the progressive 
clearing of the cytoplasm and dissolution of the germinal vesicle. 
 
 
Figure 2.2 Bubble chart showing the amount of RNA and the diameter of oocytes at each 
stage 
 
Bubbles show RNA amount in ng, diameter has been measured in mm by (Bally-Cuif, Schatz 
et al. 1998). Stages Ia and Ib have been designated “1” and “1.5”, respectively, for the 
purposes of graphing.  
2.3.2 RT-PCR showed the expected gene expression changes between stages 
 
The changes in gene expression between stages, as detected by RT-PCR, were as expected 
based on the literature for the majority of genes. Polyadenylated cyclin B1 mRNA was most 
prevalent in stage I oocytes (Figure 2.2A) and igf3 mRNA was most prevalent in stage IV 
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(Figure 2.2B). Zorba mRNA was found to decrease steadily (Figure 2.2C) and ziwi mRNA 
expression peaked during stage II, before also decreasing steadily (Figure 2.2D). Vasa 
mRNA expression was high in stage II, low in stage IV, and stages I and III showed similar 
middle levels of expression (Figure 2.2E). This confirms the oocytes collected are of the 
expected stages and that a stage specific collection can be done producing RNA suitable for 
RT-PCR analysis. 
 
 
Figure 2.3 RT-PCR results from stage-separated zebrafish oocytes correspond to known 
expression changes from the published literature  
 
Results were as expected with the exception of the relatively high value found for vasa 
expression stage II oocytes, as the expectation was for a lower value than stages I and III.  
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2.3.3 Low pH has a negative effect of oocyte survival 
 
Finding the right media in which to culture the oocytes, with minimal amounts of damage 
was accomplished through testing oocyte survival after a 24-hour incubation in different 
media conditions. A greater number of healthy cells were found when incubating in media 
with a higher pH compared to the same media with a low pH, as can be observed in Figure 
2.3. For instance, the sample photographed at pH 7.1 (A) has many more damaged and dying 
oocytes present than the sample photographed at pH 9.0 (E). This was found to be consistent 
throughout all pH levels tested, indicating a high pH of 9.0 is most suitable for oocyte culture 
within our facility. 
 
 
 
Figure 2.4 Trypan Blue staining of ovary masses after 24-hour incubation in modified 
L15 media at different pH levels 
 
Ovary mass cultured at: A) pH 7.1 B) pH 7.3 C) pH 8.0 D) pH 8.6 and E) pH 9.0. Ovary 
masses were stained in HBSS containing Trypan blue for ~ 1 minute. Dead cells, stained blue 
by the dye, have been labelled with red arrows to aid identification. 
 
2.3.4 High concentrations of enzyme led to oocyte death  
 
Extended incubation (~2 hours) in 1mg/ml collagenase dissociated the majority of oocytes 
from the ovary mass, as can be seen in Figure 2.5, however many early stage oocytes remain 
attached together. Following treatment at this concentration, stage III and IV oocytes appear 
very damaged with their external membranes separating from the surface of the oocyte, and 
some oocytes have not survived the treatment (red arrows). Additionally, although some 
follicle cells have been removed from oocytes, follicle cell removal has not been complete. 
Similar results were obtained for other concentrations and incubation times tested. Overall, 
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high concentrations and longer incubation times resulted in increased damage and cell death, 
while low concentrations of collagenase limited dissociation of cells. Cells were found to be 
healthy after treatment with 50 µg/ml collagenase for 30 minutes, however only low amounts 
of dissociation was observed. See Table 2.5 for further details. 
 
 
Figure 2.5 Oocytes following 2h treatment with 1 mg/ml collagenase in HBSS  
 
Oocytes appear damaged with outer membranes separating from the surface off the cell 
(labelled with yellow arrows) and cell death occurring (red arrows). 
 
Collagenase Conc. Time Observations 
1mg/ml 2 hours Membrane detachment, cell death 
500 µg/ml 2 hours Membrane detachment, cell death 
250 µg/ml 1 hour Membrane detachment 
125 µg/ml 1 hour Membrane detachment 
200 µg/ml 30 minutes Some membrane detachment, limited dissociation, 
cells relatively healthy 
100 µg/ml 30 minutes Some membrane detachment, limited dissociation, 
cells relatively healthy 
50 µg/ml 30 minutes Cells healthy, no dissociation of stage I and II 
 
Table 2.5 Observations of ovary masses incubated in various concentrations of 
collagenase for various periods of time  
 
High concentrations and longer incubation times resulted in increased damage and cell death, 
while low concentrations of collagenase resulted in a limited dissociation of cells. 
 
2.3.5  Collagenase was the most effective enzyme for dissociation of oocytes 
 
While a low concentration of collagenase (~50 µg/ml) was found not to damage oocytes after 
a 10-minute incubation – trypsin, even at a low dose (~0.01%), resulted in damage to the 
oocytes and separation of the membranes from the surface. Additionally, similar to 
observations in collagenase, oocytes incubated in trypsin did not completely dissociate from 
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the ovary mass. It was quickly determined that trypsin damaged the oocytes rapidly and did 
not improve dissociation compared to 50 µg/ml collagenase. See Table 2.6 for further details.  
 
Enzyme Concentration Observations 
50 µg/ml Collagenase Oocytes do not completely dissociate, little damage evident 
when in modified L-15 
0.05% Trypsin Oocytes do not completely dissociate, membrane 
detachment, damage evident after 10 minutes 
0.025% Trypsin Oocytes do not completely dissociate, membrane 
detachment, damage evident after 15 minutes 
0.01% Trypsin Oocytes do not completely dissociate, relatively healthy, little 
damage evident after 20 minutes 
 
Table 2.6 Observations of ovary tissue incubated in various concentrations of trypsin 
and collagenase for 10 minutes  
2.3.6 Physical separation of oocytes using a needle resulted in the highest quality RNA 
 
To compare the effects of processing stage I oocytes, different conditions were tested and the 
quality of the resulting RNA was compared. All samples produced traces with well-defined 
18S and 28S peaks and low levels of baseline degradation (data not shown). Surprisingly, 
separating stage I oocytes using a 21G Microlance 3 needle (BD) attached to a 1 mL syringe 
produced the lowest level of baseline degradation and the highest quality sample as 
determined by both RIN score (Table 2.7, RIN 8.7) and 28S/18S rRNA ratio. Increased 
incubation of the oocytes resulted in the highest levels of degradation of those observed and 
the lowest quality RNA sample as determined by RIN score (Table 2.7, RIN 6.2). Use of 
enzymes slightly improved rRNA ratio and RIN scores 
 
Test Condition rRNA ratio (28S/18S) RIN 
Normal 1.0 7.0 
Needle 5.3 8.7 
Long Incubation 0.9 6.2 
Enzyme Free 0.7 6.4 
 
Table 2.7 RNA quality scores after processing stage I oocyte samples under different 
conditions 
2.3.7 RNALater improved the quality of stored RNA over snap freezing 
 
The standard method of snap freezing tissue produced similar RNA traces to those obtained 
using RNALater (Figure 2.6) indicating both methods can be used to store samples until 
processing – however comparing the ratio of the area of the 28S rRNA peak to the 18S rRNA 
peak, the snap frozen sample has a much lower ratio of rRNA peaks than the RNALater 
sample, indicating processing using RNALater yields better quality RNA. 
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Figure 2.6 RNA quality of stage I & II oocytes stored using different methods prior to 
RNA extraction 
 
Comparisons of rRNA ratios to determine RNA quality after samples were stored using 
different methods. A significant difference was found between snap frozen samples and those 
placed in RNALater. Three stars (***) indicates a highly significant p-value of <0.001. 
 
2.4 Discussion 
2.4.1 Oocyte staging was accurate 
 
Oocytes from all stages were easily visually identified (Figure 2.1C) and have been 
confirmed by an expert in the field. This result provides high confidence that improper or 
ambiguous staging will not be an issue for further experiments. The oocytes from the various 
stages bare close resemblance to the descriptions by Selman, Wallace et al. (1993): Stage Ia 
oocytes were typically found in clusters and were translucent. Stage Ib oocytes had a 
prominent germinal vesicle (nucleus) and were slightly larger in size than the stage Ia 
oocytes. Stage II oocytes were surrounded by the vitelline envelope, and were larger in size 
than the Stage Ib oocytes. Stage III oocytes accumulated yolk bodies, which pigment the 
oocyte in a ring around the centre. Stage IV oocytes were completely pigmented and near to 
their maximal size. The stage IV oocyte shown on the far right of Figure 2.1C is an example 
of the beginnings of germinal vesicle breakdown (GVBD) and ‘clearing’ to once again 
become translucent, this maturation process produces mature Stage V oocytes, which have an 
asymmetrically localized germinal vesicle towards to animal pole of the cell and are ready to 
be ovulated. For consistent staging throughout, Stage IV oocytes were chosen which most 
closely reflected the completely pigmented non-GVBD labelled oocyte from Figure 2.1.  
As the oocytes were vastly different in size, it was predicted that different numbers 
needed to be collected for each stage. This was found to be the case as 50 stage IV oocytes 
were needed to obtain 10 µg of RNA, while many thousand stage I oocytes were needed to 
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obtain an equivalent amount. Using the average RNA content per oocyte in Table 2.4, 
approximate numbers of each stage needed for future experiments were calculated. As it is 
not possible to compare RNA from the same number of oocytes reliably, comparisons were 
made between equal amounts of RNA extracted per stage.  
Confirmation of staging was achieved by comparing expression of selected genes to 
previously published results by RT-PCR. Overall the trends of expression were as expected 
based on the literature search. Cyclin B1 was determined to be a very effective marker for 
stage I oogenesis despite the fact that the actual transcript levels do not change throughout. 
The mechanism involved was first identified in Xenopus oocytes (McGrew, Dworkin-Rastl et 
al. 1989), and is conserved in zebrafish and mice (Nagahama, Yoshikuni et al. 1995, Tay, 
Hodgman et al. 2000, Zhang and Sheets 2009). Certain maternal mRNAs, such as cyclin B1, 
are regulated by shortening and lengthening of polyA tails during oogenesis and early 
embryonic development (Stebbins-Boaz, Hake et al. 1996, Zhang and Sheets 2009, Yasuda, 
Kotani et al. 2010). Our methods of RT-PCR rely on long polyA tails to reverse transcribe 
the mRNAs to cDNA for detection, therefore the mRNA would only be detected at high 
levels when polyadenylated, during stage I of oogenesis. The polyA tail of cyclin B1 is 
lengthened again in response to progesterone, a hormonal signal produced to initiate oocyte 
maturation and cyclin B1 would be detectable at a high level by RT-PCR in Stage V oocytes 
(Stebbins-Boaz, Hake et al. 1996). Figure 2.2 shows this pattern of expression was observed 
– indicating staging has been done correctly and reliably, even when collecting large numbers 
of oocytes. 
Stage IV oocytes were predicted to have high expression of igf3 and negligible 
expression in the other stages (Li, Liu et al. 2011), a pattern which was observed in the RT-
PCR data (Figure 2.2B). This confirms appropriate staging has taken place. Zorba mRNA 
expression was predicted to be highest in early stages and lower in later stages based on in 
situ data showing specific localization of zorba to the cortex and animal pole after stage II 
(Bally-Cuif, Schatz et al. 1998, Dai, Ma et al. 2009). As expected, expression of zorba 
mRNA was found to be high in stages I and II, and low in stages III and IV. Vasa is an 
mRNA that is also highly expressed in stage I and II oocytes, and then localized to the cortex 
during stage III and IV (Braat, Zandbergen et al. 1999, Howley and Ho 2000, Draper, 
McCallum et al. 2007). This pattern was recapitulated in the results (Figure 2.2E) with the 
highest expression found during stage II, decreasing to very limited expression detected 
during stage IV. The results found for ODC expression (Figure 2.2F), initially high in stage I 
and decreasing steadily until stage IV, is proportional to the number of oocytes used in the 
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preparation of the RNA for each stage. As ODC is considered a housekeeping gene and 
should be expressed at relatively the same in all oocytes, samples with higher numbers of 
oocytes would have a higher number of transcripts detected, as in the RT-PCR results. The 
stages of oogenesis can easily be differentiated by differential expression of at least one of 
the mRNAs analysed here and all results reflect the predictions made indicating oocytes have 
been correctly staged and have been collected with negligible contamination from other 
stages.  
The ziwi mRNA expression prediction was also made from available in situ data, 
which indicated high expression in stage I, then no observable expression throughout the rest 
of oogenesis (Draper, McCallum et al. 2007). Expression of ziwi was found to be high in 
stage I (Figure 2.2D), however the expected drop off in expression did not occur until after 
stage II. The differences observed between the predictions and results obtained could be due 
to the more sensitive nature of using RT-PCR to analyse the samples – transcripts are more 
widely dispersed in larger oocytes not easily visualized by in situ, and therefore the 
prediction of negligible expression during stage II could be wrong. As the general trend of 
expression, high during stage I and low during stage IV, has been shown within the results, 
and all other tested mRNAs correlated well with their predictions, this likely indicates that 
the prediction was incorrect. Ziwi has multiple functions within the oocyte, the best studied of 
which is in transposon silencing that occurs in primordial germ cells very early in oogenesis 
(stage Ia) (Draper, McCallum et al. 2007, Houwing, Kamminga et al. 2007). Additional roles 
for ziwi in meiosis extending past transposon silencing have been described (Houwing, 
Berezikov et al. 2008), the effects of which we could be observing here as expression of ziwi 
extends into stage Ib and stage II oocytes. Further investigation of ziwi’s binding partners and 
interacting molecules during stage II of oogenesis could reveal more about the role of ziwi 
outside transposon-related functions and provide useful insight into aspects of meiosis 
occurring during stage II of oogenesis.  
Taken together, all of these results indicate that staging has been done correctly and 
accurately, and therefore will not present a problem during the collection of oocytes for 
future experiments.  
2.4.2 The ideal medium for culturing oocytes is modified L-15 media at pH 9.0 
 
An effective culture media for zebrafish oocytes has been published (Seki, Kouya et al. 
2008), but due to differences in fish strains, incubators, and other environmental factors, the 
media was tested within our facility to ensure the best possible selection had been made. In 
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previously published reports, a high percentage of L-15 media is used as a base to which 
other components are added such as BSA and L-glutamate, with the largest variation seen in 
pH levels (Selman, Wallace et al. 1993, Selman, Petrino et al. 1994, Seki, Kouya et al. 2008). 
To investigate an appropriate pH level to culture all stages of zebrafish oocytes, an overnight 
incubation and viability assessment under different pH levels using Trypan Blue was done. 
Oocytes were found to tolerate a broad range of pH levels during overnight culture, 
with an increased amount of cell death being observed at low pH levels (~7.0) (Figure 2.3A). 
Higher pH levels of between 8.5-9.0 resulted in the lowest levels of cell death, and as a result 
90% L-15 medium (with L-glutamate) with 5% BSA at a pH of 9.0, (referred to hereafter as 
modified L-15 media), was selected for use in all experimental work involving short term 
culture of oocytes.  
Extended culture of oocytes within the modified L-15 media had a detrimental effect 
of the quality of the extracted RNA (Figure 2.4). This decrease in RNA quality could indicate 
that zebrafish oocytes are not suitable for long-term culture, differentiating them from 
Xenopus oocytes, which are known to respond well to long-term culture methods (Wallace 
and Misulovin 1978). This is unlikely given the number of published methods involving the 
culture of zebrafish oocytes (Seki, Kouya et al. 2008, Tsai, Rawson et al. 2010), suggesting 
an alternative theory that although zebrafish oocytes show good survival after long-term 
incubation – the oocytes have received some damage affecting the quality of the RNA at a 
level which does not affect survival. Therefore long-term culture in modified L-15 media 
may be suitable for some uses, however further research into a more suitable media 
composition should be done if cultured oocytes are intended for RNA based studies.  
2.4.3 Low concentrations of collagenase aided dissociation without damaging the oocytes, 
but had limited effectiveness 
 
The method described by Guan, Rawson et al. (2008), to dissociate oocytes from the ovary 
mass through the use of enzymes, provided an ideal starting point for determining the best 
concentration of collagenase to use for more prolonged incubation during which many 
oocytes could be collected. According to their findings, incubation in a 0.4 mg/ml solution of 
collagenase for 10 minutes was sufficient to dissociate oocytes with 94.6± 0.9% remaining 
viable after treatment. When a similar concentration (0.5 mg/ml) was tested during an 
extended incubation of 2 hours, the oocytes did not survive and were seriously damaged by 
the treatment (Table 2.5). Reducing both time and concentration of the collagenase used 
resulted in higher survival rates, with the lowest concentration tested (50 µg/ml) and the 
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shortest incubation (30 minutes) giving the best results. Unfortunately, the majority of the 
oocytes, especially early stage oocytes, did not dissociate from the ovary mass, even in high 
concentrations of the enzyme.  
To see if this was consistent across all typically used dissociation enzymes, 
collagenase was compared with various concentrations of trypsin, an enzyme commonly used 
in dissociating cells during cell culture. Trypsin successfully dissociated the early stage 
oocytes, however it also highly damaged the oocytes making them unusable for experiments 
(Table 2.6). This was found even after very short incubations (10 minutes) at very low doses 
of trypsin (0.01%). It was quickly determined that collagenase is a preferable enzyme to 
trypsin for dissociation of oocytes from the ovary mass.  
Treatment with low doses of collagenase (50 µg/ml) for 30 minutes was determined 
to be the most effective enzyme and dose for the purpose of collecting large numbers of 
oocytes, if enzymes are to be used. 
2.4.4 Physical dissociation rather than enzymatic dissociation should be used for zebrafish 
oocytes 
 
A comparison of different physical and enzymatic techniques was done to determine the most 
efficient method to collecting large numbers of stage I oocytes with the highest levels of 
RNA integrity preserved. In addition, the effects of increased incubation within culture media 
were tested to help determine best practise methods.  
Increased physical manipulation and use of a needle to manually separate the oocytes 
was originally predicted to have the most detrimental effects on the oocytes, however the 
opposite was observed – this method produced RNA with very low baseline RNA 
degradation levels and very high RNA integrity scores (RIN) and 28S/18S rRNA ratios 
(Table 2.7). A possible explanation for this is that the largely reduced amount of time the 
oocytes spend between dissection and freezing limits the degradation possible by cellular 
RNases, which have more time to act during the other collection methods. In support of this 
theory, extended incubation times before freezing resulted in increased baseline degradation 
and low RIN score.  
A small difference was noted in the use of the enzyme collagenase compared to 
samples where it was absent, suggesting the amount of dissociation gained by adding the 
enzyme over only manual processing is small. After the collection of Xenopus oocytes using 
enzymes, a stabilization period of up to 4 hours is required before they can be used 
(Tokmakov, Iwasaki et al. 2005). If also true of zebrafish oocytes, a long incubation would 
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be necessary to ensure gene expression had normalized. This is not preferable, as extending 
incubation times was shown to have a detrimental effect on oocyte RNA scores (Table 2.7). 
Additionally, enzymatic treatment has been shown to result in proteomic and transcriptomic 
changes within cells (Huang, Hsing et al. 2010, Vrtacnik, Kos et al. 2014). Based on these 
results, oocytes were collected in the absence of enzyme, using a needle and forceps. 
2.4.5 Using RNALater resulted in higher quality RNA from oocytes 
 
For RNA analysis, the most important aspect is preserving the integrity of the RNA from 
RNases present both within the cell and in the surrounding environment, as these will quickly 
damage any available RNA altering results. To compare techniques used within the lab, an 
ovary was bisected and single oocytes collected, total RNA was extracted and two storage 
conditions were used: snap freezing and RNALater. The RNA traces were compared to 
identify any differences in resulting quality. When compared, snap freezing tissue in liquid 
nitrogen resulted in higher levels of RNA degradation than using RNALater. Once stored, the 
integrity of the RNA is expected to remain the same and not diminish over short periods of 
time, therefore the degradation must be occurring at some stage of isolation of the individual 
oocytes and processing. The mostly likely reason for the difference observed between the two 
methods, is the slightly different amounts of time between isolation and storage. Time is an 
important factor when collecting tissues for RNA analysis; increased time increases the 
potential for RNA damage. The amount of processing time to isolate stage I and II oocytes 
was equal between the two storage methods used, however culture was slightly extended in 
the snap frozen samples as collection continued until enough oocytes were acquired before 
snap freezing. When using RNALater, oocytes are transferred individually to eppendorfs for 
storage and immediately protected by the solution – this variation in time could result in the 
difference of RNA quality observed.  
As a result, RNALater was chosen to be the method of storage for samples between 
collection and RNA extraction.  
2.4.6 Concluding remarks 
 
In this chapter, I have developed a method for the staging and isolation of oocytes from the 
zebrafish ovary while ensuring the highest level of RNA integrity is maintained (Figure 2.7). 
Staging was determined to be accurate through gene expression studies and morphology 
confirmed by an expert in the field. Culture media options were tested and modified L-15 
medium was found to be suitable for short-term culture of oocytes, although in contrast to 
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previous research, it was found not to be ideal for longer-term culture. Oocytes were strongly 
negatively affected by enzymatic treatments, and an alternative method for the physical 
dissociation of oocytes was described. Snap freezing was compared to RNA protectant 
solutions, such as RNALater, and was found to result in higher rates of RNA degradation 
when isolating and staging large numbers of cells, therefore RNALater was recommended for 
use. The protocol described here is time consuming, but will result in the highest quality 
oocytes from zebrafish ovaries, with the nearest equivalent expression to what is observed in 
vivo – an essential part of transcriptomic analysis. 
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Figure 2.7 Workflow diagram of oocyte collection protocol 
 
Overview of the developed protocol for the collection of high quality zebrafish oocytes for 
RNA analysis and experimentation. Adult zebrafish photo was taken by Christopher Dooley 
and gifted for use in this work. Zebrafish ovary illustration has been adapted from Beer and 
Draper (2013). Scientific images (eppendorf, needle and forceps) were downloaded from 
various open/free-use clipart pages.  
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3.1 Introduction 
3.1.1 A brief introduction to non-coding RNA 
 
‘Non-coding RNA’ is a general term for transcripts that do not encode proteins. Like protein 
coding RNAs, non-coding RNA sequences are conserved across species and throughout 
evolution, and produce a phenotype when they are knocked out. There are many different 
subtypes, some well known and extensively studied, such as transfer RNA (tRNA) and 
ribosomal RNA (rRNA), both of which play a role in the translation of messenger RNA 
(mRNA) into proteins, while others are still being discovered and described. Non-coding 
RNAs are loosely classified into three size categories: small, medium, and large. Transcripts 
are considered large if they are >200 nt, medium sized transcripts can range from 20-200 nt, 
and small transcripts can range from 15-32 nt (Esteller 2011). Differences in convention 
sometimes results in only two categories, leaving out the medium transcripts – in these 
publications descriptions of small transcripts include everything <200 nt, while everything 
>200 is considered a large or normal sized transcript (Huttenhofer, Brosius et al. 2002). Non-
coding RNAs have various different functions, many relating to altering gene expression. 
Generally speaking, small non-coding RNAs largely regulate the translation of mRNAs, 
while medium non-coding RNAs regulate transcription by influencing the binding of proteins 
to promoters and transcription start sites, and large non-coding RNAs operate by changing 
the epigenetic or chromatin state of genomic regions, changing the accessibility of the DNA 
(Ponting, Oliver et al. 2009, Rinn and Chang 2012, Dhanasekaran, Kumari et al. 2013). An 
excellent review of the different types of non-coding RNAs, also covering the role of non-
coding RNAs in disease has been published by Esteller (2011) for readers who want to learn 
more about this topic. For brevity, only a few examples of non-coding RNAs relevant to 
Teleost species will be described in this chapter in more detail.  
3.1.2 Non-coding RNAs during embryonic development and gametogenesis 
 
Small non-coding RNAs were first identified in C. elegans when Lee, Feinbaum et al. (1993) 
knocked out lin-4, a short transcript with unknown function and no clear protein coding 
counterpart. Lin-4 was found to repress translation of the mRNA lin-14 and a lack of lin-4 
RNA lead to an accumulation of LIN-14 protein (Lee, Feinbaum et al. 1993), this resulted in 
adults that lacked sexual structures such as the vulva and cuticle (Wightman, Ha et al. 1993). 
Lin-4 was classified as a type of small RNA called a “microRNA” (miRNA), which are 
antisense to sections of target mRNAs allowing them to bind complementarily and form a 
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stretch of double stranded RNA. When double stranded, the translation machinery is 
prevented from accessing the transcript and the transcript is degraded via Dicer protein 
(Bernstein, Caudy et al. 2001).  
Many aspects of development are regulated using non-coding RNAs, and 
gametogenesis is no exception. The most extensively studied non-coding RNAs in 
gametogenesis are piwi RNAs (piRNAs) during spermatogenesis. piRNAs block translation 
and lead to degradation by binding complementary sequences, however they use a different 
mechanism than miRNAs and interact with a protein called Piwi – unlike miRNA, piRNAs 
are mainly sequences complementary to transposons and repeat elements (Klattenhoff and 
Theurkauf 2008). Germ stem cells undergo extensive epigenetic reprogramming to become 
pluripotent during development into mature germ cells, during which a small window of 
permissive transcription takes place where self replicating elements such as transposons can 
be transcribed (Castañeda, Genzor et al. 2011).  piRNAs repress the transposon derived 
transcripts and prevent them from re-integrating into the genome, where they could 
potentially cause deleterious mutations in offspring, and initiate de novo methylation of 
repeat element DNA to repress their transcription (Aravin, Sachidanandam et al. 2008, 
Klattenhoff and Theurkauf 2008, Kuramochi-Miyagawa, Watanabe et al. 2008). piRNAs 
protect genomic integrity in a wide variety of species, including the Zebrafish (Houwing, 
Kamminga et al. 2007, Houwing, Berezikov et al. 2008).   
Small RNAs play an important role in the regulation of important developmental 
programs and are involved in maintenance and protection of the genome during 
gametogenesis. 
3.1.3 Small & medium RNAs in Xenopus and teleost oocytes 
 
The role of small RNAs during oogenesis has become a prominent question, with numerous 
groups sequencing the small RNAs of human (Assou, Al-edani et al. 2013) and mouse 
oocytes (Mishima, Takizawa et al. 2008, Tam, Aravin et al. 2008, Watanabe, Totoki et al. 
2008, Ahn, Morin et al. 2010). Interest in the small RNA of Teleost fish ovaries has been a 
much more recent centre of focus and species sequenced so far include: the Atlantic Halibut 
(Hippoglossus hippoglossus) (Bizuayehu, Babiak et al. 2012), the yellow catfish (Pylodictis 
olivaris) (Jing, Wu et al. 2014), the Nile tilapia (Oreochromis niloticus) (Xiao, Zhong et al. 
2014), the Olive Flounder (Paralichthys olivaceus) (Gu, Zhang et al. 2014), and the zebrafish 
(Desvignes, Beam et al. 2014, Vaz, Wee et al. 2015). However, all of these studies focus on 
the fish ovary as a whole and do not examine the oocytes in a stage specific manner. 
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Additionally, transcripts greater than the expected size of miRNA (~24 nt) are thrown out 
during the sequencing pipeline, often in the library preparation stage, resulting in the loss of 
all small RNAs > 24 nt and medium sized RNA reads. These RNAs are of particular interest 
when studying oogenesis in fish and frogs.  
Early studies of Xenopus oogenesis revealed that small and medium RNA accounts 
for >75% of the RNA within early oocyte stages (Mairy and Denis 1971, Mazabraud, 
Wegnez et al. 1975). A finding that has also been observed in a variety of fish species 
(Kroupova, Trubiroha et al. 2011). This massive burst of RNA expression can easily be 
observed through running denaturing gels of ovary RNA or through Bioanalyzer traces, as 
observed in Figure 3.1, which depicts Bioanalyzer traces from Roach (Rutilus rutilus) 
oocytes. Experiments examining the content of this RNA in Xenopus suggested it is 
composed mainly of two types: transfer RNA (tRNA) and 5S ribosomal RNA (rRNA) (Ford 
1971, Mairy and Denis 1971, Mazabraud, Wegnez et al. 1975). This massive production is 
thought to occur to produce enough tRNA and 5S rRNA to supply ribosomes during the 
initial stages of embryonic development and these transcripts are conserved until needed 
within the oocyte (Denis and Mairy 1972, Mairy and Denis 1972, Verheggen, Le Panse et al. 
1998). 5S rRNA is not the only rRNA needed to make ribosomes and while 5S rRNA is 
present in the genome in many thousand copies, >20,000 in Xenopus, the other rRNAs are 
only present in approximately 400 copies (Peterson, Doering et al. 1980, Tata 1986). 
These other rRNA transcripts, the 5.8S, 18S and 28S, are transcribed as a single polycistronic 
RNA known as the “45S pre-rRNA”, which is processed into the individual rRNA transcripts 
needed to form the ribosome (Figure 3.2). To ensure enough copies are produced to match 
the number of transcripts produced by the >20,000 5S rRNA genes, the DNA encoding the 
45S pre-rRNA transcript undergoes region specific amplification to form “Lampbrush 
chromosomes” during stage Ib of oogenesis (Flemming 1882, Brown and Dawid 1968, W.S. 
Vincent 1968, Wegnez and Denis 1972, Baumeister 1973, Callan, Gall et al. 1988, Okuthe 
2012). Lampbrush chromosomes are thought to form in the oocytes of all oviparous animals, 
which lay external eggs, and have not been described in mammals during oogenesis.  (Tata 
1986, Gall and Murphy 1998, Tian, Kopf et al. 2001, Liu and Gall 2012). As with the tRNA 
and 5S rRNA, the 45S pre-rRNA transcripts are produced to supply ribosomes for the initial 
stages of embryonic development (Verheggen, Le Panse et al. 1998) and are stored during 
oogenesis until required. 
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Figure 3.1 RNA Electropherogram traces from Roach (Rutilus rutilus) ovaries 
 
Bioanalyzer traces showing a large peak of small/medium sized RNA during early oogenesis. 
Reproduced from Kroupova, Trubiroha et al. (2011). pg – primary growth (stage I), eca – 
early cortical alveolus (stage II), lca – late cortical alveolus (Stage III), and lvit – late 
vitellogenic (Stage IV).  
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Figure 3.2 Transcription and processing of rDNA into rRNA transcripts 
 
Ribosomal DNA (rDNA) is transcribed from the promoter to form the 45S pre-rRNA 
transcript. The 45S is cleaved in a series of steps to form the 18S, 5.8S and 28S rRNAs. 
Boxes – rRNA coding regions, right angled arrow – promoter, ETS – external transcribed 
sequence, ITS – internal transcribed sequence, scissors (  ) – cleavage sites, bold line – DNA, 
thin lines – RNA, coloured lines – rRNA, dashed lines – degraded RNA.  
 
This peak of small RNA expression during early oogenesis has only been studied in 
Xenopus and has yet to be described in detail in zebrafish. Although many core aspects of 
oogenesis discovered in Xenopus hold true for zebrafish, there are some established 
differences between the species (Zhang and Sheets 2009, Marlow 2010), and deviations from 
what has been observed in Xenopus have not been examined. A detailed examination of this 
peak of RNA expression in the zebrafish would clarify if it is conserved between species and 
could reveal additional information about the process in general – especially as the majority 
of work on this RNA was done before the advent of sequencing.  
Currently, zebrafish ovary sequencing datasets have been focused on miRNAs and 
lack all other small and medium sized RNAs – including this peak of RNA expression. 
Additionally, all these datasets are on whole ovary tissue and none have examined small 
RNA in a stage specific manner. In this chapter, I describe the small and medium RNAs 
found in stage I oocytes through a variety of steps. First, by developing a method to compare 
18S 5.8S 28S 
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the variation in the proportion of small RNA compared to the 18S and 28S rRNAs, then by 
limiting sources of degradation and analysing if apoptosis had a role in the formation of the 
peak, and finally through small RNA sequencing methods.  
3.1.4 Sequencing using multiple replicates 
 
Initial studies and investigative work can often done using only one sample, these types of 
experiments provide insight into the cell type in question and a good starting point for the 
design of further studies, however having only one sample can limiting, both in the range of 
what can be detected and in the confidence in what was identified. Replication of sequencing 
studies is essential to show the results are not an anomaly and are reproducible. This is also 
true of RNA-Seq studies, for instance an investigation into novel exon-exon junctions 
identified through RNA-Seq showed >80% of these were replicated using another method, 
although this demonstrates a high level of reproducibility of findings in RNA-Seq 
experiments, it showed the effect fluctuations in technical variation and sampling noise 
between replicates can have on results (The Seqc Maqc-Iii Consortium 2014).   
Technical variations and noise have stronger effects on samples with low input 
amounts; low and moderately abundant transcripts are lost, and biases in enzymes or the 
ligation of primers to RNAs becomes greatly magnified during the amplification steps 
(Bhargava, Head et al. 2014, Raabe, Tang et al. 2014). Simply increasing the depth of 
sequencing on this type of sample is not always possible, and more recently it has been 
shown that it does not necessarily result in more useful data (Liu, Zhou et al. 2014). Instead, 
using lower depth but multiple replicates has shown to be effective in providing reliable 
results about expression and variation (Liu, Zhou et al. 2014). Therefore, repeating RNA-Seq 
experiments using multiple replicates is the best method to obtain a complete analysis of the 
transcriptome during oogenesis.  
3.1.5 Transcript Counting as a polyA RNA-Seq method 
 
RNA-Seq has become a popular technique for studying the transcriptome, however 
comparing between experiments is difficult as the extensive variation in the way libraries are 
prepared can have effects on the sequence data produced. In our lab, we attempted to find a 
reliable, high throughput method of making comparable libraries, which could be adapted for 
use in in the Zebrafish Mutation Project (Kettleborough, Busch-Nentwich et al. 2013) to 
analyse whole embryos as well as adult tissues. This library making protocol has been termed 
“Transcript Counting” as it counts only the 3’ ends of transcripts to estimate expression. This 
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method increases the number of transcripts that can be sequenced and identified, reducing 
costs and noise, but results in a loss of information about alternative exons and transcription 
start sites. This method is useful when studying the presence or absence of expression of 
transcripts or 3’ end use, and can be useful when funding for sequencing runs is limited. 
The DeTCT (Differential expression Transcript Counting Technique) pipeline was 
developed within our lab for mapping of reads from transcript counting libraries and for the 
analysis of differential expression between conditions (Morris, Collins et al. 2012). 
Fragmentation is done prior to polyA tailing (as shown in Figure 4.1) and correctly tagged 3’ 
ends of transcripts are mapped to the genome using BWA independently from annotation 
information (Li and Durbin 2009), and differential expression analysis is done using DESeq 
(Anders and Huber 2010).  
Multiple benefits arise from annotation independent mapping: new 3’ ends can be 
identified for existing transcripts and alternative splice forms described, new transcripts can 
be discovered, and partially annotated, non-mature genomes can be more effectively used in 
transcriptome studies (Bradnam, Fass et al. 2013). As the zebrafish genome still lacks in 
annotation and has large scaffolds, transcript counting presents a method that can overcome 
these issues and will contribute to future annotation of the genome.  
3.1.6 Transcript Counting vs. standard RNA-Seq in oocyte samples 
 
Although much can be gained from using a standard RNA-Seq library preparation, using 
transcript counting would increase the number of transcripts detected, provide a better 
estimate of the transcripts present, and allow the identification of new transcript 3’ ends. The 
benefits of using transcript counting, in this instance, out weigh the loss of isoform 
information, particularly as isoform differences are not been at the centre of our investigation 
for this stage. Additionally, as transcript counting libraries are a non-standard method, they 
are made within the lab and not by the in-house Illumina library-making team, allowing the 
addition of other custom aspects, such as barcoding. 
Barcoding is a relatively new technique that involves including a short stretch of 
unique molecules within the index tag (Kivioja, Vaharautio et al. 2012, Shiroguchi, Jia et al. 
2012). Using this method, each transcript can be uniquely individually identified during 
sequencing as repeated barcodes represent transcripts duplicated during amplification steps. 
This allows a more accurate count of the number of transcripts present and removes 
sequence-based biases during cDNA conversion and primer ligation (Shiroguchi, Jia et al. 
2012, Islam, Zeisel et al. 2013).  
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Through the use of transcript counting a larger number of transcripts can be 
sequenced and a more accurate quantification of expression determined, both aspects that we 
hope to improve upon by sequencing replicates of the oocyte samples. 
3.1.7 Stage I focus and comparing small RNA and polyA RNA sequencing 
 
All aspects of oogenesis are fascinating and would benefit from more in depth study, 
however sequencing of the stage I oocytes would provide the greatest amount of knowledge 
about oogenesis at this time. During stage I, the oocytes are undergoing a wide variety of 
processes, including some which are unique to this stage and cell type.  
Procedures developed during Chapter 2, to isolate the <200 nt RNA fraction from a 
pool of RNA, could be adapted to allow collection of both the small (<200 nt) and large 
(>200 nt) RNA fractions for sequencing from the same sample. The large RNA fraction 
contains the majority of the polyA mRNA and could be assessed by transcript counting, 
however as the small RNA fraction is largely comprised of transcripts that lack polyA tails, 
these replicates will be using a custom small RNA library preparation described in detail in 
the methods. Small RNA and polyA RNA came from the same sample pool as described in 
Figure 3.3 to enable comparison between types of RNA present within the sample.  
 
       
   
 
 
 
 
   
  
 
 
 
 
 
 
 
Figure 3.3 Relationship between samples and RNA for sequencing 
 
Three separate samples consisting of pools of stage I oocytes (yellow circles) will be 
collected and separated into <200 and >200 RNA fractions for sequencing. 
 
Sample 1 Sample 2 Sample 3 
<200 
RNA 1 
>200 
RNA 1 
<200 
RNA 2 
>200 
RNA 2 
<200 
RNA 3 
>200 
RNA 3 
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Directly comparing between fractions would provide useful information about the two 
populations, however the best computational methods involved for determining the numbers 
of transcripts present in each type of library are different – ideally, the small RNA would be 
aligned with a TopHat type aligner, while transcript counting relies on BWA for 
identification of transcripts. Although these methods are similar, there are important 
differences in the ways transcripts are assembled. These differences in mapping 
methodologies prevent a direct comparison between datasets, as differences identified could 
be due the use of different methods rather than biological differences. To overcome this both 
sequencing experiments were mapped using both TopHat and the transcript counting pipeline 
to enable comparison between datasets.    
3.2 Methods  
3.2.1 RNA Extraction 
3.2.1.1 Zebrafish 
 
Adult H-Longfin wild type fish were culled according to Home Office procedures and 
dissected to obtain samples of the gonads, heart and tail muscle. Ovaries were dissected to 
separate oocytes by stage and collected into pools using the methodology developed and 
described in detail in Section 2.2.1 “Oocyte Staging”. Tissues were stored in RNALater at 
4oC until processed. RNA was extracted using the Trizol-chloroform method and run on an 
RNA Nano Bioanalyzer Chip. Resulting electropherogram images were analysed. 
Various methods in addition to Trizol-chloroform RNA extraction were performed on 
staged pools of oocytes to elucidate whether some aspect of the RNA extraction was 
producing the small sized RNA peak. Column based methods to extract RNA included using 
the miRNEasy Kit (Qiagen) using the manufacturer’s protocol: “Purification of Total RNA 
from Animal Cells” as described in the miRNEasy Mini Handbook (referred to hereafter as 
the miRNEasy method) and according to the Qiagen Supplementary Protocol: “Purification 
of miRNA from animal cells using the RNEasy Plus Kit (Qiagen) and RNEasy MinElute 
Clean-up kit (Qiagen)” (referred to as the MinElute method). Lastly, Agencourt RNAClean 
XP SPRI beads (Beckman Coulter) were used to extract RNA according to the 
manufacturer’s specifications (referred to as the SPRI method). Once extracted, all RNA 
samples were run on a bioanalyzer using an RNA Nano Chip and analysed. 
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3.2.1.2 Xenopus 
 
Adult female wild type Xenopus laevis were primed and boosted the following day according 
to standard procedures to stimulate egg laying and clearing the ovary of an excess of large 
late stage oocytes. Two weeks were allowed to pass and then frogs were culled according to 
Home Office procedures. Frogs were dissected to obtain samples of the ovary, heart and leg 
muscle. Tissues were stored in RNALater at 4oC until processed. RNA was extracted using 
the Trizol-chloroform method and run on an RNA Nano Bioanalyzer Chip. Resulting 
electropherogram images were analysed and compared to the ovary zebrafish traces. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Overview of column based RNA extraction procedure to obtain <200 and 
>200 nucleotide RNA fractions separately 
 
Small RNA was extracted from cells and isolated separately to larger RNAs for analysis. This 
protocol was originally developed by Qiagen (2006). 
Disrupt & Homogenize Cells in Buffer RLT Plus 
Centrifuge through gDNA Eliminator spin column 
Apply to RNEasy Mini spin column 
Wash spin column 
membrane 
Add 0.65 volumes of 
100% ethanol to flow 
through 
 
Add 1 volume 70% ethanol 
Elute total RNA >200 
nucleotides 
Apply to RNEasy 
MinElute spin column
Wash spin column 
membrane 
Elute small RNA <200 
nucleotides 
3.2 Methods 
 
52 
$
!
$
$ $
` `
3.2.1.3 Small RNA extraction and isolation 
 
Stage I oocytes were collected using the procedures previously described. Small sized RNA 
was extracted using a protocol provided by Qiagen for the purification of <200 nt and >200 
nt RNAs separately from animal cells (Qiagen 2006). Briefly, cells are disrupted and 
homogenized in Buffer RLT Plus and centrifuged through a gDNA Eliminator spin column. 
70% ethanol is added to the sample and it is spun through an RNEasy Mini column. The flow 
through is saved. The RNEasy Mini column is then processed as normal to give the >200 nt 
RNA fraction. 100% ethanol is added to the retained flow through and it is spun through an 
RNEasy MinElute column to produce the <200 nt RNA fraction (Figure 3.4).  
3.2.2 RNA analysis 
3.2.2.1 RNA electropherogram traces 
RNA from each stage was run on a Bioanalyzer (Agilent) using an RNA Nano Chip 
according to the manufacturer’s instructions. Using the 2100 Expert Software (Agilent): the 
rRNA and unknown peaks were identified and the area under each peak quantified. 
Assessments of RNA quality were measured, as discussed in Section 2.1.6, by taking the 
ratio of the area of 28S/18S rRNA peaks. Adapting this method, the area of each unknown 
peak was compared to the area of the relatively stable 18S rRNA peak to obtain a quantitative 
measure of the size of the unknown peaks (Figure 3.5). Ratios were compared between stages 
to determine if the small RNA peak was stage specific. 
 
 
 
 
 
Figure 3.5 Sample electropherogram showing areas used to calculate rRNA and small 
RNA ratios 
 
Area under the line is calculated using the 2100 Expert program (Agilent). rRNA ratio is 
determined by comparing the area of the 28S rRNA peak to the relatively stable 18S. Small 
RNA ratios can be determined by comparing the small RNA area to the 18S. Red line 
represents the RNA trace, green the area of the small RNA peak, blue the 18S rRNA area and 
orange the 28S rRNA area. 
`
`
`
`
rRNA = 28S area 
          18S area  
 
Small RNA = Peak Area  
18S Area 
 
Peak 18S 28S 
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RNA was extracted using the Trizol-chloroform extraction method multiple times to 
confirm the results were not an anomaly or error in processing. RNA was then extracted 
using multiple alternative methods to determine if the Trizol-chloroform method was 
influencing the peak size or RNA quality. Additional comparisons were done to investigate 
the effect of different methods on the collection of samples and storage procedures for 
indications of RNA degradation or apoptosis occurring. In each case, RNA quality and 
amount was assessed using the Bioanalyzer chips. 
3.2.2.2 Estimation of small RNA peak size 
 
Ovaries were then collected and RNA extracted as described above to obtain the small RNA 
population (<200 nt) separate from larger RNAs and was run on a Bioanalyzer Small RNA 
Chip (Agilent) using standard protocols. Proportions of miRNA, and other small RNAs were 
determined using features available in the 2100 Expert software (Agilent). Boundaries were 
set between 20-40 nt for miRNA (program default), 40-80 nt for the lower peak and 80-100 
nt for the upper peak, and the area under the trace line within each of the region was 
calculated (Figure 3.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Depiction of boundaries and areas measured during small RNA chip analysis 
 
Area under the line is calculated using the 2100 Expert program (Agilent). Red line 
represents the RNA trace, light blue the area represents miRNA, the peak itself was divided 
into two parts: the lower portion shown in purple and the upper portion shown in green. 
3.2.2.3 Comparison with normal RNA degradation 
 
An extensive literature search and study of electropherograms of degraded RNA was 
undertaken to determine if any pattern of degradation similar to the small RNA peak had 
been observed. As a comparison, degradation was induced in ovary and oocyte samples by 
40 nt 80 nt 100 nt 20 nt 
miRNA  Area  (20-40 nt) 
Lower Peak Area (40-80 nt) 
Upper Peak Area (80-100 nt) 
3.2 Methods 
 
54 
$
!
$
$ $
extending the time between the tissue being dissected and before cryoprotecting the samples 
and extracting RNA; allowing the cellular RNases to degrade the RNA within the samples. 
RNA was extracted using the Trizol-chloroform method, then run on a Bioanalyzer and 
analysed compared to traces found in the literature. 
3.2.2.4 Denaturing polyacrylamide gel electrophoresis 
 
RNA was prepared using the Trizol-chloroform method and mixed with 2X RiboRulerTM 
RNA loading dye (Thermo Scientific). RNA was denatured at 70oC for 3 minutes and placed 
on ice prior to loading. 6% TBE-Urea Gels (Invitrogen) were run at 180V for 1.5 hours in 1X 
TBE buffer. Gels were stained using SYBR Safe DNA gel stain (Invitrogen) for 30 minutes 
and imaged using an ImageQuant LAS 4000 (GE Healthcare Life Sciences). RiboRulerTM 
High Range & Low Range RNA Ladders (Thermo Scientific) were used. 
3.2.3 Apoptosis 
3.2.3.1 Analysis of the ovaries of p53-/- mutant female zebrafish 
 
Heterozygous zebrafish from a p53 knockout line obtained from ZIRC (Berghmans, Murphey 
et al. 2005) were incrossed to produce homozygous (-/-), heterozygous (+/-) and wild type 
(+/+) siblings and embryos were raised to adult hood. Once adulthood was reached, the adult 
fish were culled according to Home Office procedures. Ovaries were dissected and oocytes 
were separated using the methods described in Section 2.2.1 into two pools: ‘early’ – stage I 
and stage II oocytes and ‘late’ – stage III and stage IV oocytes. RNA was extracted from the 
pooled oocytes using the Trizol-chloroform method and run on an RNA Nano Bioanalyzer 
chip. The resulting traces were analysed. 
3.2.3.2 Induction of RNA degradation with 6’Hydroxyurea 
 
Pairs of adult H-Longfin wild type zebrafish were set up overnight and 50 embryos collected 
at the 2-cell stage. Embryos were incubated in egg water with 30 mM 6’-hydroxyurea as 
described by Ikegami, Hunter et al. (1999), with control embryos from the same clutch 
incubated in normal egg water for 6 or 24 hours. Embryos were viewed under a microscope 
to confirm apoptosis had taken place and were snap frozen. RNA was extracted from the 
embryos using the miRNEasy columns (Qiagen) using the standard procedures for total RNA 
extraction and run on an RNA Nano Bioanalyzer chip. The resulting traces were analysed.   
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3.2.4 Small RNA sequencing 
3.2.4.1 Library Prep  
 
A strand-specific library was prepared from the <200 nt RNA fraction using the TruSeq 
Stranded Total RNA LT Sample Prep Kit (Illumina) using random hexamers by Lira 
Mamanova from the in-house Sequencing Research and Development team. The library was 
sequenced on a MiSeq (Illumina) using 150 bp paired-end reads. 
3.2.4.2 Sequence mapping to Zv9 genome and processing  
 
Adaptors and poor quality sequences (Q<30) reads were removed using Fastx_trimmer 
(Hannon Lab 2010). Reads were then mapped by Ian Sealy using BWA (Li and Durbin 2009) 
to the Zebrafish genome Zv9 (version 75) (Howe, Clark et al. 2013). BWA was used as 
alternative programs catering for directional paired-end sequencing data were not available at 
the time. I extracted information relating to the length and type of transcripts sequenced using 
Perl/BioPerl (Stajich, Block et al. 2002) and the Ensembl API (Rios, McLaren et al. 2010, 
Flicek, Amode et al. 2012), and calculated statistics related to the dataset.  
To help determine the exonic/intronic nature and 5’/3’ bias of the RNA fragments; 
Jorge Zamora wrote two python scripts – 1) which analysed each read, taking into account 
directionality, and classified whether it mapped to exonic or intronic regions of the genome, 
using this I calculated statistics to determine the overall percentage intronic/exonic of the 
sequenced reads – and 2) which uses BED tools (Quinlan 2002) to scan along each transcript 
calculating the total number of reads that map onto each individual base, and then indicates 
the base, within each transcript, with the highest read count (Figure 3.7). Once these bases 
were identified, I calculated the number of bases from the 5’ end to give a percentage of the  
 
 
 
 
  
 
Figure 3.7 Determination of 5’/3’ bias of reads across a transcript  
 
For every base along the transcript (shown in black), the numbers of reads (blue) mapping to 
that location were counted. The location with the highest number of reads was identified (red 
box) and the base within this location with the highest number of reads (red star) was used for 
calculations of distance from the 5’ end of the transcript (grey line).  
5’   3’ 
     Transcript 
Reads 
* 
Distance from 5’ end  
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length of the entire transcript (including untranslated regions). Using percentages rather than 
absolute numbers ensured the distances were comparable between transcripts of differing 
length. This allows us to see if the sequence reads were originating from a specific end or 
section of the transcript and determine if any 5’ or 3’ end bias is present in the sequences. 
3.2.4.3 GO term analysis  
 
The top 1000 highest expressed genes from the dataset were selected for GO term analysis 
with GeneCodis3 (Carmona-Saez, Chagoyen et al. 2007, Nogales-Cadenas, Carmona-Saez et 
al. 2009, Tabas-Madrid, Nogales-Cadenas et al. 2012) to identify any enrichment in the 
RNAs within this population.  
3.2.4.4 Ensembl ID investigation 
 
The Ensembl gene IDs with the highest read counts were viewed in the Ensembl browser 
(Fernandez-Suarez and Schuster 2010, Cunningham, Amode et al. 2015) and using SAMtools 
(Li, Handsaker et al. 2009) to identify neighbouring genes and genomic features which could 
account for the high read counts – for instance repetitive sequences or potential genome 
assembly errors. 18S and 28S rRNA sequences do not exist in the current zebrafish genome 
assembly. To examine rRNA content of the sequencing data, gene IDs found immediately 
adjacent to sequences for 5.8S rRNA genes (within ~500 bp) were reclassified as potential 
rRNA sequences. This was referred to as “strict” reclassification. The majority of these 
reclassified gene IDs were not strongly supported by evidence and often labelled as unknown 
transcript types, pseudogenes, or microRNAs. A “loose” reclassification was done as well, 
changing the transcript type of all IDs within 5 Kb of the 5.8S rRNA sequences to potential 
rRNA and the proportion of reads from different transcript types was calculated. 
3.2.4.5 Zebrafish rRNA reference genome 
 
For a more detailed and accurate examination of the rRNA content of the sequencing data, a 
zebrafish rRNA reference was built. Collaborators with the Stemple lab have identified a 
BAC (BX296557) and ESTs that align with very high sequence similarity with fully 
annotated rRNA sequences of other species, such as the carp and mouse (Table 3.1). I 
downloaded the BAC and EST sequences from BioMart and generated a consensus 
alignment representing the entire 45S pre-rRNA transcript using the Lasergene program, 
SeqMan (DNASTAR) (Figure 3.8). 18S, 28S and 5.8S rRNAs were annotated within the pre-
45S transcript by aligning the confirmed orthologous rRNA sequences. Additional sequence 
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information, such as the external transcribed sequences (ETS) and internal transcribed 
sequences (ITS) were annotated based on the location of the rRNA transcripts and predicted 
sizes (Table 3.2). Putative zebrafish rRNAs were entered into BLAST to confirm the 
sequences had high similarity to rRNA transcripts.  
 
Species 18S Identity (%) 5.8S Identity (%) 28S Identity (%) 
Carp 94 97 94 
Mouse 90 95 82 
 
Table 3.1 rRNA percentage identity match between species 
 
Percentage identity match from Zebrafish EST and BAC sequences to carp and mouse rRNA 
genes. 
 
 
Region 5S 5’ETS 18S ITS1 5.8S ITS2 28S 3’ETS 45S 
Size (bp) 119 1534 1531 33 155 1208 3266 1775 9715 
 
Table 3.2 Size (bp) of zebrafish rRNA transcripts 
 
Size (bp) of each rRNA transcript calculated using alignments from rRNA of similar species.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 BAC and EST sequences and their relationship to the 45S rRNA transcript  
  
Illustrative image showing layout and directionality 
of BAC and EST sequences compared to the 45S 
rRNA transcript annotated with the constituent rRNA 
sequences. Not to scale. ITS and ETS stand for 
internal and external transcribed sequence, 
respectively. ESTs and the BAC have been depicted 
with the arrow pointing towards the 3’ direction of the 
transcript, indicating the direction of transcription. 
Stars (*) indicate areas for which no EST sequences 
were available. Legend contains labels and names of 
EST sequences, in 5’ to 3’ order, and the putative 
regions of the 45S pre-rRNA transcript they align to.  
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5S rRNA sequences were downloaded from BioMart and strings of 200 Ns added between 
each FASTA entry to ensure correct read mapping. The Ns will remove any context 
information included by listing the 5S rRNA genes consecutively; adjacent sequences are 
interpreted as adjacent on a chromosome by mapping software. Including Ns rather than 
extracting surrounding sequences will decrease the number of reads failing to map due to 
strain differences in regions of the genome not under selection. The 5S rRNA sequences and 
45S rRNA sequences were concatenated to the Zv9 cDNA reference file available from the 
Ensembl FTP site. The pre-rRNA reference and transcriptome file was formatted as a 
FASTA file and indexed using BWA. A separate reference FASTA file of Danio rerio rRNA 
sequences from the SILVA ribosomal gene database (Quast, Pruesse et al. 2013) was made 
as above, and concatenated to the Zv9 cDNA reference file. Sequences from this database 
have been used by other groups to identify rRNA within small RNA sequencing to determine 
the amount of rRNA present in zebrafish samples (Chew, Pauli et al. 2013). The SILVA 
database contains information on the fully processed rRNA genes, however it lacks the ITS 
and ETS sequences present in the 45S pre-rRNA and is not fully annotated to indicate the 
specific rRNA transcript present in a given sequence.  
3.2.4.6 Zebrafish transposable element & rRNA reference genome 
 
Transposable element (TE) sequences found for Danio rerio, Deuterostomia, Euteleostomi, 
Teleostei, Teleostomi, and Vertebrata!were downloaded from Repbase (Bao, Kojima et al. 
2015) in FASTA format.  These sequences were concatenated and processed as described in 
Section 3.2.4.4 to the constructed rRNA reference genome.  
3.2.4.7 Sequence mapping to custom references and processing  
 
I mapped the reads from the stand specific sequencing library using BWA using the default 
settings to the custom reference genomes and filtered the dataset to include only sequences 
with high similarity (good cigar strings) and high quality (Q>30). Both the 45S rRNA 
reference and SILVA rRNA reference were compared to sequence data to obtain the 
maximum available information about which rRNA transcripts were present and for 
comparability between other small RNA sequencing experiments. Statistics and images were 
produced using SAMtools and R.   
An estimation of the number of reads expected to be observed, if originating from the 
entire pre-45S rRNA, was calculated using the knowledge that the ITS and ETS transcripts 
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are transcribed at an equal rate to the final rRNA transcripts as they are produced as one long 
pre-rRNA polycistronic transcript. Longer rRNA transcripts within the pre-rRNA would have 
a higher number of reads mapping despite the transcripts being produced at a proportional 
rate – this concept is similar to the that used in the calculations of fragments per kilobase per 
million (FPKM) used to determine transcript abundance in methods such as the TopHat suite, 
among others (Dillies, Rau et al. 2012). The total number of rRNA mapping reads was 
distributed according to their lengths to give the proportion expected. Mapping to the derived 
3’ETS sequence was not successful as few EST sequences were available for building this 
region; therefore it was removed from this analysis. 
3.2.5 Small RNA replicate sequencing  
3.2.5.1 Oocyte collection and RNA extraction for replicate sequencing 
 
3 replicates of 400 stage I oocytes (each) were collected using the methods derived in 
Chapter 2. Briefly, the ovary mass was dissected from adult zebrafish and placed in HBSS 
and individual oocytes are separated from the ovary mass using a mouth pipette, needle and 
forceps, staged visually, then sorted into eppendorfs containing RNALater. RNA was then 
extracted, as described in Section 3.2.1.3, to obtain separate >200 nt and < 200 nt RNA 
fractions using the RNEasy Mini Kit (Qiagen) and MinElute columns (Qiagen), and stored at 
-80oC until use.  
3.2.5.2 Small RNA replicate library prep 
 
3 strand-specific libraries were prepared from 49 ng of RNA from <200 nt fractions using the 
TruSeq Stranded dUTP Total RNA LT Sample Prep Kit (Illumina) with random hexamers by 
the in-house Bespoke Illumina Sequencing team; as the length of the RNA in question is 
already relatively small, additional fractionation was not done. No additional rRNA removal 
treatments were done, such as rRNA digestion, as the size selection during the RNA 
extractions excludes the majority of rRNAs present in the samples. The libraries were 
sequenced on a MiSeq (Illumina) using 150 bp, paired-end reads. I filtered reads to Q>30 and 
trimmed them to 30 nt using FASTX_trimmer from the FASTX-Toolkit (Hannon Lab 2010). 
3.2.5.3 Small RNA replicate sequence mapping using TopHat 
 
Reads produced from the 3 small RNA sequencing replicates were mapped using TopHat 
(Trapnell, Roberts et al. 2012) to the zebrafish genome (Zv9, release 75) (Howe, Clark et al. 
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2013). Downstream analysis on the resultant mapped reads was done using R (Ihaka and 
Gentleman 1996) and the R package cummeRbund as described by Trapnell, Roberts et al. 
(2012). Further information about transcripts, including canonical lengths and types, was 
extracted from the Ensembl API (Rios, McLaren et al. 2010, Flicek, Amode et al. 2012) 
using Perl/BioPerl (Stajich, Block et al. 2002). I filtered the data to include only reads which 
were properly paired, passed vendor quality checks, and were not PCR duplicates. Statistics 
were obtained using SAMtools (Li, Handsaker et al. 2009). The top 1000 most abundantly 
expressed Ensembl transcript IDs were submitted to GeneCodis3 for GO term analysis 
(Carmona-Saez, Chagoyen et al. 2007, Nogales-Cadenas, Carmona-Saez et al. 2009, Tabas-
Madrid, Nogales-Cadenas et al. 2012). 
3.2.5.4 Small RNA replicate sequence mapping to the custom built rRNA reference 
 
Section 3.2.4.5 describes the building of the custom rRNA reference genome. BWA was used 
to map the small RNA replicate libraries to the rRNA reference genome as described in 
Section 3.2.4.7. Statistics were obtained using SAMtools.  
3.2.5.5 Small RNA replicate sequence mapping using DeTCT 
 
Reads produced from the 3 small RNA sequencing replicates were also mapped to the 
zebrafish genome (Zv9, release 75) using the DeTCT pipeline (Morris, Collins et al. 2012, 
Collins, Wali et al. 2015). Data was filtered to include only reads that were properly paired, 
passed vendor quality checks, and were not PCR duplicates. Statistics were obtained using 
SAMtools.  
3.2.6 PolyA RNA sequencing by Transcript Counting 
 
3 strand-specific libraries were prepared from 400 ng (each) of RNA from the  >200 nt 
fractions. Briefly, RNA was fractionated by heat treatment and subsequently subjected to 
polyA pull down using Streptavidin Magnetic Beads to retain only the 3’ ends of transcripts. 
Partial Illumina adaptors and unique molecular identifiers were added and RNA was 
converted to cDNA. Illumina Adaptors were completed by PCR to produce libraries ready to 
sequence. Full details of the protocol have been included below and an overview of the 
procedure can be seen in Figure 3.9. 
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Figure 3.9 Overview of the Transcript Counting Library Making Protocol 
 
Polyadenylated RNAs (light blue) are extracted and fragmented. Biotinylated polyTNV 
primers (purple letters) are used to pull down the polyA 3’ end of molecules and partial 
Illumina adaptors (red) are ligated to the 5’ end of the fragment. The molecule is reverse 
transcribed to produce cDNA (dark purple) using a polyT primer containing partial adaptor 
sequences (red), a random 4 base sequence (yellow) and an index sequence (green). Cycles of 
PCR complete the Illumina adaptors (blue and pink) to finish the library. (Graphic graciously 
provided by Neha Wali.)  
 
 
3.2.6.1 DNase I treatment and fragmentation of RNA 
 
A 1 µl of a 1:100 dilution of the ERCC spikes (Life Sciences) was added to each sample (465 
pg per sample). RNA was DNase I (NEB) treated for 10 minutes at 37oC and fragmented by 
heating to 75oC for 90 minutes.  
RNA!Fragment!
AAAAAAAAAAAA 
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3.2.6.2 Preparation of biotinylated polyTNV primers 
 
50 µL of Wash/Binding Buffer (0.5M NaCl2, 20 mM Tris-HCl pH 7.5, 1 mM EDTA) was 
added to an empty, clean 96-well plate. 12 µL of Streptavidin Magnetic Beads (NEB) were 
then added to each well, mixed thoroughly, and placed on a plate magnet (Invitrogen) until 
the solution clears (~1 min). The supernatant was discarded and the plate was removed from 
the magnet. The beads were washed twice. For each wash: 100 µL of Wash/Binding Buffer 
was added to each well and the beads were resuspended. The plate was placed on the plate 
magnet until the solution cleared, then the supernatant was removed from the wells and the 
plate removed from the plate magnet. After the second wash, 1 µL of 30T biotinylated 
polyTNV primer (Sigma) was added to each well, mixed, and allowed to bind to the beads 
for 5 minutes. During this time the plate was placed on a tube rotator or other moving 
platform to ensure proper mixing and no sedimentation of the beads. The plate is then placed 
on the plate magnet until the solution clears, then supernatant carefully removed without 
disturbing the beads.  The plate was washed (as described above) and the beads were 
resuspended in 100 µL 2X Wash/Binding Buffer (1 M NaCl2, 20 mM Tris-HCl pH 7.5, 2 
mM EDTA) with 1µL of RNase Inhibitor (NEB) added.   
3.2.6.3 Annealing the fragmented RNA to biotinylated polyTNV primers 
 
Fragmented RNA was carefully added to the plate and mixed well to resuspend the beads. 
RNA was allowed to bind to the poly T primers for 20 minutes while being gently mixed to 
prevent bead sedimentation. The RNA-bead mixture was moved to a new plate and placed on 
the plate magnet until the solution cleared. The supernatant is carefully removed, without 
disturbing the beads and washed twice (described above). Once removed from the plate 
magnet, the beads were resuspended in 100 µL of cold No EDTA/Low Salt Buffer (0.15 M 
NaCl2, 20 mM Tris-HCl pH 5.5) and returned to the plate magnet until the solution cleared 
again. The supernatant was removed and the beads and fragmented RNA were resuspended 
in 18.9 µL RNase-free water (Sigma). 
3.2.6.4 Ligation of partial Illumina adaptor oligos 
 
Fragmented RNA was phosphorylated using T4 Polynucleotide Kinase 3’ phosphatase minus 
(NEB) with 1 µL RNase Inhibitor for 30 minutes at 37oC and Illumina adaptor oligos 
(sequences obtained from Bentley, Balasubramanian et al. (2008)) were ligated on using T4 
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RNA Ligase (NEB), according to an adapted protocol for ligation of an oligo to a single 
stranded template by incubating the reaction at 37oC for 120 minutes. The RNA was washed 
once using 2X Wash/Binding Buffer then twice more using 1X Wash/Binding Buffer (as 
described above). The beads containing adaptor ligated RNA were resuspended in 100 µL of 
cold ‘No EDTA/Low Salt Buffer’ and the plate placed on the plate magnet until the solution 
cleared. The supernatant was removed and the RNA was resuspended in 13 µL of RNase-free 
water. 
3.2.6.5 Elution from streptavidin magnetic beads 
 
The plate was heated to 80oC for 2 minutes and placed on the plate magnet. The supernatant 
immediately removed and retained. If cloudy, the supernatant was placed in a new plate, 
heated to 80oC for 1 minute and the placed on the plate magnet. The supernatant was 
removed and the process repeated until the eluted RNA was clear.  
3.2.6.6 First strand cDNA synthesis by reverse transcription 
 
10 µL of eluted RNA was transferred to a new plate and cDNA was synthesized using 
Superscript II Reverse Transcriptase (Invitrogen) according to the manufacturer’s instructions 
for oligo(dT) primers. PolyT primers (Sigma) consisted of partial Illumina adaptor oligos and 
a unique molecular identifier, containing 5 random bases and 5 base index sequences 
(NNNNNVHBVB), followed by the sample index. RNA was then degraded using Exo I, and 
primers were removed using the PCR clean-up kit (Qiagen), eluted into 38 µL of EB.    
3.2.6.7 PCR amplification and completion of Illumina adaptors 
 
cDNA was amplified using KOD Hot Start Polymerase (Millipore) and primers that complete 
the partial Illumina adaptor sequences. PCR were done according to the manufacturer’s 
instructions, with an annealing temperature of 60oC for 30 seconds and cycling 20 times. 
PCR products were cleaned-up using RNAClean XP SPRI-beads (Agencourt) and a 
DynaMag-96 Sided Skirted Magnet (Life Technologies), according to the manufacturer’s 
instructions and resuspended in 53 µL RNase-free water. 5 µLs of the PCRs were examined 
by gel electrophoresis to confirm the presence of the correctly sized cDNA libraries and the 
absence of genomic DNA contamination.   
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3.2.6.8 PolyA RNA sequence mapping using TopHat 
 
Reads produced from the 3 large RNA sequencing replicates were mapped using TopHat to 
the zebrafish genome (Zv9, release 75 and downstream analysis on the resultant mapped 
reads was done using R and the R package cummeRbund as described by Trapnell, Roberts et 
al. (2012). Further information about transcripts, including canonical lengths and types, were 
extracted from the Ensembl API using Perl/BioPerl. Data was filtered in include only reads 
which were properly paired, passed vendor quality checks, and were not PCR duplicates. 
Statistics were obtained using SAMtools. The top 1000 most abundantly expressed Ensembl 
transcript IDs were submitted to GeneCodis3 for GO term analysis. 
3.2.6.9 PolyA RNA sequence mapping using DeTCT 
 
Reads produced from the 3 polyA RNA sequencing replicates were also mapped to the 
zebrafish genome (Zv9, release 75) using the DeTCT pipeline. Data was filtered to include 
only reads that were properly paired, passed vendor quality checks, and were not PCR 
duplicates. Statistics were obtained using SAMtools.  
3.2.7 Comparison between small RNA and polyA RNA datasets 
 
The highest expressed Ensembl IDs were compared between datasets and expression values 
for each replicate recorded in a heat map table.  
Ensembl IDs were matched between polyA sequencing and the small RNA 
sequencing datasets for each replicate to compare expression. Numbers of genes expressed in 
each dataset separately, and in both, were tallied. The numbers were plotted on a Venn 
diagram. 
Expression of all Ensembl IDs for each replicate was compared between the small 
RNA and polyA RNA sequencing datasets. Expression values were plotted for the two 
datasets using Excel (Microsoft) in order of highest to lowest expression (>1 normalized 
count) in the polyA RNA dataset.  
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3.2.8 Workflow diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Workflow diagram for small RNA and polyA RNA sequencing in multiple 
replicates  
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3.3 Results 
3.3.1 Small RNA peak observed in Xenopus ovaries can be observed in zebrafish ovaries 
 
An abundant peak of RNA was identified within zebrafish oocytes when total RNA extracted 
using the Trizol-chloroform method was run on a Bioanalyzer. This peak was approximately 
100 nt in size. Repeated RNA extractions from whole ovaries using the Trizol-chloroform 
method, as well as alternative methods, did not eliminate the peak, however the relative 
height of the peak varied between samples.  
 
 
 
Figure 3.11 RNA electropherogram traces from Xenopus and zebrafish ovaries and muscle 
 
Representative electropherogram traces of RNA extracted from Xenopus laevis A) ovary and 
B) muscle. Representative electropherogram traces of RNA extracted from zebrafish C) 
ovary and D) muscle. Areas measured for the peak, 18S rRNA and 28S rRNA have been 
labelled in blue, pink and green, respectively. FU – Fluorescence Units, nt - nucleotides 
 
3.3.2 Characterization of the small RNA in zebrafish oocytes 
3.3.2.1 The small RNA peak decreases throughout oogenesis 
 
To determine if the variation in peak size observed was due to a stage specific change in the 
peak RNA was extracted from groups of staged oocytes. It was found that the area of the 
peak, compared to the area of the 18S rRNA area, changed in accordance with the stage: 
stage I oocytes had the largest peak area relative to 18S rRNA area (~12x, Figure 3.12A and 
E), the peak decreased in stage II (Figure 3.12B), decreased again in stage III (Figure 3.12C), 
and was almost absent by stage IV (Figure 3.12D). These proportions were found to be 
reproducible over multiple RNA extractions. 
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Figure 3.12 RNA electropherograms showing the relative heights of rRNA peaks in 
different stages 
 
(A) Stage I (B) Stage II (C) Stage III (D) Stage IV. 18S and 28S rRNAs are labelled in pink 
and green, respectively. (E) Bar graph showing the ratio of the area of the peak compared to 
18S rRNA for each stage of oogenesis. FU – Fluorescence Units; nt – nucleotides. 
 
 
3.3.2.2 The small RNA peak was only observed in ovary tissue 
 
To test if the small RNAs are produced in a tissue specific manner, RNA was extracted from 
various zebrafish tissues and run on Bioanalyzer nano chips. The peak of small RNA was 
only found in ovary tissue, however many tissues had evidence of small RNA expression, for 
instance in the testis and intestine (Figure 3.13 B & E), these increases can be explained 
through the increase in piRNAs known to occur during spermatogenesis (Houwing, 
Kamminga et al. 2007) and due to the fact that lower RIN scores were recorded for the 
intestine samples, indicating RNA degradation had taken place – potentially inflating the 
small RNA peak areas. Comparisons determined the peak ratio for the ovary was 
significantly different from all other tissue types with a p-value of <0.05, with the exception 
of the intestine, which had a p-value of 0.07 (Figure 3.13E).  
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Figure 3.13 RNA electropherograms depicting zebrafish tissue specificity 
 
(A-D) Representative electropherogram traces of RNA extracted from Zebrafish ovary, testis, 
heart and muscle, respectively. Areas measured for peak, 18S rRNA, and 28S rRNA have 
been labelled in blue, pink and green, respectively in each trace. FU – Fluorescence Units, nt 
- nucleotides (E) Bar graph showing peak area: 18S rRNA area in various tissues. Two stars 
(**) indicates significant a p value of <0.05 compared against ovary samples in a Student’s t-
test.  
3.3.2.3 The small RNA peak can be resolved into two peaks of RNA 
 
RNA extracted from Zebrafish ovaries was run on a small RNA Bioanalyzer chip to more 
accurately determine its size. When run at a greater resolution, the single peak observed in 
ovary and oocyte samples, can be observed as two peaks occurring at ~80 nt and ~100 nt. 
The smaller of the two, at 80 nt has a slightly more broad range than the higher peak at 100 
nt, which was observed to be very sharp (Figure 3.14). 
 
     
 
Figure 3.14 Small RNA size estimation from electropherogram traces 
 
(A) Representative small RNA electropherogram traces of RNA extracted from Zebrafish 
ovary. Boundary regions for miRNA, lower, and upper peaks have been labelled in light blue, 
purple, and green, respectively. FU – Fluorescence Units, nt – nucleotides (B) Graph 
showing the average area percentage of small RNA measured within each boundary, from the 
small RNA electropherogram traces from zebrafish ovaries.  
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3.3.3 Confirmation using established protocols 
3.3.3.1 No differences were observed using alternative extraction methods 
 
The methods of RNA extraction used on oocytes or ovaries did not effect the formation of the 
small RNA peak. Differences in the area of the peaks, extracted under different protocols, 
were determined to be non-significant by a Student’s T-Test (Table 3.3).  
 
Method 1 Method 2 Student’s T-Test Result 
MiRNEasy Columns MinElute Columns p = 0.639 
MinElute Columns Trizol  p = 0.572 
Trizol MiRNEasy Columns p = 0.348 
 
Table 3.3 Comparison of RNA extraction methods 
 
Results from Student’s T-Tests showing non-significant changes in the peak to 18S rRNA 
ratios between methods tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 RNA polyacrylamide gel of various zebrafish tissues 
 
A denaturing gel run to look at the profile of the RNA extracted from various tissues and 
embryos, confirming results obtained from the Bioanalyzer. Strong 18S and 28S rRNA bands 
are present in all tissues, however an additional band at the size of the 5S rRNA, 100 nt in 
size, was visible within the ovary tissue, which was absent in control tissues. Low Range 
RNA Ladders (Thermo Scientific) were used. 
3.3.3.2 RNA Analysis using polyacrylamide gel electrophoresis 
 
Ovary RNA was run on a denaturing gel to visualize it using an alternative method to the 
Bioanalyzer. Ovary RNA in addition to Muscle and Embryo RNA all showed strong 18S and 
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28S rRNA bands, however, as was observed on the Bioanalyzer traces, a peak of ~100 nt was 
present in the ovary sample, at approximately the size of the 5S rRNA band (Figure 3.15). 
3.3.4 Comparison with normal RNA degradation 
 
The literature search showed good quality RNA run on Bioanalyzer chips produced traces 
with low baselines, varying from zero only when a strong sharp peak is present and returning 
to the zero line after the peak, as observed in Figure 3.16A. Large deviations from this, such 
as broad peaks, variable baselines or baselines which do not return to zero, as observed in 
Figure 3.16B, was indicative of low quality RNA. Using these qualifiers and 28S/18S rRNA 
ratios as a means of determining RNA quality (as discussed in Chapter 2), electropherogram 
traces of RNA extracted from oocytes were examined. For oocyte samples with high rRNA 
ratios: the peak of small RNA was observed to be sharp, non-variable and did not result in a 
variation of the baseline from zero; all factors indicating the RNA was of good quality 
(Figure 3.16C). Samples with low rRNA ratios had high, non-zero returning baselines and 
large broad peaks – with the small RNA peak still present, rising from the altered baseline, 
indicating the RNA was of low quality (Figure 3.16D). The maintenance of the small RNA 
peak in the low quality samples and the presence of the peak in samples considered to be high 
quality both suggest the peak is not the result of normal RNA degradation. 
 
 
 
Figure 3.16 Quality Assessment of RNA Electropherograms 
 
Representative RNA electropherograms showing the relative heights of rRNA peaks and the 
baseline from the literature: A) a good quality RNA sample, and B) an RNA sample with 
degradation; and experimental samples: C) good quality stage III oocyte RNA, and D) 
degraded stage III oocyte RNA. Panels A & B have been adapted from Peña-Llopis and 
Brugarolas (2013). 18S and 28S rRNAs are labelled in pink and green, respectively. FU – 
Fluorescence Units, nt – nucleotides, s – seconds. 
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3.3.5 Role of apoptosis 
3.3.5.1 The small RNA peak is present in the ovaries of apoptosis deficient p53-/- mutant 
female zebrafish 
 
RNA from stage I and II oocytes was extracted from p53 heterozygous (+/-) and homozygous 
(-/-) knockout siblings and analysed to establish if the formation of the small RNA was 
related to p53-mediated apoptosis. Homozygous females, which lack functional p53 protein 
and therefore are unable to undergo p53-mediated apoptosis, were observed to produce the 
small RNAs at a similar level to heterozygous females, indicating the formation of the peak is 
not reliant on p53-mediated apoptosis (Figure 3.17). Additional small RNAs within the size 
range of piRNAs and miRNAs were found in the heterozygous fish, which were absent in the 
homozygous fish examined.   
  
 
 
Figure 3.17 RNA electropherogram traces from p53 mutant fish 
 
Representative Bioanalyzer RNA electropherogram traces of stage I and II oocytes from A) 
p53 heterozygous (+/-) and B) p53 homozygous (-/-) zebrafish. Black arrow indicates 
additional small RNA species present in heterozygous fish, with functioning apoptotic 
pathways. Areas measured for peak, 18S rRNA, and 28S rRNA have been labelled in blue, 
pink and green, respectively. FU – Fluorescence Units, nt - nucleotides 
 
3.3.5.2 Inducing degradation and apoptosis using 6’hydroxyurea did not produce the small 
RNA  
 
Wild type embryos were treated with 6’hydroxyurea to determine if the induction of 
apoptosis and RNA degradation led to the formation of the small RNA peak observed. No 
significant difference was observed in the small RNA region of interest between the treated 
and control embryos after 6 or 24 hours of incubation, indicating apoptosis does not play a 
role in the formation of the small RNA peak (Figure 3.18). 
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Figure 3.18 Representative bioanalyzer RNA electropherogram traces of zebrafish 
embryos treated with 6’hydroxyurea (6HU)  
 
A) Control embryos incubated in egg water. B) 6HU treated embryos. Absence of the small 
RNA peak indicates it does not form in response to apoptosis. 18S and 28S rRNAs are 
labelled in pink and green, respectively.  FU – Fluorescence Units, nt - nucleotides 
 
3.3.6 Small RNA sequencing initial results 
3.3.6.1 Successful small RNA extraction and isolation 
 
High quality RNA was successfully extracted from stage I oocytes and cleanly separated into 
two fractions – small RNA (< 200 nt) and large RNA (>200 nt), as described in Section 
3.2.1.3, with negligible contamination between the two (Figure 3.19). This result shows the 
method to be effective in separating small RNA from large RNAs, and will be used 
throughout future experiments where separate fractions are needed. 
 
 
 
Figure 3.19 RNA electropherogram traces showing separation of small and large RNA 
fractions 
 
Overlaid RNA electropherograms of ovary sample fractions divided using the size separation 
protocol described in Section 3.2.1.3. The red line is the trace for the >200 nt RNA fraction, 
and the blue line is the trace for the <200 nt RNA fraction. A marker peak at 25 nt is present 
in both samples. FU – Fluorescence Units, nt – nucleotides 
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3.3.6.2 The majority of sequences mapped to the ends of a small number of Ensembl IDs 
 
19.2 million paired-end reads were sequenced and mapped to the genome using BWA. 
92.67% mapped to the zebrafish genome (Zv9) and 7.33% were filtered out due to low 
quality scores, improper pairing or aligning across chromosomes. Of the reads mapping to the 
genome, only 2.5 million paired-end reads mapped to Ensembl Gene IDs, 12.62% (Figure 
3.20B). The remaining reads successfully mapped to the zebrafish genome outside of 
Ensembl Gene ID regions.  
The reads that mapped to Ensembl IDs with >1 paired-end read, mapped across 
15,894 different gene IDs potentially indicating the presence of RNA from 47.1% of all the 
genes within the genome. Interestingly, a large majority of the RNA mapped to gene IDs with 
expected transcripts lengths larger than the size selection limits set during the library prep - 
97.5% of the transcripts identified were expected to be larger than 200 nt and 84.7% expected 
to be larger than 1000 nt (Figure 3.20A). In addition, the majority of reads (61%) mapping to 
IDs originated from protein coding IDs, while small RNA IDs, which were expected to make 
up the majority of the library, accounted for a smaller proportion (20%) of the reads (Figure 
3.20C and Table 3.4).  
Reads were detected in both sense and antisense directions across the dataset, 
however antisense reads were almost exclusively mapped to miRNA and known antisense 
transcripts, indicating no unexpected antisense transcripts were present. Further analysis of 
protein coding IDs revealed the reads consisted almost exclusively of exonic sequences, with 
only 2% coming from intronic sequences (Figure 3.20D). When viewed in Ensembl (data not 
shown), these intronic sequences often were overlapped by or were antisense to another 
transcript, the majority of which were miRNA.  
Looking at where reads mapped along the transcripts; the base with the highest 
number of reads was most often at the 5’ most end of the transcript, within the first 1% of the 
sequence. The next base with the highest number of reads was at the 3’ end, in the last 1% of 
the transcript, with fewer reads mapping across the central regions (Figure 3.20E).   
Taking into account only Ensembl IDs with >100 paired-end reads (a commonly used 
level of significance), the number of IDs the RNA mapped to dropped to 1,026 IDs, ~ 3.0% 
of the genes within the genome. Again, the majority of these reads mapped to protein coding 
transcript types (52%, see Figure 3.21C and Table 3.4), with the next most abundant 
transcript type being miRNA (25%). 
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Genes with >1 paired-end read 15,894 (47.1% of genes) 
Genes with >100 paired-end reads 1,026 (3.0% of genes) 
Genes in Zebrafish Genome (Zv9) 33,737  
Mean read span (calculated) 317 nt (STD 128.79 nt) 
Size Selected during RNA prep <200 nt  
Transcripts with expected length >200 nt 15,504 (97.5% of reads) 
Transcripts with expected length >1000 nt 13,469 (84.7% of reads) 
                     
            
 
 
 
Figure 3.20 Initial small RNA sequencing Ensembl ID mapping statistics  
 
A) Table of ID numbers and length statistics. B) Pie chart showing the proportion of reads 
originating from Ensembl IDs, filtered out, and mapping to the Zebrafish genome outside of 
Ensembl ID regions. C) Pie chart showing the percentage of the Ensembl ID reads mapping 
to various transcript types: miscRNA (green) includes rRNA, lincRNA, snoRNA, and 
snRNA. D) Pie chart showing the percentage of the Ensembl ID reads mapping to exonic and 
intronic sequence for all IDs. E) 5’ or 3’ Bias of the nucleotide with the highest read count 
per transcript, depicted in a histogram. 
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The top 34 Ensembl IDs produced more than 50% of the reads that mapped to 
Ensembl IDs (Figure 3.21D). 23 of these IDs were miRNA and 6 were found to be protein 
coding, however more reads mapped to these 6 protein-coding transcripts than to the miRNA 
transcripts in total (Table 3.4). This was possible as the Ensembl ID with the highest read 
count, ENSDARG00000088951 (AL935186.6), accounted for 11.4% of all the reads that 
mapped to Ensembl IDs. 
Additional statistics and information have been included in Figures 3.17 and 3.18, as 
well as in the Supplementary Materials, Tables S3-S5.   
Transcript Type 
Number of Gene IDs Number of Reads 
Top 34 IDs Top 1,026 IDs Top 34 IDs Top 1,026 IDs 
Protein coding 6 863 568417 1025622 
miRNA 23 44 425491 484345 
misc RNA 2 61 21272 198594 
Mt rRNA 2 2 174466 174466 
lincRNA 1 1 38189 38189 
snoRNA 0 32 0 25305 
rRNA 0 5 0 6069 
Processed transcript 0 6 0 5853 
Pseudogene 0 5 0 4545 
snRNA 0 2 0 1375 
Mt tRNA 0 2 0 969 
Antisense 0 1 0 433 
Polymorphic pseudogene 0 1 0 394 
 
Table 3.4 Transcript types of Ensembl ID mapping reads 
 
3.3.6.3 Transcripts were highly enriched for terms related to oogenesis, embryogenesis and 
the ribonucleoprotein complex 
 
GO term analysis was done on the IDs with >100 paired-end reads to look for underlying 
associations within the dataset. KEGG pathway analysis revealed many of the transcripts 
found were associated with RNA production, processing and degradation (marked in blue, 
Figure 3.22). Also highly enriched were transcripts with oocyte specific functions, such as 
‘oocyte meiosis’ and ‘progesterone-mediated oocyte maturation’ (marked in red, Figure 
3.22). Many embryonic related terms, such as ‘determination of dorsal/ventral asymmetry’, 
‘digestive tract development’ and ‘endoderm formation’, were found to be highly associated 
during biological process analysis as well as terms related to RNA translation (Table S6). 
The cellular component with the lowest p-value was the ribonucleoprotein complex 
(p=9.31x10-14), with other related terms also scoring low p-values. This was reflected in the 
molecular function analysis, as terms related to ribosomes, nucleotide and nucleic acid 
binding were highly associated. Terms related to translation and protein processing were  
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IDs Predicted Min 1st Quartile Median Mean 3rd Quartile Max 
Top 34 81    86.0 90.0 291.2 301.2 1683 
Top 1,026 67 676.2 1801.5 2427.2 3107.0 25178 
All 48 1282.0 2008.0 2520.0 3125.0 93957 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21 Initial small RNA sequencing Ensembl ID transcript type statistics   
 
A) Table of statistics about the lengths in nucleotides (nt) calculated from the most highly 
expressed 34 and 1,026 Ensembl IDs. Pie charts of the types of transcripts making up the top 
34 Ensembl IDs (B) and top 1,026 Ensembl IDs (C), depicted with percentages. “Other 
RNA” includes lincRNA, snoRNA, snRNA, etc. D) A cropped view of the graph that depicts 
read counts for each Ensembl gene ID sequenced. The data continues in this trend throughout 
the remaining ~15,000 Ensembl IDs and has been simplified for clarity. The red dashed line 
depicts 50% of the reads. 
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highly represented, as were those relating to chromatin binding, including DNA 
topoisomerase activity. 
MicroRNA analysis showed many associated microRNAs including miR-430, known 
to be involved in embryonic development (Giraldez, Mishima et al. 2006), and miR-16 & 
miR-457 which have been associated with inducing cell-cycle arrest in cell lines (Liu, Fu et 
al. 2008) and could be initiating a similar process of meiotic arrest during oogenesis. 
Full tables of GO term results are available in Supplementary Materials (Tables S6-S10). 
 
 
 
Figure 3.22 KEGG pathway analysis of Ensembl IDs sequenced in the small RNA fraction  
 
IDs with >100 reads were analysed by KEGG pathway analysis. Terms are listed in order of 
corrected p-value significance. Highlighted terms in red are oocyte specific functions and 
those in blue are related to RNA production, processing, and degradation. See Supplementary 
Materials Table S6 for the complete results. 
 
3.3.6.4 Highly expressed Ensembl IDs and reads within unannotated regions were found 
adjacent to 5.8S rRNA genes and have potentially been incorrectly classified 
 
Gene IDs with the highest read counts were viewed in the Ensembl web browser. The 
majority of these gene IDs had been tentatively classified as protein coding and miRNA by 
sequence similarity and had little specific functional annotation attributed to them. Many of 
the reads extended past the defined boundaries of the transcripts possibly indicating problems 
in the annotation of the zebrafish genome or problems with mapping, due to repeat regions or 
areas of high sequence similarity. No specific repeats or features stood out as a possible cause 
for the high read counts in these regions, and a number of these IDs and associated reads 
were found to be adjacent to 5.8S rRNA genes. 5.8S rRNA regions elsewhere in the genome 
were viewed, the same pattern was observed (Figure 3.23).  
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Figure 3.23 Ensembl browser images of reads mapping to regions adjacent to 5.8S rRNA 
genes 
 
Small RNA sequencing reads displayed on the Ensembl website under the heading ‘ssmiseq’ 
and shown as grey bars. 5.8S rRNA Ensembl IDs of interest in the region have been 
highlighted in green. A) ENSDARG00000080925 (5.8S rRNA), B) ENSDARG00000087890 
(5.8S rRNA), C) ENSDARG00000091828 (5.8S rRNA). Many reads map adjacent to 5.8S 
rRNA sequences, both within gene regions and in unannotated regions.  
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Figure 3.24 Transcript types after reassignment of Ensembl IDs  
 
A) Pie chart showing the number of reads mapping to each transcript type after strict 
reclassification. IDs were reclassified if within 500 bp of 5.8S rRNA gene annotations. B) Pie 
chart showing the number of reads mapping to each transcript type after loose 
reclassification. IDs were reclassified if within 5 kb of a 5.8S rRNA gene. 
 
3.3.6.5 Unmapped reads align to zebrafish rRNA reference genes 
 
After the highly expressed genes and surrounding transcripts were reassigned transcript 
types, it became clear the proportion of rRNA needed to be investigated (Figure 3.24). Re-
mapping to the custom rRNA references showed the majority of reads were rRNA derived. 
11.3 million paired-end reads mapped to the derived zebrafish rRNA reference genome, 
accounting for 52.63% of the reads sequenced, 12.62% mapped to known cDNAs (including 
small RNAs), 0.14% represented expression from transposable elements and the remaining 
31.43% was expression of other genomic regions (Figure 3.25A). 5S rRNA, expected to be 
the most highly represented species, only accounted for 0.08% of the total reads (Figure 
3.25B). 
Of the total, 33.98% of the reads mapped to the rRNA transcript sequences 
themselves, while 18.65% mapped to the internal and external transcribed sequences that 
make up the rest of the 45S pre-rRNA transcript. The numbers of reads observed were highly 
similar to what was expected if the entire 45S pre-rRNA transcript was producing the reads at 
an equal, proportional rate for their lengths (Figure 3.25C). The amount of 28S and 18S 
rRNA mapping reads were 22.19% and 11.62% of the total respectively, which correlates 
highly compared to expected percentages of 22.21% and 10.41%, respectively (Figure 
3.25C). Slightly less reads were observed than expected for the 5.8S rRNA and 5’ETS 
regions, at 0.10% and 7.26% respectively, compared to the expected percentages of 1.05% 
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and 10.43%, respectively. Part of this discrepancy can be accounted for when reads that map 
across boundaries are taken into account – 2.69% of reads map across the boundary between 
the 5’ETS and 18S regions bringing the total containing 5’ETS reads to 9.95% (Table 3.5). 
An excess of ITS mapping reads were identified, 11.34% compared to the expected 8.44%. 
One suggested explanation is that a proportion of these reads could represent 5.8S rRNA 
transcripts or overlapping 5.8S and ITS reads. The 5.8S rRNA transcript is small, at only 155 
nt, decreasing the number of reads likely to map successfully with both ends entirely in this 
region. 
 
 
Figure 3.25 rRNA Reference Mapping Statistics 
 
A) Pie chart showing the percentage of reads mapping to final rRNA sequences, pre-rRNA 
junction sequences, cDNAs (Ensembl IDs), and transposable elements of the total reads 
sequenced. Other reads mapped to the zebrafish genome outside of these categories. B) Bar 
chart showing the percentage of reads mapping to the 5S rRNA transcript out of the total 
sequenced in dark blue (observed) and the percentage of reads expected to be found based on 
existing literature in light blue (expected). C) Bar chart showing the percentage of reads 
mapping to specific rRNA transcripts, of the total reads sequenced, in dark blue (observed) 
and the percentage of reads expected to be found if expressed in equal proportions, in light 
blue (expected). 5’ETS and 3’ETS stand for 5’ and 3’ external transcribed sequences, 
respectively, ITS includes both internal transcribed sequences, ITS1 and ITS2. D) Density 
plot showing the length of templates from reads mapping to the 45S pre-rRNA transcript. 
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Regions 5'ETS & 18S 18S & ITS 5.8S & ITS 28S & ITS 28S & 3'ETS Total Across  
Reads 1031586 922 8 88598 612 1121726 
Percentage  2.69% 0.00% 0.00% 0.23% 0.00% 2.92% 
 
Table 3.5 Reads mapping across rRNA transcript boundaries 
 
Table of adjacent rRNA regions from the 45S pre-rRNA with counts of reads mapping across 
the boundaries, and the percentages of the total number of reads sequenced this represents. 
 
 
3.3.7 Small RNA sequencing replicate results 
3.3.7.1 Sequencing was successful 
 
A total of 8.1 million paired-end reads were generated across the 3 replicates within the run. 
The first wild-type replicate (WT1) accounted for 1.9 million paired-end reads (23.4%), the 
second replicate (WT2) accounted for 2.4 million paired-end reads (29.6%) and the third 
replicate (WT3) accounted for 3.8 million paired-end reads (46.9%) (Table 3.6). Further 
statistics have been included in the Supplementary Materials S4.1, Tables S34-S36.  
 
Replicate Reads  
WT1 1.9 M 
WT2 2.4 M 
WT3 3.8 M 
 
Table 3.6 Number of paired-end reads sequenced for the small RNA sequencing 
replicates 
 
Numbers of reads were provided by the in-house sequencing team. M – million. 
 
3.3.7.2 Mapping was successful using TopHat 
 
A total of 5.6 million paired-end reads mapped to the zebrafish transcriptome using TopHat, 
accounting for 69.1% of the reads sequenced. WT1 accounted for 1.7 million reads (89.5%), 
WT2 accounted for 2.4 million reads (~99%) and WT3 accounted for 1.5 million reads 
(39.5%) (Table 3.7). Size factors were calculated and the data was normalized to account for 
differences between replicates. Flagstat statistics generated by SAMtools for each sample 
have been included in the Supplementary Materials S4.2. 
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Replicate Reads Mapped Size Factor 
WT1 1.7 M (89.5%) 1.554870926 
WT2 2.4 M (~99%) 0.562505764 
WT3 1.5 M (39.5%) 1.805871334 
 
Table 3.7 Number of reads paired-end mapped and size factors calculated for each small 
RNA sequencing replicate 
 
Numbers of reads were calculated using SAMtools Flagstat after mapping. Size factors were 
calculated during the DeTCT pipeline run. M – million  
 
3.3.7.3 Read Trimming improved mapping of reads using TopHat 
 
Mapping the untrimmed reads resulted in a low percentage of the total reads mapping, with 
an average of only 45.4% (Table 3.8). This was improved to an average of 94.3% when the 
reads were trimmed to 30 nt using FASTX_trimmer to remove any adapter sequences, 
therefore reads were trimmed before mapping.  
 
Sample Untrimmed Trimmed 
WT1 0.8 M (43.5%) 1.7 M (92.1%) 
WT2 0.8 M (33.7%) 2.3 M (94.6%) 
WT3 2.2 M (59.1%) 3.6 M (96.2%) 
Average 1.3 M (45.4%) 2.5 M (94.3%) 
   
Table 3.8 Overall small RNA replicate read alignment rates after mapping with TopHat, 
with and without trimming reads  
 
Numbers of reads were calculated using SAMtools Flagstat after mapping. M – million  
 
3.3.7.4 Replicates were of high quality and showed similar in expression 
 
To ensure the data is of high quality and comparable, a number of quality control steps were 
done using the cummeRbund R package. Density plots of expression levels observed within 
each replicate showed the shape of the datasets to be similar, indicating they are comparable 
and not over-dispersed (Figure 3.26A). WT2 had a slightly higher number of highly 
expressed genes (shown in pink) compared to the other two replicates, however this was 
accounted for during normalization and is not expected to influence results. Figure 3.26B 
depicts the same results using boxplots; there are no large variations in the overall shape of 
the datasets again confirming the results are comparable and not over-dispersed. Dispersion 
plots are another method of observing over-dispersion in RNA-Seq datasets. Figure 3.26C 
depicts a dispersion plot of the sequencing replicates showing they are highly similar and not  
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Figure 3.26 Visualization of small RNA replicates using cummeRbund 
 
A) Density plot, B) bar plot, and C) dispersion plot comparing the small RNA sequencing 
replicates WT1, WT2 and WT3. D) MA plot comparing WT1 and WT2. E) MA plot 
comparing WT1 and WT3. F) MA plot comparing WT2 and WT3. 
A B 
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over-dispersed. MA plots comparing fold-change between pairs of replicates did not reveal 
any systemic bias in the data (Figures 5.4D-F). Overall these quality control measures show 
the datasets are similar and not effected by over-dispersion or large underlying systemic 
biases. Figure 3.27 compares expression values between the replicates in a variety of ways. 
The matrix of scatterplots shown in Figure 3.27A, indicates expression is highly correlated 
and similar between the replicates. This is shown again in the matrix of volcano plots (Figure 
3.27B), with the majority of genes having a low value for fold change between replicates and 
few significantly differently expressed genes. Overall the expression levels between 
replicates were highly similar.  
 
 
 
Figure 3.27 Matrix visualization of small RNA replicates using cummeRbund 
 
A) Matrix of scatterplots comparing small RNA sequencing replicates WT1, WT2, and WT3. 
B) Matrix of volcano plots comparing small RNA sequencing replicates. 
3.3.7.5 Similar Ensembl IDs and transcript types were expressed in all of the replicates  
 
An average of 6,613 Ensembl gene IDs were identified as expressed with >1 paired-end read 
using the DeTCT pipeline, indicating 19.6% of all zebrafish genes were identified within this 
dataset (Table 3.9). This number fell to an average of 122 gene IDs (0.3%) using an 
alternative cut off for expression of >100 paired-end reads, indicating that although many 
transcripts are represented at a low level, there are several highly abundant transcripts. This 
can clearly be seen in Figures 5.6 A and B, which depict read counts for each gene ID. The 
top 4-5 Ensembl IDs account for a much larger percentage of the reads than the remaining 
IDs, with the top ~25 Ensembl IDs accounting for over 10% of all the reads.  
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Replicate 
Gene IDs 
>1 
Gene IDs 
>100 
WT1 6,758 (20.0%) 115 (0.3%) 
WT2 6,117 (18.1%) 136 (0.4%) 
WT3 6,965 (20.6%) 116 (0.3%) 
 
Table 3.9 Ensembl gene IDs identified within the small RNA sequencing replicates 
 
The number of Ensembl gene IDs identified was calculated for each replicate at two levels of 
significance, >1 FPKM and >100 FPKM. Percentages indicate the proportion of Ensembl IDs 
expressed out of the total within the zebrafish genome. 
 
An average of 61% of reads were identified as protein coding, 17% were types of 
small RNA, such as miRNA or snoRNA, and 22% represented other transcript types such as 
pseudogenes, processed transcripts, and lincRNAs (Figure 3.28C). There was a high amount 
of overlap between the highest expressed genes within each replicate, and the highest 
expression found for all replicates was a 5.8S rRNA transcript (Table 3.10). The differences 
in the number of reads identified between the replicates are possibly due to differences in the 
total number of reads sequenced. The amount of variation in expression between replicates 
was low, with the vast majority of transcripts having a coefficient of variation <0.6, although 
a small number had values >1.6 (Figure 3.28D). Highly variable transcripts were mostly 
lowly expressed (Figure 3.28E) and uncharacterized or poorly defined transcripts (Table 
3.11), possibly affecting mapping ability or depth of sequencing. These transcripts all had 
expression in only one replicate. 
 
 
 
 
 
 
 
 
 
 
 
Table 3.10 Highest expressed genes from small RNA-Seq replicates  
 
Highest expressed genes identified in the small RNA-seq replicates calculated using DeTCT 
pipeline. Numbers indicate the rank within each replicate. Colours indicate read count.  
Gene ID Gene Name Transcript type 1 2 3 
ENSDARG00000081218 5_8S_rRNA rRNA 1 1 1 
ENSDARG00000085067 AL935186.2 miRNA 2 2 2 
ENSDARG00000070212 zgc:158463 protein_coding 3 4 4 
ENSDARG00000089382 zgc:158463 protein_coding 4 3 3 
ENSDARG00000082753 AC024175.17 Mt_rRNA 5 5 5 
ENSDARG00000079546 BX548000.1 protein_coding 6   
ENSDARG00000052879 si:ch73-207h17.1 protein_coding 7   
ENSDARG00000083337 RNase_MRP misc_RNA 8   
ENSDARG00000089108 BX571823.5 pseudogene 9   
ENSDARG00000087504 CABZ01045618.2 miRNA 10 6 7 
ENSDARG00000088673 CT956064.5 miRNA  7 10 
ENSDARG00000088510 BX537263.7 miRNA  8  
ENSDARG00000096403 si:dkey-153m14.1 lincRNA  9 9 
ENSDARG00000087732 Metazoa_SRP misc_RNA  10  
ENSDARG00000083567 CR753902.1 miRNA   6 
ENSDARG00000058869 NEK3 protein_coding   8 
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Figure 3.28 Small RNA sequencing replicate expression comparisons 
 
A) Expression counts for each gene ID was averaged across all three replicates and plotted in 
order of highest to lowest expression. Read counts for all zebrafish gene IDs, the dashed red 
line indicates 50% of the reads. B) Focus on the first 100 gene IDs from A, the red dashed 
line indicates 10% of the reads. C) Pie charts of the percentages of reads mapping to Ensembl 
IDs for each transcript type across all 3 replicates. D) Histogram of the coefficient of 
variation (CV) (standard deviation/mean). E) Graph depicting the squared coefficient of 
variation (CV2) vs. average number of read counts.   
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Ensembl ID Gene name Average Count CV 
ENSDARG00000087095 Metazoa_SRP 20.14794167 1.732050808 
ENSDARG00000090549 CU896602.1 3.64446114 1.732050808 
ENSDARG00000079534 CABZ01112215.1 4.14810564 1.732050808 
ENSDARG00000094800 zgc:173545 5.92586520 1.732050808 
ENSDARG00000092026 CABZ01112215.2 8.29621127 1.732050808 
ENSDARG00000094800 zgc:173545 11.25914387 1.732050808 
ENSDARG00000080987 RNase_MRP 45.59202627 1.732050808 
ENSDARG00000086651 Metazoa_SRP 65.77710368 1.732050808 
ENSDARG00000088923 si:dkeyp-98a7.10 3.50707894 1.732050808 
ENSDARG00000082611 SNORA23 4.28760134 1.732050808 
ENSDARG00000008255 cnot6 48.01208178 0.031314332 
ENSDARG00000029406 h2afx 76.13458744 0.030371974 
ENSDARG00000089314 mapta 12.46673826 0.020776403 
ENSDARG00000074057 calm1a 10.49267913 0.018086467 
ENSDARG00000056462 crp2 73.34452148 0.01506148 
ENSDARG00000058842 ZNF609 (2 of 2) 18.01974945 0.013778051 
ENSDARG00000078904 brd4 7.12810715 0.008955324 
ENSDARG00000057772 march7 7.12810715 0.008955324 
ENSDARG00000041081 suv420h1 7.12810715 0.008955324 
ENSDARG00000056515 spsb1 55.26517810 0.002493205 
Table 3.11 Most and least variable genes within the small RNA sequencing replicates 
 
Average counts and the coefficient of variation (CV) was calculated for each Ensembl ID. 
IDs with an average of < 3 counts were excluded from analysis.  
 
Figure 3.29 Results of KEGG pathway analysis on the small RNA sequencing replicates  
 
Gradient indicates corrected p-value significance ranging from 0.05 to 3.38E-32. Highlighted 
terms in red are oocyte specific functions and those in blue are related to RNA production, 
processing and degradation. Terms ranked by significance. Not to scale. 
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Figure 3.30 Venn diagrams depicting shared GO terms between small RNA sequencing 
replicates 
 
Venn diagrams showing: A) Shared terms between small RNA sequencing replicates of the 
KEGG pathway analysis. B) The number of shared terms from the results of the biological 
process analysis. C) The number of shared terms from the results of the cellular component 
analysis. D) The number of shared terms from the results of the molecular function analysis.  
 
3.3.7.6 GO term analysis indicated the replicates were highly similar and contained oocyte 
specific terms 
 
A list of the top 1000 highest expressed genes, determined by average read counts after 
mapping with TopHat, was subjected to KEGG pathway analysis to produce a comparable 
table of GO terms to the initial small sequencing and to create a figure similar to Figure 3.22. 
  3.3 Results 
 
 
89 
$
!
$
$ $
This analysis revealed many transcripts associated with RNA production, processing and 
degradation (marked in blue, Figure 3.29). Also highly enriched were transcripts with oocyte 
specific functions, such as ‘oocyte meiosis’ and ‘progesterone-mediated oocyte maturation’ 
(marked in red, Figure 3.29). Many terms found in the previous small RNA analysis were 
also identified here. 
GO term and KEGG pathway analysis was also done on the highly expressed genes 
identified in the DeTCT pipeline for each replicate. A Venn diagram showing the overlap in 
terms found between in replicate can be seen in Figure 3.30. Similar terms were found to 
those identified in the transcripts mapped using TopHat indicating little difference between 
mapping methods. The majority of terms identified were found within all three replicates. 
This finding was consistent between KEGG pathway, biological process, cellular component, 
and molecular function analysis; the majority of terms found were the same in all replicates.  
Complete lists of the specific terms found to be overrepresented are available in the 
Supplementary Materials S4.2 and S4.3. 
3.3.7.7 Short fragments of 45S rRNA accounted for the majority of reads within the dataset 
 
Mapping the reads from the small RNA sequencing replicates to the rRNA reference revealed 
a large proportion of reads are likely rRNA derived. For WT2 and WT3 rRNA accounted for 
61% and 51%, respectively, however rRNA only accounted for 29% of the reads in WT1 
(Figure 3.31B). The distribution of reads was as expected, once normalized for the lengths of 
each transcript (Table 3.2) and a very low number of 5S rRNA transcripts were identified 
(Figure 3.31A).  
Template lengths of reads mapping to the rRNA reference and zebrafish 
transcriptome were compared and plotted as density plots (Figure 3.31 C & D). The reads 
observed mapping to the rRNA reference produced a sharp peak indicating they were of a 
specific length, while the reads mapping to the transcriptome were less specific in size and 
showed a rounded peak. 
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Figure 3.31 Small RNA sequence replicates rRNA mapping statistics 
 
A) Percentages of reads mapping to rRNA transcripts for each replicate out of the total 
sequenced. B) Percentage of reads mapping to the entire 45S rRNA transcript for each 
replicate out of the total sequenced. C) Density of template lengths observed for reads 
mapping to the 45S rRNA reference library. D) Density of template lengths observed for 
reads mapping to Zv9 Genome. 
 
3.3.8 PolyA RNA sequencing replicate results 
3.3.8.1 Sequencing was successful 
 
A total of 42.6 million paired-end reads were sequenced across all 3 polyA RNA sequencing 
replicates. The first replicate (WT1) accounted for 13.6 million reads (31.9%), WT2 
accounted for 12.6 million reads (29.6%), and WT3 accounted for 16.4 million reads (38.5%) 
(Table 3.12). Further statistics have been included in the Supplementary Materials S5.1.  
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Replicate Reads 
WT1 13.6 M 
WT2 12.6 M 
WT3 16.4 M 
 
Table 3.12 Number of paired-end reads sequenced for each transcript counting replicate 
 
Calculated using SAMtools Flagstat after mapping. Size factors were calculated during the 
DeTCT pipeline run. M – million 
 
3.3.8.2 Mapping rates were low but sufficient using TopHat 
 
A total of 8.2 million paired-end reads mapped to the zebrafish transcriptome using TopHat, 
accounting for 19.3% of the reads sequenced. A high amount of contaminating reads were 
identified accounting for the low rate of mapping. These reads were excluded from analysis. 
WT1 accounted for 2.5 million reads (18.4%), WT2 accounted for 2.6 million reads (20.6%) 
and WT3 accounted for 3.1 million reads (18.9%). Size factors were calculated and the data 
was normalized to account for differences between replicates. Flagstat statistics generated by 
SAMtools for each sample have been included in the Supplementary Materials S5.1. 
 
Replicate Reads Mapped Size Factor 
WT1 2.5 M (18.4%) 1.140859484 
WT2 2.6 M (20.6%) 1.057506652 
WT3 3.1 M (18.9%) 1.258747313 
 
Table 3.13 Number of paired-end reads mapped using TopHat and size factors calculated 
for each transcript counting replicate 
 
Calculated using SAMtools Flagstat after mapping. Size factors were calculated during the 
DeTCT pipeline run. M – million  
 
3.3.8.3 Replicates were of high quality and similar in expression 
 
To ensure the data is of high quality and comparable, a number of quality control steps were 
done using the cummeRbund R package. A density plot comparing the expression levels 
observed for the polyA sequencing replicates showed the shape of the datasets were similar, 
indicating they are comparable, and that the data is not over-dispersed (Figure 3.32A). Figure 
3.32B depicts the same results as boxplots, again showing the similarity between the datasets. 
Dispersion plots are another method of observing over-dispersion in RNA seq datasets. 
Figure 3.32C depicts a dispersion plot of the sequencing replicates showing they are highly 
similar and not over-dispersed. MA plots comparing fold-change between pairs of replicates 
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Figure 3.32 Visualization of transcript counting replicates using cummeRbund 
 
A) Density plot, B) bar plot, and C) dispersion plot comparing the transcript counting 
replicates WT1, WT2 and WT3. D) MA plot comparing WT2 and WT3. E) MA plot 
comparing WT1 and WT2. F) MA plot comparing WT1 and WT3.  
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did not reveal any systemic bias in the data (Figures 5.11D-F). Overall these quality control 
measures show the datasets are similar and not effected by over-dispersion or large systemic 
biases. Figure 3.33 compares expression values between the replicates in a variety of ways. 
The matrix of scatterplots shown in Figure 3.33A, indicates expression is highly correlated 
and similar between the replicates. This is shown again in the matrix of volcano plots (Figure 
3.33B) with the majority of genes having a low value for fold change between replicates and 
few significantly differently expressed genes. Overall the expression levels between 
replicates were highly similar. 
 
 
 
Figure 3.33 Matrix visualization of transcript counting replicates using cummeRbund 
 
A) Matrix of scatterplots comparing transcript counting replicates WT1, WT2, and WT3. B) 
Matrix of volcano plots comparing transcript counting replicates WT1, WT2, and WT3. 
3.3.8.4 Similar Ensembl IDs and transcripts types were expressed in all replicates 
 
An average of 1,255 Ensembl IDs were identified as expressed with >1 paired-end read using 
the DeTCT pipeline, indicating 3.7% of all zebrafish genes were identified within this dataset 
(Table 3.13). This number fell drastically to an average of 9 gene IDs (0.03%) using an 
alternative cut off for expression of >100 paired-end reads, indicating that numerous 
transcripts are represented at a low level, while there are very few highly abundant 
transcripts. 
An average of 97% of reads were identified as protein coding and 3% represented 
other transcript types such as pseudogenes, and processed transcripts (Figure 3.34A). There 
was a high amount of overlap between the highest expressed genes within each replicate, 
A B 
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with the highest expression assigned to acin1a (ENSDARG00000054290) in replicates WT2 
and WT3, while the highest expressed gene in replicate WT1 was hsp90ab1 
(ENSDARG00000029150) (Table 3.14). The amount of variation in expression between 
replicates was low, with the majority of transcripts having a coefficient of variation <0.6, 
although a small number had values >1.6 (Figure 3.34B). Highly variable transcripts were 
mostly lowly expressed (Figure 3.34C) and some were uncharacterized or poorly defined 
transcripts (Table 3.16). Overall however, there is good correlation in terms of expression 
between the replicates.  
 
Replicate 
Gene IDs 
>1 
Gene IDs 
>100 
WT1 1,245 (3.6%) 11 (0.03%) 
WT2 1,259 (3.7%) 7 (0.02%) 
WT3 1,263 (3.7%) 10 (0.03%) 
 
Table 3.14 Ensembl gene IDs identified within the PolyA RNA sequencing replicates 
 
 
 
 
      
Figure 3.34 PolyA RNA sequencing replicate expression comparison 
 
A) Pie charts of the percentages of reads mapping to Ensembl IDs for each transcript type 
across all 3 replicates. B) Histogram of the coefficient of variation (CV) (standard 
deviation/mean). C) Graph depicting the squared coefficient of variation (CV2) vs. average 
number of read counts. 
B 
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Table 3.15 Highest expressed genes from polyA RNA sequencing replicates 
 
Highest expressed genes identified in the transcript counting replicates using the DeTCT 
pipeline. Numbers indicate the rank within each replicate. Colours indicate read count. 
 
 
Ensembl ID Gene name Average CV 
ENSDARG00000083567 CR753902.1 15.359185380 173.2050808 
ENSDARG00000094960 si:dkey-4c23.8 15.623998930 173.2050808 
ENSDARG00000058869 NEK3 8.474033316 173.2050808 
ENSDARG00000013863 fam133b 3.416881971 153.5104134 
ENSDARG00000054973 itsn2b 11.255328490 147.0548353 
ENSDARG00000092887 si:dkeyp-46h3.3 4.086148924 136.3384774 
ENSDARG00000091643 FP085412.2 4.086148924 136.3384774 
ENSDARG00000019763 acp5a 3.736423187 134.6322686 
ENSDARG00000070714 zgc:173544 3.497303709 132.1922187 
ENSDARG00000087193 prrg2 5.447450728 130.7246736 
ENSDARG00000089966 si:zfos-1505d6.3 62.605334430 6.257512291 
ENSDARG00000042502 h2afvb 4.917979732 6.021311475 
ENSDARG00000042129 zp3a.1 61.714285490 5.745659272 
ENSDARG00000055996 rps8a 57.294390720 4.818830573 
ENSDARG00000043493 cltca 4.625802353 4.571030298 
ENSDARG00000010779 tlk2 9.251604707 4.571030298 
ENSDARG00000041619 gnb2l1 56.802153820 4.240067139 
ENSDARG00000033126 prkrip1 5.498000116 3.898590634 
ENSDARG00000041314 ndufb9 5.498000116 3.898590634 
ENSDARG00000044902 atp2b4 8.671584323 1.615121968 
 
Table 3.16 Most and least variable genes within the polyA RNA sequencing replicates 
 
Average counts and the coefficient of variation (CV) was calculated for each Ensembl ID. 
IDs with an average < 3 expressed transcripts were excluded from analysis. 
Gene ID Gene Name Transcript type 1 2 3 
ENSDARG00000029150 hsp90ab1 protein_coding 1  6 
ENSDARG00000076949 zgc:173837 protein_coding 2  4 
ENSDARG00000037870 actb2 protein_coding 3 4 2 
ENSDARG00000054290 acin1a protein_coding 4 1 1 
ENSDARG00000042130 zp3a.2 protein_coding 5   
ENSDARG00000078638 zgc:171750 protein_coding 6 8  
ENSDARG00000056462 crp2 protein_coding 7  3 
ENSDARG00000088772 BX548000.3 protein_coding 8   
ENSDARG00000037746 actb1 protein_coding 9  10 
ENSDARG00000029150 hsp90ab1 retained_intron 10 6  
ENSDARG00000081443 AC024175.10 Mt_tRNA  2  
ENSDARG00000087655 CLSPN (1 of 2)  protein_coding  3  
ENSDARG00000039208 nasp protein_coding  5  
ENSDARG00000074289 tuba4l protein_coding  7 8 
ENSDARG00000016484 dkc1 protein_coding  9  
ENSDARG00000039828 zp3b protein_coding  10  
ENSDARG00000040344 h1m protein_coding   5 
ENSDARG00000086352 zp2.1 protein_coding   7 
ENSDARG00000003701 cldng protein_coding   9 
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Figure 3.35 Venn diagrams depicting shared GO terms between replicates 
 
Venn diagrams showing: A) Shared terms between transcript counting replicates of the 
KEGG pathway analysis. B) The number of shared terms from the results of the biological 
process analysis. C) The number of shared terms from the results of the cellular component 
analysis. D) The number of shared terms from the results of the molecular function analysis.  
3.3.8.5 GO term analysis indicated the replicates were highly similar and contained oocyte 
specific terms 
 
GO term and KEGG pathway analysis was also done on the highly expressed genes identified 
in the DeTCT pipeline for each replicate. A Venn diagram showing the overlap in terms 
found between the replicates can be seen in Figure 3.35. The majority of terms identified 
were found within all three replicates. This finding was consistent between KEGG pathway, 
biological process, cellular component, and molecular function analysis; the majority of 
terms found were the same in all replicates. Lists of specific terms found to be 
overrepresented for each replicate are available in the Supplementary Materials S5.2. 
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Table 3.17 Highest expressed genes from polyA sequencing 
replicates with counts from the small RNA sequencing replicates 
  
Highest expressed genes identified using the DeTCT pipeline. 
Numbers indicate the rank within each replicate. Colours indicate 
normalized read count. 
 
Table 3.18 Highest expressed genes from small RNA sequencing 
replicates with read counts from the polyA RNA sequencing 
replicates 
 
Highest expressed genes identified using the DeTCT pipeline.    
Numbers indicate the rank within each replicate. Colours indicate 
read count. 
   PolyA RNA Small RNA 
Gene ID Gene Name Transcript type 1 2 3 1 2 3 
ENSDARG00000029150 hsp90ab1 protein_coding 1  6    
ENSDARG00000076949 zgc:173837 protein_coding 2  4    
ENSDARG00000037870 actb2 protein_coding 3 4 2    
ENSDARG00000054290 acin1a protein_coding 4 1 1    
ENSDARG00000042130 zp3a.2 protein_coding 5      
ENSDARG00000078638 zgc:171750 protein_coding 6 8     
ENSDARG00000056462 crp2 protein_coding 7  3    
ENSDARG00000088772 BX548000.3 protein_coding 8      
ENSDARG00000037746 actb1 protein_coding 9  10    
ENSDARG00000029150 hsp90ab1 retained_intron 10 6     
ENSDARG00000081443 AC024175.10 Mt_tRNA  2     
ENSDARG00000087655 CLSPN (1 of 2)  protein_coding  3     
ENSDARG00000039208 nasp protein_coding  5     
ENSDARG00000074289 tuba4l protein_coding  7 8    
ENSDARG00000016484 dkc1 protein_coding  9     
ENSDARG00000039828 zp3b protein_coding  10     
ENSDARG00000040344 h1m protein_coding   5    
ENSDARG00000086352 zp2.1 protein_coding   7    
ENSDARG00000003701 cldng protein_coding   9    
   PolyA RNA Small RNA 
Gene ID Gene Name Transcript type 1 2 3 1 2 3 
ENSDARG00000081218 5_8S_rRNA rRNA    1 1 1 
ENSDARG00000085067 AL935186.2 miRNA    2 2 2 
ENSDARG00000070212 zgc:158463 protein_coding    3 4 4 
ENSDARG00000089382 zgc:158463 protein_coding    4 3 3 
ENSDARG00000082753 AC024175.17 Mt_rRNA    5 5 5 
ENSDARG00000079546 BX548000.1 protein_coding    6   
ENSDARG00000052879 si:ch73-207h17.1 protein_coding    7   
ENSDARG00000083337 RNase_MRP misc_RNA    8   
ENSDARG00000089108 BX571823.5 pseudogene    9   
ENSDARG00000087504 CABZ01045618.2 miRNA    10 6 7 
ENSDARG00000088673 CT956064.5 miRNA     7 10 
ENSDARG00000088510 BX537263.7 miRNA     8  
ENSDARG00000096403 si:dkey-153m14.1 lincRNA     9 9 
ENSDARG00000087732 Metazoa_SRP misc_RNA     10  
ENSDARG00000083567 CR753902.1 miRNA      6 
ENSDARG00000058869 NEK3 protein_coding      8 
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3.3.9 All but one highly expressed Ensembl gene ID from the polyA RNA sequencing was 
identified within the small RNA sequencing dataset 
 
To determine if the highly expressed genes present in the polyA RNA sequencing replicates 
were also represented in the small RNA sequencing replicates, the read counts were 
compared across datasets. All Ensembl IDs, with the exception of AC024175.10 
(ENSDARG00000081443) a mitochondrial tRNA, showed expression in the small RNA 
dataset at a low level (Table 3.17). Read counts from highly expressed IDs from the small 
RNA sequencing replicates was examined in the polyA RNA sequencing dataset (Table 
3.18). A number of protein coding transcripts were expressed including BX548000.1 
(ENSDARG00000079546), si:ch73-207h17.1 (ENSDARG00000052879), and nek3 
(ENSDARG00000058869), as well as a pseudogene, BX571823.5 
(ENSDARG00000089108), and an miRNA, CR753902.1 (ENSDARG00000083567).  
3.3.10 In stage I oocytes, the majority of gene IDs expressed in the small RNA dataset are 
also present in the polyA RNA dataset 
 
For each replicate, the majority of Ensembl IDs expressed in the small RNA dataset could be 
found as expressed in the polyA RNA dataset (Figure 3.36). The small RNA-Seq datasets 
were expected to have a larger proportion of gene IDs not found in the polyA RNA-Seq 
dataset, as many small RNAs such as microRNA and snoRNAs would not be picked up by 
the methods used for the polyA sequencing. However, all the polyA RNA-Seq replicates 
were found to contain many more expressed gene IDs than those not found in the small RNA 
datasets. Overall, the number of gene IDs expressed in only one dataset was low compared to 
the number commonly expressed in the datasets, indicating the populations are similar.  
    
 
Figure 3.36 Venn diagram comparing gene IDs expression in the polyA and small RNA-
Seq datasets  
 
Expression in the polyA RNA-Seq was compared to expression in the small RNA datasets for 
each replicate. Blue represents the small RNAs and purple the polyA RNAs. Not to scale. 
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Figure 3.37 Expression plot comparing stage I polyA and small RNA replicates 
 
Gene expression was compared between small RNA and polyA RNA datasets for replicates 
A) WT1, B) WT2, and C) WT3. Counts are shown in Log10. 
A 
B 
C 
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Comparing the expression of these commonly found IDs showed that highly 
expressed IDs in the polyA datasets were often found at relatively high levels in the small 
RNA datasets and the R2 values produced comparing the datasets were quite high, ~0.7 in all 
replicates (Figure 3.37). As previously observed in Figure 3.36, Figure 3.37 showed a 
number of gene IDs had expression in one dataset, but not the other, resulting in a number of 
data points along the intercepts – interestingly, many of these had high expression values in 
the dataset where they were expressed, suggesting their absence in the other dataset is not due 
to statistical or sampling error. A few IDs with low expression in the polyA RNA sequencing 
had very high counts within the small RNA sequencing – these gene IDs were the same IDs 
found in Table 3.10 of highly expressed genes in the small RNA sequencing, and were 
consistently found to be highly expressed between the replicates.  
 
3.4 Discussion  
3.4.1 The small RNA within zebrafish oocytes is similar to the small RNA in Xenopus 
oocytes 
 
The presence of the small RNA peak, and the changes in it’s size observed between stages, 
have been identified in Xenopus as well as in Teleost fish previously (Mairy and Denis 1971, 
Kroupova, Trubiroha et al. 2011, Diaz De Cerio, Rojo-Bartolomé et al. 2012), however this 
is the first extensive study to date of the phenomenon in Zebrafish.  
By comparing the Bioanalyzer traces in Figure 3.11, a small RNA peak equivalent to 
that observed in Xenopus ovaries was identified in zebrafish ovaries. This peak was 
exclusively found in the ovaries of both species. The approximated size of the small RNA, 
~100 nt, and it’s prevalence in stage I oocytes compared to later stages of oogenesis, is in 
agreement with the previous published research. Figure 3.13E is the first attempt at a 
quantitative measure of the small RNA; in stage I oocytes the area of the small RNA was 
~12X that of the 18S rRNA, while in the other stages the area of the small RNA was roughly 
equal to the area of the 18S rRNA, decreasing as the stage increased.  
Variability in the size and amount of small RNAs can be dependent on the quality of 
the RNA sample or the result of a process the RNA has undergone – confirmation using 
multiple methods is necessary to ensure results are accurate and properly representative of the 
sample. Much work went into ensuring the quality of the RNA extracted using the methods 
developed (as discussed in Chapter 2) and the same quality standards were applied here.  
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RNA extracted using various different methods did not result any statistically 
significant differences in the size or shape of the small RNA peak (Table 3.3), showing the 
RNA being studied is consistently reproducible between experiments and the peak itself is 
not the result of manipulations made during the methods used. Multiple methods of 
visualization of the small RNAs (Figures 3.11 and 3.12) confirmed the peak is not the result 
of using RNA Nano Bioanalyzer chips to view the RNA, potentially a concern as the chips 
are known to sometimes be sensitive to reagents such as Trizol, which is added during RNA 
extraction. All the tested methods of RNA extraction and visualization showed the small 
RNA peak consistently as occurring at ~100 nt, with the area of the peak varying according 
to the proportion of stage I oocytes within the ovary.  
The variability observed between stage I oocyte samples could be natural variability 
between individual cells or due to the pooling of various stage I oocyte types as this category 
included stage Ia and stage Ib oocytes as well as early oocyte germ stem cells. Collection of 
these specific cell types separately could reveal if the small RNAs are more prevalent or 
exclusively found in a specific type. Additionally, the variation could be due when the fish 
were last cycled – an examination of this was attempted however nothing significant was 
found (data not shown) and a number of environmental factors may have influenced the study 
including: feeding times or time of day collections were done, although it is unlikely these 
limitations have produced a large effect and measures were taken to reduce differences 
between collections.  
Closer examination of the small RNA peak using the small RNA Bioanalyzer chips 
revealed it is in fact two distinct peaks (Figure 3.14), a finding that is consistent with research 
of other species (Mairy and Denis 1971), and indicates the RNA extraction methods and 
isolation procedures have successfully captured the intended small RNA. Further analysis of 
the two peaks separately to determine any differences in their content could be achieved by 
separating the RNA, for instance using gel electrophoresis, followed by analysis such as 
sequencing the RNA fractions. The main limitation to undertaking this type of study is the 
very limited amount of starting RNA present within the fractions to analyse. Progress has 
been made in our ability to analyse increasingly small amounts of RNA, with sequencing 
technologies now able to capture the transcriptome of a single cell (Tang, Barbacioru et al. 
2009, Islam, Zeisel et al. 2013, Picelli, Faridani et al. 2014), however for accurate and 
meaningful results hundreds of cells must be used. Collection and processing of hundreds of 
stage I oocytes into fractions will be incredibly difficult and improvements in the capabilities 
of the technology will have to advance for this type of analysis to be possible.  
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This evidence, taken with the previously published finding, lends confidence that the 
small RNA found in early zebrafish oogenesis is produced due to a biological process that 
occurs across oviparous species, and is the same small RNA that has been described in 
Xenopus oocytes.  
3.4.2 Degradation and apoptosis do not influence the small RNA of oocytes 
 
RNA is reduced to smaller fragments during degradation and is thus a large concern when 
working with small RNA. RNA degradation can easily be detected using Bioanalyzer chips 
or on denaturing gels as distinct RNA bands such as rRNA are reduced to a smear when RNA 
subjected to degradation. Comparisons between traces of good quality and degraded RNA 
within this work showed the persistence of the small RNA peak and indicated it is not 
induced or changed by normal RNA degradation mechanisms.  
In addition to concerns about degradation, the effects of apoptosis on the small RNA 
peak were a concern. Vertebrate oocytes undergo a process known as atresia, a normal 
occurrence in developing ovaries, where unneeded developing oocytes initiate apoptosis 
pathways and regress back into the ovary (Üçüncü and Çakıcı 2009). To investigate if atresia, 
and specifically apoptosis have any effect on the small RNA peak, the ovaries of apoptosis 
null (p53-/-) adult zebrafish were examined and embryos were induced to undergo apoptosis. 
The small RNA peak was observed in p53-/- zebrafish, indicating its formation is not reliant 
on the p53-mediated apoptosis pathway. Apoptosis can occur via non-p53-dependant 
pathways; therefore embryos were exposed to 6’hydroxyurea to induce extreme stress and 
apoptosis in an attempt to produce the small RNA peak. The peak was not observed in 
apoptosing embryos, indicating the presence of the small RNA peak is not due to apoptosis of 
the cells.  
Having examined the major factors that could be influencing the small RNA peak 
formation and found neither the methods used nor degradation and apoptotic process were 
involved – a deeper investigation into the identity of the transcripts could begin.  
3.4.3 The majority of the small RNA does not map to known Ensembl IDs 
 
To identify the small RNAs within the stage I oocytes, the RNA was size separated using a 
column based method (Figure 3.4), a library was made using random hexamers, and the small 
RNA was sequenced to produce a single investigative dataset. The sequencing library and 
reads were of a good quality, however very few reads, only 6.25%, successfully mapped to 
annotated genes with Ensembl IDs (Figure 3.20B). This is unusual for this type of 
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experiment. One possibility is the comparatively poor genome annotation available for the 
zebrafish compared to other vertebrates or the large strain differences observed for zebrafish 
compared to mouse (Guryev, Koudijs et al. 2006, Yen 2012). High amounts of reads aligning 
to Ensembl IDs are typical in mouse or human experiments, which have very well annotated 
genomes. As annotation of the zebrafish genome is not at the standard of the human or 
mouse, it is possible many genes have not been correctly annotated or located leading to 
improper mapping outside of Ensembl ID regions. Thankfully, progress is being made and 
new annotations are constantly being released which improve the quality of the reference 
(Cunningham, Amode et al. 2015). Sequencing experiments using zebrafish, such as the one 
presented here, often identify new transcripts and can add information to further complete the 
annotation, a task which is already being done with in incorporation of RNA-Seq reads into 
the genebuild (Collins, White et al. 2012, Kelkar, Provost et al. 2014). For our purposes 
however, as the identity of these unmapped reads was not known, the focus was initially 
placed on those we could identify.  
97.5% of the reads that mapped to Ensembl IDs mapped to transcripts predicted to be 
longer than the maximum size allowed through the size selection, 200 nt (Figure 3.20A). It is 
possible that these transcripts were present in the RNA sequenced and not successfully 
removed during the size selection, however the results from the size selection experiments 
(Figure 3.19) suggest that this is not the case. Another possibility is that we are seeing 
fragments of only parts of these Ensembl IDs, such as the introns and untranslated sequences 
removed during splicing, which was investigated next.  
3.4.4 The small RNA reads that map to Ensembl IDs are from a small number of spliced 
transcripts present at high abundance 
 
A large proportion (61%) of the reads from the initial sequencing that mapped to Ensembl 
IDs were found to be from protein coding transcripts rather than the expected small RNA 
transcript types such as miRNA and piRNA. This was also found to be true of the small RNA 
sequencing replicates, with an average of 61% of Ensembl IDs found to be protein coding 
transcripts and only 17% from small RNA populations such as microRNAs (Figure 3.28C). 
Additionally, the percentage of reads mapping to intronic sequences was low compared with 
exonic and junction sequences (Figure 3.20D), indicating the transcripts sequenced were 
likely post transcriptionally modified and had already been spliced to remove introns.  
As the size of the RNAs was much smaller than their predicted transcript length, I 
investigated at what position along the transcripts our reads were mapping to. The reads 
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mostly covered the ends of the transcripts (Figure 3.20E), possibly due to the accessibility of 
the ends and ease of binding of the random hexamers. The finding that many of the 
associated GO terms were related to processes known to occur in oogenesis and rRNA 
production supports this theory, as these are transcripts expected to be expressed within the 
oocyte at this time and it is possible only the ends of the transcripts have been sequenced. 
However, this would not explain the presence of the small RNA peak observed and would 
only be possible if these transcripts were present in addition to the unknown small RNA. 
Also, the likelihood of all the random hexamers priming at the ends of the transcripts across 
all Ensembl IDs is low. Further investigation of the identity of the transcripts within the small 
RNA was done. 
In the investigative small RNA sequencing dataset, 1,026 IDs were found to have 
>100 reads, which represents only 3% of genes within the zebrafish genome. In addition, 
over 50% of the reads that mapped to Ensembl IDs, mapped to just 34 IDs (Figure 3.21D) 
indicating the majority of these reads resulted from a largely homogeneous population of 
transcripts. The ID with the highest expression, AL935186.6, accounted for >140,000 paired-
end reads and 11.4% of all the reads that mapped to Ensembl IDs, indicating these few 
transcripts were at very high abundance. AL934186.6 has an expected transcript length of 
~650 nt and was not expected within this dataset. This was also found to be true in the 
replicate sequencing datasets – a small number of transcripts were present at high abundance, 
accounting for the majority of reads while many other transcripts were only present at very 
low levels (Figure 3.28). An average of only 122 IDs were found to have >100 FPKM, a 
smaller amount than in the initial sequencing dataset due to the lower sequencing depth used, 
but following the same pattern observed previously. Many of these highly expressed 
transcripts were the same transcripts found in the initial sequencing experiment, indicating 
this is not an anomaly and the small RNAs are produced consistently in a size and sequence 
specific manner. A number of these highly abundant transcripts were poorly defined or had 
not been assigned a official name yet, and as little information was available on them, the 
high proportion of protein coding transcripts became the focus of investigation.  
3.4.5 A proportion of the small RNAs may be derived from fragments of the polyA RNAs 
expressed during stage I 
 
As a large number of transcripts within the small RNA peak were identified as protein coding 
or other non-small RNA transcript types, the small RNA and polyA RNA sequencing 
datasets for each replicate were compared and contrasted. The two sequencing experiments 
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described here originated from the same pool of RNA for each sample (Figure 3.3), therefore 
comparisons between the sequenced populations could reveal if any transcripts expressed 
normally as polyA RNAs are also present in the population of small RNAs, without needing 
to account for inter-sample differences.  
The majority of IDs (69.26%) found in one dataset could be identified within the 
other, with 11,531 IDs commonly occurring (Figure 3.36). Some overlap is expected as some 
small polyA RNAs under 200 nt would be sequenced by both methods, however the number 
of these was expected to be low as there are only 31 protein coding genes in the zebrafish 
genome are under 200 nt. PolyA transcripts other than protein coding transcripts less than 
200 nt may exist, but these are assumed to be few as well, and would not account for the 
large overlap observed between these datasets.  
A low amount of additional transcripts longer than 200 nt could have been present in 
the small RNA population as the size selection was not expected to be 100% efficient, 
however as previously discussed, this does not account for the incredibly large amount of 
transcripts >200 nt observed as previous tests showed high efficiency at separating the RNA 
fractions. The relatively large number of reads found mapping to polyA RNA species 
suggests transcripts are present in this population that normally would be longer, or that the 
small RNA population is actually made up of pieces of longer RNA transcripts. The overlap 
observed in the gene IDs expressed in both datasets possibly indicates the small RNA is 
being derived from transcripts expressed during this stage. Another possibility is expression 
of the short RNAs from alternative start sites, however this is unlikely as multiple unknown 
start and termination sites would have to exist within many transcript IDs throughout the 
genome, that have been undetected until now. The more likely explanation is that the 
transcripts have formed through fragmentation of transcripts expressed during stage I. 
More uniquely expressed IDs were found within the polyA RNA sequencing than the 
small RNA sequencing, with an average of 3,668 IDs compared to 1,457 (Figure 3.36). These 
IDs potentially represent transcripts that are not being fragmented and are selectively 
remaining whole. Without further experiments, it cannot be determined if these transcripts 
are being preserved or if they have simply not been sampled in the small RNA population 
and would become evident if deeper sequencing was done. However, it is well established 
that mRNAs are preserved and prevented from degrading within the oocyte during oogenesis 
– maternal transcripts are preserved and stored in the oocyte to direct early embryogenesis 
prior to zygotic genome activation (Duval, Bouvet et al. 1990, Abrams and Mullins 2009, 
Tadros and Lipshitz 2009, Marlow 2010), suggesting this could be a common feature within 
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other stages of oogenesis. Potentially, these uniquely expressed transcripts are important for 
processes in oogenesis and are being preserved against fragmentation (Kaplan and Apirion 
1975, Cheng and Deutscher 2003, Basturea, Zundel et al. 2011). These preserved polyA 
RNAs should be compared to transcripts known to be important for oogenesis, as well as to 
maternal transcripts, to see if any correlation exists.  
A recent study by Heim, Hartung et al. (2014) discovered buc transcripts were 
degraded into fragments in stage I oocytes when they were incorrectly localized. As correct 
localization of buc is essential for establishment of polarity and successful oogenesis 
(Marlow and Mullins 2008, Heim, Hartung et al. 2014), potentially buc is a protected 
transcript, normally preserved from fragmentation as described above and mislocalization has 
led to aberrant fragmentation – and consequently to incomplete establishment of polarity and 
unsuccessful oogenesis. This would suggest the protected transcripts are those required for 
early events within oogenesis and further investigation into which transcripts are protected 
could reveal additional transcripts important for early oogenic processes.  
Having determined that there is an overlap between the populations, highly expressed 
genes within the polyA RNA sequencing replicates were examined in the corresponding 
small RNA sequencing replicates, and expression values were compared (Table 3.15). These 
genes were found to be present at low levels in the small RNA sequencing, with the 
exception of a mitochondrial tRNA which has no detectable expression in the small RNA 
fraction. This shows an overlap in genes expressed in the polyA RNA sequencing and in the 
small RNA sequencing, and supports the theory that these fragments are derived from 
expressed protein coding genes, although it appears they make up a minority of the RNAs 
present in the small RNA population.  
The converse comparison, highly expressed transcripts within the small RNA 
sequencing examined in the corresponding polyA RNA sequencing revealed that highly 
expressed small RNA transcripts such as miRNAs or other small RNAs could not be found 
within the polyA RNA sequencing, as expected. However, highly expressed protein coding 
transcripts were observed to have corresponding expression within the polyA RNA 
sequencing (Table 3.17). This again shows an overlap in the RNAs present within both 
datasets.  
Expression of one of these highly expressed genes, nek3, correlated between the 
sequenced fractions – the highest expression of nek3 was identified within replicate WT3 of 
the polyA RNA sequencing and the highest expression of nek3 within the small RNA 
sequencing was also within the WT3 replicate. Although this suggests the level of expression 
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of the genes influences the amount of identified within the small RNA, this is only one 
example, and highly expressed protein coding transcript fragments did not always have an 
expressed polyA RNA counterpart – for example zgc:158463 (Table 3.15). When all 
expressed gene IDs were taken into account, additional instances of protein coding transcripts 
were observed within the small RNA fraction that did not have a polyA RNA expressed 
counterpart, however many of these transcripts were lowly expressed and it is difficult to 
determine if they haven’t been sampled within the polyA RNA dataset, or if they are in fact 
not expressed at this time.  
Interestingly, when the reads for these highly expressed transcripts from the small 
RNA sequencing datasets were viewed in the Ensembl web browser (Figure 3.23), numerous 
reads aligned to regions immediately adjacent to their annotated locations. Expression of 
small RNAs outside of normally transcribed regions has been the subject of debate for some 
time, with some believing transcription is ‘pervasive’ and occurs throughout the genome, 
while others believe what is being detected is background noise and errors associated with 
sequencing (Clark, Amaral et al. 2011). The ENCODE project has given some supporting 
evidence for pervasive transcription (The ENCODE Project Consortium 2007), as has other 
work in humans (Kapranov, Cheng et al. 2007, Hangauer, Vaughn et al. 2013). Evidence also 
exists in the mouse (Okazaki, Furuno et al. 2002, Carninci, Kasukawa et al. 2005, Katayama, 
Tomaru et al. 2005) and simpler organisms such as bacteria (Wade and Grainger 2014), 
suggesting it is a conserved aspect across many species. Although an exact mechanism has 
yet to be described, many suggestions have been made as to the production and function of 
these RNAs – which has been reviewed by Wade and Grainger (2014).  
Studies have potentially identified pervasive transcription in the zebrafish during 
development (Nepal, Hadzhiev et al. 2013), possibly indicating our results are another 
instance of pervasive transcription from intergenic genomic regions. However, exact size of 
the RNAs observed and their concentration in origin from specific Ensembl IDs suggests 
otherwise. Although interesting, it is not believed that these RNAs are the result of pervasive 
transcription of the zebrafish genome. To gain further information about the small RNAs 
described in this chapter, additional regions where these clusters of gene expression outside 
of annotated genes were examined.  
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3.4.6 The majority of the small RNA is rRNA  
 
Analysis of the regions around Ensembl IDs with high numbers of reads revealed that many 
reads had mapped to the surrounding unannotated genomic sequences adjacent to highly 
expressed IDs and 5.8S rRNA genes (Figure 3.23). The 5.8S rRNA genes are expressed as a 
part of a long polycistronic RNA (45S pre-rRNA), therefore the co-expressed 18S and 28S 
rRNA transcripts should feature adjacent to the 5.8S rRNA in the genome – however as the 
rDNA is repeated in clusters and the regions are highly repetitive, the current genome 
annotation does not include the 18S and 28S rRNAs (as can be seen in Figure 3.23) (Howe, 
Clark et al. 2013). This is standard in genome annotation procedures, however it does not aid 
our attempts to estimate rRNA expression.  
As the total length of the 45S pre-rRNA is predicted to be ~9.7 kb, reclassification of 
the Ensembl IDs immediately adjacent to (strict classification) and within a 5 kb region 
adjacent to the 5.8S rRNA (loose classification) approximately estimates the amount of IDs 
which have been wrongly classified, assuming all 5.8S rRNA genes have been annotated 
within the genome. Under strict reclassification, the proportion of reads from the initial 
sequencing annotated as rRNA increased from 0.05% to 25%, and under loose classification 
it increased again to 41%. It is possible these reads have not been misclassified as some 
overlapped putative protein coding genes and miRNAs, however many of these Ensembl IDs 
have been removed from the newest gene set (GRCz10 release 80) potentially indicating poor 
annotation of these regions (Kelkar, Provost et al. 2014).  
The proportion of rRNA within the zebrafish oocyte is expected to be similar to that 
of the Xenopus oocyte, which contains ~75% 5S rRNA and tRNA transcribed at high levels 
from ovary-specific 5S rRNA genes (Ford 1971, Denis and Mairy 1972, Wegnez and Denis 
1972, Wegnez, Monier et al. 1972, Ford and Southern 1973, Peterson, Doering et al. 1980, 
Callan, Gall et al. 1988). This burst of 5S expression is thought to produce a large stockpile 
of 5S rRNA transcripts that are stored for use during early embryonic development. The 5S 
rRNA is transcribed prior to the other rRNA transcripts, which are produced through 
expression from areas of regional specific amplification (known as Lampbrush 
chromosomes) – this results in equimolar amounts of rRNA transcripts produced overall 
(Scheer, Trendelenburg et al. 1977, Callan, Gall et al. 1988, Roger, Moisand et al. 2002). 
Teleost fish, including the zebrafish, also have ovary-specific 5S rRNA genes and a similar 
peak of 5S rRNA sized RNA in early oogenesis, therefore the same process of rRNA 
production is expected to occur in zebrafish (Mazabraud, Wegnez et al. 1975, Denis and 
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Wegnez 1977, Martins and Galetti 2001, Diaz De Cerio, Rojo-Bartolomé et al. 2012, Rojo-
Bartolomé and Cancio 2014). Additionally, as it is known that many rRNA transcripts are not 
annotated within the genome and we have found that many reads from the small RNA library 
mapped outside of annotated regions, it was clear the reads had to be compared to the 
zebrafish rRNA sequences. 
When compared to the rRNA reference, 58.66% of the reads from the initial 
sequencing mapped to rRNA indicating the majority of reads are rRNA derived (Figure 
3.25A). This was also true of the small RNA sequencing replicates; for WT2 and WT3 rRNA 
accounted for 61% and 51%, respectively, however rRNA only accounted for 29% of the 
reads in WT1 (Figure 3.31B). These results are lower than the expected ~75% which has 
been observed in Xenopus, however the figure for Xenopus includes not only rRNA 
transcripts but tRNA transcripts as well, the exact proportions of which have not been 
described in more detail. When the tRNA content of the small RNA was investigated, a low 
percentage of reads were found to be tRNA transcripts, only 0.058% of the total successfully 
mapped. This is possibly due to the method of library construction and extensive secondary 
structure of tRNAs; tRNAs are most effectively sequenced if treated with T4 polynucleotide 
kinase to remove end modifications and if adaptors are end-ligated to the transcripts (Su, 
Tripp et al. 2013), two processes which were not done in the creation of this library.  
Potentially, the lower percentage of 5S rRNA and tRNA observed in the zebrafish is due to a 
limitation in the sequencing methods, and the remaining tRNAs are present, but have not 
been detected.  
An additional factor to consider is the fact that the rRNA zebrafish reference 
sequences are a custom made library, designed using ESTs and based on sequence similarity 
to other species. If additional substitutions have occurred or differences between fish strains 
exist, the number of mismatches recorded would be increased and the read may be discarded 
during quality filtering. Both of these factors suggest it is possible that this is a low estimate 
of the total actual rRNA and tRNA percentage within zebrafish. Nevertheless, compared to 
other small RNA studies the proportion of rRNA found was slightly higher in oocytes than 
other zebrafish tissues and whole embryos (Chew, Pauli et al. 2013), which is consistent with 
findings in Xenopus. Despite the fact that fewer rRNA transcripts were detected than 
expected, the majority of transcripts within the small RNA libraries are rRNA derived. 
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3.4.7 The small RNA is fragmented 45S pre-rRNA 
 
Once the proportion of rRNA was identified within the small RNA peak, further investigation 
into the specific sequences was done. In contrast to early studies in Xenopus, which 
previously identified the small RNA transcripts as 5S rRNA (Denis and Mairy 1972), 5S 
rRNA only made up 0.08% of sequences in the initial sequencing dataset (Figure 3.25B) and 
an average of 0.22% in the replicates (Figure 3.31A). This was very surprising, however not 
detecting a transcript with a sequencing experiment does not mean it is not present within a 
cell. 5S rRNA is clearly produced during this time, as it has been used as a sex specific 
marker, reliably sexing individuals before sex can be determined visually (Diaz De Cerio, 
Rojo-Bartolomé et al. 2012), but was unable to be picked up by our sequencing techniques. 
This suggests the transcript is present, but inaccessible, possibly due to binding to a protein or 
conformational changes in the RNA preventing priming or another aspect of sequencing. 
Many RNAs produced during oogenesis are packaged and stored for later use (Pelegri 
2003, Marlow 2010); it is possible in these states, the RNAs are not readily accessible for 
sequencing. It has been shown that in addition to acting as a transcription factor for 5S 
transcription, transcription factor IIIA (TF IIIA) mediates the formation of 5S rRNA into 7S 
particles in oocytes (Rojo-Bartolomé and Cancio 2014) – therefore it is possible proteins 
within the 7S particles are preventing the 5S rRNA from being detected within our 
experiments as the RNA is removed with the protein during the RNA extraction step. More 
research into the state of the 5S rRNA transcripts at this stage is needed to determine exact 
quantities of the 5S rRNA in the zebrafish, how the transcript has been inaccessible to our 
methods, and how it is stored until needed during embryonic development.  
Assuming 5S rRNA is present but has not been detected, further research into the 
identity of the transcripts that were found during sequencing was done. These sequences 
mapped across all rRNA transcripts, including internal and external transcribed sequences of 
the 45S pre-rRNA (Figure 3.25C and Figure 3.31A). When the lengths of the reads mapping 
to the 45S pre-rRNA reference were calculated, the majority were short and within our 
expected range based on size selection, between 100-200 nt in length (Figure 3.25D and 
Figure 3.31C), and much smaller than the entire expected transcript sizes. This suggests that 
these reads are the basis of part of the small RNA peak, and the highly specific length 
suggests that the reads could potentially originate from fragments derived from entire rRNA 
transcripts. 
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In the initial small RNA sequencing, short fragments of the final 28S and 18S rRNA 
transcripts were found at a higher proportion than the pre-rRNA ITS and ETS sequences, 
33.98% of the total reads and 18.65%, respectively. If normal processing and degradation 
were occurring to produce the fragments, a high proportion of the reads would map to the 
pre-rRNA ITS and ETS sequences as they are known to be removed and degraded during 
rRNA processing and few final rRNA transcripts would be found, however this is not the 
case in the initial small RNA sequencing dataset (Figure 3.25C) or in the replicates (Figure 
3.31A). The ITS and ETS sequences are known to be removed in a stepwise manner using 
one of two pathways (detailed in Figure 3.38). Deviations from the expected amounts would 
indicate the fragmentation occurs after the 45S pre-rRNA is processed, however proportional 
amounts of reads for the pre-rRNA transcripts and final rRNA transcripts were observed 
(Figure 3.25C), indicating that the entire 45S pre-rRNA has been fragmented before or during 
the initial processing steps. A small percentage of reads from the initial small RNA 
sequencing were found to map across the final rRNA transcripts and the ITS/ETS sequences, 
2.92% in the initial sequencing, indicating the removal of the ITS/ETS sequences was not  
 
 
Figure 3.38 Pathways for the stepwise removal of ITS/ETS sequences from the pre-45S 
rRNA transcript 
 
The 45S pre-rRNA transcript undergoes a series of stepwise reactions to remove the 
transcribed sequences (ITS and ETS) following one of two pathways: A or B. ITS/ETS 
sequences have been represented by black lines, the blue box indicates the 18S rRNA region, 
the red box indicates the 5.8S rRNA region, and the green box indicates the 28S rRNA 
region. Sizes of each are shown. Adapted from Romanova, Grand et al. (2009). 
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complete for some transcripts (Table 3.5). A negligible amount of reads from this dataset 
were found across all but two of the boundaries – the 5’ETS/18S and the ITS/28S, which had 
2.69% and 0.23% of the total reads respectively. This suggests that some of the cleavage 
steps have possibly already occurred, leading to few reads being produced from across these 
junctions, while the reads mapping across the 5’ETS/18S and ITS/28S junctions represent 
transcripts where this cleavage has not occurred yet. One notable difference between the 
pathways is the early removal of the 5’ETS sequences in pathway A. The existence of 
5’ETS/18S mapping sequences suggests the pathway in use is pathway B, however it is 
possible reads mapping across the other boundaries exist and are not being picked up in our 
analysis. Alternatively it is also possible that the fragments are being produced from the 
entire 45S pre-rRNA transcript before any processing steps have begun, or that a mix of 
processed and unprocessed 45S pre-rRNA transcripts are being fragmented. Small RNAs 
derived from rRNA sequences have been described before. A recent report identified an 
miRNA within the rDNA repeats in Drosophila (Chak, Mohammed et al. 2015), and several 
miRNAs and piRNAs have been found to map to both rDNA sequence and the reference 
genome in mice (Wei, Zhou et al. 2013). A class of small rRNAs derived from rDNA 
sequences, termed srRNA, including these miRNAs and piRNAs, has been proposed by Wei, 
Zhou et al. (2013). Similar to the zebrafish, rDNA is not included in the human or mouse 
transcriptome assemblies. Wei, Zhou et al. (2013) analysed several human and mouse small 
RNA libraries and found that small percentages (2-6%) of the unmapped reads aligned to the 
rDNA from the relevant species. These were termed “srRNAs” and were18-25 nt in length, 
with 21 nt RNAs at the highest abundance, and derived from the coding rRNA transcripts 
themselves rather than from the entire pre-rRNA as we have observed here. A number of 
these srRNAs were successfully co-immunoprecipitated with Argonaute and Piwi proteins, a 
key member of the RNA-induced silencing complex responsible for generating siRNAs, 
miRNAs and piRNAs (Wei, Zhou et al. 2013). Finally, studies in mice revealed the srRNA 
profile within the liver correlated with diabetes suggesting a role for srRNAs in the 
pathogenesis of the disorder. Taken together, these results suggest the srRNAs are not 
generated due to random degradation and could be considered a bona fide class of small 
RNAs.  
A number of similarities between srRNAs and the medium sized rRNA-derived 
RNAs (mrRNA) have been identified within this chapter. Both have a very specific length 
present at high abundance, something that would not occur if they were being produced by 
normal RNA degradation. They are both produced from the coding rRNA transcripts, 
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although mrRNAs also originate from other aspects of the pre-rRNA sequences. 
Additionally, they correlate with specific states: srRNAs with diabetes and mrRNA with 
specific stages within oogenesis. It is proposed that these RNAs represent an undescribed 
category of RNAs present within early oogenesis in the zebrafish, and possibly other 
oviparous species.  
Nothing is known about the production of srRNAs or mrRNAs, however insights 
from previous work have suggested the production of fragments could occur during an 
alternative pathway of rRNA degradation used when the cell is under stressful conditions, 
such as starvation or other conditions with limited nutrients (Kaplan and Apirion 1975, 
Cheng and Deutscher 2003, Basturea, Zundel et al. 2011). Pre-ribosomes and mature-
ribosomes are degraded in bulk to recycle nucleotides and essential cellular building blocks 
to cope with the stress (Lafontaine 2010). Work by Kaplan and Apirion (1975) has suggested 
this process begins with fragmentation of rRNA by an unknown endoribonuclease, and that 
the fragments are subsequently degraded by exoribonucleases into mononucleotides for 
recycling and reuse. Importantly, the fragments observed by Kaplan and Apirion (1975) were 
approximately the size of tRNAs, ~100 nt, which is the size range under investigation of our 
mrRNAs. 
 Kaplan and Apirion (1975) suggested the fragments observed would only be 
detectable due to the loss of function of the downstream exoribonucleases and that under 
normal conditions the fragments would be quickly degraded for recycling. It is possible a 
similar process is occurring here and the presence of the mrRNAs could be explained by an 
increase in the expression of the endoribonuclease responsible during stage I of oogenesis, an 
increase that is not matched in expression by the exoribonucleases which usually prevent the 
fragments from being observed. This would allow the fragments to be observed during stage I 
and would cause them to persist into the later stages of oogenesis as they are progressively 
degraded, as has been observed in this Chapter.  
Therefore, I would like to propose that the formation of mrRNAs could be due to a 
mass recycling effort where the majority of rRNAs are degraded to free up nucleotides for the 
production of maternal RNAs, mRNAs, tRNAs, and new 45S pre-rRNAs, which are known 
to be produced during early oogenesis and required for early embryonic development. This 
process would represent an early event in stage I oocytes, possibly involving an 
endoribonuclease capable of generating the ~100 nt fragments. Once produced, small RNAs 
can function in many different ways within the cell: inhibiting translation, degrading target 
mRNAs, modifying site specific regions, and directing splicing, however it is possible that 
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these small RNAs identified here are not functional, but merely a by-product of this recycling 
of nucleotides within the early oocyte. Unfortunately, as the sequencing library was made 
with random hexamers, the ends of the fragments cannot be used to determine any potential 
consensus sequences of this unknown RNase or to infer any function based on similarity to 
other known small RNA species. Attempts were made to generate an end-ligation small RNA 
library of the fragments to investigate this during this project, however a final library did not 
come together in time to be included within this work. Interestingly although the fragments 
could successfully be polyadenylated in vitro at their 3’ end (data not shown), ligation to the 
5’ end was unsuccessful, even using extended ligation times such as those recommended 
during piRNA library making protocols (Wei, Salichos et al. 2012). This suggests some sort 
of end-modification is present on the 5’ end preventing ligation, however more research into 
this is required to draw any conclusions. Once it is determined in the molecules can be ligated 
to, an end-ligation library of the fragments will provide essential information to uncovering if 
an RNase is involved in this process. Identification of a specific enzyme involved could 
provide insight into possible functions and it would provide an opportunity to undertake 
knockout or site-specific mutation experiments in vivo or in vitro, potentially revealing 
additional functional information. 
Future experiments such as sequencing the small RNA fraction of the other stages of 
oogenesis will identify if the same mrRNAs can be found and potentially indicate which of 
the fragments persist through oogenesis, if any bias is present. Identification of persisting 
fragments could aid in the identification of the exoribonuclease suggested by Kaplan and 
Apirion (1975) responsible for degrading rRNA once fragmented. Additionally investigations 
of this phenomenon in other species would be beneficial to elucidate if the process is 
conserved within and outside of oviparous species. 
These results indicate the small RNA fragments, mrRNAs, are reproducible and a 
common feature of early oocytes that needs to be studied in further detail. The additional 
finding that polyA RNA fragments were potentially derived from some polyA RNAs 
expressed during stage I, but not others, implies a form of selection or preservation of 
specific transcripts and indicates this process is highly regulated. It is tempting to speculate 
about the purpose of this mass fragmentation and degradation and I have presented a theory 
that this occurs to unneeded transcripts, ribosomes and 45S pre-rRNA molecules to free up 
nucleotides for the production of new ribosomes and maternal transcripts necessary to drive 
early embryonic development. Further comparisons between the datasets and follow up 
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experiments confirming these findings should be done before more conclusions can be drawn 
and this theory can be tested. 
3.4.8 Concluding remarks 
 
Within this chapter I have shown that zebrafish oocytes produce a medium-sized peak 
of RNA during stage I of oogenesis, similar to that produced in the Xenopus. This peak 
coincides with a large increase in the amount of 5S rRNA present within the oocyte and 
persists at a low level into the later stages of oogenesis. This peak was a constant, 
reproducible size of 80-100 nt and it’s formation was not due to any methods of oocyte or 
RNA processing or normal RNA degradation. Additionally, there was no link between the 
formation of the peak and p53 mediated apoptosis. The content of the peak was mainly small 
sized fragments of rRNA, originating from pre-45S rRNA transcripts and may have 
undergone some processing, as well as some fully spliced protein coding transcripts. While 
the function of this RNA is not known in the cell, it bears resemblance to small RNAs 
identified by other groups within small RNA sequencing datasets. Additionally, fragments of 
polyA transcripts expressed during stage I were found within the small RNA sequencing 
dataset suggesting the fragments are being produced from existing RNAs. As some polyA 
RNAs were identified without corresponding small RNA fragments, it is possible some 
transcripts are being selectively preserved from fragmentation, as they are important for early 
oogenic processes.  
Overall, I have provided an in depth characterization of the polyA and small RNA 
transcriptomes of stage I oocytes, using multiple replicates. This work can be used as a 
reliable resource for future studies of early oogenesis or transcriptomics, and is particularly 
interesting for researcher interested in small RNAs and rRNAs. 
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4.1 Introduction 
4.1.1 Profiling by RNA-Seq  
 
Previous research has shown RNA-Seq to be an effective method of profiling the 
transcriptome of specific cell types and that important information can be learned through 
undertaking these types of approaches. A number of projects are underway across multiple 
model organisms to sequence the transcriptomes of various tissues and make them available 
to the research community and zebrafish is no exception (Aanes, Winata et al. 2011, 
Vesterlund, Jiao et al. 2011, Collins, White et al. 2012). Ovary tissue as a whole has 
previously been sequenced in this effort (Li, Chia et al. 2004), however zebrafish ovaries 
contain numerous oocytes at various different points of development and sequencing of the 
tissue as a whole does not include any stage specific information about oogenesis. 
Sequencing stage specific pools of oocytes would provide this information and give insights 
into the production of maternal RNAs required for early embryonic development. A method 
for the fast and efficient collection of zebrafish oocytes in a stage specific manner was 
developed during Chapter 2 of this thesis, along with the sequencing resources available at 
the Wellcome Trust Sanger Institute, this provided the perfect opportunity to investigate the 
transcriptomes of oocytes in a stage specific manner.  
4.1.2 RNA-Seq method options 
 
A number of aspects must be taken into consideration when deciding on a method of 
transcriptome sequencing; variations in the method of library construction can affect the 
RNA population and proportion of the RNA actually sequenced. The RNAs of greatest 
interest, in this case, are the protein coding polyadenylated (polyA) mRNAs produced within 
the cell and a library targeting these molecules will be needed. Oocytes contain large amounts 
of rRNA and relatively few polyA mRNAs in comparison; therefore methods of rRNA 
elimination are of interest to enrich for the polyA transcripts of interest and reduce 
sequencing costs. There are two main methods for dealing with rRNA during RNA-Seq 
library preparation: rRNA depletion using Ribo-Zero (Illumina) and polyA pull down of 
mRNA transcripts. Ribo-Zero works by aligning short antisense rRNA probes to form double 
stranded RNA and either degrading them using double stranded RNases or removing them 
using magnetic beads which bind the probes (Sooknanan, Pease et al. 2010). Ribo-Zero has 
been optimized for use in human, mouse, and rat, and is expected to be able to remove 
zebrafish rRNA from samples, however no publications using Ribo-Zero in zebrafish had 
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been published at the time of study design and the specificity of the treatment on zebrafish 
samples was unknown (Illumina 2012). Using Ribo-Zero to remove rRNA allows detection 
of partially degraded transcripts, transcripts being processed, and non-coding non-polyA 
RNAs, providing more information about the RNAs present within the sample, but these 
sequences cannot be distinguished from intact mRNAs and can result in high proportions of 
sequences which cannot be mapped (Zhao, He et al. 2014). Due to these reasons, the well-
described method of polyA pull down was used for generating libraries within this work.  
PolyA pull down can be done before or after fragmentation of the RNA to produce 
two different types of libraries. Fragmentation before polyA pull down results in a pool of 
RNAs containing only the 3’ ends of polyA transcripts while fragmentation after polyA pull 
down provides the entire polyA transcript for sequencing (Figure 4.1). Both have been used 
to successfully profile the transcriptomes of various species, but it is important to note that 
they are not interchangeable and provide different information about transcripts. 
Fragmentation prior to polyA pull down provides short transcript identifying sequences from 
the 3’ ends of mRNAs (Derti, Garrett-Engele et al. 2012), while entire transcript sequencing 
can provide additional information about transcript start sites, splicing isoforms, and the 
sequence of newly discovered transcripts (Aanes, Winata et al. 2011). As this study is 
intended to be of the entire transcriptome and investigative in nature, the maximum amount 
of information possible was gathered about the transcripts and entire transcript sequencing 
was selected. 
4.1.3 Analysis method options 
 
For analysing RNA-Seq data a number of packages are available to help to resolve the 
transcripts and estimate transcript abundance. A number of different programs have been 
built to deal with different types of organisms: some have references genome available, while 
others do not, and some cater for bacterial genomes without the need to take splicing into 
account, while others require complex splice-aware aligners.  Differences in these programs 
can affect the quantification of reads as well as the isoforms of transcripts predicted 
themselves (Engstrom, Steijger et al. 2013), therefore selection of a program to use is an 
important step in study design. As a zebrafish reference genome is available and reads 
generated from entire transcripts would provide the most information possible from our 
RNA, a program and strategy combining these two elements was needed. Fortunately, a 
number of programs fit these criteria, and to decide between them additional aspects of their 
performance needed to be taken into consideration.   
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Figure 4.1 Resulting RNA after fragmentation and polyA pull down in different library 
types 
 
Depiction of resultant RNAs produced after A) fragmentation prior to polyA pull down and 
B) fragmentation after polyA pull down. Fragmentation prior (A) results in only the 3’ ends 
of polyA transcripts while fragmentation after (B) results in entire transcripts. 
 
Early genome-guided programs relied on much shorter reads than are currently 
available (Denoeud, Aury et al. 2008), and as a result are not ideal for longer or alternatively 
spliced transcripts (Garber, Grabherr et al. 2011). Programs designed to take advantage of the 
longer read lengths, such as Scripture (Guttman, Garber et al. 2010) and Cufflinks (Trapnell, 
Williams et al. 2010), function in similar ways to align reads, but resolve transcripts into 
isoforms using different methods. Scripture calculates maximum number of possible isoforms 
for a given transcript while Cufflinks identifies the minimum number of possible isoforms 
relying on the read counts to identify the most likely isoforms present (Garber, Grabherr et al. 
2011). Cufflinks is able to report on more lowly expressed genes than the alternative 
programs available and is able to estimate isoform expression levels (Garber, Grabherr et al. 
2011). Therefore, at the time, it was concluded the best program available to use was 
Total RNA  Total RNA 
Fragmentation PolyA pull down 
PolyA pull down Fragmentation 
      rRNA & non-polyA RNA 
      polyA RNA 
A B 
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Cufflinks and the Tuxedo suite, which includes Bowtie, TopHat, Cufflinks, and CuffDiff 
(Langmead, Trapnell et al. 2009, Trapnell, Pachter et al. 2009, Garber, Grabherr et al. 2011, 
Chu and Corey 2012, Givan, Bottoms et al. 2012, Trapnell, Roberts et al. 2012).  
4.2 Methods 
4.2.1 RNA extraction from staged oocytes 
 
Adult H-Longfin wild type fish were culled according to home office procedures and 
dissected to remove the ovary. Oocytes were staged and separated as described in Chapter 
2.2.1. RNA was extracted from pools of staged oocytes as described in Chapter 3.2.1.1 using 
the Trizol-chloroform method. RNA was run on a RNA Nano Bioanalyzer Chip and the 
resultant electropherogram traces were analysed for quality. 
4.2.2 RNA sequencing  
 
4 standard libraries were prepared using the TruSeq RNA Sample Prep Kit v2 (Illumina) by 
the in-house Illumina-C Bespoke Sequencing team. Briefly, equal amounts of RNA was 
subjected to a polyA pull down and converted into cDNA using a polyT primers and reverse 
transcriptase. Resulting cDNA was fragmented and size selected, and then ligated to 
barcoded Illumina adapters. The adapter ligated cDNA libraries were sequenced on a HiSeq 
(Illumina) using 75 bp, paired-end reads.  
4.2.3 Sequence mapping and processing 
 
Reads were filtered to remove adapter and poor quality sequences (Q<30), and mapped using 
the Tuxedo suite (Bowtie/TopHat/Cufflinks) (Trapnell, Roberts et al. 2012) to the zebrafish 
transcriptome (Zv9) by Ian Sealy. I obtained information about transcript types using 
Perl/BioPerl (Stajich, Block et al. 2002) and the Ensembl API (Rios, McLaren et al. 2010, 
Flicek, Amode et al. 2012). Differentially expressed genes were identified using CuffDiff. A 
few highly abundant Ensembl IDs were found within each stage and in the small RNA 
sequencing dataset from Chapter 3. When viewed in Ensembl using the gene build GRCz10 
(release 80) these IDs had been depreciated (Table 4.1). FASTA sequences of these IDs were 
downloaded using BioMart (Kasprzyk 2011) and the Ensembl Archive with the previous 
gene build, Zv9 (release 79), and run through BLAST using blastn (discontiguous megablast) 
(Zhang, Schwartz et al. 2000). These sequences returned with very high similarity to rRNA 
genes from other bony fish species, all matching with 100% identity. These reads were 
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excluded from future analysis. Statistics and images were generated using R and the R 
package cummeRbund (Goff L 2013).  
 
Gene ID Gene Name 
ENSDARG00000086085 CT956064.1 
ENSDARG00000090619 CT956064.5 
ENSDARG00000090280 BX296557.5 
ENSDARG00000085067 AL935186.3 
ENSDARG00000086638 CU651569.2 
ENSDARG00000085168 AL935186.4 
ENSDARG00000090909 CU651569.6 
ENSDARG00000086966 BX548011.2 
ENSDARG00000088313 BX296557.3 
ENSDARG00000088494 CT956064.4 
 
Table 4.1 Ensembl IDs Excluded from analysis 
 
A number of Ensembl IDs were depreciated between Ensembl gene builds (release 79 – 80). 
These IDs were investigated, found to be rRNA derived and removed from future analysis.  
 
 
To compare expression between sequencing datasets, rankings rather than expression 
values were used in order to better display the data. Expression was ranked from highest to 
lowest for both all sequencing datasets. Rankings were compared via scatterplot for the two 
datasets; using Excel (Microsoft Office), a linear line of best fit was drawn and an R2 value 
was calculated.  
4.2.4 GO term analysis 
 
The top 1000 highest expressed genes from the dataset for each stage were selected for GO 
term analysis with GeneCodis3 (Carmona-Saez, Chagoyen et al. 2007, Nogales-Cadenas, 
Carmona-Saez et al. 2009, Tabas-Madrid, Nogales-Cadenas et al. 2012) to identify any 
enrichment and to compare with known processes that occur during oogenesis.  
Additionally, differentially expressed genes between stages were subjected to GO 
term analysis using GeneCodis3. Four datasets were analysed separately: genes which 
changed between stages I and II, genes which changed between stages II and III, genes which 
increased between stages III and IV, and genes which decreased between stages III and IV. 
Between stages I and II as well as II and III, only one or two genes were identified as 
decreasing between stages and these datasets were excluded from analysis. Statistics were 
calculated and graphs made using Excel. 
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4.2.5 Comparison between stage I whole molecule RNA sequencing and transcript counting 
 
Ensembl IDs were matched between the stage I polyA RNA sequencing described in this 
Chapter and transcript counting datasets from Chapter 3 to compare expression. Expression 
values were plotted on a scatterplot with Log10 scales to facilitate comparison.  
 
4.3 Results 
4.3.1 Different numbers of cells needed to be collected 
 
An equal number of cells would not have resulted in comparable pools of RNA as stage I 
oocytes are known to measure 7-140 µm in diameter, while stage IV can be up to 0.73mm in 
diameter (Bally-Cuif, Schatz et al. 1998). To overcome this, an equal amount of RNA for 
each stage was used at the beginning of the library preps and different numbers of cells were 
collected. At the time, the library making team requested 10 µg of RNA to be collected for 
each stage for successful deep sequencing, a task which required the collection of 1,613 stage 
I oocytes, 355 stage II oocytes, 229 stage III oocytes and 54 stage IV oocytes.  
4.3.2 Sequencing revealed expression of many different Ensembl IDs throughout oogenesis  
 
168 million paired-end reads were sequenced across all stages. Reads were mapped to the 
zebrafish transcriptome (Zv9) using TopHat (Trapnell, Roberts et al. 2012) and assembled 
into transcripts using Cufflinks. After filtering for quality, 104.2 million reads remained 
(62.02%) which mapped successfully to 17,475 Ensembl gene IDs with >1 FPKM (a 
commonly used statistical threshold). Of these, 20.2 million paired-end reads had been 
sequenced for the stage I oocyte pool, 42 million reads for stage II, 22.5 million for stage III, 
and 19.5 million for stage IV. During each stage ~13,000 gene IDs were identified as 
expressed with >1 FPKM (Table 4.2).  
Another commonly used statistical threshold is >100 FPKM, as this clearly identifies 
transcripts which are present. During each stage between 1,200 – 1,600 gene IDs were 
identified as expressed with >100 FPKM, with a total of 5,443 being represented across all 
stages (Table 4.2). Additional statistics have been included in the Supplementary Materials 
S3.1, Tables S11-S13.  
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Stage Reads Gene IDs (>1) Gene IDs (>100) 
I 20.2 M 13,495 (40.0%) 1,594 (4.7%) 
II 42.0 M 13,970 (41.4%) 1,267 (3.8%) 
III 22.5 M 13,912 (41.2%) 1,277 (3.8%) 
IV 19.5 M 13,335 (39.5%) 1,539 (4.6%) 
Total 104.2 M 17,475 (51.7%) 5,443 (16.1%) 
 
Table 4.2 Number of reads and Ensembl gene IDs found at each stage 
 
Two levels of significance have been detailed here: >1 read per gene ID and >100 reads per 
gene ID – both commonly used levels of significance. Stages are denoted by roman numerals. 
Percentages indicate the proportion of Ensembl IDs expressed out of the total within the 
zebrafish gene build. M – million. 
 
4.3.3 Expression between the stages was similar; stage IV showed the most unique 
expression 
 
To ensure the data is of high quality and comparable, a number of quality control steps were 
done using the cummeRbund R package.  
Density plots of expression levels observed for each stage showed the shape of the 
datasets were similar, indicating they are comparable and not over-dispersed (Figure 4.2A). 
Stage IV, (“oocyte_4” shown in green), had a slightly larger amount of transcripts expressed 
at low levels than other stages, however as transcripts with <1 FPKM are not being included 
within the analysis, this is not predicted to influence results.  
The matrix of scatterplots showed good correlation of gene expression observed 
between all of the stages. The greatest amount of dispersion was between stages I and IV, 
while stages II and III showed the tightest correlation and thus similarity in expression 
profiles (Figure 4.2B).  
The MA plot comparing the values of fold-change observed (M) and the intensity or 
frequency of the observations (A) did not reveal any systemic bias in the data (Figure 4.2C).  
Volcano plots were plotted to investigate expression changes between the stages. The 
greatest number of statistically differentially expressed genes was observed in the comparison 
of stage III and stage IV results (Figure 4.2D, shown in red), while the comparisons of stage I 
and II as well as stage II and III had less genes differentially expressed and those that were 
differentially expressed, had a slightly higher p-value.  
The dendrogram depicting the relationship between the stages confirms the 
observations within the volcano plots – stages II and III are the most similar, with stage IV 
having the greatest differences in gene expression from all other stages (Figure 4.2E).  
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Figure 4.2 Visualization of gene expression between stages using cummeRbund 
 
A) Density plot of expression values. B) Scatter plot matrix comparing expression between 
stages. C) MA plot showing fold change vs. intensity between all pairs of stages. D) Volcano 
plot matrix comparing statistically significantly differentially expressed genes. E) A 
dendrogram of the relationship between stages calculated based on similarity of expressed 
genes. F) Venn diagram depicting uniquely and commonly expressed genes within each stage 
of oogenesis. Genes were as expressed within a stage if they had a value of >1 FPKM.  
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Figure 4.3 Comparison of expression of Ensembl IDs between stages 
 
Gene expression was ranked from highest to lowest for each pair of datasets. A) Stage I and 
Stage II. B) Stage II and Stage III. C) Stage III and Stage IV. Only genes with expression 
values >1 FPKM are depicted.  
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The Venn diagram depicting uniquely and commonly expressed genes within each 
stage of oogenesis revealed stage IV had the highest proportion of uniquely expressed genes, 
while stages I, II and III were highly similar (Figure 4.2F). Taken together these results show 
the datasets are comparable and that expression of genes within stage IV is the most different 
compared to expression found within stages I, II and III. 
Scatterplots comparing gene expression between each stage also indicate high 
similarity between the stages. Figure 4.3 shows a high correlation between the rankings of all 
stage comparisons and high R2 values. Figure 4.3A, the comparison between stages I and II, 
resulted in an R2 value of 0.84337, Figure 4.3B, the comparison between stages II and III, 
resulted in an R2 value of 0.88118, and Figure 4.3C, the comparison between stages III and 
IV, resulted in an R2 value of 0.75779. As previously observed, the change between stage III 
and IV showed the highest level of variation in expression and lowest correlation between 
stages.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.3 Top highly expressed transcripts in each stage 
 
Ensembl gene IDs, short gene names, transcript types, and FPKM found for the highest 
expressed genes for each stage. Stages have been listed using roman numerals and ranking of 
transcripts is from highest to lowest using ascending numbers. Colours correspond to FPKM 
value according to the legend. Many highly represented gene IDs had no expression in the 
other stages. 
 
Gene ID Gene Name Transcript type I II III IV 
ENSDARG00000081342 CU550700.1 miRNA 1    
ENSDARG00000088129 SNORD60 snoRNA 2 1   
ENSDARG00000081799 snoZ30 snoRNA 3  3  
ENSDARG00000095908 si:ch1073-228p2.2 Protein coding 4 3 1 2 
ENSDARG00000092869 si:dkey-43b14.3 Processed transcript 5    
ENSDARG00000082320 BX546477.1 miRNA 6    
ENSDARG00000080082 CABZ01102169.1 miRNA 7    
ENSDARG00000086766 CABZ01086927.1 Protein coding 8  6  
ENSDARG00000090768 zgc:173556 Protein coding 9    
ENSDARG00000086151 CABZ01088149.2 Protein coding 10 4 5 10 
ENSDARG00000095816 hadhb Processed transcript  2 4  
ENSDARG00000088980 CU499328.1 miRNA  5   
ENSDARG00000090288 CABZ01094029.1 miRNA  6  7 
ENSDARG00000081132 CT027701.1 miRNA  7   
ENSDARG00000086165 CABZ01089399.1 miRNA  8   
ENSDARG00000093590 si:dkey-104e13.1 Protein coding  9   
ENSDARG00000060994 fbxw7 Protein coding  10   
ENSDARG00000081608 dre-mir-216a miRNA   2  
ENSDARG00000063912 mt-co3 Protein coding   7 3 
ENSDARG00000081758 AC024175.12 Mt-tRNA   8 4 
ENSDARG00000063911 Mt-atp6 Protein coding   9 5 
ENSDARG00000063910 Mt-atp8 Protein coding   10 6 
ENSDARG00000080268 snoMBII-202 snoRNA    1 
ENSDARG00000081310 BX323876.5 miRNA    8 
ENSDARG00000088278 CR812468.1 miRNA    9 
 10000 
 1000 
 100 
 10 
 1 
 0 
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4.3.4 Highly expressed genes indicated similarities between stages of oogenesis and 
identified stage specific expression of genes 
 
While genes with important functions are not necessarily expressed at high levels, genes that 
are expressed at high levels have high expression for important functional reasons by the cell. 
Therefore, to investigate differences between stages genes IDs with the highest levels of 
expression were examined for each stage. Although some genes were represented at high 
levels within all of the stages, many of the gene IDs had no detectable expression within the 
other datasets (Table 4.3). For instance, si:ch1073-228p2.2 (ENSDARG00000095908) was 
among the top 4 hits in each stage, while CU550700.1 (ENSDARG00000081342) was the 
top hit in stage I oocytes, but was completely absent from all other stages. Notably, a number 
of the most highly expressed genes were small RNA species, such as microRNAs and 
snoRNAs, a large proportion of which have not been described in detail. 
MicroRNAs were found in every stage and represented a decreasing proportion of the 
total RNAs as the stages progressed: 4% in stage I, 3% in stage II, 2% in stage III and 1% in 
stage IV (Figure 4.4). In the first three stages, the most abundant transcript type observed  
 
 
 
Figure 4.4 Percentage of transcript types in each stage 
 
Pie charts depicting the proportion reads mapping to different transcript types identified in 
the RNA-Seq dataset. A) Stage I oocytes. B) Stage II oocytes. C) Stage III oocytes. D) Stage 
IV oocytes. The term ‘other’ includes pseudogenes, other small RNAs and miscellaneous 
transcripts.  
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were protein coding transcripts, representing between 84-88% of the transcripts, while in 
Stage IV protein coding transcripts only made up 44% of the total. Interestingly, the most 
prominent transcript type during stage IV was snoRNA. SnoRNA was present in the other 
stages, however only at low levels between 3-6%. 
4.3.5 GO term analysis found many terms occurring in all stages of oogenesis as well as a 
few stage specific terms 
 
GO term and KEGG pathway analysis revealed the highly similar results for each stage, with 
many statistically significant terms being found relating to oocyte specific processes and 
general cell cycle processes, as well as RNA related terms such as RNA processing, RNA 
splicing, rRNA processing. Transport, of both protein and RNA featured highly as did 
various terms related to chromatin modelling. Interestingly, terms relating to embryo 
development and embryo cleavage were identified within all stages of oogenesis, as was 
‘negative regulation of apoptotic processes’ (Figure 4.5). There were a number of terms that 
were only significantly represented within specific stages. Stage I specific terms included: 
meiosis, DNA methylation involved in gamete generation, and piRNA metabolic processes. 
Stage II specific terms included nucleosome assembly and tRNA processing, among others. 
Stage IV was the most unique and had numerous terms related to histone deacetylase activity 
significantly represented. The term ‘snoRNA binding’ was present in stages I to III but absent 
from stage IV. 
4.3.6 Genes changing in expression between stages and GO term analysis results reflect the 
known biology during oogenesis 
 
Many gene IDs related to oogenesis and oocyte maturation were found within the list of 
differentially expressed genes. Complete tables of differentially expressed genes and GO 
terms have been included in the Supplementary Materials S3.2.  
Briefly, between stages I and II the gene cyp19a1a increased in expression and the 
GO term for transport was significantly overrepresented. Between stages II and III expression 
of cdk19 increased, as did the prevalence of terms related to transport, ATP biogenesis, and 
cell division. Many terms were identified as changing significantly between stages III and IV, 
which is consistent with our knowledge of changes happening within oogenesis and the onset 
of oocyte maturation. Increasing terms already known to be involved in the process of 
oogenesis included lhb, lhcgr, nts, lox, clu, and ace, among others (Figure 4.6). 
Overrepresented GO terms included differentiation, regulation of embryonic development, 
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Figure 4.5 Common and stage specific GO terms 
 
Radial Venn diagram showing stage specific and a small representative selection of 
commonly found GO terms during the pilot RNA-Seq experiment. ‘Common terms’ were 
found within all four stages at significant levels.  
 
 
 
 
 
 
 
Figure 4.6 Differentially expressed genes previously known to have a role in oogenesis 
 
Differential expression was measured using CuffDiff. Genes were considered to be 
previously known to have a role in oogenesis if literature existed describing expression 
within related species. Green arrows indicate a significant increase in expression in the later 
stage, while red arrows indicate a decrease. 
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luteinizing hormone signalling pathway, luteinizing hormone receptor activity, and protein 
localization. GO terms that decreased during this transition included: cell division, potassium 
ion transport and potassium channel associated terms.  
Many of these genes are already known to have specific roles in the cell as well as in 
some oocyte specific processes, such as meiosis. Further investigation into these genes, and 
the processes they are involved in, is key to understanding more about oogenesis and 
developmental timings. The importance and implications of the specific genes mentioned 
here will be examined in full in the discussion. 
4.3.7 Novel differential expression of genes was identified during oogenesis 
 
65 genes not previously known to be differentially expressed during oogenesis were 
identified during analysis, 51 of which showed a change in expression between stages III and 
IV (Figure 4.7) – the stage previously shown to have the largest changes of expression 
(Figures 4.2-4.4). Three genes had been previously identified as expressed in oocytes, but the 
timing of expression was unknown. ndrg1b was previously identified in whole ovaries in 
mice (Chen, Kang et al. 2015), atoh8, a maternally supplied transcript, was known to be 
present in unfertilized zebrafish oocytes (Yao, Zhou et al. 2010) and expression of id2b has 
been identified in the ovary in studies in rainbow trout (Oncorhynchus mykiss) (Rescan 1997, 
Gahr, Rodriguez et al. 2005). Several other genes, TGFBR3L, slc2a11a and slc7a8, had 
paralogs or other family members with known to be expressed in the ovary, but evidence for 
these specific genes were lacking (Bobe, Montfort et al. 2006, Sarraj, Chua et al. 2007). 
Interestingly, two mitochondrial genes, mt-nd5 and mt-cyb, were identified as increasing 
between stage I and stage II, coinciding with a previously described increase in expression of 
the mitochondrial gene mt-tfa, which was observed in Xenopus (Shen and Bogenhagen 2001). 
3 genes were identified as differentially expressed multiple times: MFAP4 (5 of 13) and 
MFAP4 (6 of 13) were identified as increasing between stage I and stage II, as well as 
between stage II and stage III and cdk19 was found to increase dramatically from stage II to 
stage III, and then to decrease in stage IV.  
Many of the genes identified are poorly described and some continue to have the si:, 
zgc: and wu: prefixes, indicating they were recently identified by sequencing projects. Very 
little information relating the potential function of these genes could be found and 
identification here represents the first insights into their expression and function.    
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Figure 4.7 Novel differentially expressed genes in oogenesis 
 
Differential expression was measured using CuffDiff. Genes were considered to be 
previously known to have a role in oogenesis if literature existed describing expression 
within related species. Green arrows indicate a significant increase in expression in the later 
stage, while red arrows indicate a decrease. 
 
4.3.8 Whole-molecule polyA RNA-Seq of stage I oocytes was comparable to transcript 
counting, and indicated expression of many additional genes 
 
To compare between the two sequencing methods used to estimate gene expression in stage I 
oocytes, an average of the counts produced by transcript counting described in Chapter 3 was 
compared to the polyA RNA-Seq FPKM values produced within this chapter. A scatterplot of 
the comparison (Figure 4.10) shows expression was loosely correlated, but showed 
comparable expression. Whole-molecule polyA RNA-Seq identified expression of >1 FPKM 
4.3 Results 
 
133 
$
!
$
$ $
in 13,495 gene IDs, while transcript counting only identified expression of 3,626 gene IDs 
most likely due to the lower sequencing depth used for the transcript counting replicates. 
Transcript counting identified many more potential 3’ ends not associated with Ensembl IDs 
that could not be compared within this analysis, but still provide additional information about 
gene expression during this stage.   
 
 
 
Figure 4.8 Scatterplot comparing expression between stage I standard polyA RNA-Seq 
and transcript counting RNA-Seq methods 
 
Expression of genes in stage I oocytes measured by an average of transcript counting (TC) 
counts and standard polyA RNA-Seq (RNAseq) FPKMs. A Log10 scale has been used. 
 
4.4 Discussion 
4.4.1 The sequencing data reflects the known biology of oogenesis 
 
The libraries generated for each stage were comparable in terms of the number of reads 
produced, and the slight increase in the number of reads generated for stage II did not effect 
the number of genes that expression was identified for. As the libraries were constructed 
using RNA from differing numbers of cells, it is important to remember the data produced for 
each of the stages is a snapshot of a pool of the RNAs expressed at that time and changes 
between stages represent the changes seen between similar amounts of total RNA not 
changes between a cell from one stage to another. The amount of RNA found within oocytes 
generally increases corresponding to their size, maintaining the same proportions throughout 
– a cell twice the volume of the previous would have twice the number of transcripts present. 
For instance, an equal expression value between two stages represents no change in the 
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proportion of the transcript in comparison to the others, but does represent a large increase in 
the number of transcripts per cell. It is important all of the results of this work are considered 
with this in mind. 
The distributions of gene expression between each stage were similar and correlated 
well (Figure 4.2A & B), this indicates the datasets could be compared to one another and that 
expression within the samples was normal. The MA plot (Figure 4.2C) showed a slight 
increase in the number of differentially expressed genes increasing as opposed to decreasing 
between stages, but there was not a significantly large change to indicate the sequencing 
results are unreliable or biased. Higher amounts of dispersion between stages I and IV in 
Figure 4.2B show these stages are the most divergent in terms of gene expression, which was 
expected as the onset of oocyte maturation was predicted to involve the expression of many 
genes absent from previous stages and cessation of expression of genes required for growth 
and early meiotic events. Conversely, the expression between stages I, II and III were 
expected to be highly similar, and this is reflected in the scatterplot matrix (Figure 4.2B) as 
well as in the individual scatter plots of gene expression rankings (Figure 4.3A-C). The R2 
values calculated for the comparison between gene expression rankings show stages II and III 
to be the most similar (R2 = 0.88118), followed by stage I and II (0.84337), and lastly that 
expression between stages III and IV was similar, but the most divergent of the stages 
analysed (R2= 0.75779). The volcano plots, dendrogram, and Venn diagram further confirm 
these findings, with the highest number of differentially expressed genes, uniquely expressed 
genes, and the greatest overall expression differences both being found within stage IV 
(Figure 4.2D-F). Overall, the datasets reflect what is already known about the biology of 
oogenesis, stages I-III are similar and stage IV is the most unique, and the results here show 
they provide an accurate, comparable representation of gene expression within these stages. 
4.4.2 Highly expressed genes provide insight into processes occurring during oogenesis and 
revealed a role for snoRNAs during stage IV 
 
Analysis of the most highly expressed genes resulted in some interesting findings. One gene 
highly expressed throughout oogenesis, CABZ01086927.1, referred to as polycomb group 
ring finger protein 3 (pcgf3) in other species, is a member of the polycomb group proteins 
(PcG). PcG genes were first identified in Drosophila where they modify chromatin to silence 
Hox genes during embryonic development and are known to have a conserved role in 
zebrafish (Lewis 1978, Le Faou, Volkel et al. 2011). Little is known about the function of 
pcgf3 specifically, however similar PcG genes have been shown to be expressed and play a 
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role within the ovary in humans and Drosophila (Hinkins, Huntriss et al. 2005, Kai, Williams 
et al. 2005). In Drosophila, some PcG genes expressed in the ovary were found to prevent 
follicle stem cell renewal, while others delayed cytokinesis in pre-meiotic germ cells (Kai, 
Williams et al. 2005, Li, Han et al. 2010). The high expression level of pcgf3 found here 
suggests a similar role for this gene throughout oogenesis in the zebrafish as well. Not much 
is known about the changing chromatin state of oocytes during oogenesis and investigation 
into this gene could yield some insights into this area.  
Another gene of interest is F-box/WD repeat containing protein 7 (fbxw7), which is 
expressed throughout oogenesis peaking at stage II and decreasing to a low level by stage IV. 
Fbxw7 is a component of the ubiquitin ligase complex scaffold and is known to bind cyclin 
E, potentially targeting it for ubiquitin-mediated degradation (Koepp, Schaefer et al. 2001, 
Moberg, Bell et al. 2001). Cyclin E is a key regulator of the cell cycle and controls the 
transition between G1 and S phase in complex with cyclin-dependant kinase 2 (Cdk2) protein 
(Hinds, Mittnacht et al. 1992). Cyclin E and Cdk2 have been shown in C. elegans to function 
in germ stem cells to prevent meiosis, maintaining the G1 phase until oocyte maturation 
(Jeong, Verheyden et al. 2011). This is also observed in Xenopus, where expression of cyclin 
E peaks during meiosis II after germinal vesicle breakdown (Rempel, Sleight et al. 1995). 
Expression of fbxw7 throughout stages I to IV suggests a similar profile of Cyclin E in the 
zebrafish, where Fbxw7 regularly represses the action of Cyclin E by tagging it for ubiquitin 
mediated degradation. As levels of fbxw7 fall approaching germinal vesicle breakdown, 
Cyclin E is no longer degraded and binds to Cdk2 to drive the transition to the S phase of the 
cell cycle. As Cyclin E is a maternally provided during the cleavage stages of embryonic 
development, production of enough Cyclin E must occur between stages IV and V of 
oogenesis, while fbxw7 expression is low, or is possibly stored and protected from tagging by 
Fbxw7 until needed. Analysis and knowledge of the timings of gene expression such as 
fbxw7, can lead to more inferences about the synthesis and storage of maternal products. 
Mitochondria are known to be highly active during oogenesis (Lee, Kim et al. 2004) 
and are very abundant (Barritt, Kokot et al. 2002), therefore finding high expression of 
mitochondrial genes was not unexpected. Essential parts of the respiratory electron transport 
chain such as subunits of the mitochondrial ATP synthase (mt-atp6 and mt-atp8) and 
cytochrome C oxidase (mt-co3) were expressed at a high level throughout stages II to IV, 
beginning in stage I with mid level expression. These transcripts are involved in the 
production of ATP required to maintain the activity of mitochondria (Kagawa and Racker 
1966, Yoshikawa, Shimada et al. 2015). Mitochondrial hydroxyacyl-CoA dehydrogenase β 
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(hadhb) was also detected at a high level throughout oogenesis. Hadhb is involved in the β-
oxidation of long fatty acid chains, the binding of RNAs and the destabilization of mRNAs. 
Its precise role within oocytes is not known, however it is known to interact with oestrogen 
receptor α, a key signalling receptor in oogenesis (Zhou, Zhou et al. 2012), and therefore 
likely plays an important role in oogenesis. 
A number of miRNAs and snoRNAs were identified with within every stage of the 
dataset. Small RNAs such as these cannot be typically detected using this type of sequencing 
and their presence indicates we have picked up polyadenylated forms of these transcripts. 
Polyadenylation of small RNAs can happen during their synthesis or as a method of 
degradation, depending on the type. miRNAs are produced from longer polyadenylated 
precursor molecules called primary miRNA (pri-miRNA) (Lee, Kim et al. 2004), and this is 
the likely form we have detected here. The action of the miRNA likely occurs within the 
same stage as the expression of the pri-miRNA or immediately following their production. 
mir216a was identified as one of these pri-miRNAs and was produced specifically in stage 
III of oogenesis at a very high level. The role of mir216a in the normal ovary is not known, 
although the transcript has been shown to have a role in ovarian and other cancers in 
increasing the number of stem cell-like cells with tumours (Xia, Ooi et al. 2013). The discrete 
window of expression and the high level of expression observed suggest a highly important 
and regulated role for this miRNA during stage III of oogenesis.  
snoRNAs have been shown to be polyadenylated in vivo (Reinisch and Wolin 2007), 
however the reasons behind polyadenylation of these transcripts are still unclear; 
polyadenylation has been linked to the maturing of the snoRNA after transcription as well as 
being involved in degradation (Grzechnik and Kufel 2008, Lemay, D'Amours et al. 2010). 
Establishment of the role of polyadenylation in snoRNA processing is necessary to further 
understand these results. That said, the detection of polyadenylated snoRNA transcripts does 
indicate the mature transcripts are present in the oocytes, even if the reason behind the 
polyadenylation is not known. Two C/D box snoRNAs were identified among the highest 
expressed genes, snoRD60 and snoZ30. Both of these transcripts were highly abundant 
during stage I with expression falling in stage II and ceasing or continuing at a low level, 
respectively. A third C/D box snoRNA, snoMBII-202 was highly expressed exclusively 
during stage IV. C/D box snoRNPs bind to rRNAs, and introduce 2'-O-methylation at 
specific locations (Galardi, Fatica et al. 2002). The regions they act on are determined by a 
small antisense stretch within the snoRNA, therefore it is possible to predict their targets 
(Kiss-László, Henry et al. 1996). snoRD60 has been suggested to target a specific nucleotide 
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within the 28S rRNA gene (Kiss-László, Henry et al. 1996, Kiss 2001), while snoZ30 binds 
the U6 snRNA and has a role in splicing efficiency (Zhou, Chen et al. 2002). A potential 
target for snoMB-II-202 has not been identified. The expression of snoRNAs during 
oogenesis is of particular interest as some C/D box snoRNAs have been found to aid in 
establishment and conservation of the structure of chromatin regions in Drosophila and 
humans, and due to their role in the processing of rRNA which is a highly important process 
during oogenesis (Schubert, Pusch et al. 2012).  
Overall, identifying genes with high expression has provided an insight into the 
underlying processes and can be used as a resource for the study of gene expression during 
oogenesis.  
4.4.3 GO terms identified the stage at which oocyte specific processes occurred and 
uncovered a previously unknown enrichment of snoRNA expression during stage IV 
 
Many terms identified during the GO term analysis were consistently found in every stage of 
oogenesis, suggesting similar core processes are at work throughout. A number of these were 
related to normal cell function such as the cell cycle, and RNA processing, and splicing. 
Terms related to oocytes including: meiosis, progesterone-induced maturation, and 
homologous recombination, were also found throughout. Interestingly, terms related to 
embryonic development and cleavage processes were also identified, possibly representing 
transcripts being produced for later use as maternally supplied molecules in the developing 
embryo. The majority of other terms found were related to RNA and DNA, and included 
everything from replication to chromatin remodelling. Oocytes are known not to be 
replicating past stage Ia and therefore the appearance of replication related terms could be 
seen as unusual, however the terms may be present here due to an increase in genes involved 
in the maintenance of DNA during replication, or other such processes, rather than driving 
replication itself. This is supported by the increase in terms related to DNA repair also 
observed throughout oogenesis and the enrichment of nucleosome assembly during stage II, 
as nucleosome assembly is known to be involved in the protection of the genome after 
replication or repair processes have taken place (Burgess and Zhang 2013). These protective 
mechanisms are highly important in the development of oocytes, as oocytes can be arrested in 
meiosis for extended periods of time.  
Finding chromatin related terms that are neither silencing nor activating throughout 
all the stages of oogenesis indicates a balance between chromatin states is being maintained, 
allowing transcription to continue to occur throughout oogenesis until stage IV, where 
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silencing chromatin related terms become highly significant and transcription ceases. 
Multiple histone deacetylase and NAD-dependant histone deacetylase activity related terms 
were also highly enriched for in stage IV, during the predicted time of onset of transcriptional 
quiescence, suggesting they have a role in this process.  
Stage I had a number of unique GO terms related to the known biology of oogenesis – 
meiosis was significantly enriched and is known to be occurring during this stage. Other 
aspects, such as the piRNA metabolic process and DNA methylation involved in gamete 
generation, were also known to occur during oogenesis, however the timing and stage at 
which these took place were previously unknown (Houwing, Kamminga et al. 2007, 
Houwing, Berezikov et al. 2008, Klattenhoff and Theurkauf 2008, Goll and Halpern 2011, 
Bamezai, Rawat et al. 2012).  
snoRNA binding was up regulated during stages I, II and III, but absent from stage 
IV. snoRNAs are known to bind to target rRNA as it is being transcribed, and are not 
activated until transcription of the rRNA has been terminated (Gerbi SA 2000), suggesting 
the majority of snoRNA activity, or the preparation for activity, occurs during the earlier 
stages of oogenesis and snoRNAs are polyadenylated in the oocyte during stage IV for 
degradation.   
Stage II and III were once again the most similar stages, with both having snoRNA 
and tRNA related terms enriched further showing the similarity in processes involved during 
these stages.  
Analysis of GO terms enriched within specific stages revealed the timing of processes 
previously unknown during oogenesis and highlights the relatedness of the stages to one 
another.  
4.4.4 Genes significantly differentially expressed between stages and their associated GO 
terms reflect the known biology during oogenesis 
 
Genes that change expression levels and their associated GO terms can also provide insight 
into processes beginning or ending during that stage transition. Between stages I and II a 
number of terms that were related to cellular respiration, oxidation, the electron transport 
chain, and transport increased. This was expected as the cells transition from germ stem cells 
and early meiotic oocytes into growing oocytes, massively increasing in size. During this 
transition the gene cyp19a1a was identified as increasing as well. cyp19a1a (cytochrome 
p450/aromatase) is known to be expressed within the follicle cells of stage II oocytes 
(Chiang, Yan et al. 2001) and converts testosterone into 17β-estradiol (von Hofsten and 
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Olsson 2005). 17β-estradiol is a key regulator of oocyte growth (Nagahama, Yoshikuni et al. 
1995), and genes related to its synthesis were expected to be found at this stage.  
Similar to the changes observed between stages I and II, the changes observed 
between stages II and III were largely related to further upregulation of transport and energy 
production, specifically ATP biogenesis and ATPase activity. cmah, a gene increasing in 
expression between stage II and stage III was previously identified in studies of trout 
oogenesis and is predicted to be involved in ligand-receptor binding or cell-cell interactions, 
although it’s function in oogenesis is unknown (Kawano, Koyama et al. 1995, Bobe, 
Montfort et al. 2006, Gohin, Bobe et al. 2010).  
The greatest changes in expression were observed in genes increasing between stages 
III and IV. This was expected, as genes related to oocyte maturation become active and 
signalling switches to the luteinizing hormone (LH) and 17-hydroxyprogesterone (Chu, Li et 
al. 2014). This was reflected in the GO terms of the genes found to be significantly 
increasing at this stage, for instance: the LH signalling pathway, and LH receptor activity. 
The LH β gene (lhb) itself was found to significantly increase in stage IV, as well as the 
LH/choriogonadotropin receptor (lhcgr). Lhb and the Lhcgr are specifically involved in 
oocyte maturation and ovulation (Ascoli, Fanelli et al. 2002, Chu, Li et al. 2014), and have 
both been previously identified within stage IV of zebrafish oogenesis (Liu, Lin et al. 2011). 
Other genes related to the regulation of LH were also significantly increased, for instance 
neuotensin (nts) and clusterin (clu). Nts has been implicated in the regulation of LH 
(Alexander, Mahoney et al. 1989, Dungan Lemko, Naderi et al. 2010), although it has only 
been studied in the hypothalamus of the zebrafish (Levitas-Djerbi, Yelin-Bekerman et al. 
2015). Clu in mammals acts opposite to LH when no pregnancy has occurred to release 
follicle-stimulating hormone and drive the development of a new oocyte (Forni, Zannoni et 
al. 2003). Clu may act slightly differently in zebrafish and other oviparous species compared 
to mammals, as no pregnancy occurs within the mother. Potentially, Clu promotes 
development of new oocytes upon maturation and ovulation rather than at the event of a non-
pregnancy, however little research has been done into this area and the role of these 
hormones in oviparous species. Research into clu has only been done on the brain in 
zebrafish and it’s role in the ovary remains unknown (Jiao, Dai et al. 2011).  
Other genes known to have a role in oocyte maturation were also significantly 
increased. Angiotensin (ace) is known in other species to be involved in oocyte maturation 
and ovulation (Yoshimura 1997), as well as in the resumption of meiosis (Giometti, 
Bertagnolli et al. 2005). Lysyl oxidase (lox) crosslinks collagen and elastin (Bedell-Hogan, 
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Trackman et al. 1993) and is known to be important in oocyte maturation in Xenopus (Ortiz, 
Buhler et al. 2014). Both of these genes, although known to be involved in oocyte 
maturation, have not been studied within the zebrafish specifically.  
Additional GO terms from the list of significantly increasing genes between stages III 
and IV included various aspects of differentiation and the regulation of embryonic 
development – these terms are expected to be associated with genes which are produced 
during maturation and stored for later use, or to be terms that have roles in both maturation 
and other aspects of development. This study of significantly differentially expressed genes 
and their associated GO terms has identified stage specific processes consistent with the 
previous literature and findings.  
4.4.5 Differential expression analysis identified new genes involved in oogenesis and 
highlight a specific role for cdk19 during stage III 
 
A number of the differentially expressed genes identified have not previously been 
shown to be involved in zebrafish specific stages of oogenesis before. A few belonged to 
protein families in which the other members have been shown to be expressed in the ovary, 
such as slc2a11a and slc7a8, while a few others had been observed within the ovary 
previously, either in zebrafish or in other related Teleosts such as the rainbow trout 
(Oncorhynchus mykiss), however the timing of their expression was unknown. The remaining 
genes had not been identified in the ovary previously, and this represents the first description 
of their involvement in oogenesis.  
Multiple genes that function in the extracellular matrix were identified as 
differentially expressed throughout oogenesis. In earlier stages, stage II and stage III, the 
MFAP4 proteins and Tgfbi, which bind collagen, were upregulated, while in stage IV lama5, 
a member of the laminin family was significantly increased. Also in stage IV, 4 genes 
encoding transcription factors were differentially expressed: atoh8, creb3l3, nr0b2a, and 
id2b. The timing of expression of these genes suggests they are potential regulators of oocyte 
maturation.  
Cyclin dependant kinase 19 (cdk19) was found to significantly increase between stage 
II and stage III. cdk19 is not well described, however its sequence and predicted structure 
very closely resembles that of cdk8 (Tsutsui, Umemura et al. 2008), which is involved in 
regulation of the cell cycle (Li, Inoue et al. 2004). Between stages III and IV cdk19 was 
found to significantly decrease, indicating that its action is specific to stage III and that 
specific cell cycle processes take place at this stage – it would be interesting to investigate the 
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role of cdk19 and any relation of changes in the cell cycle during stage III in preparation for 
the next stage of meiosis during oocyte maturation. 
  Also decreasing between stage III and stage IV was the U4/U6 small nuclear 
ribonucleoprotein prpf4. Like other small nuclear ribonucleoproteins, Prpf4 is involved in 
splicing (Horowitz, Kobayashi et al. 1997) and a significant decrease of this gene between 
stages indicates a reduction in the amount of splicing occurring. This could be related to a 
general decrease in the amount of transcription before the onset of maturation and 
transcriptional quiescence, however more aspects of the splicing machinery need to be 
examined to confirm this.  
These novel significantly differentially expressed genes provide interesting candidate 
genes for further exploration and important information about oogenic processes, including 
preparation for oocyte maturation and maturation itself. Even in genes previously shown to 
be expressed in the ovary, these results show the specific timings of expression during 
oogenesis and can be used to help infer aspects of their function.  
4.4.6 Whole-molecule polyA RNA-Seq of stage I oocytes showed similar results to 
Transcript Counting, but provided more information 
 
Comparison between the polyA RNA sequencing replicates and the stage I sequencing 
experiment is difficult due to the different methods used in preparing the libraries and in the 
quantification of expression. While the method used in this Chapter sequenced fragmented 
entire RNAs and then used TopHat to align and quantify the transcripts, the transcript 
counting protocol only sequences the 3’ ends of genes and relies on the alignment program 
BWA to quantify transcripts. Normalization methods are different between these programs 
and the units used for quantifying transcripts differs, and as a result the quantification of 
transcripts can appear to differ in absolute quantity when in fact they are highly similar 
(Martin and Wang 2011). Nevertheless, a comparison between the stage I oocyte RNA 
sequencing experiment described in this Chapter and the previous stage I polyA RNA 
sequencing replicates using Transcript Counting was done.  
Highly expressed genes identified during each experiment differed with many smaller 
sized mRNAs and pri-miRNAs identified in the whole-molecule sequencing that were not 
present in the transcript counting. These would not be identified during the replication study 
due to a change in the methods between experiments. In order to obtain small RNAs for 
sequencing, a size separation step was added eliminating any polyadenylated RNAs under 
200 nt in length from the current study. If polyA RNA was examined in the <200 nt fraction, 
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it is expected these RNAs would be identified, therefore these differences can be discounted 
as due to differences in the methods used. The remaining protein coding genes and processed 
transcripts were identified within the replicates, although not at the same relative abundance.  
Changes in abundance such as those observed here could be due to the differences in 
how the quantification was done between experiments. Transcript counting uses barcodes to 
identify unique molecules and gives the number of transcripts detected in the original sample 
(Morris, Collins et al. 2012), while TopHat produces an estimation of the number of 
transcripts in FPKM, fragments per kilobase per million reads (Trapnell, Roberts et al. 2012). 
Methods using FPKM have recently been shown to be less effective as a measure of 
quantification (Engstrom, Steijger et al. 2013) and the general move in the field has been 
away from using programs similar to TopHat and towards using programs similar to 
transcript counting which allow identification of individual transcripts via barcoding, which 
were unfortunately unavailable at the time of sequencing. Despite these challenges, highly 
expressed transcripts >200 nt found in the previous sequencing experiment were also 
detected in the sequencing replicates described here. 
A better way to compare experiments such as these is through GO term analysis, as 
the overrepresented terms rely on multiple genes being expressed and general processes 
occurring can be identified. GO term analysis of the replicates showed a high level of 
similarity between overrepresented terms, with majority of terms found within all three 
replicates. Most of the GO terms identified within the replicates were those found during the 
GO term analysis of stage I oocytes, this indicates the replicates are not only highly similar to 
each other, but also to the whole—molecule sequencing of stage I oocytes described in this 
Chapter.  
Overall, the standard whole-molecule polyA RNA-Seq of stage I oocytes was loosely 
correlated with the results produced from the transcript counting done in Chapter 3 (Figure 
4.10) and identified many more Ensembl gene IDs as being expressed. This is likely due to 
differences in the methods of assigning reads to gene IDs, as many 3’ peaks of reads within 
the transcript counting datasets were not assigned to Ensembl IDs, as well as slight 
differences in methods of library construction and sequencing depth. Previous comparisons 
of RNA-Seq and transcript counting have also identified a higher number of genes expressed 
in RNA-Seq datasets and additional 3’ ends within transcript counting datasets (Collins, Wali 
et al. 2015). Although not the focus of our studies in this analysis, whole-molecule RNA-Seq 
provides additional information about isoform use, which could provide interesting additional 
information about changes occurring during oogenesis. Transcript counting was developed 
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mainly to use in comparative experiments and not for the profiling of samples, and as such 
using standard whole-molecular profiling techniques were better suited for these experiments.   
4.4.7 Concluding remarks 
 
Building on the work of previous Chapters, where I developed a method to collect high 
quality, staged oocytes and provided a thorough characterization of the small RNA peak 
observed in early oogenesis, in this Chapter I have collected oocytes and successfully 
sequenced them to provide transcriptional profiles of the polyA RNA within each stage of 
oogenesis in the zebrafish. A thorough analysis of the transcripts present each stage was 
done. The proportions of transcript types were compared between the stages and GO term 
analysis was done for each stage. Differentially expressed genes were identified and 
additional GO term analysis was done on these genes, identifying an increase in polyA 
snoRNAs, indicating an undescribed role for snoRNAs within stage IV oocytes. Additionally, 
cdk19 was found to have a potentially significant role during stage III oogenesis, possibly 
preparing the cell for maturation, although the mechanism of this is unknown. A comparison 
between the stage I small RNA sequencing from Chapter 3 and the stage I polyA RNA in this 
Chapter revealed that in addition to the rRNA fragments, the small RNA sequencing included 
fragments of many polyA RNAs which are expressed during stage I. This indicates the 
fragments may be derived from RNAs present in the oocyte at that time. Not all polyA RNAs 
were found within the small RNA sequencing, suggesting that while the majority of RNAs 
during this stage are fragmented, some are selectively preserved within the oocyte. These 
results provide a useful resource for others interested in the transcriptome during oogenesis. 
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5.1 Summary of results 
 
In this thesis I have used a variety of approaches to closely investigate and profile the RNAs 
transcribed during oogenesis in the zebrafish. These have included a wide variety of 
sequencing approaches and the development of new methods for the isolation of individual 
zebrafish oocytes and sequencing of small RNAs.  
The development of a method for the isolation and staging of oocytes, while 
maintaining RNA quality and minimizing degradation, has provided a way of collecting the 
large numbers of oocytes required to obtain enough RNA for sequencing and helped reveal 
the content of the large peak of small RNA present within early oocyte of the zebrafish. I 
compared this peak to a similar peak of small RNA observed in Xenopus and examined the 
RNA in depth using well established RNA visualization techniques to further characterize it’s 
formation and reproducibility in zebrafish oocyte samples. After establishing the small RNAs 
were consistently produced and not the result of normal degradation processes or apoptosis 
within the cells, the small RNAs were sequenced. The content of the small RNAs was found 
to be different to the RNAs observed in Xenopus, which contained 5S rRNA and tRNA, and 
consisted largely of fragmented 45S ribosomal RNA. As the formation of the small RNA was 
determined to be a normal process within the oocytes and not due to sample processing, the 
transcriptome of each stage of oogenesis was profiled and described using GO term analysis. 
Consequently, snoRNAs were found to have an important role in late oogenesis. Finally, in 
depth analysis of the polyA and small RNA of stage I oocytes was done identifying 
similarities between datasets suggesting some of the small RNA is derived from polyA RNAs 
expressed during stage I and that some polyA RNAs are protected from fragmentation. 
Through this work, a theory was developed about the generation of the fragments of 
RNAs whereby the unneeded and excess transcripts are fragmented at a high rate in stage I 
oocytes and then degraded to recycle the nucleotides for reuse in the production of transcripts 
which are important for oogenesis and/or are conserved within the oocyte to drive early 
embryonic development.   
5.2 Development of a method for collection of high quality oocytes in a stage specific 
manner 
 
Methods for collecting zebrafish oocytes existed prior to the beginning of this project, mostly 
involving the use of enzymes, such as collagenase or hyaluronidase, to separate the oocytes 
(Guan, Rawson et al. 2008). As discussed in Chapter 2, although this allowed for easy 
collection of oocytes, the quality of the cells recovered were not optimal for use in RNA 
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experiments and there were concerns about the enzymes affecting the transcriptional profiles 
of the cells leading to misrepresentation of the RNAs present at each stage. This has been 
observed during the collection of Xenopus oocytes, as they require up to 4 hours of 
stabilization in culture media after enzymatic treatment before they can be subsequently used 
(Tokmakov, Iwasaki et al. 2005). As a result I returned to previous techniques used to isolate 
and collect oocytes by incubating portions of the ovary in culture medium and carefully 
manually separating the cells from the ovary mass (Wallace and Misulovin 1978). This 
provided a consistent method for the dissociation and collection of oocytes of high quality 
that could be used for RNA studies and other studies requiring high quality unaltered oocytes. 
It should be noted that this method does not remove follicle cells from oocytes, the follicle 
cell layer can be removed manually through careful manipulation with forceps – however for 
our purposes this was determined to extend the collection time excessively, risking RNA 
degradation, and was not preformed. More work regarding suitable enzymes and 
concentrations, or other methods of follicle cell removal, needs to be done in order to develop 
a method that combines fast and accurate collection of high quality oocytes with the removal 
of the follicle cell layer.  
5.3 Description of the small RNA peak within early zebrafish oocytes and comparison to 
findings from previous research 
 
Having established a method for the collection of high quality oocytes, oocytes of the 
different stages were isolated and RNA was visualized using Bioanalyzer chips. Previous 
research into oogenesis in other Teleosts and Xenopus indicated that a large peak of relatively 
small RNAs would be present in early oocytes (Mairy and Denis 1971, Denis and Mairy 
1972, Mazabraud, Wegnez et al. 1975), which was found to be true of zebrafish in Chapter 3 
of this work: a strong peak of RNAs at ~100 nt was observed associated with a large 
reduction in the amount of 18S and 28S rRNAs present. As the stages increased, the size of 
the small RNA peak dropped dramatically until stage IV where the small RNA peak had 
almost entirely disappeared. As the small RNA peak decreases, 18S and 28S rRNAs become 
the predominant RNA species in the oocyte. Work on Xenopus in the showed this peak 
consisted largely of 5S rRNA and tRNAs, and stored until needed during early embryonic 
development – similarities between Xenopus and zebrafish suggested the same would be 
found for the zebrafish (Ford 1971, Denis and Mairy 1972, Wegnez and Denis 1972, 
Wegnez, Monier et al. 1972, Ford and Southern 1973, Peterson, Doering et al. 1980, Callan, 
Gall et al. 1988).  
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Sequencing of the small RNA peak in stage I oocytes revealed it consisted mostly of 
rRNA, as expected, however little to no expression of 5S rRNA was observed. Instead, 
transcripts within the small RNA fraction were found to be ~100 nt fragments of the 45S 
rRNA and protein coding genes. The rRNA fragments, termed mrRNAs to differentiate them 
from previously described small rRNA (srRNA) fragments discovered in mice (Wei, Zhou et 
al. 2013), originated from the 45S pre-rRNA in the approximate proportions expected if 
derived from the entire 45S transcript and included reads which mapped across pre-rRNA 
and final rRNA transcripts, again suggesting they are derived from intact or nearly intact 45S 
pre-rRNA molecules. The size of the mrRNA fragments was highly specific and precise 
suggesting they are a product of an as-of-yet undescribed process, rather than forming due to 
standard degradation mechanisms (Wei, Zhou et al. 2013). Similar sized fragments from the 
ends of protein coding genes were also identified within the sequenced population, although 
at a much lower abundance than the mrRNAs.  
Sequencing multiple replicates enabled an estimation of the variation in the sequences 
that make up the mrRNAs and allowed a paired exploration of sequences within both the 
small RNA and polyA RNA fractions of the same pool to be done. The sequencing resulting 
from these fractions were compared to further analyse the content of the small RNA dataset 
against polyA transcripts expressed at that time. Similarities between the small RNA 
fragments and expressed genes were observed suggesting some of the fragments were 
derived from transcripts expressed during stage I. A number of transcripts appeared to be 
excluded from fragmentation and degradation, suggesting the fragmentation process selective 
or that these RNAs are protected by an unknown mechanism. This protection and storage is 
also observed in the preservation and storage of maternal RNAs until needed after 
fertilization (Abrams and Mullins 2009, Marlow 2010), suggesting the preserved transcripts 
may have specific importance for the oocyte after or during the fragmentation process. 
The role of these fragmented sequences remains unknown, however, I have proposed 
here that these sequences represent a controlled degradation or clearing of RNAs at the start 
of oogenesis to provide enough free nucleotides for the production of maternal RNAs and 
transcripts required for early embryonic development, in a method that is independent from 
apoptosis related degradation. This process would represent an early event in stage I oocytes, 
possibly involving an endoribonuclease capable of generating the ~100 nt fragments.  
There are a number of limitations to this dataset that could be overcome by re-
sequencing using an alternative strategy. End-ligation of the mrRNAs followed by 
sequencing would reveal any consensus sequences within the ends of the fragments, 
5 Discussion 
 
149 
$
!
$
$ $
providing information about the potential endoribonuclease involved in their production. 
Importantly, identification of the RNase involved would open up the possibility of knockout 
experiments to identify a possible function of these fragments and bring us closer to an 
understanding of the implications of these findings. 
Although additional work is needed, the findings in Chapter 3 indicate there is a 
fragmentation process at work, reducing 45S pre-rRNA transcripts into small–medium sized 
(80-100 nt) fragments during early oogenesis in the zebrafish.  
5.4 Transcriptome profiles of the stages of oogenesis 
 
After developing a method for the collection of high quality oocytes and determining the 
nature of the small peak of RNA observed, the transcriptome of each stage was sequenced 
using whole molecule RNA-Seq. Comparisons between the transcriptomes were made in 
Chapter 4 identifying differentially expressed genes and genes expressed uniquely within a 
particular stage of oogenesis. Novel information was found, such as the role of cdk19 during 
stage III, however the functional of this gene during oogenesis and meiosis is not yet known. 
GO term analysis of each stage as well as of the differentially expressed genes additionally 
identified provided insight into the timing of specific developmental processes and confirmed 
the staging of the oocytes. Stage IV contained terms related to oocyte maturation while stage 
I included cell cycle terms and those relating to meiosis – processes previously known to 
occur in these stages.  
Interestingly, an increase in polyA snoRNAs was discovered during stage IV, 
although the function of snoRNAs during this time is not known. As some snoRNAs are 
known to associate with chromatin to initiate chromatin remodelling (Schubert, Pusch et al. 
2012, Schubert and Langst 2013), further analysis of the snoRNAs specifically identified 
here could provide insight into the establishment of transcriptional quiescence, a major part 
of oogenesis and early embryonic development which is not well understood.  
 Further analysis and inferences can be made using the transcriptome data as well as 
the GO term analysis in follow up studies. As an example of this I attempted to narrow down 
and investigate a list of possible candidates for the RNase involved in generating the small 
RNA fragments described within Chapter 3. Our working theory predicted the RNase to be 
highly expressed in stage I of oogenesis, but almost absent from the other stages – therefore 
gene IDs which had both this pattern of expression and ‘ribonuclease activity’ as a related 
GO term were selected as candidates. Candidates were considered even if little information 
on their activity was present or if the association was based on sequence similarity, as it was 
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expected not much information would be present on our target RNase. Once this list was 
compiled, the associated GO terms with each candidate ID were examined: those predicted to 
use double stranded templates or to have exonuclease activity were removed from the list, 
limiting it to endoribonucleases and RNases on unknown function. These IDs were 
investigated in detail to determine if it’s functions were known and if it was well described in 
other processes. If the RNase was known to be involved in other processes, it was excluded 
from the final candidate list. To investigate the final candidates for involvement in the 
production of the RNase, I utilized a recently developed technology for the generation of 
knockout mutants known as the Clustered Regularly Interspaced Short Palindromic Repeats 
(CRISPR) system (Schwank, Koo et al. 2013, Wu, Liang et al. 2013).  
The CRISPR/Cas9 system has been well described for use in zebrafish (Blackburn, 
Campbell et al. 2013, Xiao, Wang et al. 2013), and is currently in use in our lab 
(Kettleborough, Busch-Nentwich et al. 2013). This system has clear benefits compared to 
other site-specific nuclease technologies, especially in difficult-to-edit genomes such as the 
zebrafish, however an in-depth review of the CRISPR system is outside of the scope of what 
I would like to cover in this thesis – those interested in more information about CRISPRs and 
their use in multiple different organisms for the generation of transgenic animals, please see a 
review such as that by Seruggia and Montoliu (2014). To identify potential functions of the 
RNases, the knockout fish were raised to adulthood and screened for transmission. 
Transmitting fish were going to be incrossed and their offspring analysed for developmental 
phenotypes as well as in depth examinations of their ovaries of any resulting female fish – 
unfortunately a miscommunication within the lab led to all of the fish being culled before this 
could take place, and there was not enough time remaining to reinject and raise the fish prior 
to submission. One candidate had already been knocked out within the Zebrafish Mutation 
Project and fish from this line were incrossed to observe the effect – interestingly, the 
homozygous fish were found to have a variable phenotype during gastrulation and did not 
reach adulthood. This suggests that this RNase is involved in early developmental processes, 
a function which has not been described for RNases previously. It is clear this RNase does 
not have an oogenesis specific function and therefore this mutant is being followed up and 
investigated by another member of our lab. GO term analysis combined with the availability 
of transcriptomic data is an effective way of identifying and narrowing down candidates for 
functional follow up. Re-injection of the CRISPRs and further investigation would provide 
information about the predicted involvement of an RNase in the fragmentation process 
described in Chapter 3, and is something that should be undertaken to further this work.  
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The stage specific oocyte transcriptomes provided here are useful resources for 
researchers interested in not only oogenesis, but transcriptomics as well developmental 
biology and have identified a number of important and interesting candidates involved in 
oogenic processes to be further investigated.  
5.5 Future work 
 
Numerous different experimental avenues exist to follow up and continue this work. For the 
study of the mrRNAs, alternative sequence strategies, such as end-ligation, or small RNA 
sequencing within the other stages of oogenesis, are currently possible and would provide 
valuable information about this phenomenon. Additionally, identification of the RNases 
involved in the process, through motifs generated from the end-ligation sequencing data or 
via knockouts from the Zebrafish Mutation Project, would greatly progress research into this 
area.  
Sequencing of additional replicates for stages II, III, and IV of oogenesis would 
provide more accurate results regarding transcript expression and further insights into the 
differences between stages. This would be especially beneficial for stage IV where processes 
specific to oocyte maturation occur. In particular, studies of maturation would benefit from a 
newly described technique known as “single cell RNA-Seq”. 
RNA-Seq technology is progressing at a very rapid rate and already sequencing from 
pooled RNA samples is no longer necessary with libraries being made from single cells or 
small pool of only a few cells (Tang, Barbacioru et al. 2009, Tang, Barbacioru et al. 2010). 
Initially, single-cell sequencing libraries required an extensive amount of amplification and 
generated very low numbers of reads per cell making them unsuitable for many studies. 
However, as single cell RNA-Seq has advanced dramatically over the last few years, it has 
become the new standard for transcriptome analysis and is a powerful tool for uncovering 
variation within cells, tissues, and embryos. Single cell RNA-Seq is especially well suited to 
developmental biology studies as low input amounts of RNA can now be used (Tang, 
Barbacioru et al. 2009, Tang, Barbacioru et al. 2010). Global changes in gene expression 
during first stages of embryonic development have been profiled using this technology 
(Hashimshony, Wagner et al. 2012, Deng, Ramsköld et al. 2014), including in the zebrafish 
where single-cell gene expression is being paired with positional information about cells in 
the embryo (Satija, Farrell et al. 2015). Now, hundreds of thousands of cells can be profiled 
to examine heterogeneity within a population (Fan, Fu et al. 2015). Analyses of oogenesis 
using this technology would produce very valuable information, especially within the stage I 
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oocytes, which are known to be comprised of a wide variety of different cell types. 
Specifically, identifying the changes in the transcriptome that occur while differentiating 
from a germ stem cell to a primary oocyte would help to identify key regulators in germ cell 
differentiation and stem cell renewal which could have implications within other tissues and 
systems. Similarly, single cell RNA-Seq is ideal for analysis of oocyte maturation as 
expression changes in response to 17α, 20β-dihydroxy-4-pregnon-3-one (progesterone), as 
sequencing of many cells via singe cell RNA-Seq can reveal underlying gene expression 
patterns as well as transient expression of important intermediary genes (Kolodziejczyk, Kim 
et al. 2015).  
One of the greatest challenges to successful single cell RNA-Seq is the same problem 
faced at the start of this project – the efficient collection of single cells with minimal 
alterations to gene expression. Manual dissociation using microdissection, as described 
within Chapter 2, is not possible for all tissues and are very labour intensive, while 
techniques such as laser microdissection (Frumkin, Wasserstrom et al. 2008) cannot isolate 
enough cells for large scale analysis, such as the profiling of heterogeneity discussed above. 
Advances have been made and a variety of techniques using enzymatic dissociation and 
isolation of single cells using FACS or microfluidics platforms, such as the Fluidigm C1 
robot, are now commonly found in single cell RNA-Seq methods (Kolodziejczyk, Kim et al. 
2015) – this presents a problem for the analysis of single oocytes as zebrafish oocytes were 
found to be very sensitive to enzymatic treatment, which would have to be addressed before 
it is possible to undertake a single cell approach for oocyte analysis. Another challenge is the 
increasingly complex bioinformatic approaches that need to be developed to analyse the 
transcriptomes of hundreds of thousands of cells able to be produced during a single 
experiment (Stegle, Teichmann et al. 2015). As the technology has advances, the methods 
developed for RNA-Seq analysis of pooled cells can be of use, but cannot take full advantage 
of the single cell data to cluster gene expression, identify rare cell types or to describe gene-
regulatory networks at the same level of detail (Stegle, Teichmann et al. 2015, Yalcin, 
Hakguder et al. 2015). Although promising, there are many technical aspects that need to be 
considered before single cell RNA-Seq can be effectively used for studies of oogenesis. An 
excellent review covering all the aspects of single cell RNA-Seq technology which would 
need to be considered is available from Kolodziejczyk, Kim et al. (2015).  
As methods of sequencing advance to coping with lower starting amounts of material, 
the possibility of separately examining the two peaks of small RNA observed during stage I 
oogenesis, as described in Chapter 3, is becoming a reality. Separate analysis of these RNAs 
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would identify more specifically the content of each peak and help to clarify the differences 
observed between the sizes of the mrRNAs and protein coding RNA fragments observed in 
Chapter 4. This would help to shed light on the mechanism of production of these RNAs and 
help to elucidate any differences between the populations. Unfortunately the technology does 
not exist to effectively completely separate these two peaks and using standard protocols such 
as gel extraction would result to too much cross contamination between sizes to make 
adequate conclusions. Technology for specific size separation of DNA has been developed, 
such as the Pippin Prep (Sage Science), however the separation of sizes has not reached the 
resolution required for this type of experiment and models separating RNA have not been 
successfully developed as of yet. As the technology continues to develop, this method would 
provide valuable information to further the work of this thesis.  
Additional studies of oogenesis to complement the transcriptomic data would also be 
valuable. In particular, analysis of the chromatin during late oogenesis and at the onset of 
transcriptional quiescence would provide insight into the regulation of transcription and early 
embryonic development. This could provide information on pluripotency and differentiation 
in multiple cell types, and increased information about normal oogenesis could lead to 
discoveries of when oogenesis occurs abnormally, potentially leading to developments in 
fertility treatments.  
There are numerous different directions that can be pursued from the research 
presented within this thesis, only some of which have been detailed here. The transcriptome 
datasets provided here are excellent resources for studies of oogenesis and development, as 
well as RNA biology, however the usefulness of these datasets is limited without functional 
characterization of the genes involved. Fortunately, there are large efforts underway to fully 
characterize every gene using high-throughput approaches and phenotyping, such as the 
Zebrafish Mutation Project (Kettleborough, Busch-Nentwich et al. 2013), the Mouse 
Genetics Project (White, Gerdin et al. 2013) and the KnockOut Mouse Phenotyping Program 
(Bradley, Anastassiadis et al. 2012, Brown and Moore 2012). Continued funding and 
organization of these programs is essential to furthering basic research in biology as 
sequencing technology reduces in cost and difficulty.   
5.6 Concluding remarks 
 
The main aims of this work were to profile the polyA transcriptome during each stage of 
oogenesis and develop a method for the collection of high quality oocytes for RNA studies. 
However the most significant results have been in the discovery of the identity small RNA 
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species within stage I oocytes. Contrasting with previous work in other species, this RNA 
was largely found to be 45S pre-rRNA rRNA fragments and some protein coding fragments, 
which indicates an unknown and undescribed process is at work during early oogenesis in the 
zebrafish. I presented a theory explaining the generation of the fragments based on previous 
work describing rRNA degradation whereby an endoribonuclease fragments RNAs and an 
exoribonuclease degrades the fragments into mononucleotides for recycling and reuse by the 
oocyte. This is postulated to occur to free up nucleotides for the production of new ribosomes 
and maternal RNAs, which are required to drive early embryonic development in the absence 
of zygotic gene transcription. Going forward, it is important to reinvestigate early oocytes of 
other species to establish if this process in conserved and merely not previously discovered 
due to limitations in technology, or if this is a zebrafish specific phenomenon. Further 
research into the small RNA fragments observed using alternative sequencing strategies and 
knockout approaches would provide additional information about the process at work and 
help to elucidate its function within the oocyte. The techniques applied within this thesis can 
be expanded to other studies of zebrafish oocytes furthering our understanding of oogenesis 
in the zebrafish as well as in other species. Additionally, the sequencing techniques described 
here can be used within other tissues and other species to investigate the small RNA and 
polyA RNA transcriptomes. Overall, this work has provided resources describing the polyA 
transcriptomes of each stage of oogenesis, as well as the small RNA fraction in stage I 
oocytes, and developed useful methods for future studies of zebrafish oogenesis and 
transcriptomics.  
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S1.2 RT-PCR Results  
Plate Type: Absolute Quantification  
Instrument Type: Applied Biosystems 7000 Real-Time PCR System 
 
Well Sample Name Gene Task Ct Qty 
A1 1 ODC Standard 17.54 1 
A2 2 ODC Standard 18.51 0.333 
A3 3 ODC Standard 19.84 0.111 
A4 4 ODC Standard 21.16 0.037 
A5 5 ODC Standard 23.17 0.0123 
A6 6 ODC Standard 24.44 0.00412 
A7 7 ODC Standard 26.01 0.00137 
A8 8 ODC Standard 27.11 0.000457 
B1 Stage I ODC Unknown 17.18 1.02 
B2 Stage I ODC Unknown 18.41 0.398 
B3 Stage II ODC Unknown 18.28 0.44 
B4 Stage II ODC Unknown 17.92 0.58 
B5 Stage III ODC Unknown 19.36 0.192 
B6 Stage III ODC Unknown 19.2 0.218 
B7 Stage IV ODC Unknown 27.56 0.000355 
B8 Stage IV ODC Unknown 26.77 0.000652 
C1 1 ziwi Standard 19.03 1 
C2 2 ziwi Standard 20.03 0.333 
C3 3 ziwi Standard 22.09 0.111 
C4 4 ziwi Standard 22.59 0.037 
C5 5 ziwi Standard 24.22 0.0123 
C6 6 ziwi Standard 26.02 0.00412 
C7 7 ziwi Standard 28.34 0.00137 
C8 8 ziwi Standard 29.07 0.000457 
D1 Stage I Ziwi Unknown 20.63 0.242 
D2 Stage I Ziwi Unknown 20.05 0.371 
D3 Stage II Ziwi Unknown 19.81 0.442 
D4 Stage II Ziwi Unknown 19.44 0.582 
D5 Stage III Ziwi Unknown 21.03 0.181 
D6 Stage III Ziwi Unknown 22.26 0.0728 
D7 Stage IV Ziwi Unknown 30.08 0.000229 
D8 Stage IV Ziwi Unknown 30.35 0.000188 
E1 1 Zorba Standard 15.33 1 
E2 2 Zorba Standard 17.02 0.333 
E3 3 Zorba Standard 17.58 0.111 
E4 4 Zorba Standard 19.13 0.037 
E5 5 Zorba Standard 20.21 0.0123 
E6 6 Zorba Standard 22.04 0.00412 
E7 7 Zorba Standard Undetermined 
E8 8 Zorba Standard 23.82 0.000457 
F1 Stage I Zorba Unknown 15.38 1.07 
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Well Sample Name Gene Task Ct Qty 
F2 Stage I Zorba Unknown 16.08 0.569 
F3 Stage II Zorba Unknown 15.6 0.875 
F4 Stage II Zorba Unknown 16.48 0.401 
F5 Stage III Zorba Unknown 17.28 0.194 
F6 Stage III Zorba Unknown 17.07 0.234 
F7 Stage IV Zorba Unknown 19.35 0.0303 
F8 Stage IV Zorba Unknown 20.06 0.016 
G1 1 Igf3 Standard 25.68 1 
G2 2 Igf3 Standard 28.13 0.333 
G3 3 Igf3 Standard 26.44 0.111 
G4 4 Igf3 Standard 26.89 0.037 
G5 5 Igf3 Standard 28.96 0.0123 
G6 6 Igf3 Standard 31.99 0.00412 
G7 7 Igf3 Standard 30.5 0.00137 
G8 8 Igf3 Standard 34.55 0.000457 
H1 Stage I Igf3 Unknown 30.21 0.00738 
H2 Stage I Igf3 Unknown 29.88 0.0103 
H3 Stage II Igf3 Unknown 28.38 0.0457 
H4 Stage II Igf3 Unknown 28.81 0.0297 
H5 Stage III Igf3 Unknown 29.6 0.0135 
H6 Stage III Igf3 Unknown 29.81 0.011 
H7 Stage IV Igf3 Unknown 26.19 0.405 
H8 Stage IV Igf3 Unknown 25.45 0.842 
A9 1 Cyclin B1 Standard 16.66 1 
A10 2 Cyclin B1 Standard 19.24 0.333 
A11 3 Cyclin B1 Standard 29.58 0.111 
A12 4 Cyclin B1 Standard 39.46 0.037 
B9 5 Cyclin B1 Standard 22.9 0.0123 
B10 6 Cyclin B1 Standard 24.56 0.00412 
B11 7 Cyclin B1 Standard 27.12 0.00137 
B12 8 Cyclin B1 Standard 29.89 0.000457 
C9 Stage I Cyclin B1 Unknown 17.57 58.22 
C10 Stage I Cyclin B1 Unknown 18.02 38.61 
C11 Stage II Cyclin B1 Unknown 19.55 9.4 
C12 Stage II Cyclin B1 Unknown 19.43 10.51 
D9 Stage III Cyclin B1 Unknown 21.38 1.75 
D10 Stage III Cyclin B1 Unknown 21.84 1.16 
D11 Stage IV Cyclin B1 Unknown 22.65 0.548 
D12 Stage IV Cyclin B1 Unknown 22.11 0.9 
E9 1 Vasa Standard 17.81 1 
E10 2 Vasa Standard 19.09 0.333 
E11 3 Vasa Standard 21.77 0.111 
E12 4 Vasa Standard 22.21 0.037 
F9 5 Vasa Standard 23.28 0.0123 
F10 6 Vasa Standard 24.78 0.00412 
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Well Sample Name Gene Task Ct Qty 
F11 7 Vasa Standard 25.81 0.00137 
F12 8 Vasa Standard 30.14 0.000457 
G9 Stage I Vasa Unknown 19.79 0.225 
G10 Stage I Vasa Unknown 19.68 0.245 
G11 Stage II Vasa Unknown 18.18 0.709 
G12 Stage II Vasa Unknown 20.24 0.164 
H9 Stage III Vasa Unknown 19.57 0.264 
H10 Stage III Vasa Unknown 21.32 0.0762 
H11 Stage IV Vasa Unknown 22.38 0.036 
H12 Stage IV Vasa Unknown 23.38 0.0177 
Table S2: Real-Time PCR results. 
 
S2 Small RNA Sequencing 
S2.1 Statistics 
 
Aspect Forward Reverse 
Yield, Kb 2,643,450 2,497,951 
Fasta read count 19,179,666 19,179,666 
Contaminated read count 689,514 682,224 
Contaminated reads, % 3.60 3.56 
Table S3: Forward and reverse read statistics  
Provided by the in-house sequencing team.  
  
Aspect  # Reads 
QC-passed reads + QC-failed reads 38359332 
duplicates 26076474  
mapped  
(%) 
31823435 
(82.96%)  
paired in sequencing 38359332  
read1 19179666  
read2 19179666  
properly paired 
(%) 
29341358 
(76.49%) 
with itself and mate mapped 30684034 
singletons 
(%) 
1139401 
(2.97%) 
with mate mapped to a different chr 181406 
with mate mapped to a different chr (mapQ>=5) 11021  
Table S4: SAMtools Flagstat statistics obtained prior to mapping 
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Ensembl ID Name # Reads Transcript Type 
ENSDARG00000088951 AL935186.6 280243 protein_coding 
ENSDARG00000080337 AC024175.4 112244 Mt_rRNA 
ENSDARG00000070212 zgc:158463 102450 protein_coding 
ENSDARG00000091744 BX296557.6 82518 protein_coding 
ENSDARG00000082753 AC024175.17 62222 Mt_rRNA 
ENSDARG00000085168 AL935186.4 58326 miRNA 
ENSDARG00000085067 AL935186.3 58052 miRNA 
ENSDARG00000088436 CT956064.3 50907 protein_coding 
ENSDARG00000089382 zgc:158463 44943 protein_coding 
ENSDARG00000096403 si:dkey-153m14.1 38189 pseudogene 
ENSDARG00000085949 AL935186.5 31169 miRNA 
ENSDARG00000084533 BX296557.1 22520 miRNA 
ENSDARG00000091738 CT956064.6 20344 miRNA 
ENSDARG00000090280 BX296557.5 19151 miRNA 
ENSDARG00000087953 BX537263.4 19022 miRNA 
ENSDARG00000087337 BX537263.2 18935 miRNA 
ENSDARG00000086085 CT956064.1 18765 miRNA 
ENSDARG00000087970 BX537263.5 16039 miRNA 
ENSDARG00000088533 BX537263.6 15925 miRNA 
ENSDARG00000088494 CT956064.4 14817 miRNA 
ENSDARG00000088313 BX296557.3 14771 miRNA 
ENSDARG00000087034 CT027638.1 12000 miRNA 
ENSDARG00000089384 BX296557.4 11925 miRNA 
ENSDARG00000089617 RNaseP_nuc 11397 misc_RNA 
ENSDARG00000086686 BX296557.2 11026 miRNA 
ENSDARG00000087732 Metazoa_SRP 9875 misc_RNA 
ENSDARG00000088976 BX537263.8 9742 miRNA 
ENSDARG00000088865 BX537263.7 9697 miRNA 
ENSDARG00000090175 BX537263.9 9083 miRNA 
ENSDARG00000090733 BX537263.10 9074 miRNA 
ENSDARG00000090619 CT956064.5 9012 miRNA 
ENSDARG00000087504 CABZ01045618.2 8720 miRNA 
ENSDARG00000087432 BX537263.3 7376 miRNA 
ENSDARG00000087506 BX548011.3 7356 protein_coding 
Table S5: Read counts and transcript types of the top 34 Ensembl IDs  
 
S2.2 GO Term Analysis 
 
ID Term % p-value 
Kegg:03010 Ribosome 28.9 2.75E-15 
Kegg:00190 Oxidative phosphorylation 14.8 3.72E-06 
Kegg:04114 Oocyte meiosis 14.4 8.39E-06 
Kegg:03013 RNA transport 13.3 9.01E-06 
Kegg:04141 Protein processing in endoplasmic reticulum 12.4 9.26E-06 
Kegg:03018 RNA degradation 17.6 1.18E-05 
Kegg:04110 Cell cycle 13.3 1.23E-05 
Kegg:04145 Phagosome 12.8 6.83E-05 
Kegg:03040 Spliceosome 11.8 0.000168521 
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ID Term % p-value 
Kegg:03015 mRNA surveillance pathway 13.0 0.002108270 
Kegg:04810 Regulation of actin cytoskeleton 7.3 0.018479700 
Kegg:03060 Protein export 19.0 0.023630800 
Kegg:04914 Progesterone-mediated oocyte maturation 9.2 0.033546700 
Kegg:04010 MAPK signaling pathway 6.3 0.042271200 
Table S6: KEGG pathway analysis 
KEGG pathway analysis of the pilot strand specific fraction miseq. % gives the 
number of times a term was associated within the reference list (of 1000 Ensembl 
IDs) as a percentage of the total number of ID associated with that term. Corrected p-
values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 
2012). 
 
ID Term % p-value 
GO:0022900 electron transport chain 45.8 9.36E-09 
GO:0006334 nucleosome assembly 36.1 1.21E-08 
GO:0006412 translation 15.9 1.96E-08 
GO:0042773 ATP synthesis coupled electron transport 66.7 0.001523820 
GO:0048565 digestive tract development 27.8 0.016082900 
GO:0051726 regulation of cell cycle 20.0 0.021130100 
GO:0055114 oxidation-reduction process 5.9 0.024032000 
GO:0046686 response to cadmium ion 33.3 0.024765400 
GO:0045905 positive regulation of translational termination 100 0.025044900 
GO:0006452 translational frameshifting 100 0.025044900 
GO:0045901 positive regulation of translational elongation 100 0.025044900 
GO:0048262 determination of dorsal/ventral asymmetry 100 0.025044900 
GO:0031100 organ regeneration 100 0.025044900 
GO:0017148 negative regulation of translation 100 0.025044900 
GO:0001706 endoderm formation 25.0 0.025111400 
GO:0006950 response to stress 13.2 0.025125400 
GO:0006414 translational elongation 19.2 0.025153800 
GO:0045454 cell redox homeostasis 15.8 0.025153900 
GO:0007398 ectoderm development 37.5 0.028834400 
GO:0006417 regulation of translation 23.5 0.029477600 
GO:0006810 transport 5.6 0.030803100 
GO:0006457 protein folding 10.1 0.031207400 
GO:0022904 respiratory electron transport chain 50.0 0.032362200 
GO:0006413 translational initiation 14.3 0.034266600 
GO:0000079 regulation of cyclin-dependent protein kinase 
activity 
26.7 0.036996800 
GO:0051597 response to methylmercury 33.3 0.037565700 
GO:0006355 regulation of transcription, DNA-dependent 5.0 0.037680300 
GO:0007010 cytoskeleton organization 21.1 0.040810400 
GO:0016338 calcium-independent cell-cell adhesion 66.7 0.042731000 
GO:0090244 Wnt receptor signalling pathway involved in 
somitogenesis 
66.7 0.042731000 
GO:0051225 spindle assembly 66.7 0.042731000 
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Table S7: GO Term Biological Process Analysis  
of pilot small RNA fraction sequencing% gives the number of times a term was 
associated within the reference list (of 1000 Ensembl IDs) as a percentage of the total 
number of ID associated with that term. Corrected p-values were calculated using 
GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
 
ID GO Term % p-value 
GO:0030529 ribonucleoprotein complex 23.0 9.31E-14 
GO:0070469 respiratory chain 78.6 4.55E-13 
GO:0005634 nucleus 6.7 1.43E-11 
GO:0005840 ribosome 18.5 1.34E-10 
GO:0005737 cytoplasm 7.3 2.60E-08 
GO:0000786 nucleosome 35.5 2.61E-08 
GO:0005694 chromosome 19.4 6.23E-07 
GO:0005622 intracellular 5.8 0.000199967 
GO:0005743 mitochondrial inner membrane 14.3 0.000282672 
GO:0005902 microvillus 100 0.000290437 
GO:0005739 mitochondrion 10.0 0.000294275 
GO:0031966 mitochondrial membrane 38.5 0.000313525 
GO:0015935 small ribosomal subunit 44.4 0.000917833 
GO:0030057 desmosome 75.0 0.000972808 
GO:0005938 cell cortex 29.4 0.000997330 
GO:0005783 endoplasmic reticulum  9.4 0.001025670 
GO:0016342 catenin complex 60.0 0.001847990 
GO:0005913 cell-cell adherens junction 60.0 0.001847990 
GO:0015934 large ribosomal subunit 50.0 0.003420920 
GO:0045263 proton-transporting ATP synthase complex, 
coupling factor F(o) 
100 0.005658880 
GO:0014704 intercalated disc 66.7 0.015836300 
GO:0005874 microtubule 10.8 0.020725200 
GO:0034747 Axin-APC-beta-catenin-GSK3B complex 50.0 0.028326300 
Table S8: GO Term Cellular Component Analysis 
GO Term Cellular Component Analysis of pilot small RNA fraction sequencing. % 
gives the number of times a term was associated within the reference list (of 1000 
Ensembl IDs) as a percentage of the total number of IDs associated with that term. 
Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID GO Term % p-value 
GO:0003735 structural constituent of ribosome 21.7 3.22E-11 
GO:0000166 nucleotide binding 7.0 5.20E-11 
GO:0003676 nucleic acid binding 7.8 5.10E-08 
GO:0003723 RNA binding 11.6 2.52E-07 
GO:0003677 DNA binding 6.4 5.33E-06 
GO:0008137 NADH dehydrogenase (ubiquinone) activity 46.7 6.29E-06 
GO:0005524 ATP binding 5.7 0.000921629 
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ID GO Term % p-value 
GO:0046983 protein dimerization activity 16.4 0.001124580 
GO:0019904 protein domain specific binding 27.3 0.001208570 
GO:0019901 protein kinase binding 21.4 0.003788790 
GO:0005488 binding 6.3 0.004077940 
GO:0003746 translation elongation factor activity 26.3 0.004357240 
GO:0015035 protein disulphide oxidoreductase activity 22.7 0.008434830 
GO:0016491 oxidoreductase activity 6.3 0.010602700 
GO:0003743 translation initiation factor activity 14.3 0.011229400 
GO:0005198 structural molecule activity 9.2 0.011925000 
GO:0008565 protein transporter activity 17.9 0.020653500 
GO:0016853 isomerase activity 12.3 0.023280500 
GO:0043022 ribosome binding 66.7 0.029597800 
GO:0004748 ribonucleoside-diphosphate reductase activity 66.7 0.029597800 
GO:0008190 eukaryotic initiation factor 4E binding 66.7 0.029597800 
GO:0051082 unfolded protein binding 11.5 0.032731500 
GO:0004129 cytochrome-c oxidase activity 27.3 0.040657800 
GO:0009055 electron carrier activity 8.3 0.042113500 
GO:0031490 chromatin DNA binding 50.0 0.049062900 
GO:0003918 DNA topoisomerase (ATP-hydrolyzing) activity 50.0 0.049062900 
Table S9: GO Term Molecular Function Analysis 
GO term molecular function analysis of pilot small RNA fraction sequencing. % gives 
the number of times a term was associated within the reference list (of 1000 Ensembl 
IDs) as a percentage of the total number of IDs associated with that term. Corrected p-
values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 
2012). 
 
miRNA Support % p-value 
dre-miR-146b 26 9.9% 4.29E-05 
dre-miR-16a 21 9.9% 0.0003217710 
dre-miR-457b 20 9.9% 0.0003692000 
dre-miR-738 20 9.3% 0.0006566680 
dre-miR-125c 21 8.6% 0.0010541200 
dre-miR-457a 19 9.1% 0.0010545300 
dre-miR-133c 19 8.9% 0.0010951900 
dre-miR-133a 19 8.8% 0.0011053500 
dre-miR-19b 20 8.7% 0.0011356600 
dre-miR-15b 21 8.2% 0.0011985000 
dre-miR-217 18 8.6% 0.0014518000 
dre-miR-17a 20 7.9% 0.0014772800 
dre-miR-125b 20 8.0% 0.0014915900 
dre-miR-723 20 8.1% 0.0015278500 
dre-miR-16c 18 8.5% 0.0015338900 
dre-miR-24 18 8.7% 0.0015473600 
dre-miR-430i 19 8.3% 0.0015819400 
dre-miR-133b 18 8.6% 0.0017074800 
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miRNA Support % p-value 
dre-miR-184 20 7.8% 0.0018232400 
dre-miR-200b 21 7.5% 0.0019128500 
dre-miR-200c 21 7.4% 0.0019207500 
dre-miR-101b 20 7.7% 0.0019209700 
dre-miR-101a 20 7.7% 0.0019257500 
dre-miR-93 18 8.1% 0.0019276800 
dre-miR-7b 18 8.0% 0.0021809500 
dre-miR-203b* 14 9.2% 0.0023744300 
dre-miR-26a 18 7.9% 0.0024630500 
dre-let-7f 20 7.4% 0.0024876300 
dre-miR-499 16 8.3% 0.0026076900 
dre-miR-459* 14 9.0% 0.0026081900 
dre-let-7c 20 7.1% 0.0034149500 
dre-miR-130b 19 7.2% 0.0037121900 
dre-miR-125a 19 7.3% 0.0037655400 
dre-miR-19a 17 7.7% 0.0038058300 
dre-miR-31 17 7.6% 0.0039707400 
dre-miR-204 17 7.5% 0.0040411600 
dre-let-7g 18 7.3% 0.0040563000 
dre-miR-7a 16 7.8% 0.0040745900 
dre-miR-16b 16 7.7% 0.0043970100 
dre-miR-20a 17 7.2% 0.0061941100 
dre-miR-183 16 7.2% 0.0079099900 
dre-miR-130a 17 7.0% 0.0080870200 
dre-let-7b 18 6.8% 0.0081194400 
dre-miR-15a* 14 7.6% 0.0089536100 
dre-miR-220 18 6.7% 0.0091487100 
dre-miR-216b 19 6.5% 0.0097205600 
dre-miR-18a 15 7.2% 0.0099241400 
dre-miR-132* 13 7.7% 0.0101494000 
dre-miR-454a 17 6.7% 0.0101751000 
dre-let-7a 18 6.5% 0.0108775000 
dre-miR-99 15 7.0% 0.0111370000 
dre-miR-430b 15 7.0% 0.0111370000 
dre-miR-129* 13 7.6% 0.0111530000 
dre-miR-26b 15 7.0% 0.0114323000 
dre-miR-135a 15 6.9% 0.0115328000 
dre-miR-100 14 7.3% 0.0115453000 
dre-miR-92a 16 6.7% 0.0115882000 
dre-miR-1 16 6.8% 0.0116032000 
dre-let-7e 17 6.6% 0.0116048000 
dre-miR-740 12 7.7% 0.0119732000 
dre-miR-150 14 7.1% 0.0120720000 
dre-miR-15a 16 6.6% 0.0120732000 
dre-miR-19d 15 6.9% 0.0121579000 
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miRNA Support % p-value 
dre-miR-726 14 7.1% 0.0122308000 
dre-miR-19c 15 6.8% 0.0127494000 
dre-miR-429 16 6.5% 0.0137263000 
dre-miR-206 14 6.9% 0.0137362000 
dre-miR-216a 18 6.2% 0.0139554000 
dre-let-7j 18 6.2% 0.0142470000 
dre-let-7i 17 6.3% 0.0143570000 
dre-miR-462 13 7.1% 0.0149550000 
dre-miR-301a 16 6.3% 0.0170693000 
dre-miR-735 14 6.7% 0.0176806000 
dre-miR-202 15 6.4% 0.0181344000 
dre-miR-430a 14 6.6% 0.0186641000 
dre-miR-193a 15 6.4% 0.0190548000 
dre-miR-212 16 6.1% 0.0212950000 
dre-miR-210* 12 6.9% 0.0214961000 
dre-miR-737 14 6.5% 0.0215834000 
dre-miR-20b 15 6.2% 0.0225980000     
dre-miR-199 15 6.2% 0.0231376000 
dre-miR-194a 14 6.4% 0.0233193000 
dre-miR-135b 13 6.5% 0.0258283000 
dre-miR-736 12 6.7% 0.0261254000 
dre-miR-135c 13 6.4% 0.0265353000 
dre-miR-103 14 6.2% 0.0267554000 
dre-miR-18b 14 6.2% 0.0284227000 
dre-miR-130c 14 6.1% 0.0287904000 
dre-miR-10c 15 6.0% 0.0291105000 
dre-miR-221 14 6.0% 0.0313419000 
dre-miR-140* 13 6.2% 0.0315428000 
dre-miR-365 13 6.2% 0.0315428000 
dre-miR-301b 14 6.0% 0.0320914000 
dre-miR-22b 15 5.9% 0.0321368000 
dre-miR-22a 15 5.9% 0.0321368000 
dre-miR-196a 14 6.0% 0.0325152000 
dre-miR-459 13 6.2% 0.0328473000 
dre-miR-301c 14 5.9% 0.0340698000 
dre-miR-10a* 12 6.3% 0.0342068000 
dre-miR-181a 14 5.9% 0.0360333000 
dre-miR-729 11 6.5% 0.0363755000 
dre-miR-194b 14 5.9% 0.0364995000 
dre-miR-451 12 6.2% 0.0377308000 
dre-miR-148 14 5.8% 0.0381851000 
dre-miR-727 12 6.1% 0.0412083000 
dre-miR-222 14 5.6% 0.0461693000 
dre-miR-146a 14 5.6% 0.0461693000 
dre-miR-9 11 6.1% 0.0495300000 
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Table S10: MicroRNA Association Analysis 
MicroRNA association analysis of pilot small RNA fraction sequencing. Support 
indicates the number of times a term was associated within the reference list (of 1000 
Ensembl gene IDs) and % gives this as a percentage of the total number of IDs 
associated with that term. Corrected p-values were calculated using GeneCodis3 
(Tabas-Madrid, Nogales-Cadenas et al. 2012). 
S3 RNA-Sequencing of Stages I – IV  
S3.1 Statistics 
 
Aspect Forward Reverse 
Yield (Kb) 12,536,765 12,448,260 
Fasta read count 168,681,100 168,681,100 
Contaminated read count 83,290 23,198 
Contaminated reads, % 0.05 0.01 
Table S11: Forward and Reverse Read Statistics 
 
Forward and reverse read statistics from the sequencing of stages I-IV of oogenesis, 
results provided by the in-house sequencing team.  
 
 
Aspect Stage I Stage II Stage III Stage IV 
Tag ATCACG CGATCT TTAGGC TGACCA 
Fasta read count 33,906,621 65,090,608 37,123,969 30,011,207 
% of total reads 20.10 38.59 22.01 17.79 
Table S12: Tags and Sample Statistics  
 
Statistics from the sequencing of stages I-IV of oogenesis, results provided by the in-
house sequencing team. Fasta reads counted are paired-end reads.
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S3.2 GO Term Analysis  
S3.2.1 Stage I 
 
ID Term % p-value 
Kegg:03010 Ribosome 98.8 1.05E-71 
Kegg:03013 RNA transport 75.0 2.48E-58 
Kegg:03040 Spliceosome 73.9 1.05E-52 
Kegg:00190 Oxidative phosphorylation 73.9 5.48E-51 
Kegg:03008 Ribosome biogenesis in eukaryotes 70.8 3.24E-26 
Kegg:03050 Proteasome 77.6 3.14E-24 
Kegg:04141 Protein processing in endoplasmic reticulum 47.6 3.31E-24 
Kegg:04110 Cell cycle 50.8 1.77E-23 
Kegg:04120 Ubiquitin mediated proteolysis 50.4 8.73E-22 
Kegg:03018 RNA degradation 61.8 1.09E-20 
Kegg:03030 DNA replication 77.1 2.68E-17 
Kegg:00240 Pyrimidine metabolism 48.9 5.85E-16 
Kegg:03420 Nucleotide excision repair 67.5 6.20E-15 
Kegg:03015 mRNA surveillance pathway 52.2 1.21E-14 
Kegg:04114 Oocyte meiosis 41.4 1.01E-13 
Kegg:03060 Protein export 81.0 1.05E-11 
Kegg:00020 Citrate cycle (TCA cycle) 65.5 2.35E-10 
Kegg:03430 Mismatch repair 72.7 7.44E-10 
Kegg:03020 RNA polymerase 68.0 9.28E-10 
Kegg:03022 Basal transcription factors 56.8 9.57E-10 
Kegg:00280 Valine, leucine and isoleucine degradation 52.4 2.56E-09 
Kegg:00230 Purine metabolism 30.5 1.66E-08 
Kegg:04260 Cardiac muscle contraction 40.0 3.34E-07 
Kegg:00010 Glycolysis / Gluconeogenesis 38.7 6.73E-07 
Kegg:00970 Aminoacyl-tRNA biosynthesis 50.0 1.28E-06 
Kegg:00062 Fatty acid elongation in mitochondria 81.8 1.51E-06 
Kegg:03410 Base excision repair 48.4 4.87E-06 
Kegg:04142 Lysosome 28.9 7.92E-06 
Kegg:03440 Homologous recombination 52.0 8.62E-06 
Kegg:00510 N-Glycan biosynthesis 37.2 0.000124001 
Kegg:04914 Progesterone-mediated oocyte maturation 28.7 0.000145184 
Kegg:00640 Propanoate metabolism 40.6 0.000226344 
Kegg:00071 Fatty acid metabolism 37.1 0.000653047 
Kegg:04115 p53 signaling pathway 30.0 0.000876852 
Kegg:00620 Pyruvate metabolism 36.1 0.000881118 
Kegg:04623 Cytosolic DNA-sensing pathway 37.5 0.000964318 
Kegg:00650 Butanoate metabolism 41.7 0.001136510 
Kegg:00480 Glutathione metabolism 35.3 0.001753110 
Kegg:04530 Tight junction 22.9 0.001848210 
Kegg:04145 Phagosome 23.9 0.002155720 
Kegg:04130 SNARE interactions in vesicular transport 32.5 0.002370140 
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ID Term % p-value 
Kegg:00630 Glyoxylate and dicarboxylate metabolism 46.7 0.003734350 
Kegg:00030 Pentose phosphate pathway 34.5 0.005597860 
Kegg:00270 Cysteine and methionine metabolism 29.7 0.012392800 
Kegg:04350 TGF-beta signaling pathway 22.9 0.015951000 
Kegg:04910 Insulin signaling pathway 20.5 0.015951200 
Kegg:04710 Circadian rhythm - mammal 31.0 0.019178900 
Kegg:00310 Lysine degradation 26.1 0.024251800 
Kegg:04520 Adherens junction 22.4 0.028438200 
Kegg:00350 Tyrosine metabolism 29.6 0.037802400 
Kegg:00360 Phenylalanine metabolism 38.5 0.042937400 
Table S14: KEGG Pathway Analysis  
KEGG pathway analysis of Ensembl gene IDs with the highest expression (top 4000) 
determined during stage I of the RNAseq analysis. % gives the number of times a 
term was associated within the reference list (of 1000 Ensembl IDs) as a percentage 
of the number of genes associated with that term. Corrected p-values were calculated 
using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 87.6 1.52E-92 
GO:0006457 protein folding 59.6 1.38E-23 
GO:0006397 mRNA processing 66.2 1.51E-23 
GO:0006260 DNA replication 72.0 5.51E-20 
GO:0051301 cell division 59.5 1.40E-19 
GO:0006413 translational initiation 69.4 3.67E-18 
GO:0008380 RNA splicing 72.7 4.14E-18 
GO:0007067 mitosis 71.1 1.11E-17 
GO:0007049 cell cycle 47.2 4.45E-17 
GO:0015031 protein transport 40.4 2.26E-16 
GO:0006281 DNA repair 52.9 2.38E-14 
GO:0006396 RNA processing 65.0 6.33E-13 
GO:0042254 ribosome biogenesis 77.8 7.47E-13 
GO:0006886 intracellular protein transport 46.3 1.94E-12 
GO:0055114 oxidation-reduction process 25.0 3.47E-12 
GO:0006810 transport 22.9 4.69E-12 
GO:0006364 rRNA processing 79.2 6.23E-12 
GO:0006974 response to DNA damage stimulus 55.3 9.53E-11 
GO:0006511 ubiquitin-dependent protein catabolic process 50.9 4.57E-10 
GO:0015986 ATP synthesis coupled proton transport 100 5.60E-10 
GO:0051603 proteolysis involved in cellular protein catabolic 
process 
75.0 8.27E-09 
GO:0006414 translational elongation 65.4 1.45E-08 
GO:0006099 tricarboxylic acid cycle 81.3 2.33E-08 
GO:0051726 regulation of cell cycle 60.0 3.11E-08 
GO:0045454 cell redox homeostasis 52.6 7.90E-08 
GO:0006417 regulation of translation 76.5 8.07E-08 
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ID Term % p-value 
GO:0006334 nucleosome assembly 52.8 1.81E-07 
GO:0051028 mRNA transport 72.2 2.30E-07 
GO:0032259 methylation 35.6 5.68E-07 
GO:0016192 vesicle-mediated transport 36.3 1.01E-06 
GO:0060041 retina development in camera-type eye 41.8 1.17E-06 
GO:0008152 metabolic process 21.1 1.41E-06 
GO:0022900 electron transport chain 58.3 2.98E-06 
GO:0015992 proton transport 66.7 2.98E-06 
GO:0008033 tRNA processing 53.8 1.09E-05 
GO:0016070 RNA metabolic process 71.4 1.29E-05 
GO:0006351 transcription, DNA-dependent 19.7 1.35E-05 
GO:0009790 embryo development 30.1 3.23E-05 
GO:0006418 tRNA aminoacylation for protein translation 54.5 5.62E-05 
GO:0044267 cellular protein metabolic process 69.2 6.82E-05 
GO:0007507 heart development 30.7 9.21E-05 
GO:0016568 chromatin modification 36.4 9.35E-05 
GO:0006270 DNA-dependent DNA replication initiation 77.8 0.000270098 
GO:0000079 regulation of cyclin-dependent protein kinase 
activity 
60.0 0.000344113 
GO:0006098 pentose-phosphate shunt 85.7 0.000459302 
GO:0000398 nuclear mRNA splicing, via spliceosome 100 0.000584626 
GO:0006310 DNA recombination 47.8 0.000634459 
GO:0006367 transcription initiation from RNA polymerase II 
promoter 
70.0 0.000720321 
GO:0007059 chromosome segregation 61.5 0.000733549 
GO:0006096 glycolysis 40.6 0.000957392 
GO:0043066 negative regulation of apoptotic process 40.6 0.000957392 
GO:0009451 RNA modification 75.0 0.001396280 
GO:0030261 chromosome condensation 75.0 0.001396280 
GO:0009987 cellular process 63.6 0.001572920 
GO:0006950 response to stress 32.1 0.002258170 
GO:0009165 nucleotide biosynthetic process 83.3 0.002497570 
GO:0045039 protein import into mitochondrial inner membrane 83.3 0.002497570 
GO:0022904 respiratory electron transport chain 83.3 0.002497570 
GO:0031047 gene silencing by RNA 58.3 0.003087210 
GO:0007062 sister chromatid cohesion 100 0.003534470 
GO:0043046 DNA methylation involved in gamete generation 100 0.003534470 
GO:0034587 piRNA metabolic process 100 0.003534470 
GO:0030163 protein catabolic process 50.0 0.004049890 
GO:0007283 spermatogenesis 60.0 0.006847490 
GO:0000184 nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
60.0 0.006847490 
GO:0001522 pseudouridine synthesis 71.4 0.006899010 
GO:0006357 regulation of transcription from RNA polymerase II 
promoter 
36.7 0.007910770 
GO:0006508 proteolysis 18.5 0.012026800 
GO:0007126 meiosis 54.5 0.012532400 
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ID Term % p-value 
GO:0006352 transcription initiation, DNA-dependent 54.5 0.012532400 
GO:0006338 chromatin remodeling 80.0 0.013723800 
GO:0006614 SRP-dependent cotranslational protein targeting to 
membrane 
80.0 0.013723800 
GO:0006979 response to oxidative stress 46.7 0.014483800 
GO:0006302 double-strand break repair 62.5 0.014545200 
GO:0007398 ectoderm development 62.5 0.014545200 
GO:0043248 proteasome assembly 100 0.020520200 
GO:0000070 mitotic sister chromatid segregation 100 0.020520200 
GO:0006207 'de novo' pyrimidine base biosynthetic process 100 0.020520200 
GO:0000463 maturation of LSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
100 0.020520200 
GO:0043985 histone H4-R3 methylation 100 0.020520200 
GO:0016925 protein sumoylation 100 0.020520200 
GO:0001510 RNA methylation 100 0.020520200 
GO:0040016 embryonic cleavage 100 0.020520200 
GO:0042176 regulation of protein catabolic process 100 0.020520200 
GO:0006913 nucleocytoplasmic transport 100 0.020520200 
GO:0006366 transcription from RNA polymerase II promoter 50.0 0.020689300 
GO:0006464 protein modification process 32.4 0.022620900 
GO:0006626 protein targeting to mitochondrion 55.6 0.024242000 
GO:0051597 response to methylmercury 55.6 0.024242000 
GO:0030833 regulation of actin filament polymerization 55.6 0.024242000 
GO:0060218 hemopoietic stem cell differentiation 55.6 0.024242000 
GO:0001666 response to hypoxia 38.1 0.024873700 
GO:0015991 ATP hydrolysis coupled proton transport 41.2 0.027495000 
GO:0006479 protein methylation 66.7 0.027860700 
GO:0044070 regulation of anion transport 66.7 0.027860700 
GO:0042773 ATP synthesis coupled electron transport 66.7 0.027860700 
GO:0006164 purine nucleotide biosynthetic process 50.0 0.040896400 
GO:0044237 cellular metabolic process 42.9 0.041497100 
GO:0006662 glycerol ether metabolic process 42.9 0.041497100 
GO:0005975 carbohydrate metabolic process 22.3 0.042970900 
GO:0009058 biosynthetic process 28.9 0.045629400 
GO:0007264 small GTPase mediated signal transduction 19.4 0.047626800 
Table S15: GO Term Biological Process Analysis 
GO term biological process analysis of ensembl gene IDs with the highest expression 
(top 4000) determined during stage I of the RNAseq analysis. % gives the number of 
times a term was associated within the reference list (of 1000 Ensembl IDs) as a 
percentage of the total number of ID associated with that term. Corrected p-values 
were calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
 
ID Term % p-value 
GO:0003735 structural constituent of ribosome 98.1 1.52E-89 
GO:0003723 RNA binding 56.2 6.87E-56 
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ID Term % p-value 
GO:0000166 nucleotide binding 28.3 6.11E-54 
GO:0003676 nucleic acid binding 34.6 1.64E-51 
GO:0005524 ATP binding 24.3 3.04E-21 
GO:0003743 translation initiation factor activity 69.4 2.29E-18 
GO:0005488 binding 27.1 1.65E-17 
GO:0016853 isomerase activity 63.2 1.85E-17 
GO:0016874 ligase activity 44.9 4.07E-15 
GO:0051082 unfolded protein binding 55.7 3.04E-14 
GO:0016787 hydrolase activity 23.4 3.05E-13 
GO:0046872 metal ion binding 20.1 3.73E-11 
GO:0004386 helicase activity 47.0 1.80E-10 
GO:0016491 oxidoreductase activity 24.8 1.80E-10 
GO:0003824 catalytic activity 23.1 4.05E-10 
GO:0016740 transferase activity 21.1 5.34E-09 
GO:0016881 acid-amino acid ligase activity 52.3 5.59E-09 
GO:0004298 threonine-type endopeptidase activity 75.0 6.00E-09 
GO:0003677 DNA binding 19.4 8.34E-09 
GO:0008026 ATP-dependent helicase activity 51.1 8.59E-09 
GO:0004175 endopeptidase activity 65.2 1.13E-07 
GO:0003755 peptidyl-prolyl cis-trans isomerase activity 56.7 2.03E-07 
GO:0019843 rRNA binding 90.9 2.06E-07 
GO:0003899 DNA-directed RNA polymerase activity 60.0 4.96E-07 
GO:0016616 oxidoreductase activity, acting on the CH-OH 
group of donors, NAD or NADP as acceptor 
47.6 4.98E-07 
GO:0008168 methyltransferase activity 32.7 6.16E-07 
GO:0016651 oxidoreductase activity, acting on NADH or 
NADPH 
90.0 1.25E-06 
GO:0008270 zinc ion binding 17.9 1.40E-06 
GO:0017111 nucleoside-triphosphatase activity 34.5 1.40E-06 
GO:0008565 protein transporter activity 53.6 3.29E-06 
GO:0004129 cytochrome-c oxidase activity 81.8 5.32E-06 
GO:0005525 GTP binding 22.5 1.59E-05 
GO:0015078 hydrogen ion transmembrane transporter activity 66.7 2.28E-05 
GO:0008137 NADH dehydrogenase (ubiquinone) activity 66.7 2.28E-05 
GO:0004812 aminoacyl-tRNA ligase activity 52.0 3.00E-05 
GO:0031072 heat shock protein binding 43.2 4.35E-05 
GO:0003746 translation elongation factor activity 57.9 4.50E-05 
GO:0001104 RNA polymerase II transcription cofactor activity 62.5 4.83E-05 
GO:0046933 hydrogen ion transporting ATP synthase activity, 
rotational mechanism 
77.8 0.000185353 
GO:0015035 protein disulfide oxidoreductase activity 50.0 0.000272363 
GO:0016209 antioxidant activity 85.7 0.000313763 
GO:0003684 damaged DNA binding 52.6 0.000354444 
GO:0046961 proton-transporting ATPase activity, rotational 
mechanism 
70.0 0.000500464 
GO:0009055 electron carrier activity 25.6 0.000625999 
GO:0009982 pseudouridine synthase activity 75.0 0.001001300 
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GO:0008757 S-adenosylmethionine-dependent 
methyltransferase activity 
75.0 0.001001300 
GO:0050660 flavin adenine dinucleotide binding 35.7 0.001025520 
GO:0015450 P-P-bond-hydrolysis-driven protein transmembrane 
transporter activity 
83.3 0.001878360 
GO:0016779 nucleotidyltransferase activity 35.0 0.002167630 
GO:0000287 magnesium ion binding 30.9 0.002566390 
GO:0051920 peroxiredoxin activity 100 0.002573440 
GO:0008641 small protein activating enzyme activity 100 0.002573440 
GO:0008121 ubiquinol-cytochrome-c reductase activity 100 0.002573440 
GO:0051536 iron-sulfur cluster binding 37.5 0.002697390 
GO:0003887 DNA-directed DNA polymerase activity 53.8 0.003991480 
GO:0050662 coenzyme binding 40.0 0.004675410 
GO:0008430 selenium binding 60.0 0.004860090 
GO:0008233 peptidase activity 20.4 0.005029820 
GO:0016627 oxidoreductase activity, acting on the CH-CH group 
of donors 
40.9 0.007076300 
GO:0005529 sugar binding 25.3 0.008670640 
GO:0003779 actin binding 24.7 0.009108190 
GO:0051287 NAD binding 34.4 0.009640930 
GO:0008474 palmitoyl-(protein) hydrolase activity 80.0 0.009762050 
GO:0008312 7S RNA binding 80.0 0.009762050 
GO:0004527 exonuclease activity 46.7 0.009970940 
GO:0051539 4 iron, 4 sulfur cluster binding 46.7 0.009970940 
GO:0019901 protein kinase binding 35.7 0.011084700 
GO:0016788 hydrolase activity, acting on ester bonds 37.5 0.012833200 
GO:0004749 ribose phosphate diphosphokinase activity 100 0.014065300 
GO:0003689 DNA clamp loader activity 100 0.014065300 
GO:0004579 dolichyl-diphosphooligosaccharide-protein 
glycotransferase activity 
100 0.014065300 
GO:0043022 ribosome binding 100 0.014065300 
GO:0030515 snoRNA binding 100 0.014065300 
GO:0003906 DNA-(apurinic or apyrimidinic site) lyase activity 100 0.014065300 
GO:0042162 telomeric DNA binding 100 0.014065300 
GO:0008190 eukaryotic initiation factor 4E binding 100 0.014065300 
GO:0008094 DNA-dependent ATPase activity 50.0 0.014183500 
GO:0004177 aminopeptidase activity 43.8 0.014738200 
GO:0003725 double-stranded RNA binding 43.8 0.014738200 
GO:0003729 mRNA binding 55.6 0.017163000 
GO:0003995 acyl-CoA dehydrogenase activity 46.2 0.020115400 
GO:0008308 voltage-gated anion channel activity 66.7 0.020301300 
GO:0003682 chromatin binding 32.3 0.021399900 
GO:0019904 protein domain specific binding 36.4 0.023805000 
GO:0004674 protein serine/threonine kinase activity 18.3 0.024910100 
GO:0016746 transferase activity, transferring acyl groups 26.4 0.027425700 
GO:0030170 pyridoxal phosphate binding 27.9 0.031353700 
GO:0004518 nuclease activity 30.3 0.033480300 
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GO:0031625 ubiquitin protein ligase binding 57.1 0.038532300 
GO:0008276 protein methyltransferase activity 57.1 0.038532300 
GO:0008235 metalloexopeptidase activity 57.1 0.038532300 
GO:0016818 hydrolase activity, acting on acid anhydrides, in 
phosphorus-containing anhydrides 
45.5 0.040715900 
GO:0003854 3-beta-hydroxy-delta5-steroid dehydrogenase 
activity 
75.0 0.040762100 
GO:0016799 hydrolase activity, hydrolyzing N-glycosyl 
compounds 
75.0 0.040762100 
GO:0004616 phosphogluconate dehydrogenase 
(decarboxylating) activity 
75.0 0.040762100 
GO:0003678 DNA helicase activity 75.0 0.040762100 
GO:0003918 DNA topoisomerase (ATP-hydrolyzing) activity 75.0 0.040762100 
GO:0004568 chitinase activity 75.0 0.040762100 
GO:0030234 enzyme regulator activity 75.0 0.040762100 
GO:0005528 FK506 binding 40.0 0.041553400 
GO:0004519 endonuclease activity 30.0 0.047767000 
Table S16: GO Term Molecular Function Analysis 
GO term molecular function analysis of ensembl gene IDs with the highest expression 
(top 4000) determined during stage I of the  RNAseq analysis. % gives the number of 
times a term was associated within the reference list (of 1000 Ensembl IDs) as a 
percentage of the total number of ID associated with that term. Corrected p-values 
were calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
S3.2.2 Stage II 
 
ID Term % p-value 
Kegg:03010 Ribosome 96.4 6.81E-67 
Kegg:03013 RNA transport 73.4 1.20E-55 
Kegg:00190 Oxidative phosphorylation 76.5 7.65E-55 
Kegg:03040 Spliceosome 71.4 6.21E-49 
Kegg:03008 Ribosome biogenesis in eukaryotes 76.9 2.08E-31 
Kegg:04141 Protein processing in endoplasmic reticulum 47.6 3.03E-24 
Kegg:04110 Cell cycle 51.7 3.29E-24 
Kegg:04120 Ubiquitin mediated proteolysis 50.4 1.04E-21 
Kegg:03030 DNA replication 85.7 1.11E-21 
Kegg:03050 Proteasome 73.5 1.20E-21 
Kegg:00240 Pyrimidine metabolism 50.0 9.37E-17 
Kegg:03018 RNA degradation 55.9 1.06E-16 
Kegg:03015 mRNA surveillance pathway 52.2 1.34E-14 
Kegg:04114 Oocyte meiosis 42.3 2.15E-14 
Kegg:03420 Nucleotide excision repair 65.0 7.69E-14 
Kegg:03060 Protein export 85.7 3.27E-13 
Kegg:00020 Citrate cycle (TCA cycle) 65.5 2.39E-10 
Kegg:03430 Mismatch repair 72.7 7.53E-10 
Kegg:03020 RNA polymerase 68.0 9.40E-10 
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Kegg:03022 Basal transcription factors 56.8 9.74E-10 
Kegg:00970 Aminoacyl-tRNA biosynthesis 56.3 2.28E-08 
Kegg:00230 Purine metabolism 29.8 5.42E-08 
Kegg:00010 Glycolysis / Gluconeogenesis 40.3 1.49E-07 
Kegg:00280 Valine, leucine and isoleucine degradation 45.2 7.62E-07 
Kegg:04142 Lysosome 29.8 2.95E-06 
Kegg:03410 Base excision repair 48.4 5.11E-06 
Kegg:04115 p53 signaling pathway 36.7 5.84E-06 
Kegg:04260 Cardiac muscle contraction 36.7 5.84E-06 
Kegg:00620 Pyruvate metabolism 44.4 8.32E-06 
Kegg:03440 Homologous recombination 52.0 8.40E-06 
Kegg:04914 Progesterone-mediated oocyte maturation 31.0 1.48E-05 
Kegg:00510 N-Glycan biosynthesis 39.5 2.54E-05 
Kegg:00062 Fatty acid elongation in mitochondria 72.7 2.61E-05 
Kegg:04145 Phagosome 27.5 5.86E-05 
Kegg:04130 SNARE interactions in vesicular transport 37.5 0.000171441 
Kegg:00640 Propanoate metabolism 40.6 0.000202474 
Kegg:04530 Tight junction 23.7 0.000872324 
Kegg:04623 Cytosolic DNA-sensing pathway 37.5 0.000918096 
Kegg:00480 Glutathione metabolism 35.3 0.001716100 
Kegg:04144 Endocytosis 20.7 0.001911940 
Kegg:00071 Fatty acid metabolism 34.3 0.002208220 
Kegg:00900 Terpenoid backbone biosynthesis 50.0 0.002229000 
Kegg:00520 Amino sugar and nucleotide sugar metabolism 30.4 0.002998770 
Kegg:04910 Insulin signaling pathway 22.0 0.004097680 
Kegg:00030 Pentose phosphate pathway 34.5 0.005363260 
Kegg:04520 Adherens junction 25.0 0.005448210 
Kegg:00270 Cysteine and methionine metabolism 29.7 0.011634500 
Kegg:04350 TGF-beta signaling pathway 22.9 0.015054100 
Kegg:00630 Glyoxylate and dicarboxylate metabolism 40.0 0.017851600 
Kegg:00670 One carbon pool by folate 40.0 0.017851600 
Kegg:04710 Circadian rhythm - mammal 31.0 0.018419800 
Kegg:00051 Fructose and mannose metabolism 27.5 0.020100400 
Kegg:00310 Lysine degradation 26.1 0.022026200 
Kegg:00500 Starch and sucrose metabolism 29.0 0.026336100 
Kegg:04810 Regulation of actin cytoskeleton 18.3 0.026577800 
Kegg:00350 Tyrosine metabolism 29.6 0.033760000 
Kegg:00360 Phenylalanine metabolism 38.5 0.038347100 
Kegg:00330 Arginine and proline metabolism 23.2 0.040560300 
Table S17: KEGG Pathway Analysis 
KEGG pathway analysis of ensembl gene IDs with the highest expression (top 4000) 
determined during stage II of the RNAseq analysis. % gives the number of times a 
term was associated within the reference list (of 1000 Ensembl IDs) as a percentage 
of the total number of ID associated with that term. Corrected p-values were 
calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
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GO:0006412 translation 87.6 1.88E-92 
GO:0006397 mRNA processing 66.2 1.12E-23 
GO:0006260 DNA replication 78.0 1.28E-23 
GO:0051301 cell division 63.5 1.28E-22 
GO:0006413 translational initiation 75.5 7.49E-22 
GO:0007067 mitosis 77.8 1.87E-21 
GO:0007049 cell cycle 51.9 3.47E-21 
GO:0006457 protein folding 56.2 5.67E-21 
GO:0015031 protein transport 44.4 1.19E-20 
GO:0008380 RNA splicing 72.7 3.18E-18 
GO:0006810 transport 24.8 3.61E-16 
GO:0042254 ribosome biogenesis 81.5 3.30E-14 
GO:0006886 intracellular protein transport 48.8 5.29E-14 
GO:0006511 ubiquitin-dependent protein catabolic process 58.5 1.16E-13 
GO:0006396 RNA processing 65.0 5.50E-13 
GO:0006281 DNA repair 50.0 1.06E-12 
GO:0006974 response to DNA damage stimulus 59.6 1.16E-12 
GO:0006364 rRNA processing 79.2 6.34E-12 
GO:0055114 oxidation-reduction process 24.1 1.02E-10 
GO:0045454 cell redox homeostasis 60.5 1.34E-10 
GO:0051603 proteolysis involved in cellular protein catabolic 
process 
75.0 8.87E-09 
GO:0032259 methylation 39.1 9.79E-09 
GO:0006414 translational elongation 65.4 1.49E-08 
GO:0006099 tricarboxylic acid cycle 81.3 2.39E-08 
GO:0022900 electron transport chain 66.7 3.00E-08 
GO:0051726 regulation of cell cycle 60.0 3.09E-08 
GO:0015986 ATP synthesis coupled proton transport 91.7 3.85E-08 
GO:0016192 vesicle-mediated transport 38.8 6.09E-08 
GO:0015992 proton transport 72.2 2.30E-07 
GO:0051028 mRNA transport 72.2 2.30E-07 
GO:0060041 retina development in camera-type eye 43.6 2.32E-07 
GO:0016070 RNA metabolic process 78.6 7.77E-07 
GO:0016568 chromatin modification 40.0 6.03E-06 
GO:0006418 tRNA aminoacylation for protein translation 59.1 7.27E-06 
GO:0006351 transcription, DNA-dependent 19.5 2.87E-05 
GO:0008152 metabolic process 20.0 3.50E-05 
GO:0009790 embryo development 30.1 3.59E-05 
GO:0006367 transcription initiation from RNA polymerase II 
promoter 
80.0 4.97E-05 
GO:0044267 cellular protein metabolic process 69.2 7.27E-05 
GO:0007059 chromosome segregation 69.2 7.27E-05 
GO:0030261 chromosome condensation 87.5 7.50E-05 
GO:0008033 tRNA processing 50.0 7.61E-05 
GO:0042773 ATP synthesis coupled electron transport 100 8.15E-05 
GO:0006417 regulation of translation 58.8 0.00015421 
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GO:0006270 DNA-dependent DNA replication initiation 77.8 0.000274342 
GO:0006098 pentose-phosphate shunt 85.7 0.000477077 
GO:0000398 nuclear mRNA splicing, via spliceosome 100 0.000606862 
GO:0030163 protein catabolic process 56.3 0.000683677 
GO:0007507 heart development 28.4 0.000823309 
GO:0006096 glycolysis 40.6 0.001043050 
GO:0006662 glycerol ether metabolic process 57.1 0.001560000 
GO:0006508 proteolysis 19.7 0.001822710 
GO:0006357 regulation of transcription from RNA polymerase II 
promoter 
40.0 0.002285120 
GO:0006950 response to stress 32.1 0.002462190 
GO:0009165 nucleotide biosynthetic process 83.3 0.002648540 
GO:0045039 protein import into mitochondrial inner membrane 83.3 0.002648540 
GO:0022904 respiratory electron transport chain 83.3 0.002648540 
GO:0000079 regulation of cyclin-dependent protein kinase 
activity 
53.3 0.002764690 
GO:0006366 transcription from RNA polymerase II promoter 58.3 0.003280090 
GO:0006310 DNA recombination 43.5 0.003297540 
GO:0006334 nucleosome assembly 36.1 0.003534030 
GO:0006465 signal peptide processing 100 0.003626940 
GO:0007062 sister chromatid cohesion 100 0.003626940 
GO:0006120 mitochondrial electron transport, NADH to 
ubiquinone 
100 0.003626940 
GO:0043066 negative regulation of apoptotic process 37.5 0.003840290 
GO:0016310 phosphorylation 18.1 0.004553590 
GO:0015991 ATP hydrolysis coupled proton transport 47.1 0.006824670 
GO:0043039 tRNA aminoacylation 71.4 0.006897000 
GO:0006464 protein modification process 35.3 0.006940080 
GO:0000184 nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
60.0 0.006946720 
GO:0044237 cellular metabolic process 50.0 0.009434230 
GO:0006352 transcription initiation, DNA-dependent 54.5 0.012752300 
GO:0009987 cellular process 54.5 0.012752300 
GO:0006338 chromatin remodeling 80.0 0.013770200 
GO:0006614 SRP-dependent cotranslational protein targeting to 
membrane 
80.0 0.013770200 
GO:0051276 chromosome organization 80.0 0.013770200 
GO:0006302 double-strand break repair 62.5 0.014826900 
GO:0006284 base-excision repair 62.5 0.014826900 
GO:0007264 small GTPase mediated signal transduction 20.6 0.018523700 
GO:0009058 biosynthetic process 31.6 0.018704900 
GO:0043248 proteasome assembly 100 0.020308400 
GO:0000084 S phase of mitotic cell cycle 100 0.020308400 
GO:0006269 DNA replication, synthesis of RNA primer 100 0.020308400 
GO:0000070 mitotic sister chromatid segregation 100 0.020308400 
GO:0006207 'de novo' pyrimidine base biosynthetic process 100 0.020308400 
GO:0000463 maturation of LSU-rRNA from tricistronic rRNA 100 0.020308400 
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transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
GO:0043985 histone H4-R3 methylation 100 0.020308400 
GO:0016925 protein sumoylation 100 0.020308400 
GO:0001510 RNA methylation 100 0.020308400 
GO:0040016 embryonic cleavage 100 0.020308400 
GO:0042176 regulation of protein catabolic process 100 0.020308400 
GO:0006913 nucleocytoplasmic transport 100 0.020308400 
GO:0006139 nucleobase-containing compound metabolic 
process 
34.5 0.021318700 
GO:0005975 carbohydrate metabolic process 23.4 0.021767400 
GO:0006626 protein targeting to mitochondrion 55.6 0.024107000 
GO:0051597 response to methylmercury 55.6 0.024107000 
GO:0060218 hemopoietic stem cell differentiation 55.6 0.024107000 
GO:0006915 apoptotic process 26.2 0.024161600 
GO:0001666 response to hypoxia 38.1 0.024560400 
GO:0009116 nucleoside metabolic process 41.2 0.027148000 
GO:0006479 protein methylation 66.7 0.027768300 
GO:0044070 regulation of anion transport 66.7 0.027768300 
GO:0007283 spermatogenesis 50.0 0.040426700 
GO:0006164 purine nucleotide biosynthetic process 50.0 0.040426700 
Table S18: GO Term Biological Process Analysis 
GO term biological process analysis of Ensembl gene IDs with the highest expression 
(top 4000) determined during stage II of the RNAseq analysis. % gives the number of 
times a term was associated within the reference list (of 1000 Ensembl IDs) as a 
percentage of the total number of ID associated with that term. Corrected p-values 
were calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
 
ID Term % p-value 
GO:0003735 structural constituent of ribosome 94.3 1.59E-80 
GO:0000166 nucleotide binding 28.9 5.26E-57 
GO:0003723 RNA binding 54.1 3.33E-51 
GO:0003676 nucleic acid binding 33.3 3.92E-46 
GO:0005524 ATP binding 25.4 4.70E-25 
GO:0003743 translation initiation factor activity 75.5 3.82E-22 
GO:0016874 ligase activity 46.7 1.52E-16 
GO:0005488 binding 26.5 3.73E-16 
GO:0016787 hydrolase activity 24.0 1.58E-14 
GO:0016853 isomerase activity 57.9 1.87E-14 
GO:0051082 unfolded protein binding 54.1 2.62E-13 
GO:0046872 metal ion binding 20.3 1.24E-11 
GO:0016740 transferase activity 22.3 2.52E-11 
GO:0008137 NADH dehydrogenase (ubiquinone) activity 93.3 9.78E-11 
GO:0003824 catalytic activity 23.5 9.87E-11 
GO:0016491 oxidoreductase activity 24.6 3.92E-10 
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GO:0008168 methyltransferase activity 36.4 4.49E-09 
GO:0016881 acid-amino acid ligase activity 52.3 5.32E-09 
GO:0004386 helicase activity 43.9 5.51E-09 
GO:0004298 threonine-type endopeptidase activity 75.0 5.70E-09 
GO:0008026 ATP-dependent helicase activity 51.1 8.70E-09 
GO:0008270 zinc ion binding 18.6 6.33E-08 
GO:0004175 endopeptidase activity 65.2 1.09E-07 
GO:0008565 protein transporter activity 57.1 4.85E-07 
GO:0003899 DNA-directed RNA polymerase activity 60.0 5.24E-07 
GO:0016651 
oxidoreductase activity, acting on NADH or 
NADPH 90.0 1.36E-06 
GO:0017111 nucleoside-triphosphatase activity 34.5 1.61E-06 
GO:0005525 GTP binding 23.5 1.86E-06 
GO:0016616 
oxidoreductase activity, acting on the CH-OH 
group of donors, NAD or NADP as acceptor 45.2 2.76E-06 
GO:0004812 aminoacyl-tRNA ligase activity 56.0 4.33E-06 
GO:0015035 protein disulfide oxidoreductase activity 59.1 4.88E-06 
GO:0003746 translation elongation factor activity 63.2 4.99E-06 
GO:0019843 rRNA binding 81.8 5.08E-06 
GO:0004129 cytochrome-c oxidase activity 81.8 5.08E-06 
GO:0003755 peptidyl-prolyl cis-trans isomerase activity 50.0 9.68E-06 
GO:0000287 magnesium ion binding 38.2 1.60E-05 
GO:0003677 DNA binding 17.4 4.40E-05 
GO:0001104 RNA polymerase II transcription cofactor activity 62.5 5.06E-05 
GO:0009055 electron carrier activity 27.3 0.000105739 
GO:0046933 
hydrogen ion transporting ATP synthase activity, 
rotational mechanism 77.8 0.000188948 
GO:0031072 heat shock protein binding 40.5 0.000214159 
GO:0015078 hydrogen ion transmembrane transporter activity 60.0 0.000235039 
GO:0016209 antioxidant activity 85.7 0.000312446 
GO:0008233 peptidase activity 22.2 0.000436765 
GO:0046961 
proton-transporting ATPase activity, rotational 
mechanism 70.0 0.000499921 
GO:0003887 DNA-directed DNA polymerase activity 61.5 0.000508892 
GO:0004674 protein serine/threonine kinase activity 21.1 0.000713317 
GO:0008757 
S-adenosylmethionine-dependent 
methyltransferase activity 75.0 0.001002020 
GO:0004221 ubiquitin thiolesterase activity 40.0 0.001513160 
GO:0015450 
P-P-bond-hydrolysis-driven protein transmembrane 
transporter activity 83.3 0.001880880 
GO:0016779 nucleotidyltransferase activity 35.0 0.002188320 
GO:0003684 damaged DNA binding 47.4 0.002204510 
GO:0051920 peroxiredoxin activity 100 0.002631620 
GO:0008641 small protein activating enzyme activity 100 0.002631620 
GO:0051287 NAD binding 37.5 0.002778500 
GO:0050662 coenzyme binding 40.0 0.004896880 
GO:0008430 selenium binding 60.0 0.005073540 
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GO:0008276 protein methyltransferase activity 71.4 0.005095970 
GO:0016301 kinase activity 17.8 0.005419950 
GO:0003779 actin binding 24.7 0.009762420 
GO:0051536 iron-sulfur cluster binding 34.4 0.010100800 
GO:0008474 palmitoyl-(protein) hydrolase activity 80.0 0.010169700 
GO:0008312 7S RNA binding 80.0 0.010169700 
GO:0016876 
ligase activity, forming aminoacyl-tRNA and related 
compounds 80.0 0.010169700 
GO:0004527 exonuclease activity 46.7 0.010575900 
GO:0050660 flavin adenine dinucleotide binding 31.0 0.010692200 
GO:0009982 pseudouridine synthase activity 62.5 0.010727500 
GO:0016788 hydrolase activity, acting on ester bonds 37.5 0.013424600 
GO:0004749 ribose phosphate diphosphokinase activity 100 0.015016300 
GO:0003689 DNA clamp loader activity 100 0.015016300 
GO:0004579 
dolichyl-diphosphooligosaccharide-protein 
glycotransferase activity 100 0.015016300 
GO:0043022 ribosome binding 100 0.015016300 
GO:0030515 snoRNA binding 100 0.015016300 
GO:0004185 serine-type carboxypeptidase activity 100 0.015016300 
GO:0003906 DNA-(apurinic or apyrimidinic site) lyase activity 100 0.015016300 
GO:0004526 ribonuclease P activity 100 0.015016300 
GO:0008190 eukaryotic initiation factor 4E binding 100 0.015016300 
GO:0003729 mRNA binding 55.6 0.018353400 
GO:0008308 voltage-gated anion channel activity 66.7 0.021949200 
GO:0003682 chromatin binding 32.3 0.023233200 
GO:0019904 protein domain specific binding 36.4 0.025796700 
GO:0016769 
transferase activity, transferring nitrogenous 
groups 42.9 0.032533500 
GO:0030170 pyridoxal phosphate binding 27.9 0.034422300 
GO:0004518 nuclease activity 30.3 0.036260400 
GO:0019901 protein kinase binding 32.1 0.036364800 
GO:0005529 sugar binding 22.9 0.036804300 
GO:0016620 
oxidoreductase activity, acting on the aldehyde or 
oxo group of donors, NAD or NADP as acceptor 36.8 0.039638600 
GO:0031625 ubiquitin protein ligase binding 57.1 0.041032400 
GO:0000049 tRNA binding 57.1 0.041032400 
GO:0016799 
hydrolase activity, hydrolyzing N-glycosyl 
compounds 75.0 0.042843900 
GO:0004616 
phosphogluconate dehydrogenase 
(decarboxylating) activity 75.0 0.042843900 
GO:0003678 DNA helicase activity 75.0 0.042843900 
GO:0003918 DNA topoisomerase (ATP-hydrolyzing) activity 75.0 0.042843900 
GO:0004568 chitinase activity 75.0 0.042843900 
GO:0008121 ubiquinol-cytochrome-c reductase activity 75.0 0.042843900 
GO:0030234 enzyme regulator activity 75.0 0.042843900 
GO:0005528 FK506 binding 40.0 0.043823700 
GO:0051539 4 iron, 4 sulfur cluster binding 40.0 0.043823700 
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Table S19: GO Term Molecular Function Analysis 
GO term molecular function analysis of ensembl gene IDs with the highest expression 
(top 4000) determined during stage II of the RNAseq analysis. % gives the number of 
times a term was associated within the reference list (of 1000 Ensembl IDs) as a 
percentage of the total number of ID associated with that term. Corrected p-values 
were calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
S3.2.3 Stage III 
 
ID Term % p-value 
Kegg:03010 Ribosome 97.6 3.58E-69 
Kegg:00190 Oxidative phosphorylation 78.3 1.96E-57 
Kegg:03013 RNA transport 70.3 9.78E-51 
Kegg:03040 Spliceosome 72.3 3.48E-50 
Kegg:04141 Protein processing in endoplasmic reticulum 50.3 1.83E-27 
Kegg:03008 Ribosome biogenesis in eukaryotes 69.2 4.78E-25 
Kegg:04110 Cell cycle 50.8 2.20E-23 
Kegg:03050 Proteasome 75.5 6.62E-23 
Kegg:03030 DNA replication 82.9 4.47E-20 
Kegg:04120 Ubiquitin mediated proteolysis 47.8 2.91E-19 
Kegg:03018 RNA degradation 58.8 1.24E-18 
Kegg:00240 Pyrimidine metabolism 48.9 6.16E-16 
Kegg:03420 Nucleotide excision repair 65.0 8.92E-14 
Kegg:03015 mRNA surveillance pathway 50.7 9.64E-14 
Kegg:04114 Oocyte meiosis 41.4 1.07E-13 
Kegg:03060 Protein export 85.7 3.27E-13 
Kegg:00020 Citrate cycle (TCA cycle) 65.5 2.39E-10 
Kegg:03020 RNA polymerase 68.0 9.90E-10 
Kegg:03022 Basal transcription factors 56.8 1.03E-09 
Kegg:00280 Valine, leucine and isoleucine degradation 52.4 2.75E-09 
Kegg:03430 Mismatch repair 68.2 1.07E-08 
Kegg:00010 Glycolysis / Gluconeogenesis 41.9 3.06E-08 
Kegg:04142 Lysosome 32.5 8.80E-08 
Kegg:00230 Purine metabolism 29.1 1.54E-07 
Kegg:04260 Cardiac muscle contraction 40.0 3.14E-07 
Kegg:00970 Aminoacyl-tRNA biosynthesis 50.0 1.24E-06 
Kegg:00062 Fatty acid elongation in mitochondria 81.8 1.46E-06 
Kegg:03410 Base excision repair 48.4 4.74E-06 
Kegg:04145 Phagosome 29.4 8.00E-06 
Kegg:00620 Pyruvate metabolism 44.4 8.04E-06 
Kegg:03440 Homologous recombination 52.0 8.12E-06 
Kegg:00071 Fatty acid metabolism 42.9 2.76E-05 
Kegg:04914 Progesterone-mediated oocyte maturation 29.9 4.51E-05 
Kegg:04130 SNARE interactions in vesicular transport 37.5 0.000176286 
Kegg:00640 Propanoate metabolism 40.6 0.000207899 
Kegg:04115 p53 signaling pathway 31.7 0.000258025 
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Kegg:00520 Amino sugar and nucleotide sugar metabolism 34.8 0.000263798 
Kegg:04520 Adherens junction 28.9 0.000310021 
Kegg:04530 Tight junction 24.4 0.000352077 
Kegg:00510 N-Glycan biosynthesis 34.9 0.000393605 
Kegg:04623 Cytosolic DNA-sensing pathway 37.5 0.000848975 
Kegg:04910 Insulin signaling pathway 23.5 0.000889269 
Kegg:04144 Endocytosis 21.2 0.000905172 
Kegg:00650 Butanoate metabolism 41.7 0.000934933 
Kegg:00270 Cysteine and methionine metabolism 35.1 0.000935636 
Kegg:00900 Terpenoid backbone biosynthesis 50.0 0.002027130 
Kegg:00310 Lysine degradation 30.4 0.002737940 
Kegg:00072 Synthesis and degradation of ketone bodies 62.5 0.003351570 
Kegg:00030 Pentose phosphate pathway 34.5 0.004909680 
Kegg:00480 Glutathione metabolism 32.4 0.005067840 
Kegg:04810 Regulation of actin cytoskeleton 19.9 0.005145680 
Kegg:00630 Glyoxylate and dicarboxylate metabolism 40.0 0.017099700 
Kegg:04710 Circadian rhythm - mammal 31.0 0.017292200 
Kegg:00051 Fructose and mannose metabolism 27.5 0.019291900 
Kegg:00500 Starch and sucrose metabolism 29.0 0.026234500 
Kegg:04350 TGF-beta signaling pathway 21.7 0.028240500 
Kegg:00350 Tyrosine metabolism 29.6 0.033029800 
Kegg:00360 Phenylalanine metabolism 38.5 0.037498100 
Kegg:00330 Arginine and proline metabolism 23.2 0.039746000 
Kegg:00380 Tryptophan metabolism 25.6 0.040442900 
Kegg:00340 Histidine metabolism 29.2 0.049291600 
Kegg:00410 beta-Alanine metabolism 29.2 0.049291600 
Kegg:00053 Ascorbate and aldarate metabolism 35.7 0.049939900 
Table S20: KEGG Pathway Analysis 
KEGG pathway analysis of Ensembl gene IDs with the highest expression (top 4000) 
determined during stage III of the RNAseq analysis. % gives the number of times a 
term was associated within the reference list (of 1000 Ensembl IDs) as a percentage 
of the total number of ID associated with that term. Corrected p-values were 
calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 87.6 2.00E-92 
GO:0006457 protein folding 62.9 1.60E-26 
GO:0051301 cell division 66.2 9.85E-25 
GO:0006260 DNA replication 78.0 6.48E-24 
GO:0007067 mitosis 77.8 2.27E-21 
GO:0006413 translational initiation 73.5 1.11E-20 
GO:0006397 mRNA processing 62.0 1.20E-20 
GO:0015031 protein transport 44.4 1.37E-20 
GO:0007049 cell cycle 50.0 1.56E-19 
GO:0006810 transport 25.6 4.43E-18 
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GO:0008380 RNA splicing 68.2 8.30E-16 
GO:0042254 ribosome biogenesis 81.5 3.32E-14 
GO:0055114 oxidation-reduction process 25.9 1.21E-13 
GO:0006396 RNA processing 65.0 5.93E-13 
GO:0006886 intracellular protein transport 46.3 2.01E-12 
GO:0006281 DNA repair 48.6 7.06E-12 
GO:0006364 rRNA processing 79.2 7.16E-12 
GO:0006511 ubiquitin-dependent protein catabolic process 54.7 8.03E-12 
GO:0006974 response to DNA damage stimulus 57.4 1.06E-11 
GO:0045454 cell redox homeostasis 63.2 1.16E-11 
GO:0015986 ATP synthesis coupled proton transport 100 5.71E-10 
GO:0022900 electron transport chain 70.8 2.22E-09 
GO:0051603 proteolysis involved in cellular protein catabolic 
process 
75.0 8.11E-09 
GO:0006099 tricarboxylic acid cycle 81.3 2.39E-08 
GO:0051726 regulation of cell cycle 60.0 3.22E-08 
GO:0016192 vesicle-mediated transport 38.8 6.60E-08 
GO:0032259 methylation 36.8 1.55E-07 
GO:0006414 translational elongation 61.5 1.57E-07 
GO:0015992 proton transport 72.2 2.30E-07 
GO:0051028 mRNA transport 72.2 2.30E-07 
GO:0060041 retina development in camera-type eye 43.6 2.33E-07 
GO:0016070 RNA metabolic process 78.6 7.77E-07 
GO:0006418 tRNA aminoacylation for protein translation 59.1 7.49E-06 
GO:0006417 regulation of translation 64.7 1.74E-05 
GO:0008152 metabolic process 20.3 1.98E-05 
GO:0016568 chromatin modification 38.2 2.62E-05 
GO:0009790 embryo development 30.1 3.60E-05 
GO:0006367 transcription initiation from RNA polymerase II 
promoter 
80.0 4.96E-05 
GO:0044267 cellular protein metabolic process 69.2 7.26E-05 
GO:0007059 chromosome segregation 69.2 7.26E-05 
GO:0030261 chromosome condensation 87.5 7.48E-05 
GO:0042773 ATP synthesis coupled electron transport 100 8.32E-05 
GO:0006662 glycerol ether metabolic process 64.3 0.000168205 
GO:0006351 transcription, DNA-dependent 18.8 0.000212262 
GO:0006096 glycolysis 43.8 0.000214474 
GO:0006270 DNA-dependent DNA replication initiation 77.8 0.000267703 
GO:0007507 heart development 29.5 0.000284268 
GO:0007264 small GTPase mediated signal transduction 24.1 0.000325412 
GO:0006098 pentose-phosphate shunt 85.7 0.000437613 
GO:0008033 tRNA processing 46.2 0.000443050 
GO:0000398 nuclear mRNA splicing, via spliceosome 100 0.000557363 
GO:0006310 DNA recombination 47.8 0.000610967 
GO:0030163 protein catabolic process 56.3 0.000618050 
GO:0015991 ATP hydrolysis coupled proton transport 52.9 0.001147860 
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GO:0006950 response to stress 32.1 0.002418180 
GO:0045039 protein import into mitochondrial inner membrane 83.3 0.002639380 
GO:0022904 respiratory electron transport chain 83.3 0.002639380 
GO:0000079 regulation of cyclin-dependent protein kinase 
activity 
53.3 0.002709020 
GO:0006508 proteolysis 19.4 0.002916020 
GO:0006366 transcription from RNA polymerase II promoter 58.3 0.003216730 
GO:0006334 nucleosome assembly 36.1 0.003531070 
GO:0006465 signal peptide processing 100 0.003612790 
GO:0007062 sister chromatid cohesion 100 0.003612790 
GO:0006120 mitochondrial electron transport, NADH to 
ubiquinone 
100 0.003612790 
GO:0043066 negative regulation of apoptotic process 37.5 0.003835900 
GO:0005975 carbohydrate metabolic process 25.5 0.005237530 
GO:0009116 nucleoside metabolic process 47.1 0.006808020 
GO:0001666 response to hypoxia 42.9 0.006841690 
GO:0043039 tRNA aminoacylation 71.4 0.006872760 
GO:0000184 nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
60.0 0.006924960 
GO:0006915 apoptotic process 27.9 0.011872100 
GO:0006914 autophagy 54.5 0.012372700 
GO:0006289 nucleotide-excision repair 54.5 0.012372700 
GO:0006352 transcription initiation, DNA-dependent 54.5 0.012372700 
GO:0009987 cellular process 54.5 0.012372700 
GO:0006338 chromatin remodeling 80.0 0.013364000 
GO:0006614 SRP-dependent cotranslational protein targeting to 
membrane 
80.0 0.013364000 
GO:0051276 chromosome organization 80.0 0.013364000 
GO:0006284 base-excision repair 62.5 0.014404600 
GO:0044262 cellular carbohydrate metabolic process 62.5 0.014404600 
GO:0043248 proteasome assembly 100 0.020438700 
GO:0000084 S phase of mitotic cell cycle 100 0.020438700 
GO:0006269 DNA replication, synthesis of RNA primer 100 0.020438700 
GO:0000070 mitotic sister chromatid segregation 100 0.020438700 
GO:0006207 'de novo' pyrimidine base biosynthetic process 100 0.020438700 
GO:0000463 maturation of LSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
100 0.020438700 
GO:0043985 histone H4-R3 methylation 100 0.020438700 
GO:0016925 protein sumoylation 100 0.020438700 
GO:0001510 RNA methylation 100 0.020438700 
GO:0040016 embryonic cleavage 100 0.020438700 
GO:0042176 regulation of protein catabolic process 100 0.020438700 
GO:0016310 phosphorylation 17.2 0.020490000 
GO:0008652 cellular amino acid biosynthetic process 50.0 0.020529600 
GO:0006626 protein targeting to mitochondrion 55.6 0.024269800 
GO:0051597 response to methylmercury 55.6 0.024269800 
GO:0060218 hemopoietic stem cell differentiation 55.6 0.024269800 
S3.2 Stage III RNA-Seq – GO term analysis 
 
 ! !
192 
!
! !
ID Term % p-value 
GO:0009165 nucleotide biosynthetic process 66.7 0.028495000 
GO:0006479 protein methylation 66.7 0.028495000 
GO:0044070 regulation of anion transport 66.7 0.028495000 
GO:0006164 purine nucleotide biosynthetic process 50.0 0.041889000 
GO:0044237 cellular metabolic process 42.9 0.042999600 
GO:0009058 biosynthetic process 28.9 0.047984100 
Table S21: GO Term Biological Process Analysis 
GO term biological process analysis of ensembl gene IDs with the highest expression 
(top 4000) determined during stage III of the RNAseq analysis. % gives the number 
of times a term was associated within the reference list of Ensembl IDs as a 
percentage of the total number of ID associated with that term. Corrected p-values 
were calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
 
ID Term % p-value 
GO:0003735 structural constituent of ribosome 96.2 9.00E-85 
GO:0000166 nucleotide binding 28.9 5.94E-57 
GO:0003723 RNA binding 54.5 4.00E-52 
GO:0003676 nucleic acid binding 32.3 3.57E-42 
GO:0005524 ATP binding 24.5 6.82E-22 
GO:0003743 translation initiation factor activity 73.5 7.93E-21 
GO:0005488 binding 26.9 6.14E-17 
GO:0016853 isomerase activity 61.4 2.08E-16 
GO:0051082 unfolded protein binding 59.0 3.89E-16 
GO:0016787 hydrolase activity 24.2 6.31E-15 
GO:0016874 ligase activity 43.0 1.19E-13 
GO:0016491 oxidoreductase activity 26.3 8.77E-13 
GO:0003824 catalytic activity 24.3 3.91E-12 
GO:0046872 metal ion binding 20.4 5.87E-12 
GO:0008137 NADH dehydrogenase (ubiquinone) activity 93.3 9.75E-11 
GO:0004298 threonine-type endopeptidase activity 75.0 7.11E-09 
GO:0016740 transferase activity 20.9 1.13E-08 
GO:0016616 oxidoreductase activity, acting on the CH-OH 
group of donors, NAD or NADP as acceptor 
50.0 9.60E-08 
GO:0005525 GTP binding 24.9 9.69E-08 
GO:0004175 endopeptidase activity 65.2 1.25E-07 
GO:0004386 helicase activity 40.9 1.37E-07 
GO:0003755 peptidyl-prolyl cis-trans isomerase activity 56.7 2.14E-07 
GO:0019843 rRNA binding 90.9 2.16E-07 
GO:0008026 ATP-dependent helicase activity 46.7 3.68E-07 
GO:0015035 protein disulfide oxidoreductase activity 63.6 5.13E-07 
GO:0004812 aminoacyl-tRNA ligase activity 60.0 5.22E-07 
GO:0008270 zinc ion binding 18.1 6.27E-07 
GO:0008168 methyltransferase activity 32.7 6.36E-07 
GO:0016881 acid-amino acid ligase activity 45.5 1.17E-06 
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GO:0016651 oxidoreductase activity, acting on NADH or 
NADPH 
90.0 1.17E-06 
GO:0015078 hydrogen ion transmembrane transporter activity 73.3 1.63E-06 
GO:0008565 protein transporter activity 53.6 3.25E-06 
GO:0003899 DNA-directed RNA polymerase activity 56.0 3.92E-06 
GO:0009055 electron carrier activity 28.9 1.46E-05 
GO:0017111 nucleoside-triphosphatase activity 32.2 1.68E-05 
GO:0003677 DNA binding 17.4 4.49E-05 
GO:0031072 heat shock protein binding 43.2 4.57E-05 
GO:0003746 translation elongation factor activity 57.9 4.57E-05 
GO:0000287 magnesium ion binding 36.4 6.46E-05 
GO:0004129 cytochrome-c oxidase activity 72.7 9.39E-05 
GO:0046933 hydrogen ion transporting ATP synthase activity, 
rotational mechanism 
77.8 0.000183183 
GO:0016209 antioxidant activity 85.7 0.000317739 
GO:0003684 damaged DNA binding 52.6 0.000361044 
GO:0046961 proton-transporting ATPase activity, rotational 
mechanism 
70.0 0.000496757 
GO:0008430 selenium binding 70.0 0.000496757 
GO:0003887 DNA-directed DNA polymerase activity 61.5 0.000505863 
GO:0003779 actin binding 28.1 0.000645276 
GO:0051536 iron-sulfur cluster binding 40.6 0.000662278 
GO:0008757 S-adenosylmethionine-dependent 
methyltransferase activity 
75.0 0.000974924 
GO:0050660 flavin adenine dinucleotide binding 35.7 0.000990275 
GO:0050662 coenzyme binding 44.0 0.001009280 
GO:0016627 oxidoreductase activity, acting on the CH-CH group 
of donors 
45.5 0.001471430 
GO:0008233 peptidase activity 21.3 0.001539110 
GO:0015450 P-P-bond-hydrolysis-driven protein transmembrane 
transporter activity 
83.3 0.001729000 
GO:0016779 nucleotidyltransferase activity 35.0 0.002020460 
GO:0051920 peroxiredoxin activity 100 0.002474040 
GO:0008641 small protein activating enzyme activity 100 0.002474040 
GO:0051287 NAD binding 37.5 0.002621880 
GO:0001104 RNA polymerase II transcription cofactor activity 50.0 0.002797830 
GO:0016788 hydrolase activity, acting on ester bonds 41.7 0.003063400 
GO:0008276 protein methyltransferase activity 71.4 0.004810150 
GO:0016769 transferase activity, transferring nitrogenous 
groups 
50.0 0.006570660 
GO:0019904 protein domain specific binding 40.9 0.006785590 
GO:0004674 protein serine/threonine kinase activity 19.5 0.006789330 
GO:0008474 palmitoyl-(protein) hydrolase activity 80.0 0.009488890 
GO:0008312 7S RNA binding 80.0 0.009488890 
GO:0016876 ligase activity, forming aminoacyl-tRNA and related 
compounds 
80.0 0.009488890 
GO:0004527 exonuclease activity 46.7 0.009755420 
GO:0005528 FK506 binding 46.7 0.009755420 
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GO:0051539 4 iron, 4 sulfur cluster binding 46.7 0.009755420 
GO:0009982 pseudouridine synthase activity 62.5 0.009899040 
GO:0030170 pyridoxal phosphate binding 30.2 0.012610900 
GO:0004749 ribose phosphate diphosphokinase activity 100 0.013985800 
GO:0003689 DNA clamp loader activity 100 0.013985800 
GO:0004579 dolichyl-diphosphooligosaccharide-protein 
glycotransferase activity 
100 0.013985800 
GO:0043022 ribosome binding 100 0.013985800 
GO:0030515 snoRNA binding 100 0.013985800 
GO:0004185 serine-type carboxypeptidase activity 100 0.013985800 
GO:0003906 DNA-(apurinic or apyrimidinic site) lyase activity 100 0.013985800 
GO:0008190 eukaryotic initiation factor 4E binding 100 0.013985800 
GO:0004177 aminopeptidase activity 43.8 0.014670500 
GO:0003725 double-stranded RNA binding 43.8 0.014670500 
GO:0004721 phosphoprotein phosphatase activity 24.7 0.015507800 
GO:0005529 sugar binding 24.1 0.016099800 
GO:0003729 mRNA binding 55.6 0.016523300 
GO:0004221 ubiquitin thiolesterase activity 33.3 0.016524600 
GO:0003995 acyl-CoA dehydrogenase activity 46.2 0.019404300 
GO:0008308 voltage-gated anion channel activity 66.7 0.019551500 
GO:0016301 kinase activity 16.9 0.021128600 
GO:0004518 nuclease activity 30.3 0.033664700 
GO:0019901 protein kinase binding 32.1 0.033726800 
GO:0016620 oxidoreductase activity, acting on the aldehyde or 
oxo group of donors, NAD or NADP as acceptor 
36.8 0.037227400 
GO:0031625 ubiquitin protein ligase binding 57.1 0.038546300 
GO:0000049 tRNA binding 57.1 0.038546300 
GO:0016799 hydrolase activity, hydrolyzing N-glycosyl 
compounds 
75.0 0.040826200 
GO:0004616 phosphogluconate dehydrogenase 
(decarboxylating) activity 
75.0 0.040826200 
GO:0003678 DNA helicase activity 75.0 0.040826200 
GO:0003918 DNA topoisomerase (ATP-hydrolyzing) activity 75.0 0.040826200 
GO:0004568 chitinase activity 75.0 0.040826200 
GO:0008121 ubiquinol-cytochrome-c reductase activity 75.0 0.040826200 
GO:0030234 enzyme regulator activity 75.0 0.040826200 
GO:0005385 zinc ion transmembrane transporter activity 40.0 0.041677600 
GO:0004519 endonuclease activity 30.0 0.048641000 
Table S22: GO Term Molecular Function Analysis 
GO term molecular function analysis of ensembl gene IDs with the highest expression 
(top 4000) determined during stage III of the RNAseq analysis.  gives the number of 
times a term was associated within the reference list (of 1000 Ensembl IDs) as a 
percentage of the number of genes associated with that term. Corrected p-values were 
calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
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ID Term % p-value 
Kegg:03010 Ribosome 98.8 1.19E-71 
Kegg:00190 Oxidative phosphorylation 80.0 2.61E-60 
Kegg:03040 Spliceosome 75.6 2.61E-55 
Kegg:03013 RNA transport 71.1 4.17E-52 
Kegg:04110 Cell cycle 53.3 6.27E-26 
Kegg:04141 Protein processing in endoplasmic reticulum 48.3 5.40E-25 
Kegg:03050 Proteasome 77.6 3.32E-24 
Kegg:04120 Ubiquitin mediated proteolysis 50.4 1.06E-21 
Kegg:03008 Ribosome biogenesis in eukaryotes 61.5 1.46E-19 
Kegg:03030 DNA replication 80.0 1.21E-18 
Kegg:03018 RNA degradation 55.9 1.18E-16 
Kegg:00240 Pyrimidine metabolism 47.7 4.19E-15 
Kegg:04114 Oocyte meiosis 43.2 4.33E-15 
Kegg:03015 mRNA surveillance pathway 52.2 1.26E-14 
Kegg:03420 Nucleotide excision repair 65.0 7.79E-14 
Kegg:03022 Basal transcription factors 62.2 1.06E-11 
Kegg:03060 Protein export 76.2 2.48E-10 
Kegg:03020 RNA polymerase 68.0 1.06E-09 
Kegg:04260 Cardiac muscle contraction 45.0 2.65E-09 
Kegg:00280 Valine, leucine and isoleucine degradation 50.0 2.11E-08 
Kegg:04142 Lysosome 33.3 2.58E-08 
Kegg:00020 Citrate cycle (TCA cycle) 58.6 2.66E-08 
Kegg:03430 Mismatch repair 63.6 1.34E-07 
Kegg:00010 Glycolysis / Gluconeogenesis 40.3 1.45E-07 
Kegg:00230 Purine metabolism 28.5 4.41E-07 
Kegg:03410 Base excision repair 51.6 7.08E-07 
Kegg:04115 p53 signaling pathway 38.3 1.39E-06 
Kegg:00062 Fatty acid elongation in mitochondria 81.8 1.42E-06 
Kegg:04914 Progesterone-mediated oocyte maturation 32.2 4.68E-06 
Kegg:03440 Homologous recombination 52.0 8.48E-06 
Kegg:04623 Cytosolic DNA-sensing pathway 43.8 4.40E-05 
Kegg:04145 Phagosome 27.5 6.30E-05 
Kegg:00071 Fatty acid metabolism 40.0 0.000141744 
Kegg:04530 Tight junction 25.2 0.000166423 
Kegg:04130 SNARE interactions in vesicular transport 37.5 0.000173162 
Kegg:00620 Pyruvate metabolism 38.9 0.000188608 
Kegg:00270 Cysteine and methionine metabolism 37.8 0.000261902 
Kegg:00970 Aminoacyl-tRNA biosynthesis 37.5 0.000926774 
Kegg:04350 TGF-beta signaling pathway 26.5 0.001235240 
Kegg:00480 Glutathione metabolism 35.3 0.001688910 
Kegg:04810 Regulation of actin cytoskeleton 20.9 0.001729620 
Kegg:00640 Propanoate metabolism 34.4 0.003546100 
Kegg:00630 Glyoxylate and dicarboxylate metabolism 46.7 0.003681030 
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Kegg:00510 N-Glycan biosynthesis 30.2 0.004673170 
Kegg:00650 Butanoate metabolism 37.5 0.004778460 
Kegg:00030 Pentose phosphate pathway 34.5 0.005293830 
Kegg:04520 Adherens junction 25.0 0.005385700 
Kegg:04144 Endocytosis 19.7 0.005749750 
Kegg:00860 Porphyrin and chlorophyll metabolism 34.6 0.008157190 
Kegg:00520 Amino sugar and nucleotide sugar metabolism 28.3 0.008220220 
Kegg:04710 Circadian rhythm - mammal 31.0 0.017851700 
Kegg:04210 Apoptosis 22.8 0.018253200 
Kegg:00310 Lysine degradation 26.1 0.022225000 
Kegg:04910 Insulin signaling pathway 19.7 0.026399600 
Kegg:00072 Synthesis and degradation of ketone bodies 50.0 0.027595400 
Kegg:00982 Drug metabolism - cytochrome P450 29.6 0.034047100 
Kegg:00360 Phenylalanine metabolism 38.5 0.038657200 
Kegg:00330 Arginine and proline metabolism 23.2 0.040925300 
Kegg:04140 Regulation of autophagy 33.3 0.041723400 
Kegg:04310 Wnt signaling pathway 18.4 0.044198100 
Kegg:00980 Metabolism of xenobiotics by cytochrome P450 27.6 0.047592800 
Kegg:00051 Fructose and mannose metabolism 25.0 0.047941500 
Kegg:00900 Terpenoid backbone biosynthesis 35.7 0.048225500 
Kegg:00410 beta-Alanine metabolism 29.2 0.048391300 
Kegg:04150 mTOR signaling pathway 23.9 0.048498300 
Table S23: KEGG Pathway Analysis 
KEGG pathway analysis of Ensembl gene IDs with the highest expression (top 4000) 
determined during stage IV of the RNAseq analysis% gives the number of times a 
term was associated within the reference list of Ensembl IDs as a percentage of the 
total number of ID associated with that term. Corrected p-values were calculated 
using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 86.2 4.30E-89 
GO:0006457 protein folding 60.7 2.09E-24 
GO:0006260 DNA replication 76.0 1.96E-22 
GO:0006413 translational initiation 73.5 1.51E-20 
GO:0006397 mRNA processing 62.0 1.74E-20 
GO:0008380 RNA splicing 72.7 5.17E-18 
GO:0007049 cell cycle 48.1 9.42E-18 
GO:0051301 cell division 56.8 9.49E-18 
GO:0006810 transport 25.3 2.95E-17 
GO:0015031 protein transport 41.1 4.96E-17 
GO:0007067 mitosis 68.9 1.42E-16 
GO:0055114 oxidation-reduction process 27.0 9.90E-16 
GO:0006396 RNA processing 65.0 6.18E-13 
GO:0006281 DNA repair 50.0 1.18E-12 
GO:0022900 electron transport chain 79.2 7.41E-12 
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GO:0045454 cell redox homeostasis 63.2 1.41E-11 
GO:0006974 response to DNA damage stimulus 55.3 1.07E-10 
GO:0042254 ribosome biogenesis 70.4 2.23E-10 
GO:0015986 ATP synthesis coupled proton transport 100 6.13E-10 
GO:0006364 rRNA processing 70.8 2.37E-09 
GO:0006886 intracellular protein transport 40.2 7.33E-09 
GO:0051603 proteolysis involved in cellular protein catabolic 
process 
75.0 8.23E-09 
GO:0006511 ubiquitin-dependent protein catabolic process 47.2 1.95E-08 
GO:0006367 transcription initiation from RNA polymerase II 
promoter 
100 3.22E-08 
GO:0006417 regulation of translation 76.5 8.39E-08 
GO:0051028 mRNA transport 72.2 2.57E-07 
GO:0051726 regulation of cell cycle 56.7 2.91E-07 
GO:0006099 tricarboxylic acid cycle 75.0 4.68E-07 
GO:0032259 methylation 35.6 6.01E-07 
GO:0006414 translational elongation 57.7 1.45E-06 
GO:0008152 metabolic process 20.9 3.12E-06 
GO:0015992 proton transport 66.7 3.29E-06 
GO:0016192 vesicle-mediated transport 35.0 3.95E-06 
GO:0007507 heart development 33.0 1.01E-05 
GO:0006310 DNA recombination 56.5 1.36E-05 
GO:0016070 RNA metabolic process 71.4 1.38E-05 
GO:0007264 small GTPase mediated signal transduction 25.9 2.75E-05 
GO:0009790 embryo development 30.1 3.40E-05 
GO:0044267 cellular protein metabolic process 69.2 7.05E-05 
GO:0007059 chromosome segregation 69.2 7.05E-05 
GO:0030261 chromosome condensation 87.5 7.27E-05 
GO:0042773 ATP synthesis coupled electron transport 100 8.09E-05 
GO:0016568 chromatin modification 36.4 9.32E-05 
GO:0006662 glycerol ether metabolic process 64.3 0.000159813 
GO:0006096 glycolysis 43.8 0.000203809 
GO:0043066 negative regulation of apoptotic process 43.8 0.000203809 
GO:0006270 DNA-dependent DNA replication initiation 77.8 0.000249519 
GO:0051597 response to methylmercury 77.8 0.000249519 
GO:0060041 retina development in camera-type eye 34.5 0.000332597 
GO:0006098 pentose-phosphate shunt 85.7 0.000425717 
GO:0006351 transcription, DNA-dependent 18.4 0.000497496 
GO:0000398 nuclear mRNA splicing, via spliceosome 100 0.000531903 
GO:0006334 nucleosome assembly 38.9 0.000881546 
GO:0008033 tRNA processing 42.3 0.002295020 
GO:0045039 protein import into mitochondrial inner membrane 83.3 0.002613340 
GO:0022904 respiratory electron transport chain 83.3 0.002613340 
GO:0006979 response to oxidative stress 53.3 0.002682440 
GO:0006366 transcription from RNA polymerase II promoter 58.3 0.003236770 
GO:0030833 regulation of actin filament polymerization 66.7 0.003468540 
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GO:0007062 sister chromatid cohesion 100 0.003689180 
GO:0006120 mitochondrial electron transport, NADH to 
ubiquinone 
100 0.003689180 
GO:0030163 protein catabolic process 50.0 0.004245480 
GO:0015991 ATP hydrolysis coupled proton transport 47.1 0.006931600 
GO:0006950 response to stress 30.2 0.006953480 
GO:0001666 response to hypoxia 42.9 0.006955340 
GO:0000184 nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
60.0 0.007048260 
GO:0006357 regulation of transcription from RNA polymerase II 
promoter 
36.7 0.008181100 
GO:0006418 tRNA aminoacylation for protein translation 40.9 0.010182700 
GO:0006915 apoptotic process 27.9 0.011867700 
GO:0006914 autophagy 54.5 0.012367500 
GO:0006352 transcription initiation, DNA-dependent 54.5 0.012367500 
GO:0009987 cellular process 54.5 0.012367500 
GO:0006508 proteolysis 18.5 0.012373100 
GO:0006614 SRP-dependent cotranslational protein targeting to 
membrane 
80.0 0.013527500 
GO:0051276 chromosome organization 80.0 0.013527500 
GO:0006284 base-excision repair 62.5 0.014755100 
GO:0009058 biosynthetic process 31.6 0.018627400 
GO:0030036 actin cytoskeleton organization 40.0 0.019939500 
GO:0008652 cellular amino acid biosynthetic process 50.0 0.019974400 
GO:0046686 response to cadmium ion 50.0 0.019974400 
GO:0031047 gene silencing by RNA 50.0 0.019974400 
GO:0043280 positive regulation of cysteine-type endopeptidase 
activity involved in apoptotic process 
50.0 0.019974400 
GO:0043248 proteasome assembly 100 0.020339700 
GO:0016575 histone deacetylation 100 0.020339700 
GO:0000070 mitotic sister chromatid segregation 100 0.020339700 
GO:0043985 histone H4-R3 methylation 100 0.020339700 
GO:0016925 protein sumoylation 100 0.020339700 
GO:0040016 embryonic cleavage 100 0.020339700 
GO:0042176 regulation of protein catabolic process 100 0.020339700 
GO:0006464 protein modification process 32.4 0.021687000 
GO:0006626 protein targeting to mitochondrion 55.6 0.024644800 
GO:0060218 hemopoietic stem cell differentiation 55.6 0.024644800 
GO:0009116 nucleoside metabolic process 41.2 0.028313500 
GO:0009165 nucleotide biosynthetic process 66.7 0.028902800 
GO:0044070 regulation of anion transport 66.7 0.028902800 
Table S24: GO Term Biological Process Analysis 
GO term biological process analysis of ensembl gene IDs with the highest expression 
(top 4000) determined during stage IV of the RNAseq analysis. % gives the number 
of times a term was associated within the reference list of Ensembl IDs as a 
percentage of the total number of ID associated with that term. Corrected p-values 
were calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
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GO:0003735 structural constituent of ribosome 97.2 4.52E-87 
GO:0000166 nucleotide binding 29.0 5.60E-58 
GO:0003723 RNA binding 53.6 2.83E-50 
GO:0003676 nucleic acid binding 29.7 8.86E-33 
GO:0003743 translation initiation factor activity 73.5 9.17E-21 
GO:0005524 ATP binding 23.3 5.63E-18 
GO:0016853 isomerase activity 59.6 2.53E-15 
GO:0051082 unfolded protein binding 57.4 4.23E-15 
GO:0016491 oxidoreductase activity 26.8 1.59E-13 
GO:0003824 catalytic activity 24.3 4.86E-12 
GO:0016787 hydrolase activity 22.4 3.70E-11 
GO:0005488 binding 23.7 7.15E-11 
GO:0008137 NADH dehydrogenase (ubiquinone) activity 93.3 1.09E-10 
GO:0016874 ligase activity 37.4 1.24E-09 
GO:0005525 GTP binding 26.3 2.77E-09 
GO:0046872 metal ion binding 19.3 3.70E-09 
GO:0004298 threonine-type endopeptidase activity 75.0 6.48E-09 
GO:0004175 endopeptidase activity 65.2 1.34E-07 
GO:0019843 rRNA binding 90.9 2.30E-07 
GO:0008168 methyltransferase activity 33.6 2.40E-07 
GO:0016881 acid-amino acid ligase activity 47.7 2.46E-07 
GO:0015035 protein disulfide oxidoreductase activity 63.6 5.62E-07 
GO:0003899 DNA-directed RNA polymerase activity 60.0 5.75E-07 
GO:0016651 oxidoreductase activity, acting on NADH or 
NADPH 
90.0 1.42E-06 
GO:0003755 peptidyl-prolyl cis-trans isomerase activity 53.3 1.62E-06 
GO:0017111 nucleoside-triphosphatase activity 34.5 1.68E-06 
GO:0008026 ATP-dependent helicase activity 44.4 1.93E-06 
GO:0004386 helicase activity 37.9 2.25E-06 
GO:0016616 oxidoreductase activity, acting on the CH-OH 
group of donors, NAD or NADP as acceptor 
45.2 2.67E-06 
GO:0008565 protein transporter activity 53.6 3.36E-06 
GO:0001104 RNA polymerase II transcription cofactor activity 68.8 4.49E-06 
GO:0016627 oxidoreductase activity, acting on the CH-CH group 
of donors 
59.1 4.57E-06 
GO:0004129 cytochrome-c oxidase activity 81.8 5.06E-06 
GO:0003677 DNA binding 17.9 7.61E-06 
GO:0016740 transferase activity 19.1 7.63E-06 
GO:0015078 hydrogen ion transmembrane transporter activity 66.7 2.18E-05 
GO:0031072 heat shock protein binding 43.2 4.31E-05 
GO:0009055 electron carrier activity 27.3 0.000105073 
GO:0051536 iron-sulfur cluster binding 43.8 0.000146335 
GO:0046933 hydrogen ion transporting ATP synthase activity, 
rotational mechanism 
77.8 0.000182271 
GO:0050660 flavin adenine dinucleotide binding 38.1 0.000274456 
GO:0016209 antioxidant activity 85.7 0.000308513 
GO:0046961 proton-transporting ATPase activity, rotational 70.0 0.000493201 
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mechanism 
GO:0008430 selenium binding 70.0 0.000493201 
GO:0003887 DNA-directed DNA polymerase activity 61.5 0.000501899 
GO:0051287 NAD binding 40.6 0.000670210 
GO:0008270 zinc ion binding 16.4 0.000739786 
GO:0000287 magnesium ion binding 32.7 0.000779195 
GO:0016769 transferase activity, transferring nitrogenous 
groups 
57.1 0.000959020 
GO:0015450 P-P-bond-hydrolysis-driven protein transmembrane 
transporter activity 
83.3 0.001778000 
GO:0051539 4 iron, 4 sulfur cluster binding 53.3 0.001796200 
GO:0003746 translation elongation factor activity 47.4 0.002127150 
GO:0051920 peroxiredoxin activity 100 0.002490740 
GO:0008641 small protein activating enzyme activity 100 0.002490740 
GO:0008121 ubiquinol-cytochrome-c reductase activity 100 0.002490740 
GO:0003725 double-stranded RNA binding 50.0 0.002861290 
GO:0003779 actin binding 25.8 0.003842250 
GO:0003995 acyl-CoA dehydrogenase activity 53.8 0.003881720 
GO:0030170 pyridoxal phosphate binding 32.6 0.004314150 
GO:0004812 aminoacyl-tRNA ligase activity 40.0 0.004338160 
GO:0050662 coenzyme binding 40.0 0.004338160 
GO:0008233 peptidase activity 20.4 0.004850630 
GO:0005198 structural molecule activity 22.3 0.009413720 
GO:0008474 palmitoyl-(protein) hydrolase activity 80.0 0.009501620 
GO:0008312 7S RNA binding 80.0 0.009501620 
GO:0051537 2 iron, 2 sulfur cluster binding 46.7 0.010045800 
GO:0004602 glutathione peroxidase activity 62.5 0.010188600 
GO:0004518 nuclease activity 33.3 0.012246900 
GO:0004749 ribose phosphate diphosphokinase activity 100 0.014286400 
GO:0003689 DNA clamp loader activity 100 0.014286400 
GO:0004579 dolichyl-diphosphooligosaccharide-protein 
glycotransferase activity 
100 0.014286400 
GO:0043022 ribosome binding 100 0.014286400 
GO:0030515 snoRNA binding 100 0.014286400 
GO:0004185 serine-type carboxypeptidase activity 100 0.014286400 
GO:0003906 DNA-(apurinic or apyrimidinic site) lyase activity 100 0.014286400 
GO:0004526 ribonuclease P activity 100 0.014286400 
GO:0008190 eukaryotic initiation factor 4E binding 100 0.014286400 
GO:0004177 aminopeptidase activity 43.8 0.015276600 
GO:0046983 protein dimerization activity 27.3 0.015816600 
GO:0005529 sugar binding 24.1 0.016389000 
GO:0004519 endonuclease activity 33.3 0.016830000 
GO:0003729 mRNA binding 55.6 0.016831800 
GO:0008173 RNA methyltransferase activity 66.7 0.019898300 
GO:0008308 voltage-gated anion channel activity 66.7 0.019898300 
GO:0003682 chromatin binding 32.3 0.021097400 
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GO:0019904 protein domain specific binding 36.4 0.023435700 
GO:0004842 ubiquitin-protein ligase activity 28.6 0.025672200 
GO:0003924 GTPase activity 21.4 0.030370600 
GO:0016620 oxidoreductase activity, acting on the aldehyde or 
oxo group of donors, NAD or NADP as acceptor 
36.8 0.036952400 
GO:0003684 damaged DNA binding 36.8 0.036952400 
GO:0034739 histone deacetylase activity (H3-K16 specific) 75.0 0.038537100 
GO:0031078 histone deacetylase activity (H3-K14 specific) 75.0 0.038537100 
GO:0032041 NAD-dependent histone deacetylase activity (H3-
K14 specific) 
75.0 0.038537100 
GO:0032129 histone deacetylase activity (H3-K9 specific) 75.0 0.038537100 
GO:0004407 histone deacetylase activity 75.0 0.038537100 
GO:0046969 NAD-dependent histone deacetylase activity (H3-
K9 specific) 
75.0 0.038537100 
GO:0046970 NAD-dependent histone deacetylase activity (H4-
K16 specific) 
75.0 0.038537100 
GO:0003854 3-beta-hydroxy-delta5-steroid dehydrogenase 
activity 
75.0 0.038537100 
GO:0016799 hydrolase activity, hydrolyzing N-glycosyl 
compounds 
75.0 0.038537100 
GO:0004616 phosphogluconate dehydrogenase 
(decarboxylating) activity 
75.0 0.038537100 
GO:0003678 DNA helicase activity 75.0 0.038537100 
GO:0030234 enzyme regulator activity 75.0 0.038537100 
GO:0004601 peroxidase activity 45.5 0.038598900 
GO:0008235 metalloexopeptidase activity 57.1 0.038682400 
GO:0004674 protein serine/threonine kinase activity 17.9 0.039177400 
GO:0016788 hydrolase activity, acting on ester bonds 33.3 0.039799700 
Table S25: GO Term Molecular Function Analysis 
GO term molecular function analysis of ensembl gene IDs with the highest expression 
(top 4000) determined during stage IV of the RNAseq analysis. % gives the number 
of times a term was associated within the reference list of Ensembl IDs as a 
percentage of the total number of ID associated with that term. Corrected p-values 
were calculated using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
S3.3 CuffDiff Differential Expression 
 
Ensembl ID Gene 
Log2 (Fold 
Change) p-value 
Previously 
known 
ENSDARG00000041348 cyp19a1a 5.54146 1.58E-07 Yes 
ENSDARG00000094845 MFAP4 (5 of 13) 5.33247 4.95E-09 No 
ENSDARG00000018263 pdia2 4.58986 2.54E-07 No 
ENSDARG00000091584 si:ch73-217n20.1 4.38721 6.83E-05 No 
ENSDARG00000063921 mt-nd5 4.11418 6.26E-06 No 
ENSDARG00000091166 MFAP4 (6 of 13) 2.76320 4.02E-05 No 
ENSDARG00000063924 mt-cyb 2.44964 5.03E-05 No 
ENSDARG00000087583 si:ch211-226h8.13 -4.69621 2.67E-06 No 
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Table S26: Stage I and II Differentially Expressed Genes 
RNAseq data for stages I and II were compared using Cuffdiff to produce a list of 
genes with differential expression. As replicates were not used during this analysis, 
the results suggest large changes in expression but cannot be used as statistically 
significant or confirmed changes in expression. “Previously known” indicates 
differential expression was indicated in related species from the literature. 
 
Ensembl ID Gene 
Log2 (Fold 
Change) p-value 
Previously 
known 
ENSDARG00000043858 cdk19 14.6001 1.52E-05 No 
ENSDARG00000095613 si:ch211-212o2.6 10.1697 4.55E-05 No 
ENSDARG00000071586 tgfbi 4.33458 1.29E-05 No 
ENSDARG00000018259 atp1a3a 3.77539 5.91E-06 Yes 
ENSDARG00000057714 cmah 3.14844 2.72E-05 Yes 
ENSDARG00000094845 MFAP4 (5 of 13) 2.87004 8.87E-06 No 
ENSDARG00000091166 MFAP4 (6 of 13) 2.44585 2.96E-05 No 
ENSDARG00000092505 si:dkeyp-80d11.1 -5.13794 1.33E-07 No 
Table S27: Stage II and III Differentially Expressed Genes 
RNAseq data for stages II and III were compared using Cuffdiff to produce a list of 
genes with differential expression. As replicates were not used during this analysis, 
the results suggest large changes in expression but cannot be used as statistically 
significant or confirmed changes in expression. “Previously known” indicates 
differential expression was indicated in related species from the literature.  
 
 
Ensembl ID Gene 
Log2 (Fold 
Change) p-value 
Previously 
known 
ENSDARG00000035709 lhb 7.72587 2.16E-06 Yes 
ENSDARG00000094561 si:ch211-69i14.10 7.03196 7.45E-06 No 
ENSDARG00000069375 zgc:162608 6.47552 5.29E-07 No 
ENSDARG00000017490 cel.1 5.92481 3.69E-08 No 
ENSDARG00000057887 nts 5.76225 6.20E-09 Yes 
ENSDARG00000003259 lox 5.69112 8.42E-07 Yes 
ENSDARG00000010434 clu 5.55699 6.72E-09 Yes 
ENSDARG00000088795 TGFBR3L 5.38861 4.95E-11 No 
ENSDARG00000036041 f2 5.28513 1.30E-07 Yes 
ENSDARG00000037555 atoh8 5.05836 1.63E-05 No 
ENSDARG00000010785 thbs1b 5.01296 5.41E-08 Yes 
ENSDARG00000079166 ace 4.97041 4.95E-10 Yes 
ENSDARG00000074852 wu:fd60h05 4.94451 1.50E-06 No 
ENSDARG00000068290 CYP2X12 4.86093 1.28E-07 No 
ENSDARG00000090903 CREB3L3 (2 of 2) 4.64252 4.12E-05 No 
ENSDARG00000044685 nr0b2a 4.62345 2.25E-05 No 
ENSDARG00000079372 si:ch211-264f5.6 4.6215 3.35E-05 No 
ENSDARG00000078541 CERS3 (1 of 2) 4.59611 2.91E-05 No 
ENSDARG00000015964 zgc:153311 4.52321 2.70E-06 No 
ENSDARG00000075229 SLC46A2 4.41913 9.81E-06 No 
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Ensembl ID Gene 
Log2 (Fold 
Change) p-value 
Previously 
known 
ENSDARG00000013730 slc4a4a 4.41764 2.02E-06 No 
ENSDARG00000053961 slc2a11a 4.41451 3.13E-05 No 
ENSDARG00000016598 ckmt1 4.21456 2.21E-05 Yes 
ENSDARG00000091503 FADS6 4.04974 1.86E-07 No 
ENSDARG00000029544 id2b 4.03559 3.89E-05 No 
ENSDARG00000026081 lhcgr 3.83556 5.98E-05 Yes 
ENSDARG00000058543 lama5 3.73197 2.91E-06 No 
ENSDARG00000075831 SLC7A8 (1 of 2) 3.72918 3.17E-05 No 
ENSDARG00000068280 GRB14 3.69329 3.40E-05 Yes 
ENSDARG00000002509 zgc:153911 3.63417 1.66E-07 No 
ENSDARG00000020031 cldn11a 3.39431 2.29E-07 Yes 
ENSDARG00000091234 CU019646.2 2.7489 5.14E-06 No 
Table S28: Differentially Expressed Genes Increasing Between Stages III and IV 
 RNAseq data for stages III and IV were compared using Cuffdiff to produce a list of 
genes with differential expression. Gene ID indicated increased in expression level in 
stage IV compared to stage III. As replicates were not used during this analysis, the 
results suggest large changes in expression but cannot be used as statistically 
significant or confirmed changes in expression. “Previously known” indicates 
differential expression was indicated in related species from the literature. 
  
 
Ensembl ID Gene 
Log2 (Fold 
Change) p-value 
Previously 
known 
ENSDARG00000043858 cdk19 -13.396 1.15E-06 No 
ENSDARG00000077090 PLXNB2 (5 of 5) -7.57743 3.35E-08 No 
ENSDARG00000006848 PARP9 -7.39172 1.79E-05 No 
ENSDARG00000023546 kcnn1b -6.97342 4.68E-07 No 
ENSDARG00000020671 HEATR1 (2 of 2) -6.69075 5.02E-11 No 
ENSDARG00000091349 PLEKHD1 -6.56351 2.58E-06 No 
ENSDARG00000088052 CR759791.3 -6.52277 3.01E-06 No 
ENSDARG00000088202 sh3d19 -6.50225 6.41E-07 No 
ENSDARG00000023797 ryr1b -5.8943 1.09E-05 No 
ENSDARG00000027070 acbd4 -5.7444 3.80E-05 No 
ENSDARG00000010420 ndrg1b -5.6208 1.24E-09 No 
ENSDARG00000032114 slain2 -5.45289 3.24E-05 No 
ENSDARG00000090267 CU062628.1 -4.93542 2.75E-05 No 
ENSDARG00000076960 PAQR4 (1 of 2) -4.92953 2.81E-05 No 
ENSDARG00000067639 prpf4 -4.25413 1.23E-06 No 
ENSDARG00000093255 si:dkey-229d11.3 -4.10963 3.26E-08 No 
ENSDARG00000070698 kbtbd8 -3.79196 5.66E-05 Yes 
ENSDARG00000094392 si:dkey-229d11.5 -3.45443 3.47E-07 No 
ENSDARG00000077171 A2ML1 (9 of 12) -2.71831 4.71E-06 No 
Table S29: Differentially Expressed Genes Decreasing Between Stages III and IV 
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RNAseq data for stages III and IV were compared using Cuffdiff to produce a list of 
genes with differential expression. Genes listed decreased in expression level in stage 
IV compared to stage III. As replicates were not used during this analysis, the results 
suggest large changes in expression but cannot be used as statistically significant or 
confirmed changes in expression. “Previously known” indicates differential 
expression was indicated in related species from the literature. 
 
S3.4 GO Term Analysis of Differentially Expressed Genes 
 
ID Term % p-value 
GO:0009055 electron carrier activity 2.5 2.13E-05 
GO:0022900 electron transport chain 8.3 9.97E-05 
GO:0016491 oxidoreductase activity 0.8 0.000378222 
Kegg:00190 Oxidative phosphorylation 1.7 0.000781873 
GO:0070330 aromatase activity 100 0.000866524 
GO:0022904 respiratory electron transport chain 16.7 0.002923160 
GO:0042773 ATP synthesis coupled electron transport 16.7 0.002923160 
GO:0009410 response to xenobiotic stimulus 10.0 0.003896100 
GO:0006662 glycerol ether metabolic process 7.1 0.004543770 
GO:0032355 response to estradiol stimulus 20.0 0.004872390 
GO:0055114 oxidation-reduction process 0.4 0.005119290 
GO:0045454 cell redox homeostasis 2.6 0.008203750 
GO:0006810 transport 0.3 0.008273570 
GO:0008137 NADH dehydrogenase (ubiquinone) activity 6.7 0.009735740 
Kegg:00140 Steroid hormone biosynthesis 3.2 0.010045300 
GO:0015035 protein disulfide oxidoreductase activity 4.5 0.011415800 
Kegg:04260 Cardiac muscle contraction 1.7 0.012926900 
GO:0016702 oxidoreductase activity, acting on single donors 
with incorporation of molecular oxygen, 
incorporation of two atoms of oxygen 
3.3 0.012962900 
GO:0016853 isomerase activity 1.8 0.021058200 
GO:0016705 oxidoreductase activity, acting on paired donors, 
with incorporation or reduction of molecular oxygen 
1.2 0.024076500 
GO:0004497 monooxygenase activity 1.0 0.025247500 
GO:0020037 heme binding 0.9 0.026197100 
GO:0046872 metal ion binding 0.2 0.026561000 
GO:0005506 iron ion binding 0.7 0.029728600 
Table S30: GO Term Analysis of Stage I and II Differentially Expressed Genes 
RNAseq data for stages I and II were compared using Cuffdiff to produce a list of 
genes with differential expression. Genes showing increased expression were selected 
for GO Term analysis using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 
2012). % gives the number of times a term was associated within the reference list (of  
Ensembl IDs) as a percentage of the number of IDs associated with that term. 
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ID Term % p-value 
GO:0030338 CMP-N-acetylneuraminate monooxygenase activity 100 0.00259957 
GO:0015077 monovalent inorganic cation transmembrane 
transporter activity 
11.1 0.01168940 
GO:0015672 monovalent inorganic cation transport 10.0 0.01190480 
GO:0048747 muscle fiber development 20.0 0.01191030 
Kegg:04260 Cardiac muscle contraction 1.7 0.01292690 
GO:0051537 2 iron, 2 sulfur cluster binding 6.7 0.01298100 
GO:0051536 iron-sulfur cluster binding 3.1 0.01382450 
GO:0016820 hydrolase activity, acting on acid anhydrides, 
catalyzing transmembrane movement of 
substances 
3.3 0.01555550 
GO:0006810 transport 0.3 0.01617940 
GO:0006754 ATP biosynthetic process 3.6 0.01663880 
GO:0015662 ATPase activity, coupled to transmembrane 
movement of ions, phosphorylative mechanism 
3.8 0.01685810 
GO:0022900 electron transport chain 4.2 0.01902290 
Kegg:00520 Amino sugar and nucleotide sugar metabolism 2.2 0.01984700 
GO:0042221 response to chemical stimulus 1.6 0.02065030 
GO:0051301 cell division 1.4 0.02189340 
GO:0006812 cation transport 1.7 0.02369930 
GO:0046872 metal ion binding 0.2 0.03035540 
Table S31: GO Term Analysis of Stage II and III Differentially Expressed Genes 
RNAseq data for stages II and III were compared using Cuffdiff to produce a list of 
genes with differential expression. Genes showing increased expression were selected 
for GO Term analysis using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 
2012). % gives the number of times a term was associated within the reference list (of  
Ensembl IDs) as a percentage of the number of IDs associated with that term. 
 
ID Term % p-value 
GO:0035141 medial fin morphogenesis 100 0.00623588 
GO:0061074 regulation of neural retina development 100 0.00623588 
GO:2001014 regulation of skeletal muscle cell differentiation 100 0.00623588 
GO:0042700 luteinizing hormone signaling pathway 100 0.00623588 
GO:0005198 structural molecule activity 2.3 0.00711095 
GO:0004964 luteinizing hormone receptor activity 100 0.0129514 
GO:0045995 regulation of embryonic development 33.3 0.0149522 
GO:0004104 cholinesterase activity 33.3 0.0155273 
GO:0047372 acylglycerol lipase activity 33.3 0.0155273 
GO:0008219 cell death 25.0 0.0166059 
GO:0016500 protein-hormone receptor activity 50.0 0.0172606 
GO:0030155 regulation of cell adhesion 20.0 0.0177837 
GO:0033334 fin morphogenesis 12.5 0.0180819 
GO:0035138 pectoral fin morphogenesis 12.5 0.0180819 
Kegg:04512 ECM-receptor interaction 3.6 0.018594 
GO:0008104 protein localization 16.7 0.0186643 
GO:0030334 regulation of cell migration 14.3 0.0193466 
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ID Term % p-value 
Kegg:04350 TGF-beta signaling pathway 2.4 0.0202158 
Kegg:04080 Neuroactive ligand-receptor interaction 0.9 0.0209419 
GO:0022008 neurogenesis 7.7 0.024805 
GO:0007155 cell adhesion 1.2 0.0253637 
GO:0033333 fin development 6.7 0.0265522 
GO:0016337 cell-cell adhesion 5.9 0.0280603 
GO:0007596 blood coagulation 5.3 0.0293742 
Kegg:04614 Renin-angiotensin system 10.0 0.0334379 
Kegg:04510 Focal adhesion 1.1 0.0361361 
Kegg:00100 Steroid biosynthesis 5.6 0.0399769 
GO:0007517 muscle organ development 3.2 0.0448572 
Table S32: GO Term Analysis of Differentially Expressed Genes Increasing between 
Stage III and IV 
RNAseq data for stages III and IV were compared using Cuffdiff to produce a list of 
genes with differential expression. Genes showing increased expression were selected 
for GO Term analysis using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 
2012). % gives the number of times a term was associated within the reference list (of  
Ensembl IDs) as a percentage of the number of IDs associated with that term. 
 
ID Term % p-value 
GO:0016286 small conductance calcium-activated potassium 
channel activity 
100 0.00278526 
GO:0000062 fatty-acyl-CoA binding 20.0 0.00463721 
GO:0015269 calcium-activated potassium channel activity 25.0 0.00556612 
GO:0005516 calmodulin binding 5.6 0.01247780 
GO:0051301 cell division 1.4 0.04043950 
GO:0006813 potassium ion transport 1.8 0.04171790 
Table S33: GO Term Analysis of Differentially Expressed Genes Decreasing between 
Stage III and IV 
RNAseq data for stages III and IV were compared using Cuffdiff to produce a list of 
genes with differential expression. Genes showing decreased expression were selected 
for GO Term analysis using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 
2012). % gives the number of times a term was associated within the reference list (of  
Ensembl IDs) as a percentage of the number of IDs associated with that term.  
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S4 Small RNA Sequencing Replicates 
S4.1 Statistics 
 
Aspect Forward Reverse 
Yield (Kb) 2,746,951 2,465,034 
Fasta read count 19,257,572 19,257,572 
Contaminated read count 5,174,596 5,061,394 
Contaminated reads (%)  26.87 26.28 
Table S34: Forward and Reverse Read Statistics 
Forward and reverse read statistics from the small RNA sequencing replicates, results 
provided by the in-house sequencing team. Values shown here are for the total 
sequencing project, including other samples not described in this thesis. 
 
Aspect WT1 WT2 WT3 
Fasta read count 1,892,276 2,383,232 3,807,081 
Table S35: Number of reads per Sample  
Statistics from the small RNA replicate sequencing, results provided by the in-house 
sequencing team. Fasta read counts are of paired-end reads.  
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S4.2 GO Term Analysis – Average Expression  
 
ID Term % p-value 
Kegg:03010 Ribosome 55.4 6.88E-44 
Kegg:03013 RNA transport 27.3 9.55E-21 
Kegg:04110 Cell cycle 25.0 1.04E-16 
Kegg:04141 Protein processing in endoplasmic reticulum 21.4 2.67E-15 
Kegg:04114 Oocyte meiosis 20.7 3.80E-11 
Kegg:03040 Spliceosome 19.3 1.45E-10 
Kegg:03030 DNA replication 37.1 6.28E-10 
Kegg:03018 RNA degradation 23.5 7.54E-09 
Kegg:03015 mRNA surveillance pathway 23.2 8.46E-09 
Kegg:03008 Ribosome biogenesis in eukaryotes 20.0 1.94E-06 
Kegg:04145 Phagosome 14.7 6.21E-06 
Kegg:04914 Progesterone-mediated oocyte maturation 14.9 5.11E-05 
Kegg:03430 Mismatch repair 27.3 0.00049775 
Kegg:04120 Ubiquitin mediated proteolysis 10.6 0.00287118 
Kegg:00310 Lysine degradation 15.2 0.00521005 
Kegg:04520 Adherens junction 11.8 0.00598690 
Kegg:00010 Glycolysis / Gluconeogenesis 12.9 0.00607420 
Kegg:04530 Tight junction 9.2 0.00832938 
Kegg:03420 Nucleotide excision repair 15.0 0.01051720 
Kegg:03060 Protein export 19.0 0.02372760 
Kegg:00270 Cysteine and methionine metabolism 13.5 0.03546650 
Kegg:03440 Homologous recombination 16.0 0.04103730 
Table S37: KEGG Pathway Analysis  
KEGG pathway analysis of the Ensembl gene IDs with the highest average expression 
determined by the small RNA fraction sequencing of replicates and mapping with 
Cufflinks.  gives the number of times a term was associated within the reference list (of 
1000 Ensembl IDs) as a percentage of the number of genes associated with that term. 
Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 29.7 3.92E-26 
GO:0006457 protein folding 21.3 2.55E-08 
GO:0007049 cell cycle 18.5 8.15E-08 
GO:0006260 DNA replication 28.0 8.22E-08 
GO:0044267 cellular protein metabolic process 61.5 1.54E-07 
GO:0051301 cell division 21.6 1.82E-07 
GO:0051726 regulation of cell cycle 36.7 1.84E-07 
GO:0006886 intracellular protein transport 19.5 7.68E-07 
GO:0030261 chromosome condensation 75.0 2.24E-06 
GO:0006414 translational elongation 34.6 5.17E-06 
GO:0006270 DNA-dependent DNA replication initiation 66.7 5.33E-06 
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ID Term % p-value 
GO:0006334 nucleosome assembly 27.8 8.76E-06 
GO:0006413 translational initiation 22.4 2.11E-05 
GO:0048565 digestive tract development 38.9 4.15E-05 
GO:0007067 mitosis 22.2 6.70E-05 
GO:0006396 RNA processing 22.5 0.000185751 
GO:0051276 chromosome organization 80.0 0.000198176 
GO:0015031 protein transport 11.3 0.000389703 
GO:0009790 embryo development 12.6 0.001090720 
GO:0000070 mitotic sister chromatid segregation 100 0.001096970 
GO:0016070 RNA metabolic process 35.7 0.001554820 
GO:0006662 glycerol ether metabolic process 35.7 0.001554820 
GO:0031101 fin regeneration 22.6 0.001565800 
GO:0006096 glycolysis 21.9 0.001703500 
GO:0000079 regulation of cyclin-dependent protein kinase 
activity 
33.3 0.002086800 
GO:0006397 mRNA processing 14.1 0.002560270 
GO:0032259 methylation 12.6 0.002687100 
GO:0006810 transport 6.2 0.002704810 
GO:0007062 sister chromatid cohesion 75.0 0.002709780 
GO:0071599 otic vesicle development 75.0 0.002709780 
GO:0006355 regulation of transcription, DNA-dependent 5.7 0.002795130 
GO:0060218 hemopoietic stem cell differentiation 44.4 0.002824450 
GO:0007283 spermatogenesis 40.0 0.003749870 
GO:0006754 ATP biosynthetic process 21.4 0.004495090 
GO:0007018 microtubule-based movement 17.5 0.005131700 
GO:0006950 response to stress 15.1 0.005428150 
GO:0006606 protein import into nucleus 50.0 0.010171600 
GO:0048919 posterior lateral line neuromast development 50.0 0.010171600 
GO:0006310 DNA recombination 21.7 0.012009700 
GO:0045905 positive regulation of translational termination 100 0.014582400 
GO:0006452 translational frameshifting 100 0.014582400 
GO:0045901 positive regulation of translational elongation 100 0.014582400 
GO:0031497 chromatin assembly 100 0.014582400 
GO:0045454 cell redox homeostasis 15.8 0.019176700 
GO:0042254 ribosome biogenesis 18.5 0.022365600 
GO:0007398 ectoderm development 37.5 0.022376800 
GO:0006417 regulation of translation 23.5 0.024250000 
GO:0016337 cell-cell adhesion 23.5 0.024250000 
GO:0006281 DNA repair 11.4 0.025866300 
GO:0006139 nucleobase-containing compound metabolic 
process 
17.2 0.028026800 
GO:0007507 heart development 10.2 0.029364500 
GO:0016338 calcium-independent cell-cell adhesion 66.7 0.031176900 
GO:0000028 ribosomal small subunit assembly 66.7 0.031176900 
GO:0000084 S phase of mitotic cell cycle 66.7 0.031176900 
GO:0090244 Wnt receptor signaling pathway involved in 66.7 0.031176900 
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ID Term % p-value 
somitogenesis 
GO:0006368 transcription elongation from RNA polymerase II 
promoter 
66.7 0.031176900 
GO:0051225 spindle assembly 66.7 0.031176900 
GO:0006913 nucleocytoplasmic transport 66.7 0.031176900 
GO:0000184 nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
30.0 0.034396800 
GO:0006164 purine nucleotide biosynthetic process 30.0 0.034396800 
GO:0007010 cytoskeleton organization 21.1 0.034574600 
GO:0006974 response to DNA damage stimulus 12.8 0.041096800 
GO:0007126 meiosis 27.3 0.044667200 
GO:0006464 protein modification process 14.7 0.044738600 
GO:0031017 exocrine pancreas development 18.2 0.048226700 
GO:0031047 gene silencing by RNA 25.0 0.048798300 
GO:0051056 regulation of small GTPase mediated signal 
transduction 
25.0 0.048798300 
GO:0001570 vasculogenesis 14.3 0.049249800 
GO:0008612 peptidyl-lysine modification to hypusine 50.0 0.049282000 
GO:0055001 muscle cell development 50.0 0.049282000 
GO:0040023 establishment of nucleus localization 50.0 0.049282000 
GO:0000278 mitotic cell cycle 50.0 0.049282000 
GO:0006177 GMP biosynthetic process 50.0 0.049282000 
GO:0010172 embryonic body morphogenesis 50.0 0.049282000 
GO:0008156 negative regulation of DNA replication 50.0 0.049282000 
Table S38: GO Term Biological Process Analysis 
GO term biological process analysis of ensembl gene IDs with the highest average 
expression determined by the small RNA fraction sequencing of replicates and 
mapping with Cufflinks.  gives the number of times a term was associated within the 
reference list (of 1000 Ensembl IDs) as a percentage of the number of genes associated 
with that term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, 
Nogales-Cadenas et al. 2012). 
 
 
ID Term % p-value 
GO:0005840 ribosome 33.9 1.02E-28 
GO:0005634 nucleus 9.5 7.20E-28 
GO:0030529 ribonucleoprotein complex 31.0 9.10E-23 
GO:0005737 cytoplasm 11.1 4.48E-22 
GO:0005622 intracellular 9.2 2.04E-15 
GO:0005694 chromosome 22.2 3.73E-08 
GO:0005874 microtubule 18.5 2.65E-05 
GO:0000793 condensed chromosome 100 2.67E-05 
GO:0015935 small ribosomal subunit 55.6 7.77E-05 
GO:0015934 large ribosomal subunit 66.7 0.000265965 
GO:0000786 nucleosome 22.6 0.000808050 
GO:0005783 endoplasmic reticulum 10.0 0.001197200 
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ID Term % p-value 
GO:0022627 cytosolic small ribosomal subunit 40.0 0.002573130 
GO:0005913 cell-cell adherens junction 60.0 0.003571450 
GO:0005643 nuclear pore 36.4 0.003655680 
GO:0005856 cytoskeleton 9.2 0.005577420 
GO:0033186 CAF-1 complex 100 0.007704570 
GO:0045495 pole plasm 100 0.007704570 
GO:0000796 condensin complex 100 0.007704570 
GO:0030686 90S preribosome 100 0.007704570 
GO:0005819 spindle 28.6 0.007961870 
GO:0030117 membrane coat 28.6 0.007961870 
GO:0005938 cell cortex 23.5 0.013680400 
GO:0030126 COPI vesicle coat 66.7 0.018416100 
GO:0030130 clathrin coat of trans-Golgi network vesicle 66.7 0.018416100 
GO:0005902 microvillus 66.7 0.018416100 
GO:0045261 proton-transporting ATP synthase complex, 
catalytic core F(1) 
66.7 0.018416100 
GO:0005815 microtubule organizing center 20.0 0.021130500 
GO:0005730 nucleolus 11.3 0.023473900 
GO:0005852 eukaryotic translation initiation factor 3 complex 25.0 0.029097900 
GO:0005853 eukaryotic translation elongation factor 1 complex 50.0 0.029469400 
GO:0030057 desmosome 50.0 0.029469400 
GO:0034747 Axin-APC-beta-catenin-GSK3B complex 50.0 0.029469400 
GO:0008023 transcription elongation factor complex 50.0 0.029469400 
GO:0016342 catenin complex 40.0 0.041713300 
GO:0030132 clathrin coat of coated pit 40.0 0.041713300 
GO:0016585 chromatin remodeling complex 40.0 0.041713300 
GO:0030127 COPII vesicle coat 40.0 0.041713300 
Table S39: GO Term Cellular Component Analysis 
GO term cellular component analysis of ensembl gene IDs with the highest average 
expression determined by the small RNA fraction sequencing of replicates and 
mapping with Cufflinks. % gives the number of times a term was associated within the 
reference list (of 1000 Ensembl IDs) as a percentage of the number of genes associated 
with that term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, 
Nogales-Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0000166 nucleotide binding 10.7 4.77E-32 
GO:0003735 structural constituent of ribosome 37.7 1.74E-29 
GO:0005524 ATP binding 11.3 1.66E-24 
GO:0003676 nucleic acid binding 12.1 9.30E-23 
GO:0003723 RNA binding 20.6 1.29E-22 
GO:0005488 binding 12.1 2.75E-16 
GO:0003677 DNA binding 8.3 7.48E-12 
GO:0004386 helicase activity 28.8 1.01E-11 
GO:0051082 unfolded protein binding 26.2 3.21E-09 
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ID Term % p-value 
GO:0008565 protein transporter activity 35.7 3.47E-07 
GO:0008026 ATP-dependent helicase activity 26.7 4.71E-07 
GO:0016787 hydrolase activity 7.6 2.61E-06 
GO:0003743 translation initiation factor activity 22.4 1.06E-05 
GO:0003746 translation elongation factor activity 36.8 3.20E-05 
GO:0016853 isomerase activity 17.5 0.000317061 
GO:0005198 structural molecule activity 11.5 0.000494627 
GO:0019901 protein kinase binding 25.0 0.000506634 
GO:0008168 methyltransferase activity 12.1 0.000910655 
GO:0015035 protein disulfide oxidoreductase activity 27.3 0.000948243 
GO:0008270 zinc ion binding 5.6 0.001415590 
GO:0019843 rRNA binding 36.4 0.004523800 
GO:0003682 chromatin binding 19.4 0.006256320 
GO:0016740 transferase activity 5.7 0.013134000 
GO:0018024 histone-lysine N-methyltransferase activity 20.0 0.014631900 
GO:0015662 ATPase activity, coupled to transmembrane 
movement of ions, phosphorylative mechanism 
19.2 0.016918600 
GO:0003725 double-stranded RNA binding 25.0 0.017639900 
GO:0004674 protein serine/threonine kinase activity 7.2 0.021111200 
GO:0017111 nucleoside-triphosphatase activity 10.3 0.023954600 
GO:0046872 metal ion binding 5.1 0.024482600 
GO:0016820 hydrolase activity, acting on acid anhydrides, 
catalyzing transmembrane movement of 
substances 
16.7 0.027364500 
GO:0005096 GTPase activator activity 16.1 0.028010000 
GO:0003824 catalytic activity 5.8 0.028029500 
GO:0004579 dolichyl-diphosphooligosaccharide-protein 
glycotransferase activity 
66.7 0.028842800 
GO:0043022 ribosome binding 66.7 0.028842800 
GO:0016818 hydrolase activity, acting on acid anhydrides, in 
phosphorus-containing anhydrides 
27.3 0.040342500 
GO:0019904 protein domain specific binding 18.2 0.043691800 
GO:0008094 DNA-dependent ATPase activity 25.0 0.044790300 
GO:0005388 calcium-transporting ATPase activity 25.0 0.044790300 
GO:0005529 sugar binding 9.6 0.046757600 
GO:0008641 small protein activating enzyme activity 50.0 0.047503900 
GO:0003918 DNA topoisomerase (ATP-hydrolyzing) activity 50.0 0.047503900 
GO:0003777 microtubule motor activity 16.7 0.049266400 
GO:0016788 hydrolase activity, acting on ester bonds 16.7 0.049266400 
GO:0009055 electron carrier activity 8.3 0.049360100 
Table S40: GO Term Molecular Function Analysis 
GO term molecular function analysis of Ensembl gene IDs with the highest average 
expression determined by the small RNA fraction sequencing of replicates and 
mapping with Cufflinks. % gives the number of times a term was associated within the 
reference list (of 1000 Ensembl IDs) as a percentage of the number of genes associated 
with that term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, 
Nogales-Cadenas et al. 2012). 
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ID Support % p-value 
dre-miR-184 35 13.6 3.97E-10 
dre-miR-146b 33 12.6 7.16E-09 
dre-miR-204 30 13.3 7.17E-09 
dre-miR-31 30 13.4 7.65E-09 
dre-miR-15a* 26 14.1 2.05E-08 
dre-miR-220 32 11.9 2.42E-08 
dre-miR-723 30 12.1 3.98E-08 
dre-miR-18a 27 13.0 4.91E-08 
dre-miR-216b 32 10.9 1.14E-07 
dre-miR-457a 26 12.4 1.93E-07 
dre-miR-202 27 11.6 4.22E-07 
dre-miR-17a 28 11.1 5.33E-07 
dre-miR-18b 26 11.5 6.29E-07 
dre-miR-15b 28 10.9 6.51E-07 
dre-miR-132* 22 13.1 6.54E-07 
dre-miR-15a 27 11.2 6.76E-07 
dre-miR-735 25 11.9 6.91E-07 
dre-miR-212 28 10.7 7.15E-07 
dre-miR-738 25 11.7 7.26E-07 
dre-miR-19b 26 11.3 7.63E-07 
dre-miR-7a 24 11.7 1.09E-06 
dre-miR-181a 26 10.9 1.26E-06 
dre-miR-141 26 10.8 1.43E-06 
dre-miR-101a 27 10.4 1.88E-06 
dre-miR-182 25 10.5 4.40E-06 
dre-miR-451 22 11.3 4.77E-06 
dre-miR-103 24 10.7 4.80E-06 
dre-miR-365 23 11.0 4.91E-06 
dre-miR-16c 23 10.8 6.15E-06 
dre-miR-430b 23 10.7 6.46E-06 
dre-miR-19d 23 10.6 8.11E-06 
dre-miR-457b 22 10.9 8.31E-06 
dre-miR-206 22 10.9 8.31E-06 
dre-miR-20a 24 10.2 9.01E-06 
dre-miR-430c 23 10.4 9.69E-06 
dre-miR-19a 23 10.4 1.02E-05 
dre-miR-460-3p 26 9.5 1.06E-05 
dre-miR-217 22 10.5 1.34E-05 
dre-miR-130c 23 10.1 1.48E-05 
dre-miR-16a 22 10.4 1.49E-05 
dre-miR-150 21 10.7 1.51E-05 
dre-miR-130b 25 9.5 1.52E-05 
dre-miR-26a 23 10.0 1.52E-05 
dre-miR-200c 26 9.2 1.63E-05 
dre-miR-133a 22 10.2 1.80E-05 
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dre-miR-27c* 21 10.3 2.28E-05 
dre-let-7f 25 9.2 2.31E-05 
dre-miR-214 20 10.6 2.59E-05 
dre-miR-24 21 10.2 2.69E-05 
dre-miR-20b 23 9.5 2.94E-05 
dre-miR-101b 24 9.3 3.03E-05 
dre-miR-130a 23 9.5 3.24E-05 
dre-miR-726 20 10.1 4.71E-05 
dre-miR-26b 21 9.8 4.73E-05 
dre-miR-727* 19 10.3 5.45E-05 
dre-miR-1 22 9.4 5.59E-05 
dre-miR-22b 23 9.0 6.47E-05 
dre-miR-200a 25 8.6 6.80E-05 
dre-miR-194b 22 9.2 6.90E-05 
dre-miR-107 21 9.5 6.93E-05 
dre-miR-489 22 9.1 7.60E-05 
dre-miR-23b 21 9.3 8.49E-05 
dre-miR-7b 21 9.3 8.49E-05 
dre-miR-34c 23 8.8 8.62E-05 
dre-miR-100 19 9.8 8.91E-05 
dre-miR-499 19 9.8 8.91E-05 
dre-miR-132 23 8.7 9.41E-05 
dre-miR-459 20 9.5 9.44E-05 
dre-miR-133c 20 9.3 0.00011216200 
dre-miR-18c 19 9.6 0.00011970500 
dre-miR-15c 23 8.6 0.00012086700 
dre-miR-301a 22 8.7 0.00013510800 
dre-miR-301c 21 8.9 0.00014097200 
dre-miR-181b 22 8.6 0.00015687600 
dre-miR-19c 20 9.0 0.00016268900 
dre-miR-93 20 9.0 0.00017974300 
dre-miR-138 18 9.6 0.00017979000 
dre-miR-740 16 10.3 0.00019487600 
dre-miR-129 18 9.5 0.00019846300 
dre-let-7c 23 8.2 0.00019864000 
dre-miR-125a 22 8.4 0.00020213000 
dre-miR-200b 23 8.2 0.00020456200 
dre-miR-133b 19 9.1 0.00020524500 
dre-miR-126 19 9.1 0.00020524500 
dre-miR-430j 19 9.1 0.00020524500 
dre-let-7g 21 8.5 0.00021499700 
dre-miR-19b* 16 10.1 0.00021690100 
dre-let-7h 23 8.1 0.00021711900 
dre-let-7b 22 8.3 0.00021744400 
dre-miR-30a 20 8.7 0.00022211900 
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dre-miR-23a 20 8.6 0.00026253600 
dre-miR-375 18 9.1 0.00028918900 
dre-miR-216a 23 7.9 0.00030455100 
dre-miR-194a 19 8.6 0.00035730900 
dre-miR-92a 20 8.4 0.00035912200 
dre-miR-135c 18 8.9 0.00036041900 
dre-miR-187 18 8.8 0.00042437000 
dre-miR-125c 20 8.2 0.00045467800 
dre-miR-430i 19 8.3 0.00054838900 
dre-miR-460-5p 19 8.3 0.00060650900 
dre-miR-430a 18 8.5 0.00061643300 
dre-let-7i 21 7.8 0.00065758000 
dre-miR-219 19 8.2 0.00066325500 
dre-miR-99 18 8.4 0.00067112100 
dre-miR-301b 19 8.2 0.00068008900 
dre-miR-739 17 8.6 0.00075246300 
dre-miR-737 18 8.3 0.00077182400 
dre-miR-732 18 8.2 0.00085368200 
dre-miR-139 17 8.5 0.00087081200 
dre-miR-455 18 8.2 0.00087708700 
dre-miR-29a 20 7.8 0.00088343000 
dre-miR-183 18 8.1 0.00090941100 
dre-let-7e 20 7.7 0.00091151600 
dre-miR-124 20 7.6 0.00108737000 
dre-miR-16b 17 8.2 0.00121949000 
dre-miR-10a* 16 8.4 0.00123802000 
dre-miR-143 16 8.4 0.00123802000 
dre-miR-142b-5p 17 8.1 0.00125448000 
dre-miR-181c 19 7.7 0.00128211000 
dre-miR-146a 19 7.7 0.00128211000 
dre-miR-210* 15 8.7 0.00128938000 
dre-miR-203a 15 8.6 0.00132472000 
dre-miR-730 16 8.3 0.00132946000 
dre-miR-459* 14 9.0 0.00133339000 
dre-miR-27c 17 8.1 0.00133920000 
dre-miR-125b 19 7.6 0.00134481000 
dre-miR-202* 15 8.6 0.00138315000 
dre-let-7j 21 7.2 0.00147102000 
dre-miR-733 15 8.5 0.00152994000 
dre-miR-22a 19 7.5 0.00164993000 
dre-miR-736 15 8.4 0.00168924000 
dre-let-7a 20 7.2 0.00169429000 
dre-miR-27d 17 7.8 0.00170289000 
dre-miR-21 16 7.9 0.00218331000 
dre-miR-18b* 14 8.4 0.00236948000 
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dre-miR-724 13 8.6 0.00269759000 
dre-miR-196b 16 7.7 0.00274541000 
dre-miR-222 18 7.3 0.00279158000 
dre-miR-27a 17 7.4 0.00289109000 
dre-miR-221 17 7.3 0.00326955000 
dre-miR-454a 18 7.1 0.00327870000 
dre-miR-196a 17 7.3 0.00355178000 
dre-miR-193a 17 7.2 0.00368720000 
dre-miR-223 16 7.4 0.00382608000 
dre-miR-144 15 7.6 0.00412065000 
dre-miR-731 15 7.5 0.00429342000 
dre-miR-29b 18 6.9 0.00434119000 
dre-miR-133a* 14 7.8 0.00436701000 
dre-miR-148 17 7.1 0.00458909000 
dre-miR-462 14 7.6 0.00518302000 
dre-miR-10d* 14 7.6 0.00518302000 
dre-miR-429 17 6.9 0.00531659000 
dre-miR-722 14 7.5 0.00590758000 
dre-miR-140* 15 7.2 0.00639403000 
dre-miR-27b 15 7.2 0.00639403000 
dre-miR-205 15 7.1 0.00719051000 
dre-miR-192 15 7.1 0.00719051000 
dre-miR-203b* 12 7.8 0.00732503000 
dre-let-7d 18 6.5 0.00751146000 
dre-miR-34b 17 6.6 0.00780682000 
dre-miR-34 17 6.6 0.00805816000 
dre-miR-135a 15 6.9 0.00824947000 
dre-miR-727 14 7.1 0.00872482000 
dre-miR-728 12 7.6 0.00906962000 
dre-miR-92b 15 6.8 0.00915965000 
dre-miR-27e 14 7.0 0.00933630000 
dre-miR-193b 16 6.6 0.00943764000 
dre-miR-9 13 7.2 0.00976923000 
dre-miR-153a 15 6.7 0.01090670000 
dre-miR-181a* 15 6.7 0.01127100000 
dre-miR-140 14 6.8 0.01259930000 
dre-miR-25 15 6.6 0.01296850000 
dre-miR-96 16 6.3 0.01363240000 
dre-miR-129* 12 7.0 0.01549870000 
dre-miR-135b 13 6.5 0.02203400000 
dre-miR-142a-5p 13 6.4 0.02260020000 
dre-miR-338 13 6.4 0.02260020000 
dre-miR-137 15 6.1 0.02271880000 
dre-miR-456 13 6.4 0.02402770000 
dre-miR-10d 15 6.0 0.02555660000 
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dre-miR-142a-3p 14 6.1 0.02558840000 
dre-miR-9* 12 6.5 0.02691940000 
dre-miR-461 12 6.4 0.02777530000 
dre-miR-122 14 6.0 0.02963570000 
dre-miR-153c 13 6.1 0.03067900000 
dre-miR-203b 12 6.2 0.03382740000 
dre-miR-723* 10 6.7 0.03385430000 
dre-miR-30d 13 6.0 0.03443090000 
dre-miR-199 14 5.8 0.03807910000 
dre-miR-725 12 6.1 0.03920080000 
dre-miR-363 14 5.6 0.04742910000 
dre-miR-10c 14 5.6 0.04850840000 
Table S41: MicroRNA Association Analysis  
 
MicroRNA association analysis of Ensembl gene IDs with the highest average 
expression determined by the small RNA fraction sequencing of replicates and 
mapping with Cufflinks. Support indicates the number of times a term was associated 
within the reference list (of 1000 Ensembl gene IDs) and  gives this as a percentage of 
the number of genes associated with that term. Corrected p-values were calculated 
using GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
S4.3 GO Term Analysis – Individual Replicates 
S4.3.1 WT1 
 
ID Term % p-value 
Kegg:03010 Ribosome 57.8% 8.08E-49 
Kegg:03013 RNA transport 24.2% 1.07E-17 
Kegg:04141 Protein processing in endoplasmic reticulum 20.7% 3.02E-15 
Kegg:04110 Cell cycle 20.8% 6.93E-13 
Kegg:03040 Spliceosome 17.6% 1.76E-09 
Kegg:03018 RNA degradation 23.5% 2.90E-09 
Kegg:04114 Oocyte meiosis 17.1% 1.68E-08 
Kegg:03030 DNA replication 31.4% 5.51E-08 
Kegg:03015 mRNA surveillance pathway 18.8% 1.67E-06 
Kegg:04145 Phagosome 14.7% 2.18E-06 
Kegg:03008 Ribosome biogenesis in eukaryotes 16.9% 3.71E-05 
Kegg:03430 Mismatch repair 27.3% 0.000324306 
Kegg:04914 Progesterone-mediated oocyte maturation 12.6% 0.000532302 
Kegg:04120 Ubiquitin mediated proteolysis 10.6% 0.00129573 
Kegg:03060 Protein export 23.8% 0.00234664 
Kegg:03420 Nucleotide excision repair 15.0% 0.007821 
Kegg:04520 Adherens junction 10.5% 0.0129858 
Kegg:00010 Glycolysis / Gluconeogenesis 11.3% 0.015271 
Kegg:00270 Cysteine and methionine metabolism 13.5% 0.026478 
Kegg:04530 Tight junction 7.6% 0.0350718 
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Table S42: KEGG Pathway Analysis  
KEGG pathway analysis of the Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT1 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term. Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 30.3% 9.52E-29 
GO:0051726 regulation of cell cycle 43.3% 4.02E-10 
GO:0006886 intracellular protein transport 20.7% 7.55E-08 
GO:0007049 cell cycle 17.6% 1.04E-07 
GO:0006457 protein folding 19.1% 1.73E-07 
GO:0006260 DNA replication 26.0% 2.25E-07 
GO:0051301 cell division 20.3% 4.79E-07 
GO:0030261 chromosome condensation 75.0% 1.51E-06 
GO:0044267 cellular protein metabolic process 53.8% 2.25E-06 
GO:0006414 translational elongation 34.6% 2.51E-06 
GO:0009790 embryo development 14.6% 2.99E-05 
GO:0007067 mitosis 22.2% 3.91E-05 
GO:0006334 nucleosome assembly 25.0% 4.41E-05 
GO:0006413 translational initiation 20.4% 7.72E-05 
GO:0006396 RNA processing 22.5% 9.94E-05 
GO:0006270 DNA-dependent DNA replication initiation 55.6% 0.000105751 
GO:0051276 chromosome organization 80.0% 0.000132037 
GO:0015031 protein transport 11.3% 0.000138333 
GO:0048565 digestive tract development 33.3% 0.00032332 
GO:0000070 mitotic sister chromatid segregation 100% 0.000758759 
GO:0006368 transcription elongation from RNA polymerase II 
promoter 
100% 0.000758759 
GO:0031101 fin regeneration 22.6% 0.000830675 
GO:0006355 regulation of transcription, DNA-dependent 5.6% 0.000844469 
GO:0006096 glycolysis 21.9% 0.000915772 
GO:0016070 RNA metabolic process 35.7% 0.000945946 
GO:0006662 glycerol ether metabolic process 35.7% 0.000945946 
GO:0006310 DNA recombination 26.1% 0.00108491 
GO:0006397 mRNA processing 14.1% 0.00118037 
GO:0000079 regulation of cyclin-dependent protein kinase 
activity 
33.3% 0.0011923 
GO:0060218 hemopoietic stem cell differentiation 44.4% 0.00180874 
GO:0007062 sister chromatid cohesion 75.0% 0.00194606 
GO:0071599 otic vesicle development 75.0% 0.00194606 
GO:0007283 spermatogenesis 40.0% 0.00267388 
GO:0001764 neuron migration 27.8% 0.00268746 
GO:0006754 ATP biosynthetic process 21.4% 0.00274001 
GO:0007018 microtubule-based movement 17.5% 0.00295954 
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GO:0006950 response to stress 15.1% 0.0029701 
GO:0032259 methylation 11.5% 0.00485184 
GO:0006606 protein import into nucleus 50.0% 0.00743211 
GO:0048919 posterior lateral line neuromast development 50.0% 0.00743211 
GO:0006351 transcription, DNA-dependent 5.8% 0.00908524 
GO:0045905 positive regulation of translational termination 100% 0.0113167 
GO:0006452 translational frameshifting 100% 0.0113167 
GO:0045901 positive regulation of translational elongation 100% 0.0113167 
GO:0048262 determination of dorsal/ventral asymmetry 100% 0.0113167 
GO:0031497 chromatin assembly 100% 0.0113167 
GO:0045454 cell redox homeostasis 15.8% 0.01152 
GO:0042254 ribosome biogenesis 18.5% 0.0142675 
GO:0006281 DNA repair 11.4% 0.0151251 
GO:0006417 regulation of translation 23.5% 0.015894 
GO:0016337 cell-cell adhesion 23.5% 0.015894 
GO:0007398 ectoderm development 37.5% 0.0158971 
GO:0007507 heart development 10.2% 0.0164803 
GO:0006139 nucleobase-containing compound metabolic 
process 
17.2% 0.0177348 
GO:0007010 cytoskeleton organization 21.1% 0.0237559 
GO:0016338 calcium-independent cell-cell adhesion 66.7% 0.0254973 
GO:0000028 ribosomal small subunit assembly 66.7% 0.0254973 
GO:0000084 S phase of mitotic cell cycle 66.7% 0.0254973 
GO:0090244 Wnt receptor signaling pathway involved in 
somitogenesis 
66.7% 0.0254973 
GO:0051225 spindle assembly 66.7% 0.0254973 
GO:0000184 nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
30.0% 0.026667 
GO:0006974 response to DNA damage stimulus 12.8% 0.0269001 
GO:0007126 meiosis 27.3% 0.0346978 
GO:0031017 exocrine pancreas development 18.2% 0.0358181 
GO:0008612 peptidyl-lysine modification to hypusine 50.0% 0.0434406 
GO:0055001 muscle cell development 50.0% 0.0434406 
GO:0040023 establishment of nucleus localization 50.0% 0.0434406 
GO:0008156 negative regulation of DNA replication 50.0% 0.0434406 
GO:0031047 gene silencing by RNA 25.0% 0.0438248 
Table S43: GO Term Biological Process Analysis 
 
GO term biological process analysis of ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT1 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
 
S4.3 Small RNA – WT1 GO term analysis 
 ! !
221 
!
! !
ID Term % p-value 
GO:0005840 ribosome 34.7% 2.03E-31 
GO:0005634 nucleus 9.0% 2.72E-27 
GO:0030529 ribonucleoprotein complex 31.0% 5.66E-24 
GO:0005737 cytoplasm 10.7% 9.53E-23 
GO:0005622 intracellular 8.8% 1.81E-15 
GO:0005694 chromosome 19.4% 8.21E-07 
GO:0005874 microtubule 18.5% 1.21E-05 
GO:0015935 small ribosomal subunit 55.6% 5.54E-05 
GO:0022627 cytosolic small ribosomal subunit 50.0% 9.59E-05 
GO:0005783 endoplasmic reticulum 10.6% 0.000134502 
GO:0030126 COPI vesicle coat 100% 0.000379131 
GO:0030117 membrane coat 35.7% 0.000515802 
GO:0000793 condensed chromosome 75.0% 0.00125378 
GO:0005913 cell-cell adherens junction 60.0% 0.00284392 
GO:0000786 nucleosome 19.4% 0.00302372 
GO:0015934 large ribosomal subunit 50.0% 0.00486307 
GO:0033186 CAF-1 complex 100% 0.00619317 
GO:0045495 pole plasm 100% 0.00619317 
GO:0000796 condensin complex 100% 0.00619317 
GO:0030686 90S preribosome 100% 0.00619317 
GO:0005856 cytoskeleton 8.6% 0.00726573 
GO:0071339 MLL1 complex 42.9% 0.00739209 
GO:0005938 cell cortex 23.5% 0.00958606 
GO:0030130 clathrin coat of trans-Golgi network vesicle 66.7% 0.0154003 
GO:0005902 microvillus 66.7% 0.0154003 
GO:0045261 proton-transporting ATP synthase complex, 
catalytic core F(1) 
66.7% 0.0154003 
GO:0005815 microtubule organizing center 20.0% 0.0154514 
GO:0005853 eukaryotic translation elongation factor 1 complex 50.0% 0.0245162 
GO:0030057 desmosome 50.0% 0.0245162 
GO:0034747 Axin-APC-beta-catenin-GSK3B complex 50.0% 0.0245162 
GO:0008023 transcription elongation factor complex 50.0% 0.0245162 
GO:0005852 eukaryotic translation initiation factor 3 complex 25.0% 0.0266277 
GO:0016342 catenin complex 40.0% 0.0346212 
GO:0030132 clathrin coat of coated pit 40.0% 0.0346212 
GO:0016585 chromatin remodeling complex 40.0% 0.0346212 
GO:0030127 COPII vesicle coat 40.0% 0.0346212 
GO:0005819 spindle 21.4% 0.0357116 
GO:0005788 endoplasmic reticulum lumen 33.3% 0.0495414 
Table S44: GO Term Cellular Component Analysis 
 
GO term cellular component analysis of Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT1 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
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term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0003735 structural constituent of ribosome 38.7% 6.77E-32 
GO:0000166 nucleotide binding 10.1% 2.25E-31 
GO:0003676 nucleic acid binding 11.8% 9.83E-24 
GO:0005524 ATP binding 10.6% 1.08E-23 
GO:0003723 RNA binding 20.2% 3.03E-23 
GO:0005488 binding 11.3% 2.06E-15 
GO:0004386 helicase activity 28.8% 2.57E-12 
GO:0003677 DNA binding 7.9% 6.73E-12 
GO:0051082 unfolded protein binding 23.0% 1.06E-07 
GO:0008565 protein transporter activity 35.7% 1.52E-07 
GO:0008026 ATP-dependent helicase activity 24.4% 2.06E-06 
GO:0003746 translation elongation factor activity 36.8% 2.07E-05 
GO:0003743 translation initiation factor activity 20.4% 4.08E-05 
GO:0016787 hydrolase activity 6.5% 0.00011749 
GO:0016853 isomerase activity 17.5% 0.000148971 
GO:0019843 rRNA binding 45.5% 0.000180848 
GO:0019901 protein kinase binding 25.0% 0.00026922 
GO:0008270 zinc ion binding 5.5% 0.000296114 
GO:0015035 protein disulfide oxidoreductase activity 27.3% 0.000574354 
GO:0005198 structural molecule activity 10.8% 0.000653777 
GO:0008168 methyltransferase activity 11.2% 0.00143623 
GO:0003682 chromatin binding 19.4% 0.00386733 
GO:0017111 nucleoside-triphosphatase activity 11.5% 0.0039357 
GO:0070577 histone acetyl-lysine binding 100% 0.0102234 
GO:0016740 transferase activity 5.4% 0.0103563 
GO:0003725 double-stranded RNA binding 25.0% 0.0124652 
GO:0016779 nucleotidyltransferase activity 15.0% 0.0129962 
GO:0043022 ribosome binding 66.7% 0.0268254 
GO:0016818 hydrolase activity, acting on acid anhydrides, in 
phosphorus-containing anhydrides 
27.3% 0.0370087 
GO:0003777 microtubule motor activity 16.7% 0.0445009 
GO:0016788 hydrolase activity, acting on ester bonds 16.7% 0.0445009 
GO:0008641 small protein activating enzyme activity 50.0% 0.0445954 
GO:0003918 DNA topoisomerase (ATP-hydrolyzing) activity 50.0% 0.0445954 
GO:0008094 DNA-dependent ATPase activity 25.0% 0.045116 
GO:0005388 calcium-transporting ATPase activity 25.0% 0.045116 
GO:0003779 actin binding 9.0% 0.0455604 
GO:0018024 histone-lysine N-methyltransferase activity 16.0% 0.0489152 
Table S45: GO Term Molecular Function Analysis 
 
GO term molecular function analysis of Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT1 and mapping with 
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Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
Term Support  % p-value 
dre-miR-220 32 11.9% 1.55E-08 
dre-miR-204 27 11.9% 2.14E-07 
dre-miR-146b 29 11.1% 2.16E-07 
dre-miR-31 26 11.6% 3.91E-07 
dre-miR-723 27 10.9% 6.42E-07 
dre-miR-184 27 10.5% 9.75E-07 
dre-miR-216b 29 9.9% 1.00E-06 
dre-miR-18a 24 11.5% 1.10E-06 
dre-miR-15a* 22 12.0% 1.44E-06 
dre-miR-17a 26 10.3% 1.76E-06 
dre-miR-182 25 10.5% 2.17E-06 
dre-miR-451 22 11.3% 2.38E-06 
dre-miR-103 24 10.7% 2.46E-06 
dre-miR-101a 26 10.0% 2.52E-06 
dre-miR-202 24 10.3% 3.78E-06 
dre-miR-7a 22 10.7% 5.47E-06 
dre-miR-15b 25 9.7% 5.62E-06 
dre-miR-15a 24 10.0% 5.86E-06 
dre-miR-499 21 10.9% 6.69E-06 
dre-miR-18b 23 10.1% 6.70E-06 
dre-miR-738 22 10.3% 8.70E-06 
dre-miR-141 23 9.6% 1.61E-05 
dre-miR-101b 24 9.3% 1.67E-05 
dre-miR-130a 23 9.5% 1.82E-05 
dre-miR-365 21 10.0% 1.87E-05 
dre-miR-130b 24 9.1% 1.93E-05 
dre-miR-130c 22 9.6% 1.96E-05 
dre-miR-430b 21 9.8% 2.43E-05 
dre-miR-460-3p 24 8.8% 3.10E-05 
dre-miR-132* 18 10.7% 3.11E-05 
dre-miR-727* 19 10.3% 3.14E-05 
dre-miR-20a 22 9.3% 3.20E-05 
dre-miR-27c* 20 9.9% 3.31E-05 
dre-miR-430c 21 9.5% 3.32E-05 
dre-miR-457a 20 9.6% 4.70E-05 
dre-miR-430j 20 9.6% 4.70E-05 
dre-miR-735 20 9.5% 4.92E-05 
dre-miR-459 20 9.5% 5.14E-05 
dre-miR-19b 21 9.1% 5.75E-05 
dre-miR-150 19 9.6% 6.34E-05 
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dre-miR-133a 20 9.3% 6.74E-05 
dre-miR-22b 22 8.6% 7.59E-05 
dre-miR-181a 21 8.8% 8.21E-05 
dre-miR-457b 19 9.4% 8.22E-05 
dre-miR-107 20 9.0% 9.17E-05 
dre-miR-212 22 8.4% 9.94E-05 
dre-miR-24 19 9.2% 0.000101415 
dre-miR-133b 19 9.1% 0.000118988 
dre-miR-740 16 10.3% 0.000119441 
dre-miR-26a 20 8.7% 0.000129102 
dre-miR-16a 19 9.0% 0.000139244 
dre-miR-16c 19 8.9% 0.000145711 
dre-miR-133c 19 8.9% 0.000152465 
dre-miR-736 17 9.5% 0.000159425 
dre-miR-26b 19 8.8% 0.000159517 
dre-miR-19d 19 8.7% 0.000185833 
dre-miR-194b 20 8.4% 0.000207368 
dre-miR-206 18 8.9% 0.000210854 
dre-miR-20b 20 8.3% 0.000225056 
dre-miR-34c 21 8.0% 0.000229092 
dre-miR-93 19 8.5% 0.000231791 
dre-miR-200c 22 7.8% 0.000237222 
dre-miR-7b 19 8.4% 0.000268405 
dre-miR-214 17 9.0% 0.000271051 
dre-miR-430i 19 8.3% 0.000288082 
dre-miR-126 18 8.6% 0.000292268 
dre-miR-15c 21 7.8% 0.0003153 
dre-miR-202* 16 9.1% 0.000333149 
dre-let-7f 21 7.7% 0.000334956 
dre-miR-430a 18 8.5% 0.000335137 
dre-miR-23a 19 8.2% 0.000336993 
dre-miR-99 18 8.4% 0.000356574 
dre-miR-733 16 9.0% 0.000359819 
dre-miR-18c 17 8.6% 0.000403484 
dre-miR-375 17 8.6% 0.000403484 
dre-miR-739 17 8.6% 0.000403484 
dre-miR-732 18 8.2% 0.00044584 
dre-miR-194a 18 8.2% 0.000465886 
dre-miR-183 18 8.1% 0.000486719 
dre-miR-19a 18 8.1% 0.000508365 
dre-miR-125a 20 7.6% 0.000510844 
dre-miR-125c 19 7.8% 0.000532404 
dre-miR-23b 18 8.0% 0.000610856 
dre-miR-138 16 8.5% 0.000626715 
dre-miR-129 16 8.4% 0.000698197 
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dre-miR-217 17 8.1% 0.00071059 
dre-let-7i 20 7.4% 0.000714592 
dre-miR-27c 17 8.1% 0.000734364 
dre-miR-200a 21 7.2% 0.000742185 
dre-miR-100 16 8.3% 0.000786462 
dre-miR-1 18 7.7% 0.000895299 
dre-miR-301c 18 7.6% 0.000931829 
dre-miR-737 17 7.8% 0.000962675 
dre-miR-27d 17 7.8% 0.000962675 
dre-miR-92a 18 7.6% 0.000987721 
dre-miR-726 16 8.1% 0.000990275 
dre-let-7c 20 7.1% 0.00101193 
dre-miR-489 18 7.5% 0.00112267 
dre-miR-124 19 7.2% 0.00118583 
dre-miR-21 16 7.9% 0.00122453 
dre-miR-132 19 7.2% 0.00122953 
dre-miR-153a 17 7.6% 0.00127428 
dre-let-7g 18 7.3% 0.00135961 
dre-miR-140* 16 7.7% 0.0015982 
dre-miR-27b 16 7.7% 0.0015982 
dre-miR-30a 17 7.4% 0.00160113 
dre-miR-460-5p 17 7.4% 0.00163358 
dre-miR-10a* 15 7.9% 0.00165259 
dre-miR-301a 18 7.1% 0.0017774 
dre-miR-730 15 7.8% 0.00178942 
dre-miR-203b* 13 8.5% 0.0018025 
dre-miR-22a 18 7.1% 0.00189272 
dre-miR-181b 18 7.0% 0.00196147 
dre-miR-223 16 7.4% 0.00210752 
dre-let-7e 18 6.9% 0.00219927 
dre-miR-200b 19 6.8% 0.00222954 
dre-miR-19b* 13 8.2% 0.00241292 
dre-miR-139 15 7.5% 0.00266726 
dre-let-7b 18 6.8% 0.00274644 
dre-miR-135c 15 7.4% 0.00275485 
dre-miR-181a* 16 7.1% 0.00303161 
dre-miR-462 14 7.6% 0.00305458 
dre-miR-187 15 7.3% 0.00310716 
dre-miR-216a 19 6.5% 0.00311946 
dre-let-7j 19 6.5% 0.00321736 
dre-miR-722 14 7.5% 0.00338611 
dre-miR-16b 15 7.2% 0.00338718 
dre-miR-10d 17 6.8% 0.00339315 
dre-miR-125b 17 6.8% 0.00339315 
dre-miR-27a 16 7.0% 0.00340189 
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dre-miR-142b-5p 15 7.2% 0.00352123 
dre-miR-219 16 6.9% 0.00379014 
dre-miR-192 15 7.1% 0.00391964 
dre-miR-153c 15 7.1% 0.00391964 
dre-miR-301b 16 6.9% 0.00392715 
dre-miR-724 12 7.9% 0.00395036 
dre-miR-129* 13 7.6% 0.00397147 
dre-miR-34b 17 6.6% 0.00399941 
dre-miR-210* 13 7.5% 0.00429975 
dre-let-7h 18 6.4% 0.00476071 
dre-miR-148 16 6.6% 0.00517086 
dre-miR-27e 14 7.0% 0.00538238 
dre-miR-19c 15 6.8% 0.0054827 
dre-miR-133a* 13 7.2% 0.00583199 
dre-miR-429 16 6.5% 0.00589925 
dre-miR-222 16 6.5% 0.0065853 
dre-miR-10d* 13 7.1% 0.00687359 
dre-miR-140 14 6.8% 0.00726417 
dre-miR-10c 16 6.4% 0.00728399 
dre-miR-454a 16 6.3% 0.00746236 
dre-miR-196b 14 6.7% 0.00747479 
dre-let-7a 17 6.2% 0.00773868 
dre-miR-221 15 6.5% 0.0079989 
dre-miR-196a 15 6.4% 0.00852836 
dre-miR-143 13 6.8% 0.00855542 
dre-miR-34 16 6.2% 0.00862652 
dre-miR-193a 15 6.4% 0.00874679 
dre-miR-29a 16 6.2% 0.00883019 
dre-miR-29b 16 6.2% 0.0093652 
dre-miR-203b 13 6.7% 0.00941368 
dre-miR-193b 15 6.2% 0.0106584 
dre-miR-199 15 6.2% 0.0109829 
dre-miR-731 13 6.5% 0.0117362 
dre-miR-459* 11 7.1% 0.0118618 
dre-miR-137 15 6.1% 0.0124298 
dre-miR-142a-5p 13 6.4% 0.0129676 
dre-miR-146a 15 6.0% 0.0131649 
dre-miR-96 15 6.0% 0.014993 
dre-miR-9* 12 6.5% 0.0162939 
dre-miR-122 14 6.0% 0.0171004 
dre-miR-18b* 11 6.6% 0.0182948 
dre-miR-199* 12 6.3% 0.0201266 
dre-miR-92b 13 5.9% 0.0230169 
dre-miR-203a 11 6.3% 0.0235594 
dre-miR-727 12 6.1% 0.0235817 
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dre-miR-455 13 5.9% 0.0236651 
dre-miR-153b 13 5.9% 0.0240508 
dre-miR-10b 14 5.7% 0.0241815 
dre-miR-10a 14 5.7% 0.024806 
dre-miR-181c 14 5.6% 0.0262329 
dre-miR-363 14 5.6% 0.0277169 
dre-miR-9 11 6.1% 0.0282809 
dre-let-7d 15 5.4% 0.028807 
dre-miR-142a-3p 13 5.7% 0.0288261 
dre-miR-728 10 6.3% 0.0288374 
dre-miR-25 13 5.7% 0.0295782 
dre-miR-145 11 5.8% 0.0400382 
dre-miR-135a 12 5.6% 0.0410481 
dre-miR-723* 9 6.0% 0.0487551 
dre-miR-725 11 5.6% 0.0490439 
Table S46: MicroRNA Association Analysis  
 
MicroRNA association analysis of Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT1 and mapping with 
Cufflinks. Support indicates the number of times a term was associated within the 
reference list (of 1000 Ensembl gene IDs) and % gives this as a percentage of the 
number of genes associated with that term. Corrected p-values were calculated using 
GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
S4.3.2 WT2 
 
ID Term % p-value 
Kegg:03010 Ribosome 45.8% 2.79E-33 
Kegg:03013 RNA transport 25.8% 9.68E-20 
Kegg:04110 Cell cycle 22.5% 1.21E-14 
Kegg:04141 Protein processing in endoplasmic reticulum 18.6% 1.30E-12 
Kegg:03018 RNA degradation 23.5% 3.80E-09 
Kegg:03015 mRNA surveillance pathway 21.7% 3.84E-08 
Kegg:03030 DNA replication 31.4% 6.88E-08 
Kegg:04114 Oocyte meiosis 16.2% 1.07E-07 
Kegg:03040 Spliceosome 12.6% 4.49E-05 
Kegg:04145 Phagosome 12.8% 6.76E-05 
Kegg:04914 Progesterone-mediated oocyte maturation 13.8% 0.000133736 
Kegg:03008 Ribosome biogenesis in eukaryotes 15.4% 0.000241112 
Kegg:00010 Glycolysis / Gluconeogenesis 14.5% 0.000890581 
Kegg:00310 Lysine degradation 15.2% 0.00332657 
Kegg:03430 Mismatch repair 22.7% 0.0034663 
Kegg:04520 Adherens junction 11.8% 0.00347013 
Kegg:04310 Wnt signaling pathway 7.9% 0.0145612 
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Kegg:04120 Ubiquitin mediated proteolysis 8.8% 0.0149403 
Kegg:04530 Tight junction 8.4% 0.0149592 
Kegg:03060 Protein export 19.0% 0.0183843 
Kegg:00270 Cysteine and methionine metabolism 13.5% 0.0261791 
Kegg:00240 Pyrimidine metabolism 9.1% 0.0271538 
Kegg:03440 Homologous recombination 16.0% 0.0306658 
Kegg:00230 Purine metabolism 7.3% 0.031034 
Kegg:04142 Lysosome 7.9% 0.0362471 
Kegg:00670 One carbon pool by folate 20.0% 0.0404854 
Kegg:00020 Citrate cycle (TCA cycle) 13.8% 0.0445334 
Table S47: KEGG Pathway Analysis  
 
KEGG pathway analysis of the ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT2 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term. Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 26.9% 4.06E-23 
GO:0006260 DNA replication 28.0% 5.66E-08 
GO:0007049 cell cycle 17.6% 1.06E-07 
GO:0051301 cell division 21.6% 1.31E-07 
GO:0051726 regulation of cell cycle 33.3% 1.37E-06 
GO:0044267 cellular protein metabolic process 53.8% 3.45E-06 
GO:0006270 DNA-dependent DNA replication initiation 66.7% 5.15E-06 
GO:0006886 intracellular protein transport 17.1% 1.33E-05 
GO:0006414 translational elongation 30.8% 4.58E-05 
GO:0007067 mitosis 22.2% 4.80E-05 
GO:0030261 chromosome condensation 62.5% 7.18E-05 
GO:0006413 translational initiation 20.4% 9.22E-05 
GO:0032259 methylation 14.9% 0.000107495 
GO:0006457 protein folding 14.6% 0.000129626 
GO:0006096 glycolysis 25.0% 0.000157175 
GO:0048565 digestive tract development 33.3% 0.000392952 
GO:0006754 ATP biosynthetic process 25.0% 0.000561205 
GO:0031101 fin regeneration 22.6% 0.00108632 
GO:0016070 RNA metabolic process 35.7% 0.00121018 
GO:0006662 glycerol ether metabolic process 35.7% 0.00121018 
GO:0000079 regulation of cyclin-dependent protein kinase 
activity 
33.3% 0.00168515 
GO:0006334 nucleosome assembly 19.4% 0.0024689 
GO:0071599 otic vesicle development 75.0% 0.0027711 
GO:0006950 response to stress 15.1% 0.00432586 
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GO:0007018 microtubule-based movement 17.5% 0.00436175 
GO:0006396 RNA processing 17.5% 0.00436175 
GO:0015031 protein transport 9.3% 0.00504725 
GO:0016568 chromatin modification 14.5% 0.00522835 
GO:0006606 protein import into nucleus 50.0% 0.010142 
GO:0048919 posterior lateral line neuromast development 50.0% 0.010142 
GO:0031497 chromatin assembly 100% 0.0171866 
GO:0045454 cell redox homeostasis 15.8% 0.0173171 
GO:0006810 transport 5.4% 0.0176816 
GO:0009790 embryo development 9.7% 0.0211154 
GO:0006355 regulation of transcription, DNA-dependent 4.9% 0.021975 
GO:0007398 ectoderm development 37.5% 0.0225974 
GO:0016337 cell-cell adhesion 23.5% 0.0233014 
GO:0060218 hemopoietic stem cell differentiation 33.3% 0.0313814 
GO:0007283 spermatogenesis 30.0% 0.0332972 
GO:0000184 nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
30.0% 0.0332972 
GO:0006164 purine nucleotide biosynthetic process 30.0% 0.0332972 
GO:0016338 calcium-independent cell-cell adhesion 66.7% 0.0333135 
GO:0000028 ribosomal small subunit assembly 66.7% 0.0333135 
GO:0000084 S phase of mitotic cell cycle 66.7% 0.0333135 
GO:0090244 Wnt receptor signaling pathway involved in 
somitogenesis 
66.7% 0.0333135 
GO:0000070 mitotic sister chromatid segregation 66.7% 0.0333135 
GO:0051225 spindle assembly 66.7% 0.0333135 
GO:0006913 nucleocytoplasmic transport 66.7% 0.0333135 
GO:0006974 response to DNA damage stimulus 12.8% 0.0334694 
GO:0007010 cytoskeleton organization 21.1% 0.0342881 
GO:0006351 transcription, DNA-dependent 5.4% 0.0375483 
GO:0006464 protein modification process 14.7% 0.0389294 
GO:0034968 histone lysine methylation 27.3% 0.0414307 
GO:0007126 meiosis 27.3% 0.0414307 
GO:0031017 exocrine pancreas development 18.2% 0.0426573 
GO:0055001 muscle cell development 50.0% 0.0471959 
GO:0007062 sister chromatid cohesion 50.0% 0.0471959 
GO:0040023 establishment of nucleus localization 50.0% 0.0471959 
GO:0006177 GMP biosynthetic process 50.0% 0.0471959 
GO:0010172 embryonic body morphogenesis 50.0% 0.0471959 
GO:0008156 negative regulation of DNA replication 50.0% 0.0471959 
GO:0006281 DNA repair 10.0% 0.0480995 
GO:0048048 embryonic eye morphogenesis 25.0% 0.0494145 
GO:0031047 gene silencing by RNA 25.0% 0.0494145 
GO:0051056 regulation of small GTPase mediated signal 
transduction 
25.0% 0.0494145 
GO:0006310 DNA recombination 17.4% 0.0495001 
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Table S48: GO Term Biological Process Analysis 
 
GO term biological process analysis of Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT2 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0005840 ribosome 29.0% 4.36E-23 
GO:0005737 cytoplasm 10.9% 4.67E-23 
GO:0005634 nucleus 8.3% 2.81E-22 
GO:0030529 ribonucleoprotein complex 28.3% 1.16E-20 
GO:0005622 intracellular 8.0% 4.91E-12 
GO:0005874 microtubule 18.5% 1.43E-05 
GO:0005694 chromosome 16.7% 3.85E-05 
GO:0015935 small ribosomal subunit 55.6% 5.61E-05 
GO:0022627 cytosolic small ribosomal subunit 40.0% 0.00260149 
GO:0005913 cell-cell adherens junction 60.0% 0.00336367 
GO:0005856 cytoskeleton 9.2% 0.00343972 
GO:0005643 nuclear pore 36.4% 0.00358989 
GO:0015934 large ribosomal subunit 50.0% 0.00606787 
GO:0005819 spindle 28.6% 0.00674441 
GO:0030117 membrane coat 28.6% 0.00674441 
GO:0033186 CAF-1 complex 100% 0.00812524 
GO:0030686 90S preribosome 100% 0.00812524 
GO:0005938 cell cortex 23.5% 0.0124178 
GO:0030126 COPI vesicle coat 66.7% 0.0184514 
GO:0030130 clathrin coat of trans-Golgi network vesicle 66.7% 0.0184514 
GO:0005902 microvillus 66.7% 0.0184514 
GO:0045261 proton-transporting ATP synthase complex, 
catalytic core F(1) 
66.7% 0.0184514 
GO:0000932 cytoplasmic mRNA processing body 30.0% 0.0187665 
GO:0005853 eukaryotic translation elongation factor 1 complex 50.0% 0.0284049 
GO:0030057 desmosome 50.0% 0.0284049 
GO:0034747 Axin-APC-beta-catenin-GSK3B complex 50.0% 0.0284049 
GO:0000793 condensed chromosome 50.0% 0.0284049 
GO:0043234 protein complex 16.7% 0.029026 
GO:0005852 eukaryotic translation initiation factor 3 complex 25.0% 0.0314941 
GO:0016342 catenin complex 40.0% 0.040583 
GO:0030132 clathrin coat of coated pit 40.0% 0.040583 
GO:0016585 chromatin remodeling complex 40.0% 0.040583 
GO:0005759 mitochondrial matrix 20.0% 0.0442353 
GO:0005783 endoplasmic reticulum 6.9% 0.0459317 
Table S49: GO Term Cellular Component Analysis 
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GO term cellular component analysis of Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT2 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0000166 nucleotide binding 9.6% 1.60E-27 
GO:0003735 structural constituent of ribosome 33.0% 1.45E-24 
GO:0005524 ATP binding 10.4% 2.51E-22 
GO:0005488 binding 11.7% 1.75E-16 
GO:0003723 RNA binding 16.3% 2.20E-15 
GO:0003676 nucleic acid binding 9.5% 2.59E-14 
GO:0004386 helicase activity 27.3% 3.57E-11 
GO:0003677 DNA binding 7.2% 8.30E-09 
GO:0016787 hydrolase activity 7.3% 2.14E-06 
GO:0008026 ATP-dependent helicase activity 24.4% 2.46E-06 
GO:0008565 protein transporter activity 32.1% 2.54E-06 
GO:0003743 translation initiation factor activity 20.4% 4.80E-05 
GO:0051082 unfolded protein binding 18.0% 4.99E-05 
GO:0008168 methyltransferase activity 13.1% 0.000107933 
GO:0019901 protein kinase binding 25.0% 0.000310234 
GO:0003746 translation elongation factor activity 31.6% 0.000310452 
GO:0003824 catalytic activity 6.6% 0.000687057 
GO:0015035 protein disulfide oxidoreductase activity 27.3% 0.000696206 
GO:0016853 isomerase activity 15.8% 0.00086218 
GO:0017111 nucleoside-triphosphatase activity 12.6% 0.00100215 
GO:0008270 zinc ion binding 5.3% 0.00104482 
GO:0018024 histone-lysine N-methyltransferase activity 24.0% 0.00118031 
GO:0016740 transferase activity 5.9% 0.00139068 
GO:0015662 ATPase activity, coupled to transmembrane 
movement of ions, phosphorylative 
mechanism 
23.1% 0.00142974 
GO:0005198 structural molecule activity 10.0% 0.00221968 
GO:0005529 sugar binding 12.0% 0.00256232 
GO:0019843 rRNA binding 36.4% 0.00266822 
GO:0016820 hydrolase activity, acting on acid anhydrides, 
catalyzing transmembrane movement of 
substances 
20.0% 0.00272803 
GO:0005388 calcium-transporting ATPase activity 33.3% 0.0036359 
GO:0046872 metal ion binding 5.0% 0.00731336 
GO:0009055 electron carrier activity 9.1% 0.0120923 
GO:0016887 ATPase activity 14.6% 0.0135746 
GO:0004221 ubiquitin thiolesterase activity 16.7% 0.0180809 
GO:0003924 GTPase activity 8.9% 0.0200292 
GO:0003682 chromatin binding 16.1% 0.020402 
GO:0008234 cysteine-type peptidase activity 10.3% 0.0219844 
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GO:0004579 dolichyl-diphosphooligosaccharide-protein 
glycotransferase activity 
66.7% 0.0220169 
GO:0016818 hydrolase activity, acting on acid anhydrides, 
in phosphorus-containing anhydrides 
27.3% 0.0306317 
GO:0008094 DNA-dependent ATPase activity 25.0% 0.0388938 
GO:0008641 small protein activating enzyme activity 50.0% 0.038929 
GO:0003918 DNA topoisomerase (ATP-hydrolyzing) 
activity 
50.0% 0.038929 
GO:0003777 microtubule motor activity 16.7% 0.0392845 
GO:0016788 hydrolase activity, acting on ester bonds 16.7% 0.0392845 
GO:0003779 actin binding 9.0% 0.0404288 
GO:0004197 cysteine-type endopeptidase activity 10.9% 0.0433571 
GO:0016779 nucleotidyltransferase activity 12.5% 0.0465689 
GO:0016817 hydrolase activity, acting on acid anhydrides 21.4% 0.04995 
GO:0016769 transferase activity, transferring nitrogenous 
groups 
21.4% 0.04995 
Table S50: GO Term Molecular Function Analysis 
 
GO term molecular function analysis of Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT2 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
Term Support % p-value 
dre-miR-200b 21 7.5% 0.000426253 
dre-miR-200c 24 8.5% 4.28E-05 
dre-miR-727 14 7.1% 0.00517095 
dre-miR-122 13 5.6% 0.0345329 
dre-miR-457b 18 8.9% 0.000165264 
dre-miR-15a 25 10.4% 2.80E-06 
dre-miR-138 18 9.6% 8.42E-05 
dre-miR-21 12 5.9% 0.0290119 
dre-miR-196a 17 7.3% 0.00182329 
dre-miR-462 12 6.5% 0.0154193 
dre-miR-133c 20 9.3% 4.91E-05 
dre-miR-130c 20 8.8% 9.47E-05 
dre-miR-150 18 9.1% 0.000127566 
dre-miR-129* 10 5.8% 0.0459776 
dre-miR-130b 20 7.6% 0.000473064 
dre-miR-148 16 6.6% 0.00528327 
dre-miR-723 23 9.3% 2.21E-05 
dre-miR-735 20 9.5% 4.13E-05 
dre-miR-130a 20 8.2% 0.000193435 
dre-miR-133b 19 9.1% 9.40E-05 
dre-miR-19c 17 7.7% 0.0010328 
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dre-miR-133a 22 10.2% 1.13E-05 
dre-miR-223 15 6.9% 0.00471876 
dre-miR-137 13 5.3% 0.0484096 
dre-miR-728 11 7.0% 0.0133924 
dre-miR-15a* 22 12.0% 1.62E-06 
dre-miR-96 14 5.6% 0.0300856 
dre-miR-199* 11 5.7% 0.0422501 
dre-miR-132 20 7.6% 0.000492068 
dre-miR-732 16 7.3% 0.00229361 
dre-miR-205 14 6.6% 0.00875168 
dre-miR-212 26 10.0% 2.95E-06 
dre-miR-183 16 7.2% 0.00245961 
dre-miR-181c 18 7.3% 0.00139895 
dre-miR-182 21 8.8% 7.10E-05 
dre-miR-34c 23 8.8% 4.03E-05 
dre-miR-192 15 7.1% 0.00403932 
dre-miR-301a 23 9.1% 2.98E-05 
dre-miR-125a 23 8.8% 4.07E-05 
dre-miR-184 31 12.1% 1.08E-08 
dre-miR-220 32 11.9% 1.55E-08 
dre-miR-456 14 6.9% 0.00666082 
dre-miR-9* 14 7.5% 0.00324659 
dre-miR-430c 22 10.0% 1.50E-05 
dre-miR-20b 22 9.1% 3.83E-05 
dre-miR-181b 20 7.8% 0.000344989 
dre-miR-204 28 12.4% 3.10E-08 
dre-miR-461 12 6.4% 0.0172484 
dre-miR-24 20 9.7% 3.89E-05 
dre-miR-222 14 5.6% 0.0276136 
dre-miR-193b 15 6.2% 0.011 
dre-miR-153b 12 5.4% 0.0483079 
dre-miR-140* 12 5.7% 0.034719 
dre-miR-153c 14 6.6% 0.00875168 
dre-miR-153a 14 6.3% 0.0133704 
dre-miR-451 19 9.8% 4.42E-05 
dre-let-7j 21 7.2% 0.00065972 
dre-miR-181a* 14 6.2% 0.0135263 
dre-let-7g 22 8.9% 4.31E-05 
dre-miR-196b 17 8.2% 0.000581498 
dre-miR-365 24 11.5% 1.45E-06 
dre-miR-23b 19 8.4% 0.000214045 
dre-miR-23a 19 8.2% 0.000281488 
dre-miR-18b* 12 7.2% 0.00818173 
dre-miR-216a 20 6.9% 0.00143471 
dre-miR-722 13 7.0% 0.00786279 
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dre-miR-18c 18 9.1% 0.000132532 
dre-miR-459 18 8.5% 0.000258522 
dre-miR-194b 22 9.2% 3.45E-05 
dre-miR-10a* 16 8.4% 0.000611822 
dre-miR-27c* 15 7.4% 0.00277672 
dre-miR-124 18 6.8% 0.00244218 
dre-miR-187 17 8.3% 0.000494842 
dre-miR-26b 19 8.8% 0.000126675 
dre-let-7h 24 8.5% 4.32E-05 
dre-miR-26a 20 8.7% 9.93E-05 
dre-miR-142b-5p 17 8.1% 0.00060887 
dre-miR-92b 15 6.8% 0.00529495 
dre-miR-737 16 7.4% 0.00210149 
dre-miR-92a 19 8.0% 0.000375232 
dre-miR-101b 26 10.0% 2.76E-06 
dre-miR-19b* 18 11.3% 1.81E-05 
dre-miR-146a 14 5.6% 0.0276136 
dre-miR-190b 12 5.7% 0.0363751 
dre-miR-143 14 7.4% 0.00386286 
dre-miR-731 14 7.0% 0.00545927 
dre-miR-202* 12 6.9% 0.0111399 
dre-miR-101a 25 9.6% 7.42E-06 
dre-miR-146b 22 8.4% 8.36E-05 
dre-miR-15c 22 8.2% 0.000109972 
dre-miR-15b 25 9.7% 6.82E-06 
dre-miR-457a 20 9.6% 4.23E-05 
dre-miR-375 16 8.1% 0.000895963 
dre-miR-203a 12 6.9% 0.010802 
dre-miR-139 17 8.5% 0.000408439 
dre-miR-194a 17 7.7% 0.000989903 
dre-miR-129 18 9.5% 9.06E-05 
dre-miR-739 14 7.1% 0.00525594 
dre-miR-429 17 6.9% 0.00276105 
dre-miR-17a 26 10.3% 1.96E-06 
dre-miR-99 17 7.9% 0.000762798 
dre-miR-459* 13 8.3% 0.00201018 
dre-miR-141 23 9.6% 1.54E-05 
dre-miR-100 19 9.8% 4.20E-05 
dre-miR-10d 14 5.6% 0.0286672 
dre-miR-200a 22 7.5% 0.00028448 
dre-miR-740 15 9.6% 0.000259441 
dre-miR-210* 14 8.1% 0.00181433 
dre-miR-133a* 13 7.2% 0.00591413 
dre-miR-7b 19 8.4% 0.000214045 
dre-miR-219 16 6.9% 0.00387828 
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dre-miR-34 16 6.2% 0.00879566 
dre-miR-210 13 6.3% 0.0148163 
dre-miR-103 20 8.9% 8.49E-05 
dre-miR-107 17 7.7% 0.00107724 
dre-miR-125c 21 8.6% 8.47E-05 
dre-miR-125b 19 7.6% 0.000638993 
dre-miR-132* 18 10.7% 3.11E-05 
dre-miR-455 16 7.3% 0.00238513 
dre-miR-19a* 9 6.4% 0.0363988 
dre-miR-206 19 9.4% 6.96E-05 
dre-miR-1 19 8.1% 0.000325452 
dre-miR-22b 21 8.2% 0.000136407 
dre-miR-22a 19 7.5% 0.000786642 
dre-miR-16a 21 9.9% 2.17E-05 
dre-miR-16b 15 7.2% 0.00344011 
dre-miR-140 12 5.8% 0.0327383 
dre-miR-34b 16 6.3% 0.00865152 
dre-miR-460-3p 24 8.8% 3.10E-05 
dre-miR-31 23 10.3% 7.06E-06 
dre-miR-126 18 8.6% 0.000234536 
dre-miR-726 18 9.1% 0.000132532 
dre-miR-142a-5p 12 5.9% 0.0285348 
dre-miR-724 13 8.6% 0.00155239 
dre-miR-144 16 8.1% 0.000895963 
dre-miR-135c 13 6.4% 0.0134539 
dre-miR-460-5p 17 7.4% 0.00156065 
dre-miR-736 13 7.3% 0.00568102 
dre-miR-214 17 9.0% 0.000216841 
dre-miR-155 13 5.8% 0.0277871 
dre-miR-217 20 9.5% 4.13E-05 
dre-miR-29a 16 6.2% 0.00905954 
dre-miR-30a 14 6.1% 0.0154237 
dre-miR-29b 15 5.8% 0.0195703 
dre-miR-216b 29 9.9% 1.34E-06 
dre-let-7f 26 9.6% 5.69E-06 
dre-miR-454a 16 6.3% 0.00766681 
dre-miR-193a 17 7.2% 0.00189438 
dre-miR-301c 22 9.3% 3.10E-05 
dre-miR-301b 20 8.6% 0.000123304 
dre-miR-489 21 8.7% 7.90E-05 
dre-miR-9 12 6.7% 0.0134297 
dre-miR-18a 21 10.1% 1.80E-05 
dre-miR-93 20 9.0% 8.01E-05 
dre-miR-18b 23 10.1% 7.88E-06 
dre-miR-20a 23 9.7% 1.32E-05 
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dre-miR-730 14 7.3% 0.00418806 
dre-miR-430j 21 10.0% 1.79E-05 
dre-miR-430b 24 11.2% 1.63E-06 
dre-miR-338 12 5.9% 0.0285348 
dre-miR-16c 20 9.4% 4.68E-05 
dre-let-7d 19 6.9% 0.00182174 
dre-let-7e 19 7.3% 0.000917821 
dre-let-7i 23 8.5% 5.05E-05 
dre-let-7b 22 8.3% 9.47E-05 
dre-let-7c 24 8.6% 4.00E-05 
dre-let-7a 20 7.2% 0.000792867 
dre-miR-738 25 11.7% 6.64E-07 
dre-miR-727* 17 9.2% 0.00016557 
dre-miR-202 23 9.9% 1.18E-05 
dre-miR-430a 18 8.5% 0.000271302 
dre-miR-363 14 5.6% 0.0286672 
dre-miR-25 15 6.6% 0.00750226 
dre-miR-181a 21 8.8% 6.93E-05 
dre-miR-733 13 7.3% 0.00531247 
dre-miR-19b 21 9.1% 4.77E-05 
dre-miR-27d 16 7.4% 0.00210149 
dre-miR-27a 15 6.6% 0.00750226 
dre-miR-27c 17 8.1% 0.000653584 
dre-miR-27e 12 6.0% 0.0265043 
dre-miR-27b 14 6.7% 0.00795007 
dre-miR-19d 19 8.7% 0.000142557 
dre-miR-19a 19 8.6% 0.000175128 
dre-miR-430i 20 8.8% 9.47E-05 
dre-miR-7a 21 10.2% 1.55E-05 
dre-miR-499 14 7.3% 0.00435852 
Table S51: MicroRNA Association Analysis  
 
MicroRNA association analysis of Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT3 and mapping with 
Cufflinks. Support indicates the number of times a term was associated within the 
reference list (of 1000 Ensembl gene IDs) and % gives this as a percentage of the 
number of genes associated with that term. Corrected p-values were calculated using 
GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
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ID Term % p-value 
Kegg:03010 Ribosome 48.2% 2.97E-36 
Kegg:03013 RNA transport 26.6% 7.55E-21 
Kegg:04110 Cell cycle 22.5% 1.12E-14 
Kegg:03040 Spliceosome 20.2% 4.88E-12 
Kegg:04141 Protein processing in endoplasmic reticulum 17.2% 5.02E-11 
Kegg:04114 Oocyte meiosis 18.9% 3.76E-10 
Kegg:03018 RNA degradation 22.1% 2.46E-08 
Kegg:03015 mRNA surveillance pathway 21.7% 2.68E-08 
Kegg:03030 DNA replication 31.4% 4.99E-08 
Kegg:04145 Phagosome 14.7% 2.22E-06 
Kegg:03008 Ribosome biogenesis in eukaryotes 18.5% 5.26E-06 
Kegg:04120 Ubiquitin mediated proteolysis 11.5% 0.000366798 
Kegg:04914 Progesterone-mediated oocyte maturation 12.6% 0.000543859 
Kegg:00310 Lysine degradation 15.2% 0.00311942 
Kegg:03430 Mismatch repair 22.7% 0.00325504 
Kegg:04810 Regulation of actin cytoskeleton 7.3% 0.0140266 
Kegg:04520 Adherens junction 10.5% 0.0141358 
Kegg:00010 Glycolysis / Gluconeogenesis 11.3% 0.0156554 
Kegg:03060 Protein export 19.0% 0.0181905 
Kegg:03420 Nucleotide excision repair 12.5% 0.0344356 
Kegg:04530 Tight junction 7.6% 0.0359127 
Kegg:00190 Oxidative phosphorylation 7.8% 0.0407908 
Kegg:04260 Cardiac muscle contraction 10.0% 0.0434801 
Table S52: KEGG Pathway Analysis  
 
KEGG pathway analysis of the Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT3 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term. Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 27.6% 3.06E-24 
GO:0051726 regulation of cell cycle 36.7% 1.87E-07 
GO:0006414 translational elongation 38.5% 4.36E-07 
GO:0006334 nucleosome assembly 30.6% 5.79E-07 
GO:0051301 cell division 20.3% 6.60E-07 
GO:0007049 cell cycle 16.7% 6.97E-07 
GO:0006457 protein folding 18.0% 9.17E-07 
GO:0030261 chromosome condensation 75.0% 1.33E-06 
GO:0006413 translational initiation 24.5% 1.43E-06 
GO:0006260 DNA replication 22.0% 1.33E-05 
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GO:0006396 RNA processing 25.0% 1.41E-05 
GO:0048565 digestive tract development 38.9% 2.70E-05 
GO:0007067 mitosis 22.2% 3.56E-05 
GO:0006886 intracellular protein transport 15.9% 4.82E-05 
GO:0006397 mRNA processing 16.9% 5.72E-05 
GO:0006270 DNA-dependent DNA replication initiation 55.6% 0.000104849 
GO:0051276 chromosome organization 80.0% 0.00013874 
GO:0000070 mitotic sister chromatid segregation 100.0
% 
0.000879353 
GO:0031101 fin regeneration 22.6% 0.000995504 
GO:0016070 RNA metabolic process 35.7% 0.0011725 
GO:0000079 regulation of cyclin-dependent protein kinase 
activity 
33.3% 0.00163272 
GO:0032259 methylation 12.6% 0.00177397 
GO:0009790 embryo development 11.7% 0.00181815 
GO:0060218 hemopoietic stem cell differentiation 44.4% 0.00224395 
GO:0007062 sister chromatid cohesion 75.0% 0.00237934 
GO:0071599 otic vesicle development 75.0% 0.00237934 
GO:0006417 regulation of translation 29.4% 0.00248648 
GO:0006754 ATP biosynthetic process 21.4% 0.00339399 
GO:0006950 response to stress 15.1% 0.00362497 
GO:0007018 microtubule-based movement 17.5% 0.00363809 
GO:0007010 cytoskeleton organization 26.3% 0.00386722 
GO:0008380 RNA splicing 15.9% 0.00609359 
GO:0006096 glycolysis 18.8% 0.00624018 
GO:0006355 regulation of transcription, DNA-dependent 5.1% 0.00684148 
GO:0006606 protein import into nucleus 50.0% 0.0075727 
GO:0022904 respiratory electron transport chain 50.0% 0.0075727 
GO:0048919 posterior lateral line neuromast development 50.0% 0.0075727 
GO:0006310 DNA recombination 21.7% 0.00783405 
GO:0044267 cellular protein metabolic process 30.8% 0.00791492 
GO:0006810 transport 5.6% 0.00791493 
GO:0006662 glycerol ether metabolic process 28.6% 0.00923051 
GO:0015031 protein transport 8.6% 0.0104308 
GO:0045905 positive regulation of translational termination 100.0
% 
0.0112531 
GO:0006452 translational frameshifting 100.0
% 
0.0112531 
GO:0045901 positive regulation of translational elongation 100.0
% 
0.0112531 
GO:0048262 determination of dorsal/ventral asymmetry 100.0
% 
0.0112531 
GO:0007398 ectoderm development 37.5% 0.0168018 
GO:0016337 cell-cell adhesion 23.5% 0.0174214 
GO:0006807 nitrogen compound metabolic process 30.0% 0.0273928 
GO:0007283 spermatogenesis 30.0% 0.0273928 
GO:0000184 nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
30.0% 0.0273928 
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GO:0006200 ATP catabolic process 30.0% 0.0273928 
GO:0006164 purine nucleotide biosynthetic process 30.0% 0.0273928 
GO:0016338 calcium-independent cell-cell adhesion 66.7% 0.0287032 
GO:0000028 ribosomal small subunit assembly 66.7% 0.0287032 
GO:0000084 S phase of mitotic cell cycle 66.7% 0.0287032 
GO:0090244 Wnt receptor signaling pathway involved in 
somitogenesis 
66.7% 0.0287032 
GO:0051225 spindle assembly 66.7% 0.0287032 
GO:0030036 actin cytoskeleton organization 20.0% 0.0293038 
GO:0006464 protein modification process 14.7% 0.032705 
GO:0016310 phosphorylation 5.6% 0.0354273 
GO:0001570 vasculogenesis 14.3% 0.036008 
GO:0031017 exocrine pancreas development 18.2% 0.0361252 
GO:0006542 glutamine biosynthetic process 50.0% 0.0419813 
GO:0008612 peptidyl-lysine modification to hypusine 50.0% 0.0419813 
GO:0055001 muscle cell development 50.0% 0.0419813 
GO:0040023 establishment of nucleus localization 50.0% 0.0419813 
GO:0000462 maturation of SSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
50.0% 0.0419813 
GO:0006177 GMP biosynthetic process 50.0% 0.0419813 
GO:0010172 embryonic body morphogenesis 50.0% 0.0419813 
GO:0008156 negative regulation of DNA replication 50.0% 0.0419813 
GO:0007507 heart development 9.1% 0.0423637 
GO:0006364 rRNA processing 16.7% 0.0425632 
GO:0045454 cell redox homeostasis 13.2% 0.0426858 
GO:0006281 DNA repair 10.0% 0.042694 
GO:0060041 retina development in camera-type eye 10.9% 0.0471872 
GO:0046688 response to copper ion 23.1% 0.0473201 
Table S53: GO Term Biological Process Analysis 
 
GO term biological process analysis of ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT3 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0005634 nucleus 9.4% 6.61E-31 
GO:0005840 ribosome 31.5% 7.08E-27 
GO:0030529 ribonucleoprotein complex 30.1% 8.01E-23 
GO:0005737 cytoplasm 10.1% 8.86E-20 
GO:0005622 intracellular 8.3% 1.72E-13 
GO:0005694 chromosome 22.2% 1.07E-08 
GO:0005874 microtubule 18.5% 1.21E-05 
GO:0015935 small ribosomal subunit 55.6% 5.55E-05 
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GO:0022627 cytosolic small ribosomal subunit 50.0% 9.61E-05 
GO:0015934 large ribosomal subunit 66.7% 0.000182584 
GO:0000786 nucleosome 22.6% 0.000454797 
GO:0005783 endoplasmic reticulum 9.4% 0.00155395 
GO:0005913 cell-cell adherens junction 60.0% 0.002855 
GO:0005856 cytoskeleton 9.2% 0.00286137 
GO:0045495 pole plasm 100% 0.00760625 
GO:0000796 condensin complex 100% 0.00760625 
GO:0030686 90S preribosome 100% 0.00760625 
GO:0005759 mitochondrial matrix 26.7% 0.00887993 
GO:0005938 cell cortex 23.5% 0.0116408 
GO:0005815 microtubule organizing center 20.0% 0.0181972 
GO:0030130 clathrin coat of trans-Golgi network vesicle 66.7% 0.0182893 
GO:0005902 microvillus 66.7% 0.0182893 
GO:0045261 proton-transporting ATP synthase complex, 
catalytic core F(1) 
66.7% 0.0182893 
GO:0016607 nuclear speck 27.3% 0.0229779 
GO:0005643 nuclear pore 27.3% 0.0229779 
GO:0005853 eukaryotic translation elongation factor 1 complex 50.0% 0.0262789 
GO:0030057 desmosome 50.0% 0.0262789 
GO:0034747 Axin-APC-beta-catenin-GSK3B complex 50.0% 0.0262789 
GO:0000793 condensed chromosome 50.0% 0.0262789 
GO:0005852 eukaryotic translation initiation factor 3 complex 25.0% 0.0287924 
GO:0016342 catenin complex 40.0% 0.0357583 
GO:0030132 clathrin coat of coated pit 40.0% 0.0357583 
GO:0016585 chromatin remodeling complex 40.0% 0.0357583 
GO:0005819 spindle 21.4% 0.0358582 
GO:0070469 respiratory chain 21.4% 0.0358582 
GO:0030117 membrane coat 21.4% 0.0358582 
GO:0005743 mitochondrial inner membrane 9.1% 0.0367167 
GO:0005788 endoplasmic reticulum lumen 33.3% 0.0497866 
Table S54: GO Term Cellular Component Analysis 
 
GO term cellular component analysis of ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT3 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0000166 nucleotide binding 10.1% 4.08E-31 
GO:0003723 RNA binding 21.5% 7.16E-26 
GO:0003735 structural constituent of ribosome 34.0% 7.80E-26 
GO:0003676 nucleic acid binding 11.7% 3.14E-23 
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GO:0005524 ATP binding 10.1% 1.99E-21 
GO:0005488 binding 10.1% 8.32E-12 
GO:0003677 DNA binding 7.8% 2.11E-11 
GO:0004386 helicase activity 24.2% 3.72E-09 
GO:0003743 translation initiation factor activity 24.5% 6.30E-07 
GO:0051082 unfolded protein binding 21.3% 8.90E-07 
GO:0008565 protein transporter activity 32.1% 2.33E-06 
GO:0003746 translation elongation factor activity 36.8% 1.90E-05 
GO:0008026 ATP-dependent helicase activity 22.2% 1.91E-05 
GO:0016787 hydrolase activity 6.4% 0.000264325 
GO:0019901 protein kinase binding 25.0% 0.000304251 
GO:0008168 methyltransferase activity 12.1% 0.000419352 
GO:0016853 isomerase activity 15.8% 0.000884849 
GO:0005198 structural molecule activity 10.0% 0.00282512 
GO:0008270 zinc ion binding 5.1% 0.003328 
GO:0003779 actin binding 11.2% 0.0054224 
GO:0016740 transferase activity 5.6% 0.00570567 
GO:0015035 protein disulfide oxidoreductase activity 22.7% 0.00592417 
GO:0004674 protein serine/threonine kinase activity 7.2% 0.00947568 
GO:0018024 histone-lysine N-methyltransferase activity 20.0% 0.00969146 
GO:0003824 catalytic activity 5.8% 0.010508 
GO:0003682 chromatin binding 16.1% 0.0245819 
GO:0043022 ribosome binding 66.7% 0.0278654 
GO:0009055 electron carrier activity 8.3% 0.0341694 
GO:0019904 protein domain specific binding 18.2% 0.0351742 
GO:0016301 kinase activity 5.6% 0.035479 
GO:0016818 hydrolase activity, acting on acid anhydrides, in 
phosphorus-containing anhydrides 
27.3% 0.0358046 
GO:0019843 rRNA binding 27.3% 0.0358046 
GO:0004129 cytochrome-c oxidase activity 27.3% 0.0358046 
GO:0046872 metal ion binding 4.6% 0.0381184 
GO:0004356 glutamate-ammonia ligase activity 50.0% 0.0387931 
GO:0008641 small protein activating enzyme activity 50.0% 0.0387931 
GO:0003918 DNA topoisomerase (ATP-hydrolyzing) activity 50.0% 0.0387931 
GO:0003777 microtubule motor activity 16.7% 0.038943 
GO:0016788 hydrolase activity, acting on ester bonds 16.7% 0.038943 
GO:0017111 nucleoside-triphosphatase activity 9.2% 0.0407948 
GO:0005388 calcium-transporting ATPase activity 25.0% 0.0411701 
GO:0016779 nucleotidyltransferase activity 12.5% 0.0470045 
GO:0015662 ATPase activity, coupled to transmembrane 
movement of ions, phosphorylative mechanism 
15.4% 0.0485626 
Table S55: GO Term Molecular Function Analysis 
 
GO term molecular function analysis of Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT3 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
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(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
 
ID Support % p-value 
dre-miR-146b 33 12.6% 1.61E-09 
dre-miR-220 32 11.9% 7.58E-09 
dre-miR-204 27 11.9% 1.05E-07 
dre-miR-31 27 12.1% 1.15E-07 
dre-miR-18a 25 12.0% 2.92E-07 
dre-miR-216b 29 9.9% 1.31E-06 
dre-miR-212 27 10.3% 1.32E-06 
dre-miR-723 26 10.5% 1.56E-06 
dre-miR-17a 26 10.3% 1.92E-06 
dre-miR-7a 23 11.2% 2.10E-06 
dre-miR-18b 24 10.6% 2.45E-06 
dre-miR-451 22 11.3% 2.52E-06 
dre-miR-735 23 11.0% 2.72E-06 
dre-miR-217 23 11.0% 2.72E-06 
dre-miR-15a* 21 11.4% 3.74E-06 
dre-miR-181a 24 10.1% 5.15E-06 
dre-miR-141 24 10.0% 5.65E-06 
dre-miR-130b 25 9.5% 8.02E-06 
dre-miR-430b 22 10.3% 8.17E-06 
dre-miR-738 22 10.3% 8.17E-06 
dre-miR-19b 23 10.0% 8.95E-06 
dre-miR-150 21 10.7% 9.24E-06 
dre-miR-184 24 9.3% 1.43E-05 
dre-miR-101a 24 9.2% 1.68E-05 
dre-miR-125a 24 9.2% 1.71E-05 
dre-miR-365 21 10.0% 1.77E-05 
dre-miR-457a 21 10.0% 1.77E-05 
dre-miR-202 22 9.4% 2.65E-05 
dre-let-7f 24 8.9% 2.87E-05 
dre-miR-20a 22 9.3% 2.95E-05 
dre-miR-19d 21 9.6% 2.99E-05 
dre-miR-206 20 9.9% 3.02E-05 
dre-miR-135c 20 9.9% 3.02E-05 
dre-miR-182 22 9.2% 3.20E-05 
dre-miR-430c 21 9.5% 3.27E-05 
dre-miR-19a 21 9.5% 3.32E-05 
dre-miR-93 21 9.4% 3.37E-05 
dre-miR-101b 23 8.9% 3.40E-05 
dre-miR-24 20 9.7% 3.44E-05 
dre-miR-130a 22 9.1% 3.49E-05 
dre-miR-125c 22 9.1% 3.49E-05 
S4.3 Small RNA – WT3 GO term analysis 
 ! !
243 
!
! !
ID Support % p-value 
dre-let-7c 24 8.6% 3.64E-05 
dre-miR-7b 21 9.3% 3.67E-05 
dre-miR-132 23 8.7% 3.92E-05 
dre-miR-130c 21 9.2% 4.02E-05 
dre-miR-499 19 9.8% 4.05E-05 
dre-miR-26a 21 9.2% 4.11E-05 
dre-miR-726 19 9.6% 5.60E-05 
dre-miR-181b 22 8.6% 6.81E-05 
dre-miR-15b 22 8.6% 7.09E-05 
dre-miR-27c* 19 9.4% 7.36E-05 
dre-miR-132* 17 10.1% 7.49E-05 
dre-miR-15a 21 8.7% 7.93E-05 
dre-let-7b 22 8.3% 0.000105378 
dre-miR-459 19 9.0% 0.00011932 
dre-miR-16a 19 9.0% 0.000125097 
dre-let-7i 22 8.1% 0.000132694 
dre-miR-200a 23 7.9% 0.000146 
dre-miR-26b 19 8.8% 0.000146521 
dre-miR-18c 18 9.1% 0.000147434 
dre-miR-375 18 9.1% 0.000147434 
dre-miR-460-3p 22 8.1% 0.000148944 
dre-miR-1 20 8.5% 0.000150725 
dre-miR-22b 21 8.2% 0.000151262 
dre-miR-457b 18 8.9% 0.000185741 
dre-miR-20b 20 8.3% 0.000195469 
dre-miR-489 20 8.3% 0.000195469 
dre-let-7h 22 7.8% 0.000224569 
dre-miR-103 19 8.4% 0.000227935 
dre-miR-138 17 9.0% 0.000229211 
dre-let-7g 20 8.1% 0.000245176 
dre-miR-430i 19 8.3% 0.000253583 
dre-miR-10a* 17 8.9% 0.000254073 
dre-miR-126 18 8.6% 0.000256962 
dre-miR-146a 20 8.1% 0.000259429 
dre-miR-30a 19 8.3% 0.000261672 
dre-miR-460-5p 19 8.3% 0.000270102 
dre-miR-740 15 9.6% 0.000273233 
dre-miR-125b 20 8.0% 0.000274909 
dre-miR-19b* 15 9.4% 0.000325929 
dre-miR-196a 19 8.1% 0.000326343 
dre-miR-736 16 8.9% 0.000361046 
dre-miR-183 18 8.1% 0.000457589 
dre-miR-200c 21 7.4% 0.000478277 
dre-miR-727* 16 8.7% 0.000479015 
dre-miR-18b* 15 9.0% 0.000522552 
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dre-miR-181c 19 7.7% 0.000620843 
dre-miR-222 19 7.7% 0.000620843 
dre-miR-196b 17 8.2% 0.000627599 
dre-miR-214 16 8.5% 0.000628249 
dre-miR-15c 20 7.4% 0.000635123 
dre-miR-129 16 8.4% 0.000637908 
dre-let-7j 21 7.2% 0.000692975 
dre-miR-219 18 7.8% 0.00073352 
dre-miR-16c 17 8.0% 0.000751305 
dre-miR-301a 19 7.5% 0.000756152 
dre-miR-99 17 7.9% 0.000785169 
dre-miR-301c 18 7.6% 0.000864436 
dre-miR-92a 18 7.6% 0.00094652 
dre-miR-732 17 7.8% 0.000984228 
dre-miR-194b 18 7.5% 0.000985024 
dre-miR-200b 20 7.1% 0.000994284 
dre-miR-34c 19 7.3% 0.00101575 
dre-miR-194a 17 7.7% 0.00101676 
dre-miR-19c 17 7.7% 0.00105036 
dre-miR-23b 17 7.5% 0.00134032 
dre-miR-430j 16 7.7% 0.00156652 
dre-miR-143 15 7.9% 0.00163589 
dre-miR-129* 14 8.2% 0.00167794 
dre-miR-23a 17 7.3% 0.00172999 
dre-miR-430a 16 7.5% 0.00175812 
dre-miR-301b 17 7.3% 0.00178178 
dre-miR-100 15 7.8% 0.00180262 
dre-miR-22a 18 7.1% 0.00180683 
dre-let-7d 19 6.9% 0.00181622 
dre-let-7a 19 6.9% 0.00181622 
dre-miR-203a 14 8.0% 0.00185161 
dre-miR-202* 14 8.0% 0.00194057 
dre-miR-135a 16 7.4% 0.00199801 
dre-let-7e 18 6.9% 0.00208408 
dre-miR-733 14 7.9% 0.00211129 
dre-miR-728 13 8.2% 0.00216514 
dre-miR-739 15 7.6% 0.00218121 
dre-miR-455 16 7.3% 0.00232256 
dre-miR-133a* 14 7.8% 0.00239972 
dre-miR-107 16 7.2% 0.00251029 
dre-miR-21 15 7.4% 0.00270637 
dre-miR-10d* 14 7.6% 0.0028844 
dre-miR-187 15 7.3% 0.00293394 
dre-miR-216a 19 6.5% 0.00294192 
dre-miR-140* 15 7.2% 0.00348751 
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dre-miR-96 17 6.7% 0.00351246 
dre-miR-192 15 7.1% 0.0039408 
dre-miR-724 12 7.9% 0.00400575 
dre-miR-730 14 7.3% 0.00402808 
dre-miR-34b 17 6.6% 0.00404632 
dre-miR-210* 13 7.5% 0.0043251 
dre-miR-133a 15 6.9% 0.00453898 
dre-miR-148 16 6.6% 0.00515733 
dre-miR-124 17 6.5% 0.00518183 
dre-miR-731 14 7.0% 0.00537253 
dre-miR-135b 14 7.0% 0.00583239 
dre-miR-153a 15 6.7% 0.00615665 
dre-miR-142a-3p 15 6.6% 0.0071934 
dre-miR-454a 16 6.3% 0.00764721 
dre-miR-142b-5p 14 6.7% 0.00798975 
dre-miR-221 15 6.5% 0.00825089 
dre-miR-29a 16 6.2% 0.00933987 
dre-miR-133c 14 6.5% 0.00959153 
dre-miR-27d 14 6.5% 0.0107207 
dre-miR-203b* 11 7.2% 0.0111291 
dre-miR-727 13 6.6% 0.0115214 
dre-miR-459* 11 7.1% 0.0126248 
dre-miR-139 13 6.5% 0.0133382 
dre-miR-9 12 6.7% 0.0138463 
dre-miR-27a 14 6.1% 0.0160841 
dre-miR-16b 13 6.3% 0.0170766 
dre-miR-133b 13 6.2% 0.0176043 
dre-miR-34 15 5.8% 0.0185205 
dre-miR-27c 13 6.2% 0.0186942 
dre-miR-153c 13 6.1% 0.0191377 
dre-miR-193a 14 6.0% 0.0191736 
dre-miR-29b 15 5.8% 0.0198862 
dre-miR-737 13 6.0% 0.022518 
dre-miR-193b 14 5.8% 0.0228019 
dre-miR-92b 13 5.9% 0.0238112 
dre-miR-137 14 5.7% 0.0263864 
dre-miR-142a-5p 12 5.9% 0.0291834 
dre-miR-363 14 5.6% 0.0294624 
dre-miR-25 13 5.7% 0.0321327 
dre-miR-140 12 5.8% 0.0338502 
dre-miR-462 11 6.0% 0.0342343 
dre-miR-27b 12 5.7% 0.0356843 
dre-miR-9* 11 5.9% 0.0362394 
dre-miR-722 11 5.9% 0.0372691 
dre-miR-205 12 5.7% 0.0385522 
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dre-miR-30d 12 5.6% 0.0430737 
dre-miR-223 12 5.6% 0.0430737 
dre-miR-203b 11 5.7% 0.0443198 
dre-miR-199 13 5.4% 0.0445135 
dre-miR-153b 12 5.4% 0.0490624 
Table S56: MicroRNA Association Analysis  
 
MicroRNA association analysis of Ensembl gene IDs with the highest expression 
determined by the small RNA fraction sequencing of replicate WT3 and mapping with 
Cufflinks. Support indicates the number of times a term was associated within the 
reference list (of 1000 Ensembl gene IDs) and % gives this as a percentage of the 
number of genes associated with that term. Corrected p-values were calculated using 
GeneCodis3 (Tabas-Madrid, Nogales-Cadenas et al. 2012). 
S5 Wild Type Transcript Counting 
S5.1 Statistics 
 
Aspect Forward Reverse 
Yield (Kb) 5,855,323 10,706,385 
Fasta read count 147,945,471 147,9459,471 
Contaminated read count 215,516 104,908 
Contaminated reads (%) 0.15 0.07 
Table S7: Forward and Reverse Read Statistics 
Forward and Reverse read statistics from the stage I oocyte sequencing, results 
provided by the in-house sequencing team. Values shown here are for the total 
sequencing project, including other samples not described in this thesis. 
 
Aspect WT1 WT2 WT3 
Fasta read count 13,607,898 12,631,215 16,447,950 
Table S58: Tags and Sample Statistics  
Statistics from the sequencing of stage I oocytes, results provided by the in-house 
sequencing team. Fasta read counts are of paired-end reads. 
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S5.2 GO Term Analysis 
 
S5.2.1 WT1 
 
ID Term % p-value 
Kegg:03010 Ribosome 86.7% 1.99E-106 
Kegg:03013 RNA transport 16.4% 3.98E-11 
Kegg:04141 Protein processing in endoplasmic reticulum 13.8% 2.44E-09 
Kegg:00190 Oxidative phosphorylation 13.0% 9.13E-07 
Kegg:04145 Phagosome 12.8% 2.51E-06 
Kegg:04114 Oocyte meiosis 12.6% 2.64E-06 
Kegg:04110 Cell cycle 11.7% 6.00E-06 
Kegg:03060 Protein export 28.6% 5.42E-05 
Kegg:03040 Spliceosome 10.1% 0.000140417 
Kegg:03015 mRNA surveillance pathway 11.6% 0.0011783 
Kegg:04914 Progesterone-mediated oocyte maturation 10.3% 0.00122727 
Kegg:04260 Cardiac muscle contraction 11.7% 0.00270598 
Kegg:03008 Ribosome biogenesis in eukaryotes 10.8% 0.00409465 
Kegg:03018 RNA degradation 10.3% 0.00500162 
Kegg:04530 Tight junction 6.9% 0.0160469 
Kegg:03050 Proteasome 10.2% 0.025807 
Table S60: KEGG Pathway Analysis  
 
KEGG pathway analysis of the Ensembl gene IDs with the highest expression 
determined by the polyA sequencing of replicate WT1 and mapping with Cufflinks. 
% gives the number of times a term was associated within the reference list (of 1000 
Ensembl IDs) as a percentage of the number of genes associated with that term. 
Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 47.6% 4.02E-72 
GO:0051726 regulation of cell cycle 46.7% 1.09E-13 
GO:0009790 embryo development 20.4% 1.13E-12 
GO:0006414 translational elongation 46.2% 7.99E-12 
GO:0006413 translational initiation 26.5% 2.41E-09 
GO:0051301 cell division 14.9% 3.97E-05 
GO:0006950 response to stress 17.0% 0.000112597 
GO:0006457 protein folding 12.4% 0.000192749 
GO:0042254 ribosome biogenesis 22.2% 0.000895352 
GO:0007049 cell cycle 10.2% 0.000997732 
GO:0015031 protein transport 8.6% 0.00106519 
GO:0015986 ATP synthesis coupled proton transport 33.3% 0.00300536 
GO:0006396 RNA processing 15.0% 0.00629822 
GO:0000079 regulation of cyclin-dependent protein kinase 26.7% 0.00673785 
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ID Term % p-value 
activity 
GO:0006754 ATP biosynthetic process 17.9% 0.0079241 
GO:0045905 positive regulation of translational termination 100% 0.00911006 
GO:0006452 translational frameshifting 100% 0.00911006 
GO:0045901 positive regulation of translational elongation 100% 0.00911006 
GO:0006407 rRNA export from nucleus 100% 0.00911006 
GO:0051603 proteolysis involved in cellular protein catabolic 
process 
20.0% 0.0153334 
GO:0006397 mRNA processing 9.9% 0.0164956 
GO:0006334 nucleosome assembly 13.9% 0.0179173 
GO:0007017 microtubule-based process 17.4% 0.0212721 
GO:0016338 calcium-independent cell-cell adhesion 66.7% 0.0213185 
GO:0000028 ribosomal small subunit assembly 66.7% 0.0213185 
GO:0044267 cellular protein metabolic process 23.1% 0.0355537 
GO:0008612 peptidyl-lysine modification to hypusine 50.0% 0.0360102 
GO:0000462 maturation of SSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
50.0% 0.0360102 
Table S61: GO Term Biological Process Analysis 
GO term biological process analysis of ensembl gene IDs with the highest expression 
determined by the polyA RNA sequencing of replicate WT1 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, 
Nogales-Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0005840 ribosome 54.0% 1.64E-75 
GO:0030529 ribonucleoprotein complex 41.6% 6.75E-46 
GO:0005622 intracellular 9.4% 2.98E-28 
GO:0005634 nucleus 5.5% 3.70E-13 
GO:0005737 cytoplasm 6.7% 1.60E-11 
GO:0015935 small ribosomal subunit 77.8% 1.41E-09 
GO:0022627 cytosolic small ribosomal subunit 70.0% 3.96E-09 
GO:0015934 large ribosomal subunit 66.7% 4.19E-05 
GO:0005853 eukaryotic translation elongation factor 1 
complex 
75.0% 0.000460248 
GO:0005783 endoplasmic reticulum 7.5% 0.00238379 
GO:0030686 90S preribosome 100% 0.0043439 
GO:0005839 proteasome core complex 20.0% 0.00651213 
GO:0019773 proteasome core complex, alpha-subunit 
complex 
33.3% 0.00667199 
GO:0045261 proton-transporting ATP synthase complex, 
catalytic core F(1) 
66.7% 0.0100888 
GO:0000502 proteasome complex 11.9% 0.014683 
GO:0000793 condensed chromosome 50.0% 0.0173965 
GO:0048500 signal recognition particle 40.0% 0.0240587 
GO:0005875 microtubule associated complex 40.0% 0.0240587 
S5.2 Transcript Counting – WT1 GO term analysis 
 ! !
250!
!
! !
ID Term % p-value 
GO:0005694 chromosome 8.3% 0.025389 
GO:0000786 nucleosome 12.9% 0.0266911 
GO:0005743 mitochondrial inner membrane 7.8% 0.0319454 
GO:0042719 mitochondrial intermembrane space protein 
transporter complex 
33.3% 0.0321741 
GO:0043186 P granule 28.6% 0.0388386 
GO:0000276 mitochondrial proton-transporting ATP synthase 
complex, coupling factor F(o) 
28.6% 0.0388386 
GO:0005730 nucleolus 8.1% 0.046778 
Table S62: GO Term Cellular Component Analysis 
 
GO term cellular component analysis of ensembl gene IDs with the highest 
expression determined by the polyA RNA sequencing of replicate WT1 and mapping 
with Cufflinks. % gives the number of times a term was associated within the 
reference list (of 1000 Ensembl IDs) as a percentage of the number of genes 
associated with that term.  Corrected p-values were calculated using GeneCodis3 
(Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0003735 structural constituent of ribosome 61.3% 4.53E-78 
GO:0000166 nucleotide binding 6.1% 2.59E-14 
GO:0003723 RNA binding 12.9% 6.34E-13 
GO:0005529 sugar binding 19.3% 1.40E-09 
GO:0003743 translation initiation factor activity 26.5% 1.66E-09 
GO:0003676 nucleic acid binding 6.3% 1.80E-08 
GO:0003746 translation elongation factor activity 42.1% 9.28E-08 
GO:0005488 binding 6.7% 5.76E-07 
GO:0019843 rRNA binding 54.5% 1.04E-06 
GO:0005524 ATP binding 5.1% 3.83E-06 
GO:0008026 ATP-dependent helicase activity 17.8% 0.000101424 
GO:0043022 ribosome binding 100% 0.000174594 
GO:0004386 helicase activity 13.6% 0.000215464 
GO:0051082 unfolded protein binding 13.1% 0.000798101 
GO:0004129 cytochrome-c oxidase activity 36.4% 0.000896116 
GO:0005525 GTP binding 5.9% 0.00329337 
GO:0019901 protein kinase binding 17.9% 0.0038406 
GO:0046933 
hydrogen ion transporting ATP synthase activity, 
rotational mechanism 33.3% 0.0088506 
GO:0004298 threonine-type endopeptidase activity 20.0% 0.00886587 
GO:0004175 endopeptidase activity 17.4% 0.0146058 
GO:0016853 isomerase activity 10.5% 0.0147489 
GO:0008121 ubiquinol-cytochrome-c reductase activity 50.0% 0.0251749 
GO:0008565 protein transporter activity 14.3% 0.0269129 
GO:0003924 GTPase activity 7.1% 0.0282038 
GO:0015078 hydrogen ion transmembrane transporter activity 20.0% 0.031267 
GO:0008312 7S RNA binding 40.0% 0.0349834 
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ID Term % p-value 
GO:0003677 DNA binding 3.6% 0.0364797 
Table S63: GO Term Molecular Function Analysis 
 
GO term molecular function analysis of Ensembl gene IDs with the highest 
expression determined by the polyA RNA sequencing of replicate WT1 and mapping 
with Cufflinks. % gives the number of times a term was associated within the 
reference list (of 1000 Ensembl IDs) as a percentage of the number of genes 
associated with that term.  Corrected p-values were calculated using GeneCodis3 
(Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
S5.2.2 WT2 
 
ID Term % p-value 
Kegg:03010 Ribosome 80.7% 5.15E-97 
Kegg:04141 Protein processing in endoplasmic reticulum 15.2% 1.03E-11 
Kegg:03013 RNA transport 11.7% 1.59E-06 
Kegg:03060 Protein export 28.6% 4.78E-05 
Kegg:04145 Phagosome 11.0% 4.89E-05 
Kegg:00190 Oxidative phosphorylation 10.4% 5.75E-05 
Kegg:03040 Spliceosome 10.1% 7.04E-05 
Kegg:04114 Oocyte meiosis 9.9% 0.000176674 
Kegg:03008 Ribosome biogenesis in eukaryotes 12.3% 0.000469021 
Kegg:03050 Proteasome 12.2% 0.00379668 
Kegg:04110 Cell cycle 7.5% 0.00598681 
Kegg:00010 Glycolysis / Gluconeogenesis 9.7% 0.0111322 
Kegg:03015 mRNA surveillance pathway 8.7% 0.0177831 
Kegg:04520 Adherens junction 7.9% 0.0267348 
Kegg:04260 Cardiac muscle contraction 8.3% 0.0409751 
Kegg:04914 Progesterone-mediated oocyte maturation 6.9% 0.0448505 
Table S64: KEGG Pathway Analysis  
 
KEGG pathway analysis of the Ensembl gene IDs with the highest expression 
determined by the polyA sequencing of replicate WT2 and mapping with Cufflinks. 
% gives the number of times a term was associated within the reference list (of 1000 
Ensembl IDs) as a percentage of the number of genes associated with that term. 
Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 43.4% 9.20E-65 
GO:0009790 embryo development 19.4% 4.12E-12 
GO:0006414 translational elongation 42.3% 1.53E-10 
GO:0051726 regulation of cell cycle 30.0% 4.76E-07 
GO:0006950 response to stress 15.1% 0.000765968 
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ID Term % p-value 
GO:0006457 protein folding 11.2% 0.000782327 
GO:0006096 glycolysis 18.8% 0.00196493 
GO:0006413 translational initiation 14.3% 0.00245796 
GO:0015986 ATP synthesis coupled proton transport 33.3% 0.00281389 
GO:0042254 ribosome biogenesis 18.5% 0.00656661 
GO:0006407 rRNA export from nucleus 100% 0.0128731 
GO:0051597 response to methylmercury 33.3% 0.016949 
GO:0006511 ubiquitin-dependent protein catabolic process 11.3% 0.017337 
GO:0051603 proteolysis involved in cellular protein catabolic 
process 
20.0% 0.0181458 
GO:0016338 calcium-independent cell-cell adhesion 66.7% 0.0220559 
GO:0000028 ribosomal small subunit assembly 66.7% 0.0220559 
GO:0006207 'de novo' pyrimidine base biosynthetic process 66.7% 0.0220559 
GO:0007017 microtubule-based process 17.4% 0.0236979 
GO:0015031 protein transport 6.6% 0.0251038 
GO:0007049 cell cycle 7.4% 0.0286547 
GO:0044267 cellular protein metabolic process 23.1% 0.0336158 
GO:0006465 signal peptide processing 50.0% 0.03445 
GO:0000462 maturation of SSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
50.0% 0.03445 
GO:0006662 glycerol ether metabolic process 21.4% 0.0353976 
GO:0006754 ATP biosynthetic process 14.3% 0.036771 
GO:0006260 DNA replication 10.0% 0.045136 
Table S65: GO Term Biological Process Analysis 
GO term biological process analysis of ensembl gene IDs with the highest expression 
determined by the polyA RNA sequencing of replicate WT2 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, 
Nogales-Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0005840 ribosome 49.2% 1.81E-67 
GO:0030529 ribonucleoprotein complex 36.3% 1.72E-38 
GO:0005622 intracellular 8.1% 2.61E-22 
GO:0005737 cytoplasm 6.5% 2.64E-12 
GO:0005634 nucleus 5.1% 5.14E-12 
GO:0015935 small ribosomal subunit 77.8% 7.58E-10 
GO:0022627 cytosolic small ribosomal subunit 60.0% 1.81E-07 
GO:0015934 large ribosomal subunit 66.7% 2.88E-05 
GO:0005853 eukaryotic translation elongation factor 1 complex 75.0% 0.000342176 
GO:0005783 endoplasmic reticulum 7.5% 0.00106728 
GO:0005839 proteasome core complex 20.0% 0.00538298 
GO:0005743 mitochondrial inner membrane 9.1% 0.00764093 
GO:0005787 signal peptidase complex 66.7% 0.00876582 
GO:0000502 proteasome complex 11.9% 0.0104549 
S5.2 Transcript Counting – WT3 GO term analysis 
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ID Term % p-value 
GO:0005739 mitochondrion 5.9% 0.0154113 
GO:0070469 respiratory chain 21.4% 0.0160428 
GO:0005694 chromosome 8.3% 0.0191006 
GO:0005875 microtubule associated complex 40.0% 0.0205369 
GO:0042719 mitochondrial intermembrane space protein 
transporter complex 
33.3% 0.0273515 
GO:0005788 endoplasmic reticulum lumen 33.3% 0.0273515 
GO:0043186 P granule 28.6% 0.0343431 
GO:0000276 mitochondrial proton-transporting ATP synthase 
complex, coupling factor F(o) 
28.6% 0.0343431 
GO:0005730 nucleolus 8.1% 0.0347441 
Table S66: GO Term Cellular Component Analysis 
GO term cellular component analysis of ensembl gene IDs with the highest 
expression determined by the polyA RNA sequencing of replicate WT2 and mapping 
with Cufflinks. % gives the number of times a term was associated within the 
reference list (of 1000 Ensembl IDs) as a percentage of the number of genes 
associated with that term.  Corrected p-values were calculated using GeneCodis3 
(Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0003735 structural constituent of ribosome 56.6% 4.75E-71 
GO:0003723 RNA binding 11.6% 2.67E-11 
GO:0000166 nucleotide binding 5.4% 2.86E-11 
GO:0003676 nucleic acid binding 6.2% 7.10E-09 
GO:0005529 sugar binding 15.7% 5.22E-07 
GO:0019843 rRNA binding 54.5% 9.74E-07 
GO:0005524 ATP binding 5.0% 1.45E-06 
GO:0005488 binding 5.9% 1.12E-05 
GO:0003746 translation elongation factor activity 31.6% 3.32E-05 
GO:0008026 ATP-dependent helicase activity 17.8% 6.22E-05 
GO:0004386 helicase activity 13.6% 0.000135004 
GO:0004129 cytochrome-c oxidase activity 36.4% 0.000827891 
GO:0003743 translation initiation factor activity 14.3% 0.000875709 
GO:0016853 isomerase activity 12.3% 0.00217471 
GO:0051082 unfolded protein binding 11.5% 0.00312252 
GO:0046933 hydrogen ion transporting ATP synthase activity, 
rotational mechanism 
33.3% 0.00708686 
GO:0016787 hydrolase activity 4.1% 0.00738405 
GO:0004298 threonine-type endopeptidase activity 20.0% 0.00741564 
GO:0004748 ribonucleoside-diphosphate reductase activity 66.7% 0.0115531 
GO:0004175 endopeptidase activity 17.4% 0.0115535 
GO:0046872 metal ion binding 3.5% 0.0120852 
GO:0031490 chromatin DNA binding 50.0% 0.0208119 
GO:0008565 protein transporter activity 14.3% 0.0212885 
GO:0015078 hydrogen ion transmembrane transporter activity 20.0% 0.0252316 
GO:0046914 transition metal ion binding 20.0% 0.0252316 
S5.2 Transcript Counting – WT2 GO term analysis 
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ID Term % p-value 
GO:0016491 oxidoreductase activity 4.3% 0.0281102 
GO:0003684 damaged DNA binding 15.8% 0.046837 
Table S67: GO Term Molecular Function Analysis 
GO term molecular function analysis of Ensembl gene IDs with the highest 
expression determined by the polyA RNA sequencing of replicate WT2 and mapping 
with Cufflinks. % gives the number of times a term was associated within the 
reference list (of 1000 Ensembl IDs) as a percentage of the number of genes 
associated with that term.  Corrected p-values were calculated using GeneCodis3 
(Tabas-Madrid, Nogales-Cadenas et al. 2012) 
S5.2.3 WT3 
 
ID Term % p-value 
Kegg:03010 Ribosome 90.4% 4.92E-115 
Kegg:04141 Protein processing in endoplasmic reticulum 15.9% 3.69E-12 
Kegg:03013 RNA transport 12.5% 5.12E-07 
Kegg:04145 Phagosome 12.8% 2.10E-06 
Kegg:00190 Oxidative phosphorylation 12.2% 3.32E-06 
Kegg:03060 Protein export 28.6% 5.70E-05 
Kegg:04110 Cell cycle 10.0% 0.000139548 
Kegg:03040 Spliceosome 9.2% 0.00058418 
Kegg:03015 mRNA surveillance pathway 11.6% 0.00110498 
Kegg:04260 Cardiac muscle contraction 11.7% 0.00254525 
Kegg:04114 Oocyte meiosis 7.2% 0.0199346 
Kegg:03008 Ribosome biogenesis in eukaryotes 9.2% 0.0212413 
Kegg:03018 RNA degradation 8.8% 0.0225633 
Kegg:03050 Proteasome 10.2% 0.0242035 
Kegg:04520 Adherens junction 7.9% 0.0338267 
Kegg:04530 Tight junction 6.1% 0.0404257 
Table S68: KEGG Pathway Analysis  
KEGG pathway analysis of the Ensembl gene IDs with the highest expression 
determined by the polyA sequencing of replicate WT3 and mapping with Cufflinks. 
% gives the number of times a term was associated within the reference list (of 1000 
Ensembl IDs) as a percentage of the number of genes associated with that term. 
Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, Nogales-
Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0006412 translation 47.6% 6.11E-73 
GO:0006414 translational elongation 53.8% 5.10E-15 
GO:0009790 embryo development 20.4% 6.35E-13 
GO:0051726 regulation of cell cycle 40.0% 4.54E-11 
GO:0006457 protein folding 19.1% 4.51E-10 
GO:0044267 cellular protein metabolic process 46.2% 8.11E-06 
GO:0006413 translational initiation 18.4% 4.25E-05 
S5.2 Transcript Counting – WT3 GO term analysis 
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ID Term % p-value 
GO:0042254 ribosome biogenesis 22.2% 0.000811079 
GO:0015031 protein transport 7.9% 0.00368486 
GO:0006950 response to stress 13.2% 0.00408276 
GO:0007017 microtubule-based process 21.7% 0.00408605 
GO:0006396 RNA processing 15.0% 0.00510293 
GO:0051301 cell division 10.8% 0.00527856 
GO:0042274 ribosomal small subunit biogenesis 100% 0.00764428 
GO:0000447 endonucleolytic cleavage in ITS1 to separate 
SSU-rRNA from 5.8S rRNA and LSU-rRNA from 
tricistronic rRNA transcript (SSU-rRNA, 5.8S 
rRNA, LSU-rRNA) 
100% 0.00764428 
GO:0000461 endonucleolytic cleavage to generate mature 3'-
end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, 
LSU-rRNA) 
100% 0.00764428 
GO:0045905 positive regulation of translational termination 100% 0.00764428 
GO:0006452 translational frameshifting 100% 0.00764428 
GO:0045901 positive regulation of translational elongation 100% 0.00764428 
GO:0006407 rRNA export from nucleus 100% 0.00764428 
GO:0006096 glycolysis 15.6% 0.00852446 
GO:0007049 cell cycle 8.3% 0.00876089 
GO:0051597 response to methylmercury 33.3% 0.0108839 
GO:0006397 mRNA processing 9.9% 0.0115672 
GO:0055114 oxidation-reduction process 4.6% 0.0125036 
GO:0006511 ubiquitin-dependent protein catabolic process 11.3% 0.0125294 
GO:0006334 nucleosome assembly 13.9% 0.0125796 
GO:0016338 calcium-independent cell-cell adhesion 66.7% 0.0155893 
GO:0000028 ribosomal small subunit assembly 66.7% 0.0155893 
GO:0022900 electron transport chain 16.7% 0.0176984 
GO:0015986 ATP synthesis coupled proton transport 25.0% 0.0201523 
GO:0007067 mitosis 11.1% 0.0265967 
GO:0008612 peptidyl-lysine modification to hypusine 50.0% 0.0270077 
GO:0000462 maturation of SSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
50.0% 0.0270077 
GO:0006754 ATP biosynthetic process 14.3% 0.0273082 
GO:0006614 SRP-dependent cotranslational protein targeting 
to membrane 
40.0% 0.0395738 
GO:0006260 DNA replication 10.0% 0.0398962 
Table S69: GO Term Biological Process Analysis 
GO term biological process analysis of ensembl gene IDs with the highest expression 
determined by the polyA RNA sequencing of replicate WT3 and mapping with 
Cufflinks. % gives the number of times a term was associated within the reference list 
(of 1000 Ensembl IDs) as a percentage of the number of genes associated with that 
term.  Corrected p-values were calculated using GeneCodis3 (Tabas-Madrid, 
Nogales-Cadenas et al. 2012). 
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ID Term % p-value 
GO:0005840 ribosome 55.6% 7.04E-80 
GO:0030529 ribonucleoprotein complex 39.8% 2.10E-43 
GO:0005622 intracellular 9.1% 6.08E-27 
GO:0005737 cytoplasm 6.7% 6.76E-12 
GO:0022627 cytosolic small ribosomal subunit 80.0% 3.51E-11 
GO:0015935 small ribosomal subunit 77.8% 1.10E-09 
GO:0005634 nucleus 4.5% 8.66E-08 
GO:0005853 eukaryotic translation elongation factor 1 complex 100% 2.43E-06 
GO:0015934 large ribosomal subunit 66.7% 3.13E-05 
GO:0005783 endoplasmic reticulum 8.8% 9.46E-05 
GO:0070469 respiratory chain 28.6% 0.00148773 
GO:0043186 P granule 42.9% 0.0024755 
GO:0030686 90S preribosome 100% 0.00324303 
GO:0005694 chromosome 9.7% 0.00594622 
GO:0048500 signal recognition particle 40.0% 0.0224318 
GO:0005875 microtubule associated complex 40.0% 0.0224318 
GO:0005739 mitochondrion 5.9% 0.0239029 
GO:0000786 nucleosome 12.9% 0.0240587 
GO:0005743 mitochondrial inner membrane 7.8% 0.0304553 
GO:0000276 mitochondrial proton-transporting ATP synthase 
complex, coupling factor F(o) 
28.6% 0.0392364 
GO:0005839 proteasome core complex 15.0% 0.0392731 
GO:0005730 nucleolus 8.1% 0.0445755 
GO:0000502 proteasome complex 9.5% 0.0494543 
GO:0005874 microtubule 7.7% 0.0495033 
Table S70: GO Term Cellular Component Analysis 
GO term cellular component analysis of ensembl gene IDs with the highest 
expression determined by the polyA RNA sequencing of replicate WT3 and mapping 
with Cufflinks. % gives the number of times a term was associated within the 
reference list (of 1000 Ensembl IDs) as a percentage of the number of genes 
associated with that term.  Corrected p-values were calculated using GeneCodis3 
(Tabas-Madrid, Nogales-Cadenas et al. 2012). 
 
ID Term % p-value 
GO:0003735 structural constituent of ribosome 62.3% 9.77E-81 
GO:0000166 nucleotide binding 6.2% 1.79E-15 
GO:0003723 RNA binding 12.9% 3.14E-13 
GO:0003746 translation elongation factor activity 47.4% 3.41E-09 
GO:0051082 unfolded protein binding 21.3% 1.85E-08 
GO:0005488 binding 6.9% 1.15E-07 
GO:0005529 sugar binding 15.7% 6.88E-07 
GO:0019843 rRNA binding 54.5% 9.73E-07 
GO:0005524 ATP binding 5.1% 2.00E-06 
GO:0003743 translation initiation factor activity 18.4% 1.70E-05 
GO:0003676 nucleic acid binding 4.9% 0.000163242 
S5.2 Transcript Counting – WT3 GO term analysis 
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ID Term % p-value 
GO:0008026 ATP-dependent helicase activity 15.6% 0.000732296 
GO:0004129 cytochrome-c oxidase activity 36.4% 0.000907531 
GO:0016853 isomerase activity 12.3% 0.00292568 
GO:0004386 helicase activity 10.6% 0.0068082 
GO:0005525 GTP binding 5.5% 0.00701537 
GO:0003924 GTPase activity 8.0% 0.00807208 
GO:0043022 ribosome binding 66.7% 0.0143847 
GO:0016491 oxidoreductase activity 4.5% 0.0254159 
GO:0031490 chromatin DNA binding 50.0% 0.0255223 
GO:0008121 ubiquinol-cytochrome-c reductase activity 50.0% 0.0255223 
GO:0015078 hydrogen ion transmembrane transporter activity 20.0% 0.0320555 
GO:0008312 7S RNA binding 40.0% 0.0364611 
Table S71: GO Term Molecular Function Analysis 
GO term molecular function analysis of Ensembl gene IDs with the highest 
expression determined by the polyA RNA sequencing of replicate WT3 and mapping 
with Cufflinks. % gives the number of times a term was associated within the 
reference list (of 1000 Ensembl IDs) as a percentage of the number of genes 
associated with that term.  Corrected p-values were calculated using GeneCodis3 
(Tabas-Madrid, Nogales-Cadenas et al. 2012) 
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